WorldWideScience

Sample records for treatment technologiespopulation level

  1. Comparison of six sewage effluents treated with different treatment technologies-Population level responses in the harpacticoid copepod Nitocra spinipes

    International Nuclear Information System (INIS)

    Lundstroem, Elin; Bjoerlenius, Berndt; Brinkmann, Markus; Hollert, Henner; Persson, Jan-Olov; Breitholtz, Magnus

    2010-01-01

    Since conventional treatment technologies may fail in removing many micro-pollutants, there is currently a focus on the potential of additional treatment technologies for improved sewage treatment. The aim of the present study was to evaluate six different effluents from Henriksdal Sewage Treatment Plant in Stockholm, Sweden. The effluents were; conventionally treated effluent (chemical phosphorous removal in combination with an activated sludge process, including biological nitrogen removal and a sand filter), with additional treatments individually added to the conventional treatment; active carbon filtration, ozonation at 5 mg l -1 , ozonation at 15 mg l -1 , ozonation at 5 mg l -1 + moving bed biofilm reactor and irradiation with ultraviolet radiation + hydrogen peroxide. The evaluation was done by characterizing and comparing the effluents using a Lefkovitch matrix model based on a life cycle test with the harpacticoid copepod Nitocra spinipes, combined with analysis of juvenile development and survival over time. The conventionally treated effluent resulted in the most negative effects, leading to the conclusion that all additional treatments in the present study created effluents with less negative impacts on the copepod populations. The ozone treatments with the low dose treatment in particular, resulted in the overall least negative effects. Moving bed biofilm reactor combined with ozone did not improve the quality of the effluent in the sense that slightly more negative effects on the population abundance were seen for this treatment technology compared to ozonation alone. The active carbon treatment had more negative effects than the ozone treatments, most of which could possibly be explained by removal of essential metal ions. The effluent which was treated with ultraviolet radiation + hydrogen peroxide resulted in few developmental and survival effects over time, but still showed negative effects on the population level. Matrix population modeling

  2. Comparison of six sewage effluents treated with different treatment technologies-Population level responses in the harpacticoid copepod Nitocra spinipes

    Energy Technology Data Exchange (ETDEWEB)

    Lundstroem, Elin, E-mail: elin.lundstrom@itm.su.se [Stockholm University, Department of Applied Environmental Science (ITM), S-106 91 Stockholm (Sweden); Bjoerlenius, Berndt [Stockholm Water Company, S-106 36 Stockholm (Sweden); Brinkmann, Markus; Hollert, Henner [RWTH Aachen University, Institute for Environmental Research, Department of Ecosystem Analysis, D-520 74 Aachen (Germany); Persson, Jan-Olov [Stockholm University, Department of Mathematics, S-106 91 Stockholm (Sweden); Breitholtz, Magnus [Stockholm University, Department of Applied Environmental Science (ITM), S-106 91 Stockholm (Sweden)

    2010-03-01

    Since conventional treatment technologies may fail in removing many micro-pollutants, there is currently a focus on the potential of additional treatment technologies for improved sewage treatment. The aim of the present study was to evaluate six different effluents from Henriksdal Sewage Treatment Plant in Stockholm, Sweden. The effluents were; conventionally treated effluent (chemical phosphorous removal in combination with an activated sludge process, including biological nitrogen removal and a sand filter), with additional treatments individually added to the conventional treatment; active carbon filtration, ozonation at 5 mg l{sup -1}, ozonation at 15 mg l{sup -1}, ozonation at 5 mg l{sup -1} + moving bed biofilm reactor and irradiation with ultraviolet radiation + hydrogen peroxide. The evaluation was done by characterizing and comparing the effluents using a Lefkovitch matrix model based on a life cycle test with the harpacticoid copepod Nitocra spinipes, combined with analysis of juvenile development and survival over time. The conventionally treated effluent resulted in the most negative effects, leading to the conclusion that all additional treatments in the present study created effluents with less negative impacts on the copepod populations. The ozone treatments with the low dose treatment in particular, resulted in the overall least negative effects. Moving bed biofilm reactor combined with ozone did not improve the quality of the effluent in the sense that slightly more negative effects on the population abundance were seen for this treatment technology compared to ozonation alone. The active carbon treatment had more negative effects than the ozone treatments, most of which could possibly be explained by removal of essential metal ions. The effluent which was treated with ultraviolet radiation + hydrogen peroxide resulted in few developmental and survival effects over time, but still showed negative effects on the population level. Matrix population

  3. Comparison of six sewage effluents treated with different treatment technologies--population level responses in the harpacticoid copepod Nitocra spinipes.

    Science.gov (United States)

    Lundström, Elin; Björlenius, Berndt; Brinkmann, Markus; Hollert, Henner; Persson, Jan-Olov; Breitholtz, Magnus

    2010-03-01

    Since conventional treatment technologies may fail in removing many micro-pollutants, there is currently a focus on the potential of additional treatment technologies for improved sewage treatment. The aim of the present study was to evaluate six different effluents from Henriksdal Sewage Treatment Plant in Stockholm, Sweden. The effluents were; conventionally treated effluent (chemical phosphorous removal in combination with an activated sludge process, including biological nitrogen removal and a sand filter), with additional treatments individually added to the conventional treatment; active carbon filtration, ozonation at 5 mg l(-1), ozonation at 15 mg l(-1), ozonation at 5 mg l(-1)+moving bed biofilm reactor and irradiation with ultraviolet radiation+hydrogen peroxide. The evaluation was done by characterizing and comparing the effluents using a Lefkovitch matrix model based on a life cycle test with the harpacticoid copepod Nitocra spinipes, combined with analysis of juvenile development and survival over time. The conventionally treated effluent resulted in the most negative effects, leading to the conclusion that all additional treatments in the present study created effluents with less negative impacts on the copepod populations. The ozone treatments with the low dose treatment in particular, resulted in the overall least negative effects. Moving bed biofilm reactor combined with ozone did not improve the quality of the effluent in the sense that slightly more negative effects on the population abundance were seen for this treatment technology compared to ozonation alone. The active carbon treatment had more negative effects than the ozone treatments, most of which could possibly be explained by removal of essential metal ions. The effluent which was treated with ultraviolet radiation+hydrogen peroxide resulted in few developmental and survival effects over time, but still showed negative effects on the population level. Matrix population modeling proved a

  4. Low-level-waste-treatment handbook

    International Nuclear Information System (INIS)

    Clinton, S.D.; Goeller, H.E.; Holladay, D.W.; Donaldson, T.L.

    1982-01-01

    The initial draft of the Low-Level Waste Treatment Handbook has been prepared and submitted to the DOE Low-Level Waste Management Program for review and comment. A revised draft is scheduled to be delivered to DOE Headquarters in December 1982. The Handbook is designed to be useful to all individuals and groups concerned with low-level wastes. It is one of several volumes that will ultimately comprise a Low-Level Waste Technology Handbook. The objective of the Low-Level Waste Treatment Handbook is to present an overview of current practices related to the segregation, classification, volume reduction, solidification, handling, packaging, and transportation of LLW for disposal in a shallow land burial facility. The Handbook is intended to serve as a guide to individuals interested in the treatment and handling of low-level radioactive waste. The Handbook will not explicitly tell the user how to design and operate LLW treatment facilities, but rather will identify (1) kinds of information required to evaluate the options, (2) methods that may be used to evaluate these options, and (3) limitations associated with the selection of the treatment options. The focus of the Handbook is providing guidance on how to do waste treatment for disposal by shallow land burial

  5. Hormone levels in radiotherapy treatment related fatigue

    International Nuclear Information System (INIS)

    Biswal, B.M.; Mallik, G.S.

    2003-01-01

    Radiotherapy is known to cause debilitating treatment related fatigue. Fatigue in general is a conglomeration of psychological, physical, hematological and unknown factors influencing the internal milieu of the cancer patient. Radiotherapy can add stress at the cellular and somatic level to aggravate further fatigue in cancer patients undergoing radiotherapy. Stress related hormones might be mediating in the development of fatigue. This is an ongoing prospective study to evaluate if the hormonal profile related to stress is influenced by radiotherapy treatment related fatigue. The study was conducted from September 2002 onwards in the division of Radiotherapy and Oncology of our Medical School. Previously untreated patients with histopathology proof of malignancy requiring external beam radiotherapy were considered for this study. Selection criteria were applied to exclude other causes of fatigue. Initial fatigue score was obtained using Pipers Fatigue Score questionnaire containing 23 questions, subsequently final fatigue score was obtained at the end of radiotherapy. Blood samples were obtained to estimate the levels of ACTH, TSH, HGH, and cortisol on the final assessment. The hormone levels were compared with resultant post radiotherapy fatigue score. At the time of reporting 50 patients were evaluable for the study. The total significant fatigue score was observed among 12 (24%) patients. The individual debilitating fatigue score were behavioral severity 14 (28%), affective meaning 14(28%), Sensory 13 (26%) and cognitive mood 10 (20%) respectively. From the analysis of hormonal profile, growth hormone level > 1 ng/mL and TSH <0.03 appears to be associated with high fatigue score (though statistically not significant); whereas there was no correlation with ACTH and serum cortisol level. In our prospective study severe radiotherapy treatment related fatigue was found among our patient population. Low levels of TSH and high levels of GH appear to be associated

  6. Treatment of low and intermediate level wastes

    International Nuclear Information System (INIS)

    Hoehlein, G.

    1978-05-01

    The methods described of low and intermediate level waste treatment are based exclusively on operating experience gathered with the KfK facilities for waste management, the Karlsruhe Reprocessing Plant (WAK), the ALKEM fuel element fabrication plant, the MZFR, KNK and FR 2 reactors as well as at the Karlsruhe Nuclear Research Center and at the state collecting depot of Baden-Wuerttemberg. The processing capacities and technical status are similar to that in 1976. With an annual throughput of 10000 m 3 of solid and liquid raw wastes, an aggregate activity of 85000 Ci, 500 kg of U and 2 kg of Pu, final waste in the amount of 500 m 3 was produced which was stored in the ASSE II salt mine. (orig.) [de

  7. determining treatment levels of comorbid psychiatric conditions

    African Journals Online (AJOL)

    SITWALA COMPUTERS

    This low treatment rate may contribute to poor treatment outcomes. INTRODUCTION ... significance was set at p ≤ 0.05 for all statistical analyses. All confidence .... psychotropic effects , it is strongly associated with birth defects when used in ...

  8. Psychotherapeutic treatment levels of personality disorders in older adults

    OpenAIRE

    Videler, Arjan; Cornelis, Christina; Rossi, G.; van Royen, R.J.J.; Rosowsky, E.; van Alphen, S.P.J.

    2015-01-01

    Treatment of personality disorders (PDs) in older adults is a highly underexplored topic. In this article clinical applicability of the findings from a recent Delphi study regarding treatment aspects of PDs in older adults is explored. This concerns the relevance of three psychotherapeutic treatment levels for PDs in later life: (a) personality-changing treatment, (b) adaptation-enhancing treatment, and (c) supportive-structuring treatment. By means of three cases concerning the three levels,...

  9. Microbiological treatment of low level radioactive waste

    International Nuclear Information System (INIS)

    Ashley, N.V.; Pugh, S.Y.R.; Banks, C.J.; Humphreys, P.N.

    1992-01-01

    This report summarises the work of an experimental programme investigating the anaerobic digestion of low-level radioactive wastes. The project focused on the selection of the optimum bioreactor design to achieve 95% removal or stabilisation of the biodegradable portion of low-level radioactive wastes. Performance data was obtained for the bioreactors and process scale-up factors for the construction of a full-scale reactor were considered. (author)

  10. Determining treatment levels of comorbid psychiatric conditions in ...

    African Journals Online (AJOL)

    Background: Psychiatric co-morbidities occur more frequently in patients with epilepsy but are usually undertreated. Treatment of these disorders is key to reducing mortality via suicide and other causes. This study determined the levels of treatment of psychiatric comorbidities at clinics in Lusaka, Zambia. Methodology: This ...

  11. Low-level radioactive wastes: Their treatment, handling, disposal

    Energy Technology Data Exchange (ETDEWEB)

    Straub, Conrad P [Robert A. Taft Sanitary Engineering Center, Radiological Health Research Activities, Cincinnati, OH(United States)

    1964-07-01

    The release of low level wastes may result in some radiation exposure to man and his surroundings. This book describes techniques of handling, treatment, and disposal of low-level wastes aimed at keeping radiation exposure to a practicable minimum. In this context, wastes are considered low level if they are released into the environment without subsequent control. This book is concerned with practices relating only to continuous operations and not to accidental releases of radioactive materials. It is written by use for those interested in low level waste disposal problems and particularly for the health physicist concerned with these problems in the field. It should be helpful also to water and sewage works personnel concerned with the efficiency of water and sewage treatment processes for the removal of radioactive materials; the personnel engaged in design, construction, licensing, and operation of treatment facilities; and to student of nuclear technology. After an introduction the following areas are discussed: sources, quantities and composition of radioactive wastes; collection, sampling and measurement; direct discharge to the water, soil and air environment; air cleaning; removal of radioactivity by water-treatment processes and biological processes; treatment on site by chemical precipitation , ion exchange and absorption, electrodialysis, solvent extraction and other methods; treatment on site including evaporation and storage; handling and treatment of solid wastes; public health implications. Appendices include a glossary; standards for protection against radiation; federal radiation council radiation protection guidance for federal agencies; site selection criteria for nuclear energy facilities.

  12. Mixed and Low-Level Waste Treatment Facility project

    International Nuclear Information System (INIS)

    1992-04-01

    Mixed and low-level wastes generated at the Idaho National Engineering Laboratory (INEL) are required to be managed according to applicable State and Federal regulations, and Department of Energy Orders that provide for the protection of human health and the environment. The Mixed and Low-Level Waste Treatment Facility Project was chartered in 1991, by the Department of Energy to provide treatment capability for these mixed and low-level waste streams. The first project task consisted of conducting engineering studies to identify the waste streams, their potential treatment strategies, and the requirements that would be imposed on the waste streams and the facilities used to process them. The engineering studies, initiated in July 1991, identified 37 mixed waste streams, and 55 low-level waste streams. This report documents the waste stream information and potential treatment strategies, as well as the regulatory requirements for the Department of Energy-owned treatment facility option. The total report comprises three volumes and two appendices. This report consists of Volume 1, which explains the overall program mission, the guiding assumptions for the engineering studies, and summarizes the waste stream and regulatory information, and Volume 2, the Waste Stream Technical Summary which, encompasses the studies conducted to identify the INEL's waste streams and their potential treatment strategies

  13. Mixed and Low-Level Treatment Facility Project

    International Nuclear Information System (INIS)

    1992-04-01

    This appendix contains the mixed and low-level waste engineering design files (EDFS) documenting each low-level and mixed waste stream investigated during preengineering studies for Mixed and Low-Level Waste Treatment Facility Project. The EDFs provide background information on mixed and low-level waste generated at the Idaho National Engineering Laboratory. They identify, characterize, and provide treatment strategies for the waste streams. Mixed waste is waste containing both radioactive and hazardous components as defined by the Atomic Energy Act and the Resource Conservation and Recovery Act, respectively. Low-level waste is waste that contains radioactivity and is not classified as high-level waste, transuranic waste, spent nuclear fuel, or 11e(2) byproduct material as defined by DOE 5820.2A. Test specimens of fissionable material irradiated for research and development only, and not for the production of power or plutonium, may be classified as low-level waste, provided the concentration of transuranic is less than 100 nCi/g. This appendix is a tool that clarifies presentation format for the EDFS. The EDFs contain waste stream characterization data and potential treatment strategies that will facilitate system tradeoff studies and conceptual design development. A total of 43 mixed waste and 55 low-level waste EDFs are provided

  14. Mixed and Low-Level Treatment Facility Project

    Energy Technology Data Exchange (ETDEWEB)

    1992-04-01

    This appendix contains the mixed and low-level waste engineering design files (EDFS) documenting each low-level and mixed waste stream investigated during preengineering studies for Mixed and Low-Level Waste Treatment Facility Project. The EDFs provide background information on mixed and low-level waste generated at the Idaho National Engineering Laboratory. They identify, characterize, and provide treatment strategies for the waste streams. Mixed waste is waste containing both radioactive and hazardous components as defined by the Atomic Energy Act and the Resource Conservation and Recovery Act, respectively. Low-level waste is waste that contains radioactivity and is not classified as high-level waste, transuranic waste, spent nuclear fuel, or 11e(2) byproduct material as defined by DOE 5820.2A. Test specimens of fissionable material irradiated for research and development only, and not for the production of power or plutonium, may be classified as low-level waste, provided the concentration of transuranic is less than 100 nCi/g. This appendix is a tool that clarifies presentation format for the EDFS. The EDFs contain waste stream characterization data and potential treatment strategies that will facilitate system tradeoff studies and conceptual design development. A total of 43 mixed waste and 55 low-level waste EDFs are provided.

  15. Low-level radioactive waste treatment systems in northern Europe

    International Nuclear Information System (INIS)

    Sjoeblom, R.

    1987-08-01

    In the United States, the use of low-level waste (LLW) treatment systems by low level waste generators can be expected to expand with increasing costs for disposal and continuing uncertainty over the availability of disposal space. This development increases the need for performance information and operational data and has prompted the US Department of Energy to commission several compilations of LLW systems experience. The present paper summarizes some of the know-how from Northern Europe where the incentive for LLW treatment and volume reduction is very high since deposition space has not been available for many years. 65 refs., 10 figs., 4 tabs

  16. The French centralized low level radwaste treatment centre named CENTRACO

    International Nuclear Information System (INIS)

    Barnes, C.; Sixou, Y.

    1996-01-01

    Socodei, a subsidiary company of EdF and Cogema is commissioned to design, finance, build and operate two low level radwaste treatment facilities: a contaminated scrap metal melting unit, and a solid and liquid waste incinerator. These units frame a low level radwaste treatment centre named Centraco, located near Marcoule in the south of France, and will receive in 1998 waste coming from dismantling, maintenance and operating works of French and foreign nuclear sites. The decision to create this centre is due to the low density and large variety of low level radwaste which take a volume out of proportion with their activity, specially in the surface storage centre. Up to now, all low level radwaste were sent and stored with no treatment optimization in surface storage centres. Socodei proposes in one single site, to optimize low level radwaste management and reduce the volume of ultimate waste to be stored: in a ratio of one to ten by casting ingots coming from melting contaminated scrap metals; in a ratio of one to twenty by encapsulating earth ashes and ashes resulting from incineration of solid and liquid waste. This is a centralized treatment centre and that's why Centraco is a new waste management system. Getting together all means in one place reduces costs, avoids mismanagement and risk increase, and allows consistency in safety, environmental impact, transport and personnel radioprotection. (author)

  17. Treatment and immobilization of intermediate-level radioactive wastes

    International Nuclear Information System (INIS)

    Lerch, R.E.; Greenhalgh, W.O.; Partridge, J.A.; Richardson, G.L.

    1979-01-01

    A new program underway at the Hanford Engineering Development Laboratory (HEDL) to develop and demonstrate treatment and immobilization technologies for intermediate-level wastes (ILW) generated in the nuclear fuel cycle is discussed. ILW are defined as those liquid and solid radioactive wastes, other than high-level wastes and fuel cladding hulls, that in packaged form have radiation dose readings greater than 200 millirem/hr at the packaged surface and 10 millirem/hr at three feet from the surface. The IAEA value of 10 4 Ci/m 3 for ILW defines the upper limit. For comparative purposes, reference is also made to certain aspects of low-level radioactive wastes (LLW). Initial work has defined the sources, quantities and types of wastes which comprise ILW. Because of the wide differences in composition (e.g., acids, salt solutions, resins and zeolites, HEPA filters, etc.) the wastes may require different treatments, particularly those wastes containing volatile contaminants. The various types of ILW have been grouped into categories amenable to similar treatment. Laboratory studies are underway to define treatment technologies for liquid ILW which contain volatile contaminants and to define immobilization parameters for the residues resulting from treatment of ILW. Immobilization agents initially being evaluated for the various residues include cement, urea-formaldehyde, and bitumen although other immobilization agents will be studied. The program also includes development of acceptable test procedures for the final immobilized products as well as development of proposed criteria for storage, transportation, and disposal of the immobilized ILW

  18. Low level radioactive liquid waste treatment at ORNL

    International Nuclear Information System (INIS)

    Robinson, R.A.; Lasher, L.C.

    1977-01-01

    A new Process Waste Treatment Plant has been constructed at ORNL. The wastes are processed through a precipitation-clarification step and then through an ion exchange step to remove the low-level activity in the waste before discharge into White Oak Creek

  19. Risk of suicide according to level of psychiatric treatment

    DEFF Research Database (Denmark)

    Hjorthøj, Carsten Rygaard; Madsen, Trine; Agerbo, Esben

    2014-01-01

    PURPOSE: Knowledge of the epidemiology of suicide is a necessary prerequisite of suicide prevention. We aimed to conduct a nationwide study investigating suicide risk in relation to level of psychiatric treatment. METHODS: Nationwide nested case-control study comparing individuals who died from...... suicide between 1996 and 2009 to age-, sex-, and year-matched controls. Psychiatric treatment in the previous year was graded as "no treatment," "medicated," "outpatient contact," "psychiatric emergency room contact," or "admitted to psychiatric hospital." RESULTS: There were 2,429 cases and 50......,323 controls. Compared with people who had not received any psychiatric treatment in the preceding year, the adjusted rate ratio (95 % confidence interval) for suicide was 5.8 (5.2-6.6) for people receiving only psychiatric medication, 8.2 (6.1-11.0) for people with at most psychiatric outpatient contact, 27...

  20. Multi-level barriers to LTBI treatment: a research note.

    Science.gov (United States)

    Hill, Linda; Blumberg, Elaine; Sipan, Carol; Schmitz, Katharine; West, Joshua; Kelley, Norma; Hovell, Melbourne

    2010-08-01

    This study describes the barriers to effective and timely LTBI treatment encountered in a research study on INH adherence in Latino adolescents. Participant study logs were reviewed, results of continuing medical education pretests for medical providers were examined, and participating medical facilities were contacted in order to construct a profile of multi-level barriers to LTBI treatment. A total of 285 TST positive Latino (96%) high school students were recruited into the trial. We encountered a lack of understanding of the gravity of tuberculosis infection among both the public and providers of health care. Parents and adolescents cited competing priorities, transportation problems and financial constraints as reasons for non-compliance. Improved education of the public and physicians is needed regarding the gravity of the disease and the value of treatment, as well as public and financial support for LTBI treatment by both the government and the medical community.

  1. Niacin treatment increases plasma homocyst(e)ine levels.

    Science.gov (United States)

    Garg, R; Malinow, M; Pettinger, M; Upson, B; Hunninghake, D

    1999-12-01

    Studies have reported high levels of plasma homocyst(e)ine as an independent risk factor for arterial occlusive disease. The Cholesterol Lowering Atherosclerosis Study reported an increase in plasma homocyst(e)ine levels in patients receiving both colestipol and niacin compared with placebo. Thus the objective of this study was to examine the effect of niacin treatment on plasma homocyst(e)ine levels. The Arterial Disease Multiple Intervention Trial, a multicenter randomized, placebo-controlled trial, examined the effect of niacin compared with placebo on homocyst(e)ine in a subset of 52 participants with peripheral arterial disease. During the screening phase, titration of niacin dose from 100 mg to 1000 mg daily resulted in a 17% increase in mean plasma homocyst(e)ine level from 13.1 +/- 4.4 micromol/L to 15.3 +/- 5.6 micromol/L (P ine levels in the niacin group and a 7% decrease in the placebo group (P =.0001). This difference remained statistically significant at the end of follow-up at 48 weeks. Niacin substantially increased plasma homocyst(e)ine levels, which could potentially reduce the expected benefits of niacin associated with lipoprotein modification. However, plasma homocyst(e)ine levels can be decreased by folic acid supplementation. Thus further studies are needed to determine whether B vitamin supplementation to patients undergoing long-term niacin treatment would be beneficial.

  2. USDOE activities in low-level radioactive waste treatment

    International Nuclear Information System (INIS)

    Vath, J.E.

    1981-01-01

    This paper describes current research, development and demonstration (R, D and D) programs sponsored by the US Department of Energy in the area of low-level radioactive waste treatment. During the twelve month period ending September 30, 1981, 14 prime US Department of Energy contractors were involved with over 40 low-level radioactive waste disposal technology projects. Three specific projects or task areas have been selected for discussion to illustrate new and evolving technologies, and application of technology developed in other waste management areas to low-level waste treatment. The areas to be discussed include a microwave plasma torch incinerator, application of waste vitrification, and decontamination of metal waste by melting

  3. Mixed and Low-Level Waste Treatment Facility Project

    International Nuclear Information System (INIS)

    1992-04-01

    Mixed and low-level wastes generated at the Idaho National Engineering Laboratory (INEL) are required to be managed according to applicable State and Federal regulations, and Department of Energy Orders that provide for the protection of human health and the environment. The Mixed and Low-Level Waste Treatment Facility Project was chartered in 1991, by the Department of Energy to provide treatment capability for these mixed and low-level waste streams. The first project task consisted of conducting engineering studies to identify the waste streams, their potential treatment strategies, and the requirements that would be imposed on the waste streams and the facilities used to process them. This report documents those studies so the project can continue with an evaluation of programmatic options, system tradeoff studies, and the conceptual design phase of the project. This report, appendix B, comprises the engineering design files for this project study. The engineering design files document each waste steam, its characteristics, and identified treatment strategies

  4. Overview of treatment and conditioning of low-level wastes

    International Nuclear Information System (INIS)

    Trevorrow, L.

    1986-01-01

    The consideration of alternative technologies in low-level waste management is assumed to be partly a response to current demands for lower risk in waste disposal. One of the determinants of risk in waste disposal is the set of characteristics of the materials placed into disposal cells, i.e., the products of treatment and conditioning operations. The treatment and conditioning operations that have been applied to waste streams are briefly examined. Three operations are the most important determinants of the stability that will contribute to reducing risk at the disposal cell: compaction, high-integrity containers, and solidification. The status of these three operations is reviewed

  5. Treatment of low- and intermediate-level liquid radioactive wastes

    International Nuclear Information System (INIS)

    1984-01-01

    This report aims at giving the reader details of the experience gained in the treatment of both low- and intermediate-level radioactive liquid wastes. The treatment comprises those operations to remove radioactivity from the wastes and those that change only its chemical composition, so as to permit its discharge. Considerable experience has been accumulated in the satisfactory treatment of such wastes. Although there are no universally accepted definitions for low- and intermediate-level liquid radioactive wastes, the IAEA classification (see section 3.2) is used in this report. The two categories differ from one another in the fact that for low-level liquids the actual radiation does not require shielding during normal handling of the wastes. Liquid wastes which are not considered in this report are those from mining and milling operations and the high-level liquid wastes resulting from fuel reprocessing. These are referred to in separate IAEA reports. Likewise, wastes from decommissioning operations are not within the scope of this report. Apart from the description of existing methods and facilities, this report is intended to provide advice to the reader for the selection of appropriate solutions to waste management problems. In addition, new and promising techniques which are either being investigated or being considered for the future are discussed

  6. Mixed and low-level waste treatment facility project

    Energy Technology Data Exchange (ETDEWEB)

    1992-04-01

    The technology information provided in this report is only the first step toward the identification and selection of process systems that may be recommended for a proposed mixed and low-level waste treatment facility. More specific information on each technology will be required to conduct the system and equipment tradeoff studies that will follow these preengineering studies. For example, capacity, maintainability, reliability, cost, applicability to specific waste streams, and technology availability must be further defined. This report does not currently contain all needed information; however, all major technologies considered to be potentially applicable to the treatment of mixed and low-level waste are identified and described herein. Future reports will seek to improve the depth of information on technologies.

  7. Mixed and low-level waste treatment facility project

    International Nuclear Information System (INIS)

    1992-04-01

    The technology information provided in this report is only the first step toward the identification and selection of process systems that may be recommended for a proposed mixed and low-level waste treatment facility. More specific information on each technology will be required to conduct the system and equipment tradeoff studies that will follow these preengineering studies. For example, capacity, maintainability, reliability, cost, applicability to specific waste streams, and technology availability must be further defined. This report does not currently contain all needed information; however, all major technologies considered to be potentially applicable to the treatment of mixed and low-level waste are identified and described herein. Future reports will seek to improve the depth of information on technologies

  8. Treatment and immobilization of intermediate level radioactive wastes

    International Nuclear Information System (INIS)

    Lerch, R.E.; Greenhalgh, W.O.; Partridge, J.A.; Richardson, G.L.

    1977-01-01

    This paper discusses a new program underway to develop and demonstrate treatment and immobilization technologies for intermediate level wastes (ILW) generated in the nuclear fuel cycle. Initial work has defined the sources, quantities and types of wastes which comprise ILW. Laboratory studies are underway to define treatment technologies for liquid ILW which contains volatile contaminants and to define immobilization parameters for the residues resulting from treatment of ILW. Immobilization agents initially being evaluated for the various residues include cement, urea-formaldehyde, and bitumen although other immobilization agents will be studied. The program also includes development of acceptable test procedures for the final immobilized products as well as development of proposed criteria for storage, transportation, and disposal of the immobilized ILW. 20 figures, 10 tables

  9. Mixed and Low-Level Waste Treatment Facility project

    International Nuclear Information System (INIS)

    1992-04-01

    Mixed and low-level wastes generated at the Idaho National Engineering Laboratory (INEL) are required to be managed according to applicable State and Federal regulations, and Department of Energy Orders that provide for the protection of human health and the environment. The Mixed and Low-Level Waste Treatment Facility Project was chartered in 1991, by the Department of Energy to provide treatment capability for these mixed and low-level waste streams. The first project task consisted of conducting engineering studies to identify the waste streams, their potential treatment strategies, and the requirements that would be imposed on the waste streams and the facilities used to process them. This report, Appendix A, Environmental ampersand Regulatory Planning ampersand Documentation, identifies the regulatory requirements that would be imposed on the operation or construction of a facility designed to process the INEL's waste streams. These requirements are contained in five reports that discuss the following topics: (1) an environmental compliance plan and schedule, (2) National Environmental Policy Act requirements, (3) preliminary siting requirements, (4) regulatory justification for the project, and (5) health and safety criteria

  10. The Dose That Works: Low Level Laser Treatment of Tendinopathy

    International Nuclear Information System (INIS)

    Tumilty, Steve; Munn, Joanne; David Baxter, G.; McDonough, Suzanne; Hurley, Deirdre A.; Basford, Jeffrey R.

    2010-01-01

    Background: Low Level Laser Therapy (LLLT) is used in the treatment of tendon injuries. However, the clinical effectiveness of this modality remains controversial with limited agreement on the most efficacious dosage and parameter choices. Purpose: To assess the clinical effectiveness of LLLT in the treatment of tendinopathy and the validity of current dosage recommendations for treatment. Method: Medical databases were searched from inception to 1st August 2008. Controlled clinical trials evaluating LLLT as a primary intervention for any tendinopathy were included in the review. Methodological quality was classified using the PEDro scale. Appropriateness of treatment parameters were assessed using established guidelines. Results: Twenty five trials met the inclusion criteria. There was conflicting findings from multiple trials: 12 showed positive effects and 13 were inconclusive or showed no effect. Dosages used in the 12 positive studies support the existence of an effective dosage window that closely resembled current guidelines. Where pooling of data was possible, LLLT showed a positive effect size; in high quality studies of lateral epicondylitis, participants' grip strength was 9.59 Kg higher than the control group; for participants with Achilles tendinopathy, the effect was 13.6 mm less pain on a 100 mm visual analogue scale. Conclusion: This study found conflicting evidence as to the effectiveness of LLLT in the treatment of tendinopathy. However, an effective dosage window emerged showing benefit in the treatment of tendinopathy. Strong evidence exists from the 12 positive studies that positive outcomes are associated with the use of current dosage recommendations for the treatment of tendinopathy.

  11. The Dose That Works: Low Level Laser Treatment of Tendinopathy

    Science.gov (United States)

    Tumilty, Steve; Munn, Joanne; McDonough, Suzanne; Hurley, Deirdre A.; Basford, Jeffrey R.; David Baxter, G.

    2010-05-01

    Background: Low Level Laser Therapy (LLLT) is used in the treatment of tendon injuries. However, the clinical effectiveness of this modality remains controversial with limited agreement on the most efficacious dosage and parameter choices. Purpose: To assess the clinical effectiveness of LLLT in the treatment of tendinopathy and the validity of current dosage recommendations for treatment. Method: Medical databases were searched from inception to 1st August 2008. Controlled clinical trials evaluating LLLT as a primary intervention for any tendinopathy were included in the review. Methodological quality was classified using the PEDro scale. Appropriateness of treatment parameters were assessed using established guidelines. Results: Twenty five trials met the inclusion criteria. There was conflicting findings from multiple trials: 12 showed positive effects and 13 were inconclusive or showed no effect. Dosages used in the 12 positive studies support the existence of an effective dosage window that closely resembled current guidelines. Where pooling of data was possible, LLLT showed a positive effect size; in high quality studies of lateral epicondylitis, participants' grip strength was 9.59 Kg higher than the control group; for participants with Achilles tendinopathy, the effect was 13.6 mm less pain on a 100 mm visual analogue scale. Conclusion: This study found conflicting evidence as to the effectiveness of LLLT in the treatment of tendinopathy. However, an effective dosage window emerged showing benefit in the treatment of tendinopathy. Strong evidence exists from the 12 positive studies that positive outcomes are associated with the use of current dosage recommendations for the treatment of tendinopathy.

  12. Blood hemoglobin level and treatment outcome of early breast cancer

    International Nuclear Information System (INIS)

    Henke, M.; Sindlinger, F.; Ikenberg, H.; Gerds, T.; Schumacher, M.

    2004-01-01

    Background and purpose: to determine whether the blood hemoglobin concentration correlates with the prognosis of patients with early breast cancer and, if so, whether this is restricted to treatment modality. Patients and methods: data were collected retrospectively from patients with early breast cancer (T1,2 NO-2 MO) who underwent either breast-conserving surgery followed by adjuvant radiotherapy (BCS-RT; n = 96) or a modified radical mastectomy (MRM; n = 194). The effect of preoperative blood hemoglobin level, nodal status, histological grading and hormone receptor status on disease-free survival was determined for both treatment modalities using a cox regression model and visualized by kaplan-meier plots. Results: the blood hemoglobin concentration significantly correlated with disease-free survival of patients receiving BCS-RT (relative risk [RR]: 0.67 per g/dl; p = 0.007). This was independent of other known risk factors for breast cancer patients, as determined by multivariate analysis. By contrast, the blood hemoglobin level had no prognostic significance when patients were treated with MRM. Conclusion: blood hemoglobin concentration seems to affect the prognosis of patients with early breast cancer when a treatment schedule that includes radiotherapy is applied. Reduced radiosensitivity due to diminished tumor oxygenation may be the underlying cause. Confirmative trials and studies intended to elucidate the underlying mechanism are warranted. (orig.)

  13. Treatment of ORNL liquid low-level waste

    International Nuclear Information System (INIS)

    Berry, J.B.; Brown, C.H. Jr.; Fowler, V.L.; Robinson, S.M.

    1988-01-01

    Discontinuation of the hydrofracture disposal method at Oak Ridge National Laboratory (ORNL) has caused intensive efforts to reduce liquid waste generation. Improving the treatment of slightly radioactive liquid waste, called process waste, has reduced the volume of the resulting contaminated liquid radioactive waste effluent by 66%. Proposed processing improvements could eliminate the contaminated liquid effluent and reduce solid low-level waste by an additional one-third. The improved process meets stringent discharge limits for radionuclides. Discharge limits for radionuclides are expected to be enforced at the outfall of the treatment plant to a creek; currently, limits are enforced at the reservation boundary. Plant discharge is monitored according to the National Pollutant Discharge Elimination System (NPDES) permit for ORNL. 1 ref., 4 figs., 2 tabs

  14. Treatment of groundwater contaminated with low levels of military munitions

    International Nuclear Information System (INIS)

    Bricka, R.M.; Sharp, W.

    1993-01-01

    colorless crystalline solid with about 1.3 times the explosive power of TNT. HMX is classified as a EPA Group D compound: Not Classified as to Human Carcinogenicity (McLellan et. al. 1988b). Objective of Investigation The objective of this investigation was to determine the feasibility of using granular activated carbon (GAC) and UV/Oxidation (UV/OX) to remove low levels of RDX from a drinking water source. The target treatment level in this investigation was to reduce RDX to less than 1 ppb in the treated water. Historical Treatment of HMX and RDX Until recently, the main concern for the treatment of HMX and RDX was associated with solid waste or wastewater from processing and manufacturing facilities. GAC is the primary treatment used for these wastes and has been known to be effective in removing HMX and RDX to limits which permit discharge. One recently conducted isotherm study by Hinshaw (Hinshaw et. al. 1987), investigated the treatment of synthetic and actual ''pink water'' (wastewater containing explosive) at HMX and RDX concentration levels around 5 ppm and 20 ppm, respectively

  15. Treatment of low-level radioactive waste using Volcanic ash

    International Nuclear Information System (INIS)

    Valdezco, E.M.; Marcelo, E.A.; Junio, J.B.; Caseria, E.S.; Salom, D.S.; Alamares, A.L.

    1997-01-01

    The effective application of volcanic ash, an indigenous adsorptive material abundant in the Mt. Pinatubo area, in the removal of radioiodine from radioactive waste streams was demonstrated. Factors such as availability, low cost and comparative retention capacity with respect to activated charcoal make volcanic ash an attractive alternative in the conditioning of radioactive waste containing radioiodine. Chemical precipitation was employed in the treatment of low level aqueous waste containing 137 Cs. It was shown that there exists an optimum concentration of ferric ion that promotes maximum precipitation of caesium. It was further demonstrated that complete removal of caesium can be achieved with the addition of nickel hexacyanoferrate. (author). 5 refs, 3 figs

  16. Design of safeguards information treatment system at the facility level

    Energy Technology Data Exchange (ETDEWEB)

    Song, Dae Yong; Lee, Byung Doo; Kwack, Eun Ho; Choi, Young Myong

    2001-05-01

    We are developing Safeguards Information Treatment System at the facility level(SITS) to manage synthetically safeguards information and to implement efficiently the obligations under the Korea-IAEA Safeguards Agreement, bilateral agreements with other countries and domestic law. In this report, we described the contents of the detailed design of SITS such as database, I/O layout and program. In the present, we are implementing the SITS based on the contents of the design of SITS, and then we plan to provide the system for the facilities after we finish implementing and testing the system.

  17. Treatment of low-level radioactive waste using Volcanic ash

    Energy Technology Data Exchange (ETDEWEB)

    Valdezco, E M; Marcelo, E A; Junio, J B; Caseria, E S; Salom, D S; Alamares, A L [Philippine Nuclear Research Inst., Manila (Philippines). Radiation Protection Services

    1997-02-01

    The effective application of volcanic ash, an indigenous adsorptive material abundant in the Mt. Pinatubo area, in the removal of radioiodine from radioactive waste streams was demonstrated. Factors such as availability, low cost and comparative retention capacity with respect to activated charcoal make volcanic ash an attractive alternative in the conditioning of radioactive waste containing radioiodine. Chemical precipitation was employed in the treatment of low level aqueous waste containing {sup 137}Cs. It was shown that there exists an optimum concentration of ferric ion that promotes maximum precipitation of caesium. It was further demonstrated that complete removal of caesium can be achieved with the addition of nickel hexacyanoferrate. (author). 5 refs, 3 figs.

  18. Development of safeguards information treatment system at the facility level

    Energy Technology Data Exchange (ETDEWEB)

    Lee, Byung Doo; Song, Dae Yong; So, Dong Sup; Kwack, Eun Ho [Korea Atomic Energy Research Institute, Taejeon (Korea)

    2000-04-01

    Safeguards Information Treatment System(SITS) at the facility level is required to implement efficiently the obligations under the Korea-IAEA Safeguards Agreement, bilateral agreements with other countries and domestic law. In this report, the requirements and major functions of SITS were considered, and the error checking methods and the relationships of safeguards information were reviewed. SITS will be developed to cover the different accounting procedures and methods applied at the various facilities under IAEA safeguards. Also, the resolved result of the Y2K problem in the existing nuclear material accounting program was described. 3 tabs. (Author)

  19. Medium-Level Laser in Chronic Tinnitus Treatment

    OpenAIRE

    Dejakum, K.; Piegger, J.; Plewka, C.; Gunkel, A.; Thumfart, W.; Kudaibergenova, S.; Goebel, G.; Kral, F.; Freysinger, W.

    2013-01-01

    The purpose of this study was to evaluate the effect of medium-level laser therapy in chronic tinnitus treatment. In a prospective double-blind placebo-controlled trial, either active laser (450 mW, 830 nm combined Ga-Al-As diode laser) or placebo irradiation was applied through the external acoustic meatus of the affected ear towards the cochlea. Fourty-eight patients with chronic tinnitus were studied. The main outcome was measured using the Goebel tinnitus questionnaire, visual analogue sc...

  20. Design of safeguards information treatment system at the facility level

    International Nuclear Information System (INIS)

    Song, Dae Yong; Lee, Byung Doo; Kwack, Eun Ho; Choi, Young Myong

    2001-05-01

    We are developing Safeguards Information Treatment System at the facility level(SITS) to manage synthetically safeguards information and to implement efficiently the obligations under the Korea-IAEA Safeguards Agreement, bilateral agreements with other countries and domestic law. In this report, we described the contents of the detailed design of SITS such as database, I/O layout and program. In the present, we are implementing the SITS based on the contents of the design of SITS, and then we plan to provide the system for the facilities after we finish implementing and testing the system

  1. Medium-level laser in chronic tinnitus treatment.

    Science.gov (United States)

    Dejakum, K; Piegger, J; Plewka, C; Gunkel, A; Thumfart, W; Kudaibergenova, S; Goebel, G; Kral, F; Freysinger, W

    2013-01-01

    The purpose of this study was to evaluate the effect of medium-level laser therapy in chronic tinnitus treatment. In a prospective double-blind placebo-controlled trial, either active laser (450 mW, 830 nm combined Ga-Al-As diode laser) or placebo irradiation was applied through the external acoustic meatus of the affected ear towards the cochlea. Fourty-eight patients with chronic tinnitus were studied. The main outcome was measured using the Goebel tinnitus questionnaire, visual analogue scales measuring the perceived loudness of tinnitus, the annoyance associated with tinnitus, and the degree of attention paid to tinnitus as well as psycho-acoustical matches of tinnitus pitch and loudness. The results did show only very moderate temporary improvement of tinnitus. Moreover, no statistically relevant differences between laser and placebo group could be found. We conclude that medium-level laser therapy cannot be regarded as an effective treatment of chronic tinnitus in our therapy regime considering the limited number of patients included in our study.

  2. Medium-Level Laser in Chronic Tinnitus Treatment

    Directory of Open Access Journals (Sweden)

    K. Dejakum

    2013-01-01

    Full Text Available The purpose of this study was to evaluate the effect of medium-level laser therapy in chronic tinnitus treatment. In a prospective double-blind placebo-controlled trial, either active laser (450 mW, 830 nm combined Ga-Al-As diode laser or placebo irradiation was applied through the external acoustic meatus of the affected ear towards the cochlea. Fourty-eight patients with chronic tinnitus were studied. The main outcome was measured using the Goebel tinnitus questionnaire, visual analogue scales measuring the perceived loudness of tinnitus, the annoyance associated with tinnitus, and the degree of attention paid to tinnitus as well as psycho-acoustical matches of tinnitus pitch and loudness. The results did show only very moderate temporary improvement of tinnitus. Moreover, no statistically relevant differences between laser and placebo group could be found. We conclude that medium-level laser therapy cannot be regarded as an effective treatment of chronic tinnitus in our therapy regime considering the limited number of patients included in our study.

  3. Secondary Low-Level Waste Treatment Strategy Analysis

    International Nuclear Information System (INIS)

    D.M. LaRue

    1999-01-01

    The objective of this analysis is to identify and review potential options for processing and disposing of the secondary low-level waste (LLW) that will be generated through operation of the Monitored Geologic Repository (MGR). An estimate of annual secondary LLW is generated utilizing the mechanism established in ''Secondary Waste Treatment Analysis'' (Reference 8.1) and ''Secondary Low-Level Waste Generation Rate Analysis'' (Reference 8.5). The secondary LLW quantities are based on the spent fuel and high-level waste (HLW) arrival schedule as defined in the ''Controlled Design Assumptions Document'' (CDA) (Reference 8.6). This analysis presents estimates of the quantities of LLW in its various forms. A review of applicable laws, codes, and standards is discussed, and a synopsis of those applicable laws, codes, and standards and their impacts on potential processing and disposal options is presented. The analysis identifies viable processing/disposal options in light of the existing laws, codes, and standards, and then evaluates these options in regard to: (1) Process and equipment requirements; (2) LLW disposal volumes; and (3) Facility requirements

  4. Treatment of low- and intermediate-level solid radioactive wastes

    International Nuclear Information System (INIS)

    1983-01-01

    One of the essential aims in the waste management is to reduce as much as possible the waste volumes to be stored or disposed of, and to concentrate and immobilize as much as possible the radioactivity contained in the waste. This document describes the treatment of low- and intermediate-level solid waste prior to its conditioning for storage and disposal. This report aims primarily at compiling the experience gained in treating low- and intermediate-active solid wastes, one of the major waste sources in nuclear technology. Apart from the description of existing facilities and demonstrated handling schemes, this report provides the reader with the basis for a judgement that facilitates the selection of appropriate solutions for a given solid-waste management problem. It thus aims at providing guidelines in the particular field and indicates new promising approaches that are actually under investigation and development

  5. Treatment options for low-level radiologically contaminated ORNL filtercake

    International Nuclear Information System (INIS)

    Lee, Hom-Ti; Bostick, W.D.

    1996-04-01

    Water softening sludge (>4000 stored low level contaminated drums; 600 drums per year) generated by the ORNL Process Waste Treatment Plant must be treated, stabilized, and placed in safe storage/disposal. The sludge is primarily CaCO 3 and is contaminated by low levels of 90 Sr and 137 Cs. In this study, microwave sintering and calcination were evaluated for treating the sludge. The microwave melting experiments showed promise: volume reductions were significant (3-5X), and the waste form was durable with glass additives (LiOH, fly ash). A commercial vendor using surrogate has demonstrated a melt mineralization process that yields a dense monolithic waste form with a volume reduction factor (VR) of 7.7. Calcination of the sludge at 850-900 C yielded a VR of 2.5. Compaction at 4500 psi increased the VR to 4.2, but the compressed form is not dimensionally stable. Addition of paraffin helped consolidate fines and yielded a VR of 3.5. In conclusion, microwave melting or another form of vitrification is likely to be the best method; however for immediate implementation, the calculation/compaction/waxing process is viable

  6. Treatment and conditioning of metallic intermediate level waste

    International Nuclear Information System (INIS)

    Lidar, Per; Larsson, Arne; Huutoniemi, Tommi; Blank, Eva; Elfwing, Mattias

    2014-01-01

    In 2011 SKB started an R and D program for evaluating different disposal concepts for LL-LILW. The purpose was to develop alternative repository concepts and conditioning methods for LL-LILW and to evaluate and compare them from a range of parameters. The goal is to present a comparison between identified repository concepts by 2013. The material should be of such a quality that SKB can make decisions of which concepts that are to be further investigated in a safety analysis. As a part of the R and D program for the LL-LILW disposal facility, Studsvik was assigned to investigate whether melting of metallic LL-LILW is technically feasible and, if so, what the requirements are to build and operate such a facility. Specific concern was given to the following metallic components: - Core components and reactor internals from both boiling water reactors (BWRs) and pressurized water reactors (PWRs). - Reactor pressure vessels from PWRs. The paper presents a feasibility study of a melting facility for core components and reactor internals. An overview is given of how such a facility for treatment of intermediate level waste might be designed, constructed and operated and highlights both the possibilities and challenges. A cost estimate and a risk analysis are presented in order to make a conclusion of the technical feasibility of such a facility. Based on the Studsvik authors' experience in operating a low level waste melting facility, their conclusion is presented in the paper, considering cost of constructing and operating such a facility, in conjunction with the radio-logical risks associated with operation and the benefits to disposal and long term safety. Studsvik also investigated alternative techniques for embedding of metallic ILW components. Embedding of radioactive metallic ILW components protects the component from corrosion and leakage of radionuclides from repository to biosphere can thereby be both delayed and decreased. Conditioning by embedding has

  7. Mixed and low-level waste treatment facility project. Volume 3, Waste treatment technologies (Draft)

    Energy Technology Data Exchange (ETDEWEB)

    1992-04-01

    The technology information provided in this report is only the first step toward the identification and selection of process systems that may be recommended for a proposed mixed and low-level waste treatment facility. More specific information on each technology will be required to conduct the system and equipment tradeoff studies that will follow these preengineering studies. For example, capacity, maintainability, reliability, cost, applicability to specific waste streams, and technology availability must be further defined. This report does not currently contain all needed information; however, all major technologies considered to be potentially applicable to the treatment of mixed and low-level waste are identified and described herein. Future reports will seek to improve the depth of information on technologies.

  8. Psychotherapeutic treatment levels of personality disorders in older adults

    NARCIS (Netherlands)

    Videler, Arjan; Cornelis, Christina; Rossi, G.; van Royen, R.J.J.; Rosowsky, E.; van Alphen, S.P.J.

    2015-01-01

    Treatment of personality disorders (PDs) in older adults is a highly underexplored topic. In this article clinical applicability of the findings from a recent Delphi study regarding treatment aspects of PDs in older adults is explored. This concerns the relevance of three psychotherapeutic treatment

  9. Strength training and testosterone treatment have opposing effects on migration inhibitor factor levels in ageing men

    DEFF Research Database (Denmark)

    Glintborg, D.; Christensen, L. L.; Kvorning, T.

    2013-01-01

    Strength Training and Testosterone Treatment Have Opposing Effects on Migration Inhibitor Factor Levels in Ageing Men......Strength Training and Testosterone Treatment Have Opposing Effects on Migration Inhibitor Factor Levels in Ageing Men...

  10. Low level mixed waste thermal treatment technical basis report

    Energy Technology Data Exchange (ETDEWEB)

    Place, B.G.

    1994-12-01

    Detailed characterization of the existing and projected Hanford Site Radioactive Mixed Waste (RMW) inventory was initiated in 1993 (Place 1993). This report presents an analysis of the existing and projected RMW inventory. The subject characterization effort continues to be in support of the following engineering activities related to thermal treatment of Hanford Site RMW: (1) Contracting for commercial thermal treatment; (2) Installation and operation of an onsite thermal treatment facility (Project W-242); (3) Treatment at another Department of Energy (DOE) site. The collation of this characterization information (data) has emphasized the establishment of a common data base for the entire existing RMW inventory so that the specification of feed streams destined for different treatment facilities can be coordinated.

  11. Low level mixed waste thermal treatment technical basis report

    International Nuclear Information System (INIS)

    Place, B.G.

    1994-12-01

    Detailed characterization of the existing and projected Hanford Site Radioactive Mixed Waste (RMW) inventory was initiated in 1993 (Place 1993). This report presents an analysis of the existing and projected RMW inventory. The subject characterization effort continues to be in support of the following engineering activities related to thermal treatment of Hanford Site RMW: (1) Contracting for commercial thermal treatment; (2) Installation and operation of an onsite thermal treatment facility (Project W-242); (3) Treatment at another Department of Energy (DOE) site. The collation of this characterization information (data) has emphasized the establishment of a common data base for the entire existing RMW inventory so that the specification of feed streams destined for different treatment facilities can be coordinated

  12. Treatment of uncertainty in low-level waste performance assessment

    International Nuclear Information System (INIS)

    Kozak, M.W.; Olague, N.E.; Gallegos, D.P.; Rao, R.R.

    1991-01-01

    Uncertainties arise from a number of different sources in low-level waste performance assessment. In this paper the types of uncertainty are reviewed, and existing methods for quantifying and reducing each type of uncertainty are discussed. These approaches are examined in the context of the current low-level radioactive waste regulatory performance objectives, which are deterministic. The types of uncertainty discussed in this paper are model uncertainty, uncertainty about future conditions, and parameter uncertainty. The advantages and disadvantages of available methods for addressing uncertainty in low-level waste performance assessment are presented. 25 refs

  13. Haloperidol plasmatic levels and their clinical response to the treatment

    International Nuclear Information System (INIS)

    Cabranes, J.A.; Almoguera, I.; Santos, J.L.; Prieto, P.; Ramos, J.A.

    1988-01-01

    Schizophrenic patients were treated with haloperidol. Their haloperidol levels in plasma were determined with radioimmunoassay (RIA) and radioreceptor assay (RRA). The results obtained are compared with the clinical improvement. (M.C.B.)

  14. Treatment of High-Level Waste Arising from Pyrochemical Processes

    International Nuclear Information System (INIS)

    Lizin, A.A.; Kormilitsyn, M.V.; Osipenko, A.G.; Tomilin, S.V.; Lavrinovich, Yu.G.

    2013-01-01

    JSC “SSC RIAR” has been performing research and development activities in support of closed fuel cycle of fast reactor since the middle of 1960s. Fuel cycle involves fabrication and reprocessing of spent nuclear fuel (SNF) using pyrochemical methods of reprocessing in molten alkali metal chlorides. At present pyrochemical methods of SNF reprocessing in molten chlorides has reached such a level in their development that makes it possible to compare their competitiveness with classic aqueous methods. Their comparative advantage lies in high safety, compactness, high protectability as to nonproliferation of nuclear materials, and reduction of high level waste volume

  15. Treatment technologies for non-high-level wastes (USA)

    International Nuclear Information System (INIS)

    Cooley, C.R.; Clark, D.E.

    1976-06-01

    Non-high-level waste arising from operations at nuclear reactors, fuel fabrication facilities, and reprocessing facilities can be treated using one of several technical alternatives prior to storage. Each alternative and the associated experience and status of development are summarized. The technology for treating non-high-level wastes is generally available for industrial use. Improved techniques applicable to the commercial nuclear fuel cycle are being developed and demonstrated to reduce the volume of waste and to immobilize it for storage. 36 figures, 59 references

  16. Comparison of the pre-treatment testosterone levels in benign ...

    African Journals Online (AJOL)

    D.E. Orakwe

    2017-01-26

    Jan 26, 2017 ... Abstract. Objectives: To compare serum testosterone and prostate specific antigen (PSA) levels of patients diagnosed of prostate cancer to those with benign prostatic hyperplasia (BPH). Subjects and methods: One hundred and thirteen male patients with or without LUTS who had indica- tion(s) for prostate ...

  17. Facility for low-level solid waste treatment

    International Nuclear Information System (INIS)

    Vicente, R.; Miyamoto, H.

    1987-01-01

    A facility for low-level solid waste compaction, encapsulation and storage is described. Solid wastes are compacted in 200 l drums and stored over concrete platforms covered with canvas, for decay or for interim storage before transport to the final disposal site. (Author) [pt

  18. Treatment of low level waste water by reverse osmosis

    International Nuclear Information System (INIS)

    Li Kaijun; Zhang Chuanzhi; Xue Qinhua; Liu Meijun

    1987-11-01

    A Study on the removal of certain radioactive elements Such as 141 Ce, 51 Cr 134 Cu, 106 Ru and 131 I by Reverse Osmosis and the effect of surface activity agent on property of membrance are described in this paper. RO model is carried out to examine the treatment of actual reactor waste water and radioactive laundry waste water. The removal efficiency of total β is 98%. Three preprocessing (cloth pocket filtrator, hivefiltrator and zone) and membrane cleaning methods (acid, ozone and spongeball) are also investigated

  19. Technological and culinary treatment. Effects on radioactivity levels in foodstuffs

    International Nuclear Information System (INIS)

    Grauby, A.; Miribel, J.

    1989-01-01

    As a result of the radioactive fall-out following the first overground nuclear explosions and the Windscale accident, from the end of the 1950 onwards the various radioelements began to be monitored by means of the food chain. However, few writers were concerned with the decontamination of foodstuffs. During this time the ICRP drew up recommendations which were then included in the basic safety standards of the Euratom Treaty and which are the only representative standards for public safety. The unprocessed raw product has therefore been used as the reference for the assessment of radiological risk for 25 years. In the period immediately after the Chernobyl accident, the differing levels of contamination of agricultural produce in the various countries led governments to adopt conservation measures by setting radioactivity tolerance levels for both the raw product and the processed product. These levels, which were based on economic and political considerations, caused problems for the marketing of certain products. Although these difficulties were limited by the relative unimportance of the local economy in the stricken area, it cannot be ruled out that, after a future accident, the economy of a whole region might be destroyed because of a ban on marketing products containing levels of contamination considered to be too high by market standards. Countermeasures must therefore be taken. Some experiments had previously been conducted in this area, but in the last two years many more tests have been carried out and new programmes launched. It therefore became necessary to organize a seminar on this subject in order to take stock of the work carried out and to draw up various kinds of recommendation. The latter include: - the provision of incentives for increased cooperation between the food processing industry and those responsible for nuclear safety: - the establishment of decision-making criteria for the authorities; - and lastly the identification of areas at risk

  20. Treatment of low-level liquid radioactive wastes by electrodialysis

    International Nuclear Information System (INIS)

    DelDebbio, J.A.; Donovan, R.I.

    1986-01-01

    This paper presents the results of pilot plant studies on the use of electrodialysis (ED) for the removal of radioactive and chemical contaminants from acidic low-level radioactive wastes resulting from nuclear fuel reprocessing operations. Decontamination efficiencies are reported for strontium-90, cesium-137, iodine-129, ruthenium-106 and mercury. Data for contaminant adsorption on ED membranes and liquid waste volumes generated are also presented

  1. Separation processes for high-level radioactive waste treatment

    International Nuclear Information System (INIS)

    Sutherland, D.G.

    1992-11-01

    During World War II, production of nuclear materials in the United States for national defense, high-level waste (HLW) was generated as a byproduct. Since that time, further quantities of HLW radionuclides have been generated by continued nuclear materials production, research, and the commercial nuclear power program. In this paper HLW is defined as the highly radioactive material resulting from the processing of spent nuclear fuel. The HLW is the liquid waste generated during the recovery of uranium and plutonium in a fuel processing plant that generally contains more than 99% of the nonvolatile fission products produced during reactor operation. Since this paper deals with waste separation processes, spent reactor fuel elements that have not been dissolved and further processed are excluded

  2. Treatment of complementary events in constructing the linked Level 1 and Level 2 fault trees

    International Nuclear Information System (INIS)

    Jo, Young G.; Ahn, Kwang-Il

    2009-01-01

    Complementary events in the event trees for a PRA model should be treated properly in order to evaluate plant risk correctly. In this paper, the characteristics of the following three different cutset generation methods were investigated first in order to find the best practical way for treating complementary events: (1) exact method which treats complementary events logically, (2) no-delete term method which does not treat complementary events at all, and (3) delete term method which treats complementary events by deleting nonsense cutsets which are generated as a result of ignoring complementary events. Then, practical methods for treating complementary events in constructing linked fault trees for Level 1 and Level 2 PRA were suggested and demonstrated. The suggested methods deal with the following selected four typical cases: (1) Case 1-an event tree event (E) is represented by a fault tree gate whose inputs consist of only fault tree gates, (2) Case 2-E is represented by a single basic event, (3) Case 3-E is represented by an OR fault tree gate which has a single basic event and a fault tree gate as inputs, and (4) Case 4-E is represented by an AND fault tree gate which has a single basic event and a fault tree gate as inputs. In the suggested methods, first the high level logic structures of event tree events are examined and restructured, if needed. Then, the delete term method, the exact method, and the combination of the two methods are applied to through Case 1 to Case 4, respectively. As a result, it is recommended to treat complementary events, using the suggested methods, before Level 1 and Level 2 PRA fault trees are coupled

  3. Association between addiction treatment staff professional and educational levels and perceptions of organizational climate and resources.

    Science.gov (United States)

    Krull, Ivy; Lundgren, Lena; Beltrame, Clelia

    2014-01-01

    Research studies have identified addiction treatment staff who have higher levels of education as having more positive attitudes about evidence-based treatment practices, science-based training, and the usefulness of evidence-based practices. This study examined associations between addiction treatment staff level of education and their perceptions of 3 measures of organizational change: organizational stress, training resources and staffing resources in their treatment unit. The sample included 588 clinical staff from community-based substance abuse treatment organizations who received Substance Abuse and Mental Health Services Administration (SAMHSA) funding (2003-2008) to implement evidence-based practices (EBPs). Bivariate analysis and regression modeling methods examined the relationship between staff education level (no high school education, high school education, some college, associate's degree, bachelor's degree, master's degree, doctoral degree, and other type of degree such as medical assistant, registered nurse [RN], or postdoctoral) and attitudes about organizational climate (stress), training resources, and staffing resources while controlling for staff and treatment unit characteristics. Multivariable models identified staff with lower levels of education as having significantly more positive attitudes about their unit's organizational capacity. These results contradict findings that addiction treatment staff with higher levels of education work in units with greater levels of organizational readiness for change. It cannot be inferred that higher levels of education among treatment staff is necessarily associated with high levels of organizational readiness for change.

  4. Balancing treatment allocations by clinician or center in randomized trials allows unacceptable levels of treatment prediction.

    Science.gov (United States)

    Hills, Robert K; Gray, Richard; Wheatley, Keith

    2009-08-01

    Randomized controlled trials are the standard method for comparing treatments because they avoid the selection bias that might arise if clinicians were free to choose which treatment a patient would receive. In practice, allocation of treatments in randomized controlled trials is often not wholly random with various 'pseudo-randomization' methods, such as minimization or balanced blocks, used to ensure good balance between treatments within potentially important prognostic or predictive subgroups. These methods avoid selection bias so long as full concealment of the next treatment allocation is maintained. There is concern, however, that pseudo-random methods may allow clinicians to predict future treatment allocations from previous allocation history, particularly if allocations are balanced by clinician or center. We investigate here to what extent treatment prediction is possible. Using computer simulations of minimization and balanced block randomizations, the success rates of various prediction strategies were investigated for varying numbers of stratification variables, including the patient's clinician. Prediction rates for minimization and balanced block randomization typically exceed 60% when clinician is included as a stratification variable and, under certain circumstances, can exceed 80%. Increasing the number of clinicians and other stratification variables did not greatly reduce the prediction rates. Without clinician as a stratification variable, prediction rates are poor unless few clinicians participate. Prediction rates are unacceptably high when allocations are balanced by clinician or by center. This could easily lead to selection bias that might suggest spurious, or mask real, treatment effects. Unless treatment is blinded, randomization should not be balanced by clinician (or by center), and clinician-center effects should be allowed for instead by retrospectively stratified analyses. © 2009 Blackwell Publishing Asia Pty Ltd and Chinese

  5. Low-level radioactive waste treatment technology. Low-level radioactive waste management handbook series

    International Nuclear Information System (INIS)

    1984-07-01

    Each generator of low-level radioactive waste must consider three sequential questions: (1) can the waste in its as-generated form be packaged and shipped to a disposal facility; (2) will the packaged waste be acceptable for disposal; and (3) if so, is it cost effective to dispose of the waste in its as-generated form. These questions are aimed at determining if the waste form, physical and chemical characteristics, and radionuclide content collectively are suitable for shipment and disposal in a cost-effective manner. If not, the waste management procedures will involve processing operations in addition to collection, segregation, packaging, shipment, and disposal. This handbook addresses methods of treating and conditioning low-level radioactive waste for shipment and disposal. A framework is provided for selection of cost-effective waste-processing options for generic categories of low-level radioactive waste. The handbook is intended as a decision-making guide that identifies types of information required to evaluate options, methods of evaluation, and limitations associated with selection of any of the processing options

  6. Clinical significance of changes of plasma ET and NPY levels after treatment in patients with AMI

    International Nuclear Information System (INIS)

    Zhou Jinbao

    2005-01-01

    Objective: To investigate the changes of plasma ET and NPY levels in patients with AMI. Methods: Plasma ET and NPY levels were dynamically determined in 36 patients with AMI right after establishment of diagnosis and 8h, 24h, 4ph, 72h, 7d, 14d later. Levels in 35 healthy individuals were taken as control. Results: Before treatment was initiated, the levels of Et and Np in patients with AMI were significantly higher than those in controls (P <0.01). After one week of treatment, the levels dropped toward normal. Conclusion: Dynamic measurement of plasma ET and NPY levels in patients with AMI is of clinical importance. (authors)

  7. Effect of nonsurgical periodontal treatment on C-reactive protein levels in maintenance hemodialysis patients.

    Science.gov (United States)

    Yazdi, Farin Kiany; Karimi, Noozhan; Rasouli, Manoochehr; Roozbeh, Jamshid

    2013-01-01

    C-reactive protein (CRP) has been implicated as a possible mediator of the association between periodontitis and several systemic diseases. This study evaluated the impact of nonsurgical periodontal treatment on the serum levels of CRP in chronic kidney disease (CKD) patients on hemodialysis. A total of 77 CKD patients on hemodialysis were included in this study. At baseline, periodontal examination was assessed for all the patients, and chronic periodontitis was defined through clinical attachment level and probing pocket depth, according to the American Association of Periodontology. Nonsurgical periodontal treatment was performed and serum levels of CRP were evaluated at baseline and 8 weeks after periodontal treatment. Periodontal treatment resulted in significant reductions in CRP levels (p periodontitis. Periodontitis is an important source of systemic inflammation in CKD patients. Nonsurgical periodontal treatment can effectively reduce the serum level of CRP in these patients.

  8. Effect of tian meng capsule treatment on serum TGA, TMA levels in patients with hashimoto's disease

    International Nuclear Information System (INIS)

    Huang Qingyi; Chen Jianfei

    2010-01-01

    Objective: To study the effect of tian meng capsule treatment on the serum levels of TGA, TMA in patients with chronic lymphocytic thyroiditis (CLTD or Hashimoto's disease). Methods: Serum TGA and TMA levels were determined with RIA both before and after treatment for 3 months in (1) 30 patients treated with conventional drugs (2) 30 patients treated with conventional drugs plus tian meng capsule (a traditional chinese medicine preparation No.2, tid) and (3) once in 30 controls. Results: Before treatment,the serum TGA and TMA levels in all the patients were significantly, higher than those in controls. After 3 months' treatment, serum TGA and TMA levels in all the patients dropped, but the levels in the patients treated with additional tian meng capsule were significantly lower than those in patients without tian meng capsule treatment. Moreover, 76.7% of the patients with tian meng capsule treatment had their serum TGA and TMA levels decreased over 30%, four patients even had the serum levels became normal. Conclusion: tian meng capsule treatment is very effective in lowering serum TGA and TMA levels in patients with Hashimoto's disease. (authors)

  9. Six-year experiences in the operation of a low level liquid waste treatment plant

    International Nuclear Information System (INIS)

    Wen, S.-J.; Hwang, S.-L.; Tsai, C.-M.

    1980-01-01

    The operation of a low level liquid waste treatment plant is described. The plant is designed for the disposal of liquid waste produced primarily by a 40 MW Taiwan Research Reactor as well as a fuel fabrication plant for the CANDU type reactor and a radioisotopes production laboratory. The monthly volume treated is about 600-2500 ton of low level liquid waste. The activity levels are in the range of 10 -5 -10 -3 μCi/cm 3 . The continuous treatment system of the low level liquid waste treatment plant and the treatment data collected since 1973 are discussed. The advantages and disadvantages of continuous and batch processes are compared. In the continuous process, the efficiency of sludge treatment, vermiculite ion exchange and the adsorption of peat are investigated for further improvement. (H.K.)

  10. Basal blood DHEA-S/cortisol levels predicts EMDR treatment response in adolescents with PTSD.

    Science.gov (United States)

    Usta, Mirac Baris; Gumus, Yusuf Yasin; Say, Gokce Nur; Bozkurt, Abdullah; Şahin, Berkan; Karabekiroğlu, Koray

    2018-04-01

    In literature, recent evidence has shown that the hypothalamic-pituitary-adrenal (HPA) axis can be dysregulated in patients with post-traumatic stress disorder (PTSD) and HPA axis hormones may predict the psychotherapy treatment response in patients with PTSD. In this study, it was aimed to investigate changing cortisol and DHEA-S levels post-eye movement desensitization and reprocessing (EMDR) therapy and the relationship between treatment response and basal cortisol, and DHEA-S levels before treatment. The study group comprised 40 adolescents (age, 12-18 years) with PTSD. The PTSD symptoms were assessed using the Child Depression Inventory (CDI) and Child Post-traumatic Stress Reaction Index (CPSRI) and the blood cortisol and DHEA-S were measured with the chemiluminescence method before and after treatment. A maximum of six sessions of EMDR therapy were conducted by an EMDR level-1 trained child psychiatry resident. Treatment response was measured by the pre- to post-treatment decrease in self-reported and clinical PTSD severity. Pre- and post-treatment DHEA-S and cortisol levels did not show any statistically significant difference. Pre-treatment CDI scores were negatively correlated with pre-treatment DHEA-S levels (r: -0.39). ROC analysis demonstrated that the DHEA-S/cortisol ratio predicts treatment response at a medium level (AUC: 0.703, p: .030, sensitivity: 0.65, specificity: 0.86). The results of this study suggested that the DHEA-S/cortisol ratio may predict treatment response in adolescents with PTSD receiving EMDR therapy. The biochemical parameter of HPA-axis activity appears to be an important predictor of positive clinical response in adolescent PTSD patients, and could be used in clinical practice to predict PTSD treatment in the future.

  11. Evaluation of Chlorine Treatment Levels for Inactivation of Human Norovirus and MS2 Bacteriophage during Sewage Treatment.

    Science.gov (United States)

    Kingsley, David H; Fay, Johnna P; Calci, Kevin; Pouillot, Régis; Woods, Jacquelina; Chen, Haiqiang; Niemira, Brendan A; Van Doren, Jane M

    2017-12-01

    This study examined the inactivation of human norovirus (HuNoV) GI.1 and GII.4 by chlorine under conditions mimicking sewage treatment. Using a porcine gastric mucin-magnetic bead (PGM-MB) assay, no statistically significant loss in HuNoV binding (inactivation) was observed for secondary effluent treatments of ≤25 ppm total chlorine; for both strains, 50 and 100 ppm treatments resulted in ≤0.8-log 10 unit and ≥3.9-log 10 unit reductions, respectively. Treatments of 10, 25, 50, and 100 ppm chlorine inactivated 0.31, 1.35, >5, and >5 log 10 units, respectively, of the norovirus indicator MS2 bacteriophage. Evaluation of treatment time indicated that the vast majority of MS2 and HuNoV inactivation occurred in the first 5 min for 0.2-μm-filtered, prechlorinated secondary effluent. Free chlorine measurements of secondary effluent seeded with MS2 and HuNoV demonstrated substantial oxidative burdens. With 25, 50, and 100 ppm treatments, free chlorine levels after 5 min of exposure ranged from 0.21 to 0.58 ppm, from 0.28 to 16.7 ppm, and from 11.6 to 53 ppm, respectively. At chlorine treatment levels of >50 ppm, statistically significant differences were observed between reductions for PGM-MB-bound HuNoV (potentially infectious) particles and those for unbound (noninfectious) HuNoV particles or total norovirus particles. While results suggested that MS2 and HuNoV (measured as PGM-MB binding) behave similarly, although not identically, both have limited susceptibility to chlorine treatments of ≤25 ppm total chlorine. Since sewage treatment is performed at ≤25 ppm total chlorine, targeting free chlorine levels of 0.5 to 1.0 ppm, these results suggest that traditional chlorine-based sewage treatment does not inactivate HuNoV efficiently. IMPORTANCE HuNoV is ubiquitous in sewage. A receptor binding assay was used to assess inactivation of HuNoV by chlorine-based sewage treatment, given that the virus cannot be routinely propagated in vitro Results reported here

  12. Plasma homovanillic acid levels in first-episode schizophrenia. Psychopathology and treatment response.

    Science.gov (United States)

    Koreen, A R; Lieberman, J; Alvir, J; Mayerhoff, D; Loebel, A; Chakos, M; Amin, F; Cooper, T

    1994-02-01

    To examine plasma homovanillic acid (pHVA) levels in first-episode schizophrenia, to compare pHVA levels in patients and controls, and to assess the association of pHVA levels with psychopathology and treatment response. Forty-one patients entered the study, and pHVA levels were measured at baseline and on a weekly basis for up to 6 weeks of open standardized neuroleptic treatment. Psychopathology was evaluated with the Schedule for Affective Disorders and Schizophrenia, the Scale for Assessment of Negative Symptoms, and the Clinical Global Impressions scale. Ten healthy controls were used for comparison of baseline pHVA levels. No differences were observed between patients and controls. Baseline pHVA level was not associated with psychopathology but was associated with time to reach remission. Baseline pHVA levels and week-1 pHVA levels were higher in responders than nonresponders. Regardless of responsiveness, female participants had higher pHVA levels than male participants throughout the study. The pattern of pHVA levels with treatment was similar in all patients with a short-term rise initially and then a decrease toward baseline values. These findings suggest that pHVA levels have prognostic significance for response and time to reach remission. Qualitative and quantitative differences between first-episode patients' pHVA levels and studies using a long-term, neuroleptic-exposed population suggest that changes occur with neuroleptic treatment or the progression of the illness.

  13. Effect of carvedilol treatment on plasma neuropeptides levels in patients with essential hypertension

    International Nuclear Information System (INIS)

    Li Qian; Cheng Guanghua; Yang Jian

    2008-01-01

    Objective: To study the changes of plasma neuropeptide Y(NPY) and neurotension (NT) levels in patients with essential hypertension after treatment with carvedilol. Methods: Blood pressure and plasma NPY and NT concentrations (with RIA) were measured in 56 patients with essential hypertension both before and after carvedilol therapy (5-10 mg bid) for 3 months as well as 30 controls. Results: Before treatment plasma NPY levels were significantly higher in hypertensive patients than those in controls (P<0.01), but plasma NT levels were significantly lower (P also <0.01). After carvedilol treatment, blood pressure and plasma NPY levels were reduced significantly and plasma NT levels were increased significantly. Conclusion: Treatment with carvedilol results in the correction of plasma concentrations of NPY and NT in patients with essential hypertension, the effect may be related to blood pressure decrease. (authors)

  14. Evolution of plasma homovanillic acid (HVA) levels during treatment in schizo-affective disorder.

    Science.gov (United States)

    Galinowski, A; Castelnau, C; Spreux-Varoquaux, O; Bourdel, M C; Olie, J P; Loo, H; Poirier, M F

    2000-11-01

    1. Plasma Homovanillic Acid (p HVA) levels were measured by HPLC (high performance liquid chromatography) in 5 schizo-affective depressed patients receiving a standardized treatment. (lithium, chlorpromazine and clomipramine) during 4 weeks. 2. Four patients were pretreated, without a washout period. 3. No significant difference was observed between patients and normal controls at baseline. Under treatment, pHVA levels increased (ppHVA levels that increase with clinical improvement, unlike schizophrenic patients whose increased pHVA concentrations decline with neuroleptic treatment.

  15. Biochemical Evaluation of Serum Adiponectin Level in Egyptian Breast Cancer Patients before and after Treatment

    International Nuclear Information System (INIS)

    El Shepiny, M.S.El.M.

    2010-01-01

    In this study, serum adiponectin level was evaluated in 35 primary breast cancer patients and 10 healthy females, before and after treatment to assess if there is a relation between it and breast cancer, and to find out if it has a prognostic value. Serum adiponectin level was significantly lower in all and postmenopausal breast cancer patients before taking any type of treatment, and non-significantly lower in locally advanced breast cancer patients after treatment by 4 cycles of neoadjuvant chemotherapy than healthy controls. Non-significant elevations was shown after treatment by surgery, and also after completing treatment by surgery followed by taking 2 cycles of adjuvant chemotherapy followed by treatment by radiotherapy in case of premenopausal locally advanced breast cancer patients. Triglycerides showed significantly higher level in all groups of patients. There was statistical negative correlation between serum adiponectin level and body mass index (BMI) in postmenopausal healthy controls, and between serum adiponectin level and BMI, triglycerides in all and postmenopausal breast cancer patients before taking any type of treatment. In conclusion, this study suggests that low serum adiponectin level is likely to be associated with increased breast cancer risk, particularly among postmenopausal women. The association between obesity and breast cancer risk might be partly explained by adiponectin

  16. Low level radioactive waste disposal/treatment technology overview: Savannah River site

    International Nuclear Information System (INIS)

    Sturm, H.F. Jr.

    1987-01-01

    The Savannah River Site will begin operation of several low-level waste disposal/treatment facilities during the next five years, including a new low-level solid waste disposal facility, a low-level liquid effluent treatment facility, and a low-level liquid waste solidification process. Closure of a radioactive hazardous waste burial ground will also be completed. Technical efforts directed toward waste volume reduction include compaction, incineration, waste avoidance, and clean waste segregation. This paper summarizes new technology being developed and implemented. 11 refs., 1 fig

  17. Low-level wastewater treatment facility process control operational test report

    International Nuclear Information System (INIS)

    Bergquist, G.G.

    1996-01-01

    This test report documents the results obtained while conducting operational testing of a new TK 102 level controller and total outflow integrator added to the NHCON software that controls the Low-Level Wastewater Treatment Facility (LLWTF). The test was performed with WHC-SD-CP-OTP 154, PFP Low-Level Wastewater Treatment Facility Process Control Operational Test. A complete test copy is included in appendix A. The new TK 102 level controller provides a signal, hereafter referred to its cascade mode, to the treatment train flow controller which enables the water treatment process to run for long periods without continuous operator monitoring. The test successfully demonstrated the functionality of the new controller under standard and abnormal conditions expected from the LLWTF operation. In addition, a flow totalizer is now displayed on the LLWTF outlet MICON screen which tallies the process output in gallons. This feature substantially improves the ability to retrieve daily process volumes for maintaining accurate material balances

  18. Higher Serum Uric Acid Levels in Multiple Sclerosis Patients After Longterm Interferon Beta Treatment

    Directory of Open Access Journals (Sweden)

    Toncev Gordana

    2017-10-01

    Full Text Available Interferon beta is a safe and efficacious treatment for relapsing multiple sclerosis (MS. However, there is some evidence that uric acid, a scavenger of peroxynitrite, is involved in MS pathology and that increasing serum uric acid levels might have beneficial therapeutic effects. The aim of this study is to investigate serum uric acid levels in MS patients before and after long-term interferon beta treatment. Blood samples from 101 MS patients (53 receiving interferon beta 1a treatment and 48 receiving interferon beta 1b treatment; 28 male and 73 female; mean age at treatment onset 32,4±7,3 years; mean duration of disease at treatment onset 5,1±3,2 years; mean EDSS 2±1,3 before and after interferon beta treatment (mean treatment duration 3±2 years were analysed. Serum uric acid levels were measured using a quantitative enzymatic assay (Elitech Diagnostic, Sees, France. MS patients had significantly increased serum uric acid levels after treatment compared with those at the beginning of treatment (272,31±78,21 μmol/l vs. 210,17±53,65 μmol/l; p=0,019, Wilcoxon Mann-Whitney U-test. We did not find significant differences in serum uric acid levels between the interferon beta 1a and interferon beta 1b groups (p=0.98. These results indicate that one of the beneficial effects of interferon beta in MS might be based on the elevation of serum uric acid levels as a natural scavenger of peroxynitrite.

  19. Sputum and serum microRNA-144 levels in patients with tuberculosis before and after treatment.

    Science.gov (United States)

    Lv, Yan; Guo, Shuai; Li, Xue-Gang; Chi, Jing-Yu; Qu, Yi-Qing; Zhong, Hai-Lai

    2016-02-01

    To measure the expression levels of sputum and serum microRNA-144 (miR-144) before and after the treatment of patients with tuberculosis (TB). Details of the cases of a total of 124 TB patients were collected at Qilu Hospital of Shandong University between April 2014 and April 2015. Fifty-three of these patients had sputum positive for bacteria and a cavity on imaging (group A), 20 patients had sputum negative for bacteria and a cavity on imaging (group B), and 51 patients had sputum negative for bacteria and no cavity on imaging (group C). One hundred seventeen healthy people who attended the hospital for a physical examination were recruited as controls. Quantitative real-time PCR (qRT-PCR) was used to measure the levels of sputum and serum miR-144 before anti-TB treatment and at 1 month after treatment. Before treatment, sputum and serum miR-144 expression levels in the TB patients were both higher than those of the controls (both p<0.05). After treatment, sputum and serum miR-144 levels in the TB patients were significantly lower than those measured before treatment (both p<0.05). The levels of sputum and serum miR-144 in the improved TB patients decreased significantly after treatment compared to those measured before treatment (both p<0.001). Significant differences were found in sputum and serum miR-144 levels in the TB patients, with or without improvement, compared with the healthy controls (all p<0.05). Sputum and serum miR-144 levels were significantly upregulated in the TB patients, but were found to decrease significantly after anti-TB treatment. Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.

  20. Radionuclide content of wastewater and solid waste from a low-level effluent treatment plant

    International Nuclear Information System (INIS)

    Muhamat Omar; Zalina Laili; Nik Marzukee Nik Ibrahim; Mat Bakar Mahusin

    2010-01-01

    A study on radioactivity levels of wastewater and solid waste from a Low-level Effluent Treatment Plant has been carried out. The measurement of radionuclide concentration was carried out using gamma spectrometry. Natural and anthropogenic radionuclides were detected in solid radioactive waste recovered from the treatment plant. The presence of radionuclides in waste water varies depending on activities carried out in laboratories and facilities connected to the plant. (author)

  1. Decline of HIV antigen levels in cerebrospinal fluid during treatment with low-dose zidovudine

    NARCIS (Netherlands)

    de Gans, J.; Lange, J. M.; Derix, M. M.; de Wolf, F.; Eeftinck Schattenkerk, J. K.; Danner, S. A.; Ongerboer de Visser, B. W.; Cload, P.; Goudsmit, J.

    1988-01-01

    Six HIV-antigenaemic patients with AIDS or AIDS-related complex were studied to assess the effect of treatment with low-dose zidovudine (250 mg) in 6-hourly doses on HIV antigen (HIV-Ag) levels in cerebrospinal fluid (CSF). HIV-Ag was detected in CSF of three patients before treatment. These

  2. Consumer factors predicting level of treatment response to illness management and recovery.

    Science.gov (United States)

    White, Dominique A; McGuire, Alan B; Luther, Lauren; Anderson, Adrienne I; Phalen, Peter; McGrew, John H

    2017-12-01

    This study aims to identify consumer-level predictors of level of treatment response to illness management and recovery (IMR) to target the appropriate consumers and aid psychiatric rehabilitation settings in developing intervention adaptations. Secondary analyses from a multisite study of IMR were conducted. Self-report data from consumer participants of the parent study (n = 236) were analyzed for the current study. Consumers completed prepost surveys assessing illness management, coping, goal-related hope, social support, medication adherence, and working alliance. Correlations and multiple regression analyses were run to identify self-report variables that predicted level of treatment response to IMR. Analyses revealed that goal-related hope significantly predicted level of improved illness self-management, F(1, 164) = 10.93, p consumer-level predictors of level of treatment response have not been explored for IMR. Although 2 significant predictors were identified, study findings suggest more work is needed. Future research is needed to identify additional consumer-level factors predictive of IMR treatment response in order to identify who would benefit most from this treatment program. (PsycINFO Database Record (c) 2017 APA, all rights reserved).

  3. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease.

    Science.gov (United States)

    Kuo, Ho-Chang; Liang, Chi-Di; Wang, Chih-Lu; Yu, Hong-Ren; Hwang, Kao-Pin; Yang, Kuender D

    2010-10-01

    Kawasaki disease (KD) is a systemic vasculitis primarily affecting children who are initial IVIG treatment. This study was conducted to investigate the risk factors for initial IVIG treatment failure in KD. Children who met KD diagnosis criteria and were admitted for IVIG treatment were retrospectively enrolled for analysis. Patients were divided into IVIG-responsive and IVIG-resistant groups. Initial laboratory data before IVIG treatment were collected for analysis. A total of 131 patients were enrolled during the study period. At 48 h after completion of initial IVIG treatment, 20 patients (15.3%) had an elevated body temperature. Univariate analysis showed that patients who had initial findings of high neutrophil count, abnormal liver function, low serum albumin level (≤2.9 g/dL) and pericardial effusion were at risk for IVIG treatment failure. Multivariate analysis with a logistic regression procedure showed that serum albumin level was considered the independent predicting factor of IVIG resistance in patients with KD (p = 0.006, OR = 40, 95% CI: 52.8-562). There was no significant correlation between age, gender, fever duration before IVIG treatment, haemoglobin level, total leucocyte and platelet counts, C-reactive protein level, or sterile pyuria and initial IVIG treatment failure. The specificity and sensitivity for prediction of IVIG treatment failure in this study were 96% and 34%, respectively. Pre-IVIG treatment serum albumin levels are a useful predictor of IVIG resistance in patients with KD. © 2010 The Author(s)/Journal Compilation © 2010 Foundation Acta Paediatrica.

  4. Neurophysiological model of tinnitus: dependence of the minimal masking level on treatment outcome.

    Science.gov (United States)

    Jastreboff, P J; Hazell, J W; Graham, R L

    1994-11-01

    Validity of the neurophysiological model of tinnitus (Jastreboff, 1990), outlined in this paper, was tested on data from multicenter trial of tinnitus masking (Hazell et al., 1985). Minimal masking level, intensity match of tinnitus, and the threshold of hearing have been evaluated on a total of 382 patients before and after 6 months of treatment with maskers, hearing aids, or combination devices. The data has been divided into categories depending on treatment outcome and type of approach used. Results of analysis revealed that: i) the psychoacoustical description of tinnitus does not possess a predictive value for the outcome of the treatment; ii) minimal masking level changed significantly depending on the treatment outcome, decreasing on average by 5.3 dB in patients reporting improvement, and increasing by 4.9 dB in those whose tinnitus remained the same or worsened; iii) 73.9% of patients reporting improvement had their minimal masking level decreased as compared with 50.5% for patients not showing improvement, which is at the level of random change; iv) the type of device used has no significant impact on the treatment outcome and minimal masking level change; v) intensity match and threshold of hearing did not exhibit any significant changes which can be related to treatment outcome. These results are fully consistent with the neurophysiological interpretation of mechanisms involved in the phenomenon of tinnitus and its alleviation.

  5. Department of Energy treatment capabilities for greater-than-Class C low-level radioactive waste

    International Nuclear Information System (INIS)

    Morrell, D.K.; Fischer, D.K.

    1995-01-01

    This report provides brief profiles for 26 low-level and high-level waste treatment capabilities available at the Idaho National Engineering Laboratory (INEL), Lawrence Livermore National Laboratory (LLNL), Los Alamos National Laboratory (LANL), Oak Ridge National Laboratory (ORNL), Pacific Northwest Laboratory (PNL), Rocky Flats Plant (RFP), Savannah River Site (SRS), and West Valley Demonstration Plant (WVDP). Six of the treatments have potential use for greater-than-Class C low-level waste (GTCC LLW). They include: (a) the glass ceramic process and (b) the Waste Experimental Reduction Facility incinerator at INEL; (c) the Super Compaction and Repackaging Facility and (d) microwave melting solidification at RFP; (e) the vitrification plant at SRS; and (f) the vitrification plant at WVDP. No individual treatment has the capability to treat all GTCC LLW streams. It is recommended that complete physical and chemical characterizations be performed for each GTCC waste stream, to permit using multiple treatments for GTCC LLW

  6. Design features of a reverse osmosis demonstration plant for treatment of low level radioactive waste

    International Nuclear Information System (INIS)

    Shekhar, P.; Sudesh Nath; Gandhi, P.M.; Mishra, S.D.

    1994-01-01

    Reverse osmosis, a novel process in the field of nuclear waste management, is under evaluation globally. Its application is basically considered for the treatment of low level waste; yet references are found for its possible use to treat specific intermediate level waste streams, if segregated at source. The process of reverse osmosis (RO) is proposed for use in conjunction with other conventional processes like chemical treatment, ion exchange and evaporation. Flow sheets have been developed wherein RO can come as a replacement of one of these processes or is used as a pre or post treatment stage. The emphasis is on reducing the secondary wastes so as to realize an optimum levelised cost of treatment. This paper outlines the design basis for an RO plant for treating low level radioactive wastes based on the studies carried out on laboratory as well as bench scale. (author)

  7. Design features of a reverse osmosis demonstration plant for treatment of low level radioactive waste

    Energy Technology Data Exchange (ETDEWEB)

    Shekhar, P; Nath, Sudesh; Gandhi, P M; Mishra, S D [Waste Management Projects Division, Bhabha Atomic Research Centre, Mumbai (India)

    1994-06-01

    Reverse osmosis, a novel process in the field of nuclear waste management, is under evaluation globally. Its application is basically considered for the treatment of low level waste; yet references are found for its possible use to treat specific intermediate level waste streams, if segregated at source. The process of reverse osmosis (RO) is proposed for use in conjunction with other conventional processes like chemical treatment, ion exchange and evaporation. Flow sheets have been developed wherein RO can come as a replacement of one of these processes or is used as a pre or post treatment stage. The emphasis is on reducing the secondary wastes so as to realize an optimum levelised cost of treatment. This paper outlines the design basis for an RO plant for treating low level radioactive wastes based on the studies carried out on laboratory as well as bench scale. (author). 3 figs., 3 tabs.

  8. Study of Blood Leptin Levels before and After Treatment with Metformin in Diabetes Type Ii Patients

    Directory of Open Access Journals (Sweden)

    R Didehdar

    2005-04-01

    Full Text Available Introduction: Leptin is a fat tissue hormone that has 176 amino acids with a molecular weight of 16 KD . Leptin has effects on the hypothalamus and peripheral tissues resulting in decreased food absorption and increased energy consumption that finally reduces the body weight and BMI. The aim of this research was to investigate the blood levels of leptin before and after treatment with Metformin in type II diabetic patients. Methods: 25 type II diabetic patients without any previous drug treatment history were investigated. This study was a clinical trail before and after treatment with Metformin. Results: There was no particular difference in BMI, average body weight, fat mass and free fat mass before and after treatment. Similarly, the difference in concentration levels of blood glucose, cholesterol, tri-glycerides and LDL-cholesterol before and after treatment was not statistically significant. Also, there was no difference in the average concentration of leptin and insulin before and after treatment Conclusion: This result showed that although metformin decreased glucose and lipid levels during the treatment period, (1 month it did not have an effect on leptin, Insulin and other related factors during treatment.;

  9. AERE contracts with DoE on the treatment and disposal of intermediate level wastes

    International Nuclear Information System (INIS)

    Partridge, B.A.

    1984-06-01

    This document reports work carried out in 1983/84 under 10 contracts between DoE and AERE on the treatment and disposal of intermediate level wastes. Individual summaries are provided for each contract report within the document, under the headings: comparative evaluation of α and βγ irradiated medium level waste forms; modelling and characterisation of intermediate level waste forms based on polymers; optimisation of processing parameters for polymer and bitumen modified cements; ceramic waste forms; radionuclide release during leaching; ion exchange processes; electrical processes for the treatment of medium active liquid wastes; fast reactor fuel element cladding; dissolver residues; flowsheeting/systems study. (U.K.)

  10. Effects of gender and level of parental involvement among parents in drug treatment.

    Science.gov (United States)

    Collins, Cyleste C; Grella, Christine E; Hser, Yih-Ing

    2003-05-01

    Most studies of parents in drug treatment have focused exclusively on mothers, and few studies have examined the effects of parents' level of involvement with their children on the parents' drug use and psychological functioning, either before or after treatment. This study examined mothers and fathers (n = 331) who were parents of children under the age of 18; participants were sampled from 19 drug treatment programs across four types of treatment modalities in Los Angeles County. A majority of each group (57% of 214 mothers and 51% of 117 fathers) were classified as being highly involved with their children. At the baseline assessment, higher parental involvement was related to lower levels of addiction severity, psychological severity, and symptoms of psychological distress, and to higher levels of self-esteem and perception of parenting skills. In general, fathers had higher levels of alcohol and drug-use severity than did mothers, but fathers who were more involved with their children showed lower levels of addiction severity than fathers who were less involved. Parental involvement at baseline was unrelated to drug use at the 12-month follow-up, although parents who were less involved with their children reported experiencing more stressors. Given the association of parental involvement with lower levels of addiction severity and psychological distress at baseline, treatment protocols should build upon the positive relationships of parents with their children, and seek to improve those of less-involved parents.

  11. Effects of Pesticide Treatments on Nutrient Levels in Worker Honey Bees (Apis mellifera

    Directory of Open Access Journals (Sweden)

    Haley K. Feazel-Orr

    2016-03-01

    Full Text Available Honey bee colony loss continues to be an issue and no factor has been singled out as to the cause. In this study, we sought to determine whether two beekeeper-applied pesticide products, tau-fluvalinate and Fumagilin-B®, and one agrochemical, chlorothalonil, impact the nutrient levels in honey bee workers in a natural colony environment. Treatments were performed in-hive and at three different periods (fall, spring, and summer over the course of one year. Bees were sampled both at pre-treatment and two and four weeks post-treatment, weighed, and their protein and carbohydrate levels were determined using BCA and anthrone based biochemical assays, respectively. We report that, based on the pesticide concentrations tested, no significant negative impact of the pesticide products was observed on wet weight, protein levels, or carbohydrate levels of bees from treated colonies compared with bees from untreated control colonies.

  12. Association of baseline vitamin D levels with clinical parameters and treatment outcomes in chronic hepatitis B.

    Science.gov (United States)

    Chan, Henry Lik-Yuen; Elkhashab, Magdy; Trinh, Huy; Tak, Won Young; Ma, Xiaoli; Chuang, Wan-Long; Kim, Yoon Jun; Martins, Eduardo B; Lin, Lanjia; Dinh, Phillip; Charuworn, Prista; Foster, Graham R; Marcellin, Patrick

    2015-11-01

    The relationship between vitamin D levels and chronic hepatitis B (CHB) infection and treatment outcomes are poorly elucidated. We measured pre-treatment serum vitamin D (25-hydroxyvitamin D3; 25[OH]D3) levels and determined their association with clinical parameters and treatment outcomes in active CHB patients without advanced liver disease enrolled in a global clinical trial. Patients were randomly assigned to either 48 weeks of tenofovir disoproxil fumarate (TDF) plus peginterferon alfa-2a (PegIFN), TDF plus PegIFN for 16 weeks followed by TDF for 32 weeks, PegIFN for 48 weeks, or TDF for 120 weeks. Univariate and multivariate analyses were conducted to determine associations between vitamin D, baseline factors, and week 48 clinical outcome. Of 737 patients, 35% had insufficient (⩾20 but vitamin D levels. In univariate analysis, lower vitamin D levels were significantly associated with the following baseline parameters: younger age, lower uric acid levels, HBeAg-positive status, lower calcium levels, blood draw in winter or autumn, and HBV genotype D. On multivariate analysis, only HBV genotype, season of blood draw, calcium level, and age retained their association. High baseline level of vitamin D was associated with low HBV DNA, normal ALT and HBsAg at week 48 independent of treatment groups, but the association, with the exception of ALT, became statistically insignificant after adjusting for age, gender, HBeAg and HBV genotype. Abnormally low vitamin D levels are highly prevalent among untreated, active CHB patients. Baseline vitamin D levels are not associated with treatment outcomes, but were associated with normal ALT. Copyright © 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

  13. Risk comparison of different treatment and disposal strategies of high level liquid radioactive waste

    International Nuclear Information System (INIS)

    Fang Dong

    1997-01-01

    The risk of different treatment and disposal strategies of high level liquid radioactive waste from spent fuel reprocessing is estimated and compared. The conclusions obtained are that risk difference from these strategies is very small and high level liquid waste can be reduced to middle and low level waste, if the decontamination factor for 99 Tc is large enough, which is the largest risk contributor in the high level radioactive waste from spent fuel reprocessing. It is also shown that the risk of high level radioactive waste could be reduced by the technical strategy of combining partitioning and transmutation

  14. Reduction of serum TARC levels in atopic dermatitis by topical anti-inflammatory treatments.

    Science.gov (United States)

    Yasukochi, Yumi; Nakahara, Takeshi; Abe, Takeru; Kido-Nakahara, Makiko; Kohda, Futoshi; Takeuchi, Satoshi; Hagihara, Akihito; Furue, Masutaka

    2014-09-01

    Serum thymus and activation-regulated chemokine (TARC) levels are associated with the disease activity of patients with atopic dermatitis (AD) and sensitively reflect short-term changes in skin conditions. The main treatment for AD is topical agent application. This study investigated the relationship between serum TARC levels and the dosage of topical agents, including corticosteroids and/or tacrolimus, in patients with AD. The serum TARC levels of 56 AD patients and the amounts of topical agents prescribed to them were investigated retrospectively. The weekly reduction in serum TARC levels and weekly dosage of topical agents among AD patients were compared and their associations were evaluated. The dosage of topical agents was closely related to serum TARC levels. One gram of strong rank steroid or the equivalent amount of steroid/tacrolimus is required to reduce serum TARC levels by 9.94 pg/mL weekly in moderate to severe AD patients. Higher initial TARC levels require more topical agent, which results in a more rapid decrease in TARC levels. The serum TARC levels and eosinophil numbers in peripheral blood are significantly correlated. Serum TARC level improvement and topical agent dosage are strongly correlated. TARC and eosinophil numbers are significantly correlated, but the wider range of TARC levels seems to be clinically more useful for monitoring AD severity. The serum TARC level is a very sensitive biomarker for monitoring the severity and treatment response in AD.

  15. High vitamin B12 level and good treatment outcome may be associated in major depressive disorder

    Directory of Open Access Journals (Sweden)

    Tanskanen Antti

    2003-12-01

    Full Text Available Abstract Background Despite of an increasing body of research the associations between vitamin B12 and folate levels and the treatment outcome in depressive disorders are still unsolved. We therefore conducted this naturalistic prospective follow-up study. Our aim was to determine whether there were any associations between the vitamin B12 and folate level and the six-month treatment outcome in patients with major depressive disorder. Because vitamin B12 and folate deficiency may result in changes in haematological indices, including mean corpuscular volume, red blood cell count and hematocrit, we also examined whether these indices were associated with the treatment outcome. Methods Haematological indices, erythrocyte folate and serum vitamin B12 levels were determined in 115 outpatients with DSM-III-R major depressive disorder at baseline and serum vitamin B12 level again on six-month follow-up. The 17-item Hamilton Depression Rating Scale was also compiled, respectively. In the statistical analysis we used chi-squared test, Pearson's correlation coefficient, the Student's t-test, analysis of variance (ANOVA, and univariate and multivariate linear regression analysis. Results Higher vitamin B12 levels significantly associated with a better outcome. The association between the folate level and treatment outcome was weak and probably not independent. No relationship was found between haematological indices and the six-month outcome. Conclusion The vitamin B12 level and the probability of recovery from major depression may be positively associated. Nevertheless, further studies are suggested to confirm this finding.

  16. Testosterone levels and sexual function disorders in depressive female patients: effects of antidepressant treatment.

    Science.gov (United States)

    Kumsar, Şükrü; Kumsar, Neslihan Akkişi; Sağlam, Hasan Salih; Köse, Osman; Budak, Salih; Adsan, Öztuğ

    2014-02-01

    Women suffer from depression more frequently than men, which indicates that sex hormones might be involved in the etiology of this disease. The purpose of this study was to assess the relationship between testosterone and depression pathophysiology in depressive women along with sexual function. We also investigated whether antidepressant treatment causes any change in levels of this hormone or in sexual function. Premenopausal female patients aged 25-46 years (n = 52) with diagnosed major depression were included in this study as the patient group, and 25- to 46-year-old premenopausal women without depression (n = 30) were included as the control group. Serum testosterone and sex hormone-binding globulin (SHBG) levels were measured twice, before and after the antidepressant treatment. Bioavailable testosterone (cBT) levels were calculated using the assay results for total testosterone (TT), SHBG, and albumin according to the formulas of Vermeulen et al. Depression severity was measured using the 17-item Hamilton Depression Rating Scale, and sexual function was evaluated with the Arizona Sexual Experience Scale. The mean TT and cBT levels significantly increased in the patient group after the antidepressant treatment (P treatment TT and cBT levels were significantly lower in the patient group than in the control group (P treatment serum TT and cBT levels in the patient and control groups (P > 0.05). There were no significant differences among the groups in terms of SHBG level. The low testosterone levels in depressed women compared with women in the control group and the elevated levels post-pharmacotherapy suggest that testosterone may be involved in depression. © 2013 International Society for Sexual Medicine.

  17. Changes in levels of cytokines in the treatment of infected wounds and festering in children

    Directory of Open Access Journals (Sweden)

    O. V. Spakhi

    2016-12-01

    Full Text Available Informative and prognostic significance of cytokines in assessing the effectiveness of treatment tactics no doubt. The aim was to study the levels of pro- and anti-inflammatory cytokines in the dynamics of the treatment of infected wounds and purulent (IWP in children using the proposed optimized local treatment compared with standard procedure. Materials and methods. 45 children with IWP who were treated in the department of purulent surgery of Zaporozhye Regional Children's Hospital during the period of 2015-2016 years were divided into main (n = 26 and control groups (n = 19 depending on the tactics of treatment. The therapy of the main group patients were added by optimized integrated local treatment, which included a combination of magnetic therapy, antibacterial drug liposomal solutions and hirudotherapy. Efficacy of treatment was assessed by clinical characteristics and serum levels of IL-1β and IL-10 on the 1st and the 7th day of treatment. Results. The highest levels of pro-inflammatory IL-1β were defined in children with lymphadenitis on the first day of treatment. Common trends in the dynamics of cytokines content changes on the 7th day were in the line with generally accepted: decreased in IL-1β and increased in IL-10 levels. The level of IL-1β was not statistically different on the 7th day only in children with phlegmon. The most significant changes in IL-10 were observed in children with abscesses and lymphadenitis than in children with infected wound and phlegmon. Changes in markers of inflammation conform to positive changes in the clinical course of wound healing in children at the study. Generally, there was a lag dynamics of cytokines changes in the children who received standard therapy compared with the children who received the proposed optimized local treatment. Conclusions. The use of proposed IWP complex treatment in children showed the most significant effect on the anti-inflammatory IL-10 level in children with

  18. AERE contracts with DoE on the treatment and disposal of intermediate level wastes

    International Nuclear Information System (INIS)

    Partridge, B.A.

    1984-11-01

    Reports are presented on work on the following topics concerned with the treatment and disposal of intermediate-level radioactive wastes: comparative evaluation of α and β γ irradiated medium level waste forms; modelling and characterisation of intermediate level waste forms based on polymers; optimisation of processing parameters for polymer and bitumen modified cements; α damage in non-reference waste form matrix materials; leaching mechanisms and modelling; inorganic ion exchange treatment of medium active effluents; electrical processes for the treatment of medium active liquid waste; fast reactor fuel element cladding; dissolver residues; effects of radiation on the properties of cemented MTR waste forms; equilibrium leach testing of cemented MTR waste forms; radiolytic oxidation of radionuclides; immobilisation of liquid organic waste; quality control, non-conformances and corrective action. (U.K.)

  19. Treatment needs for greater-than-Class C low-level wastes

    International Nuclear Information System (INIS)

    Ross, W.A.; Brouns, R.A.; Burkholder, H.C.

    1988-01-01

    Greater-than-Class C (GTCC) radioactive wastes are those low-level wastes that exceed the 10CFR61 limits for shallow-land burial but are not within the historical definition of high-level wastes (i.e., spent fuel and first-cycle reprocessing wastes). The GTCC category can include all transuranic (TRU) wastes, although for the purposes of this paper, contact-handled defense TRU wastes are excluded because of the major efforts in the past decade to prepare them for disposal at the Waste Isolation Pilot Plant (WIPP). Thus, the GTCC category includes all high-activity and remote-handled TRU wastes regardless of origin. This paper defines the need for treatment of existing and projected GTCC low-level radioactive wastes in the United States. The sources, characteristics, treatment considerations, and methods for treatment are reviewed

  20. Intraocular levels of methotrexate after oral low-dose treatment in chronic uveitis.

    Science.gov (United States)

    Puchta, Joachim; Hattenbach, Lars-Olof; Baatz, Holger

    2005-01-01

    To determine the intraocular levels of methotrexate in low-dose treatment of noninfectious uveitis. One day after oral administration, the methotrexate level was measured in the aqueous humor and serum of a patient with noninfectious uveitis, who underwent cataract surgery. A fluorescence polarization immunoassay was used for determination. After oral administration, methotrexate was only measurable in aqueous humor but not in serum. In uveitis, orally administered low-dose methotrexate reaches detectable levels in aqueous humor, even in the absence of detectable levels in serum. Copyright (c) 2005 S. Karger AG, Basel.

  1. Eldecalcitol normalizes bone turnover markers regardless of their pre-treatment levels.

    Science.gov (United States)

    Shiraki, Masataka; Saito, Hitoshi; Matsumoto, Toshio

    2012-09-01

    Three-year treatment with eldecalcitol has been shown to improve lumbar and total hip bone mineral density (BMD), decrease bone turnover markers, and lower the incidences of vertebral and wrist fractures in patients with osteoporosis more than with treatment with alfacalcidol under vitamin D repletion. The purpose of this study was to determine whether there was a risk of eldecalcitol causing severely suppressed bone turnover in osteoporosis patients with low pre-treatment levels of bone turnover markers. Post-hoc analysis was conducted on the data from a 3-year, randomized, double-blind, active-comparator, clinical trial of eldecalcitol versus alfacalcidol under vitamin D repletion conducted in Japan. Enrolled patients with baseline measurements of bone turnover markers were stratified into tertiles according to their pre-treatment levels of serum bone-specific alkaline phosphatase, serum procollagen type I N-terminal propeptide, or urinary collagen-N-telopeptide. Eldecalcitol treatment rapidly reduced bone turnover markers, and kept them within the normal range. However, in the patients whose baseline values for bone turnover were low, eldecalcitol treatment did not further reduce bone turnover markers during the 3-year treatment period. Further long-term observation may be required to reach the conclusion. CLINICALTRIALS.GOV NUMBER: NCT00144456. Eldecalcitol normalizes, but does not overly suppress, bone turnover regardless of baseline levels of bone turnover markers. Thus, it is unlikely that eldecalcitol treatment will increase the risk of severely suppressed bone turnover and therefore deterioration of bone quality, at least for a treatment duration of 3 years.

  2. Chemotherapeutic treatment reduces circulating levels of surfactant protein-D in children with acute lymphoblastic leukemia

    DEFF Research Database (Denmark)

    Rathe, Mathias; Sorensen, Grith L; Skov Wehner, Peder

    2017-01-01

    with acute lymphoblastic leukemia (ALL). PROCEDURE: In a prospective study, 43 children receiving treatment for ALL were monitored for mucosal toxicity from diagnosis through the induction phase of treatment. Serial blood draws were taken to determine the levels of SP-D, interleukin-6 (IL-6), C......BACKGROUND: Surfactant protein D (SP-D) is a host defense molecule of the innate immune system that enhances pathogen clearance and modulates inflammatory responses. We hypothesized that circulating SP-D levels are associated with chemotherapy-induced mucositis and infectious morbidity in children...

  3. Brain-derived neurotrophic factor levels under chronic natalizumab treatment in multiple sclerosis. A preliminary report.

    Science.gov (United States)

    Văcăraş, Vitalie; Major, Zoltán Zsigmond; Buzoianu, Anca Dana

    Our main purpose was to investigate if the chronic treatment with the disease-modifying drug natalizumab shows quantifiable effect on BDNF levels in multiple sclerosis patients. BDNF plasma concentration was evaluated using enzyme-linked immunosorbent assay in healthy individuals, not treated multiple sclerosis patients and patients treated with natalizumab. Multiple sclerosis patients have a significantly lower amount of peripheral BDNF than healthy individuals. Patients treated with natalizumab have significantly higher BDNF levels than not treated patients. Chronic natalizumab treatment is associated with significantly increased plasma BDNF concentration in multiple sclerosis. Copyright © 2017 Polish Neurological Society. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.

  4. Treatment with liraglutide may improve markers of CVD reflected by reduced levels of apoB

    DEFF Research Database (Denmark)

    Engelbrechtsen, Line; Lundgren, J; Wewer Albrechtsen, Nicolai Jacob

    2017-01-01

    Background: Dislipidaemia and increased levels of apolipoprotein B (apoB) in individuals with obesity are risk factors for development of cardiovascular disease (CVD). The aim of this study was to investigate the effect of weight loss and weight maintenance with and without liraglutide treatment ......B, despite similar body weight maintenance. Treatment with liraglutide may therefore reduce apoB levels and thus reflect lower CVD risk. Including apoB measurements in clinical practice when monitoring patients with dislipidemia or CVD might prove to be useful....

  5. Choosing solidification or vitrification for low-level radioactive and mixed waste treatment

    International Nuclear Information System (INIS)

    Gimpel, R.F.

    1992-01-01

    Solidification (making concrete) and vitrification (making glass) are frequently the treatment methods recommended for treating inorganic or radioactive wastes. Solidification is generally perceived as the most economical treatment method. Whereas, vitrification is considered (by many) as the most effective of all treatment methods. Unfortunately, vitrification has acquired the stigma that it is too expensive to receive further consideration as an alternative to solidification in high volume treatment applications. Ironically, economic studies, as presented in this paper, show that vitrification may be more competitive in some high volume applications. Ex-situ solidification and vitrification are the competing methods for treating in excess of 450 000m 3 of low-level radioactive and mixed waste at the Fernald Environmental Management Project (FEMP or simply, Fernald) located near Cincinnati, Ohio. This paper summarizes how Fernald is choosing between solidification and vitrification as the primary waste treatment method

  6. Choosing solidification or vitrification for low-level radioactive and mixed waste treatment

    International Nuclear Information System (INIS)

    Gimpel, R.F.

    1992-01-01

    Solidification (making concrete) and vitrification (making glass) are frequently the treatment methods recommended for treating inorganic or radioactive wastes. Solidification is generally perceived as the most economical treatment method. Whereas, vitrification is considered (by many) as the most effective of all treatment methods. Unfortunately, vitrification has acquired the stigma that it is too expensive to receive further consideration as an alternative to solidification in high volume treatment applications. Ironically, economic studies, as presented in this paper, show that vitrification may be more competitive in some high volume applications. Ex-situ solidification and vitrification are the competing methods for treating in excess of 450,000 m 3 of low-level radioactive and mixed waste at the Fernald Environmental Management Project (FEMP or simply, Fernald) located near Cincinnati, Ohio. This paper summarized how Fernald is choosing between solidification and vitrification as the primary waste treatment method

  7. Treatment and disposal of low- and medium-level radioactive wastes in Hungary

    International Nuclear Information System (INIS)

    Berci, Karoly; Feher, Janos; Hemm, Bela; Setenyi, Marta

    1989-01-01

    Low- and medium-level radioactive wastes from the Paks Nuclear Power Plant, Hungary, are treated and disposed according to international and Hungarian regulations. Treatment of liquid wastes is accomplished by cementing, most of solid wastes are disposed after compaction. The forming of the final disposal site satisfies every radiation protection criteria. The recommendations of radioactive waste treatment are interpreted and analyzed in detail, for the implementation of advanced radioactive waste treatment techniques and facilities for treating and disposing of the liquid and solid wastes accumulated during operation of the PNPP. (R.P.) 8 figs.; 9 tabs

  8. Cytokine Polymorphisms, Their Influence and Levels in Brazilian Patients with Pulmonary Tuberculosis during Antituberculosis Treatment

    Directory of Open Access Journals (Sweden)

    Eliana Peresi

    2013-01-01

    Full Text Available Cytokines play an essential role during active tuberculosis disease and cytokine genes have been described in association with altered cytokine levels. Therefore, the aim of this study was to verify if IFNG, IL12B, TNF, IL17A, IL10, and TGFB1 gene polymorphisms influence the immune response of Brazilian patients with pulmonary tuberculosis (PTB at different time points of antituberculosis treatment (T1, T2, and T3. Our results showed the following associations: IFNG +874 T allele and IFNG +2109 A allele with higher IFN-γ levels; IL12B +1188 C allele with higher IL-12 levels; TNF −308 A allele with higher TNF-α plasma levels in controls and mRNA levels in PTB patients at T1; IL17A A allele at rs7747909 with higher IL-17 levels; IL10 −819 T allele with higher IL-10 levels; and TGFB1 +29 CC genotype higher TGF-β plasma levels in PTB patients at T2. The present study suggests that IFNG +874T/A, IFNG +2109A/G, IL12B +1188A/C, IL10 −819C/T, and TGFB1 +21C/T are associated with differential cytokine levels in pulmonary tuberculosis patients and may play a role in the initiation and maintenance of acquired cellular immunity to tuberculosis and in the outcome of the active disease while on antituberculosis treatment.

  9. Comparison of costs for alternative mixed low-level waste treatment systems

    International Nuclear Information System (INIS)

    Schwinkendorf, W.E.; Harvego, L.; Cooley, C.R.; Biagi, C.

    1996-01-01

    Total life cycle costs (TLCCs), including disposal costs, of thermal, nonthermal and enhanced nonthermal systems were evaluated to guide future research and development programs for the treatment of mixed low-level waste (MLLW) consisting of RCRA hazardous and low-level radioactive wastes. In these studies, nonthermal systems are defined as those systems that process waste at temperatures less than 350 C. Preconceptual designs and costs were developed for thirty systems with a capacity (2,927 lbs/hr) to treat the DOE MLLW stored inventor y(approximately 236 million pounds) in 20 years in a single, centralized facility. A limited comparison of the studies' results is presented in this paper. Sensitivity of treatment costs with respect to treatment capacity, number of treatment facilities, and system availability were also determined. The major cost element is operations and maintenance (O and M), which is 50 to 60% of the TLCC for both thermal and nonthermal systems. Energy costs constitute a small fraction (< 1%) of the TLCCs. Equipment cost is only 3 to 5% of the treatment cost. Evaluation of subsystem costs demonstrate that receiving and preparation is the highest cost subsystem at about 25 to 30% of the TLCC for both thermal and nonthermal systems. These studies found no cost incentives to use nonthermal or hybrid (combined nonthermal treatment with stabilization by vitrification) systems in place of thermal systems. However, there may be other incentives including fewer air emissions and less local objection to a treatment facility. Building multiple treatment facilities to treat the same total mass of waste as a single facility would increase the total treatment cost significantly, and improved system availability decreases unit treatment costs by 17% to 30%

  10. Modulation of the sound press level by the treatment of polymer diaphragms through ion implantation method

    International Nuclear Information System (INIS)

    Yeo, Sunmog; Park, Jaewon; Lee, Hojae

    2010-01-01

    We present two different surface modification treatments, an ion implantation, and an ion beam mixing, and show that the surface modifications caused by these treatments are useful tools to modulate the sound press level. The ion implantations on various polymer diaphragms cause an increase in the resonant frequency so that the sound press level is lowered at low frequencies. On the contrary, a Cu or Fe 2 O 3 coating by using an ion beam mixing method causes a decrease in the resonant frequency, resulting in a high sound press level at low frequencies. We discuss the physical reasons for the change in the sound press level due to the ion-implantation methods.

  11. Relation between serum vitamin B12 level and duration of treatment with carbamazepine in epilepsy patients

    Directory of Open Access Journals (Sweden)

    Mohammad Tariqul Islam

    2016-12-01

    Full Text Available Vitamin B12 levels in the serum of 58 epileptic patients receiving only carbamazepine for at least 6 months were measured. Same number of epilepsy patients with no history of taking antiepileptic medicine were taken as control. The mean level of vitamin B12 in carbamazepine-treated epileptic patients was 265.5 pg/mL whereas it was 478.3 pg/mL in control. Increased duration of treatment of carbamazepine in epilepsy caused significantly decreased level of serum vitamin B12 (Pearson correlation coefficient, r = -0.9, p<0.0001. In conclusion, serum vitamin B12 level significantly decreased in relation to duration of carbamazepine treatment in epileptic patients.

  12. IGF-1 levels may increase paradoxically with dopamine agonist treatment for prolactinomas.

    Science.gov (United States)

    Akirov, Amit; Greenman, Yona; Glaser, Benjamin; S'chigol, Irena; Mansiterski, Yossi; Eizenberg, Yoav; Shraga-Slutzky, Ilana; Shimon, Ilan

    2018-05-04

    Hyperprolactinemia is common in acromegaly and in these patients, insulin-like growth factor (IGF)-1 level may decrease with dopamine agonist. We report a series of patients with prolactinoma and a paradoxical increase of IGF-1 levels during cabergoline treatment. Clinical characteristics and response to treatment of patients with prolactinomas, in whom normal or slightly elevated baseline IGF-1 levels increased with cabergoline. The cohort consisted of ten prolactinoma patients (nine males, mean age 48 ± 14 years). Mean adenoma size was 23.8 ± 16.2 mm, with cavernous sinus invasion in eight. In five patients baseline IGF-1 levels were normal and in four levels were 1.2-1.5-fold the upper limit of the normal (ULN). One patient had IGF-1 measured shortly after initiating cabergoline and it was 1.4 × ULN. During cabergoline treatment (dose range 0.5-2 mg/week) PRL normalization was achieved in all and tumor shrinkage occurred in seven patients. The mean IGF-1 increase on cabergoline was 1.7 ± 0.4 × ULN. Cabergoline dose reduction or interruption was attempted in five patients and resulted in decreased IGF-1 levels in all, including normalization in two patients. Three patients were eventually diagnosed with acromegaly, one was referred for pituitary surgery followed by complete remission, another patient was switched to somatostatin analogue, and the third was treated by combination of somatostatin analogues with pegvisomant, with reduction of IGF-1 in all these patients. IGF-1 levels may increase to clinically significant levels during cabergoline treatment for PRL-adenoma. We suggest IGF-1 monitoring in all patients treated with dopamine agonists and not only in those presenting symptoms of acromegaly.

  13. Erythropoetin treatment can increase 2,3-diphosphoglycerate levels in red blood cells.

    Science.gov (United States)

    Birgegård, G; Sandhagen, B

    2001-01-01

    Some patients experience an improved well-being during treatment with recombinant human erythropoietin even with an unchanged Hb level. We have hypothesized that this may not be only a placebo effect. 2,3-diphosphoglycerate (2,3-DPG) in red blood cells increases in response to anaemia/hypoxia and causes a shift of the oxygen dissociation curve, allowing a more effective oxygen delivery. We have investigated red cell 2,3-DPG concentrations during erythropoietin treatment in healthy volunteers as a mediator of a possible physiological explanation. Thirteen healthy subjects with no iron deficiency were recruited and randomly assigned to a treatment group comprising five males and three females and a control group including three males and two females. The treatment group was treated with erythropoietin (Recormon), 20 IE/kg subcutaneously three times/week for 4 weeks. Blood samples were collected at each injection day and 10 days after the last injection and at corresponding times in the control group. B-Hb, red cell 2,3-DPG and P50 were measured by standard techniques and oxygen-releasing capacity was calculated. due to the sampling (26 ml each time, three times/week) the mean Hb level was lowered from 140.5 +/- 5.9 to 128.6 +/- 10.4 g/L in the control group whereas the erythropoietin treatment group maintained a mean Hb level of about 142 g/L (plevel curve as well as that for oxygen releasing capacity also differed significantly between the two groups (p levels. treatment with erythropoietin causes an increase in red cell 2,3-DPG levels.

  14. Association between Serum Cortisol and DHEA-S Levels and Response to Antipsychotic Treatment in Schizophrenia

    Directory of Open Access Journals (Sweden)

    Zoja Babinkostova

    2015-02-01

    Full Text Available BACKGROUND: Previous studies suggested that alterations in serum cortisol and DHEA-S levels may play a role in the pathophysiology of schizophrenia. AIM: To compare serum cortisol and DHEA-S levels between patients with schizophrenia and healthy controls and to evaluate their association with the response to antipsychotic treatment. MATERIAL AND METHODS: In this clinical prospective study were included 60 patients with schizophrenia and 40 healthy age and sex matched control subjects. Clinical evaluation of patients was performed using the Positive and Negative Symptom Scale. A questionnaire for socio-demographic and clinical data collection was used. For the purposes of the study, the examined group was divided in two subgroups: responders and nonresponders. Serum cortisol and DHEA-S levels were measured at baseline in all participants and after 3 and 6 weeks of the antipsychotic treatment in patients with schizophrenia. RESULTS: Patients with schizophrenia had significantly higher serum cortisol and DHEA-S levels in comparison to the control group. Responders had significantly higher serum cortisol and DHEA-S levels compared with nonresponders. CONCLUSION: Elevated serum cortisol and DHEA-S levels may play a role in the pathophysiology of schizophrenia and they may be related to positive response to antipsychotic treatment in patients with schizophrenia.

  15. Comparison of Pre and Post-Treatment Orexin A Levels in Patients with Subclinical Hypothyroidism

    Directory of Open Access Journals (Sweden)

    Muhammed Erdal

    2010-01-01

    Full Text Available Aim: Subclinical hypothyroidism is a clinical condition mostly observed in women, the prevalence of which increases by age. Sleepiness and appetite problems are observed in subclinical hypothyroidism. Orexins play a role in the physiological regulations like the stabilization of cardiovascular functions and the sleep-alert cycle. Similarities in the physiological regulation areas of orexins and the clinical findings of hypothyroidism were influential in the planning of this research. Additionally, homosisteine, which is influential on the cardiovascular system and the plasma level of which changes by eating (as is the case with orexins, was also analyzed. Besides, the change in the lipid profiles of the patients was also observed. Material and Methods: Nineteen pre-menopausal female patients (mean age=39.58±12.58, mean BMI= 26.7±4.9 included in this study. Following 12 hours fasting blood samples were taken from brachial vein. All patients were given 50µg/day L-T4 TSH levels were examined in every 4-6 weeks to adjust the L-T4 doses. When euthyroidism was ensured, a re-evaluation was made 4 months later. Results:  Pre-treatment plasma orexin A levels of 19 patients with pre-menopausal subclinical hypothyroidism increased significantly following a treatment of l-tiroxin for 4 months (pre-treatment orexin level median=1.20 mg/dl (mean: 1.33±0.28 post-treatment median=1.82 mg/dl (mean: 1.70±0.42 p=0.007. A significant change in the level of plasma total homosisteine and lipid profile was not detected. Conclusions: Advanced studies are needed to study the physiological effects of orexin levels in cases with subclinical hypothyroidism and the possible benefits in treatment.

  16. Centralized treatment facility for low level radioactive waste produced in Belgium. The CILVA project

    International Nuclear Information System (INIS)

    Detilleux; Debieve; Renard, M.C.

    1993-01-01

    The CILVA unit is designed for β γ low level nuclear wastes treatments. CILVA is made of five units: the reception/storage/distribution unit, the waste preconditioning unit, the supercompaction unit, the incineration unit and the conditioning unit. Each unit will be controlled by a decentralized system connected to a central waste management monitoring system. (A.B.). 2 figs

  17. Use of competitive polymerase chain reaction to determine HIV-1 levels in response to antiviral treatments

    NARCIS (Netherlands)

    Bruisten, S. M.; Koppelman, M. H.; Roos, M. T.; Loeliger, A. E.; Reiss, P.; Boucher, C. A.; Huisman, H. G.

    1993-01-01

    OBJECTIVE: To develop a competitive polymerase chain reaction technique with which to evaluate the usefulness of HIV-1 level as a marker of response to antiviral treatment. DESIGN: HIV-1 sequences were assessed by competitive polymerase chain reaction in four subjects participating in a double-blind

  18. Level of paranormal beliefs and its relationship with explanatory models, treatment adherence and satisfaction

    Directory of Open Access Journals (Sweden)

    Dushad Ram

    2016-06-01

    Full Text Available Abstract Background Paranormal beliefs are common among patients with mental illness. Such beliefs may mediate conceptualization of illness, treatment satisfaction and medication adherence. Objective To study the level of paranormal beliefs and its relationship with explanatory models, treatment adherence and satisfaction using standardized assessment tool. Methods Eighty nine patients with mental illness in remission were assessed with Sociodemographic proforma, Revised Paranormal Belief Scale (RPBS, Mental Distress Explanatory Model Questionnaire (MMAS, Morisky Medication Adherence Scale (MMAS and Short Assessment of Patient Satisfaction (SAPS. Results Results revealed a high level of paranormal beliefs on RPBS (Mean 83.96, SD ± 23.91. Variables that had a statistically significant group difference on the score of RPBS were domicile status (p < 05, diagnosis (p < 001, method of treatment sought before (p < 001. In a linear regression analysis four variables explained 35.4% of the variance (R2 = .38, R2Adjusted = .35, F = 13.04, p < .001 in RPBS Score. These variables were total score of MDEMQ (Beta = .308, t = 3.435, p < .001, total score of MMAS (beta = .357, t = 3. 716, p < .001 and magico-religious treatment received earlier (beta = .306, t = 3.52, p < .001 and SAPS. Discussion Based on the finding of this study, it may be concluded that the level of paranormal beliefs may vary with some demographic variables. Levels of paranormal beliefs is positively associated with explanatory models and adherence in patients with mental illness in remission.

  19. Ultralow Level Mercury Treatment Using Chemical Reduction and Air Stripping: Scoping Report

    International Nuclear Information System (INIS)

    Looney, B.B.

    2000-01-01

    Data collected during the first stage of a Savannah River Technology Center (SRTC) Strategic Research and Development Project confirmed the efficacy of chemical reduction and air stripping/sparging as an ultralow level mercury treatment concept for waters containing Hg(II). The process consists of dosing the water with low levels of stannous chloride to convert the mercury to Hg. This form of mercury can easily be removed from the water by air stripping or sparging. Samples of Savannah River Site (SRS) groundwater containing approximately 130 ng/L of total mercury (as Hg(II)) were used for the study. In undosed samples, sparging removed 0 percent of the initial mercury. In the dosed samples, all of the removals were greater than 94 percent, except in one water type at one dose. This sample, which was saturated with dissolved oxygen, showed a 63 percent reduction in mercury following treatment at the lowest dose. Following dosing at minimally effective levels and sparging, treated water contained less than 10 ng/L total mercury. In general, the data indicate that the reduction of mercury is highly favored and that stannous chloride reagent efficiently targets the Hg(II) contaminant in the presence of competing reactions. Based on the results, the authors estimated that the costs of implementing and operating an ultralow level mercury treatment process based on chemical reduction and stripping/sparging are 10 percent to 20 percent of traditional treatment technologies

  20. Tacrolimus drug level and response to treatment in idiopathic childhood steroid resistant nephrotic syndrome

    International Nuclear Information System (INIS)

    Shah, S.S.; Hafeez, F.; Akhtar, N.

    2015-01-01

    The management of Steroid Resistant Nephrotic Syndrome (SRNS) is an uphill task for paediatric nephrologists as immunosuppressive agents are the mainstay of treatment in these patients. Tacrolimus is used along with steroids. This study is conducted to see the relationship between the tacrolimus dose, drug level and response in the management of SRNS. Methods: This quasi experimental study was conducted at The Childrens Hospital Lahore over a period of one year. Patients with SRNS of either sex and 1-10 years of age were included and those with secondary nephrotic syndrome were excluded. Tacrolimus was given at a dose of 0.05-0.1 mg/kg/day in 2 divided doses along with steroids. The follow-up was done for six months with proteinuria monitoring and tacrolimus drug levels done two weeks after initiation of treatment. Results: Out of 42 patients, 27 (64.3%) were males and 15 (35.7%) were females. The most common histological diagnosis observed was mesangio-proliferative glomerulonephritis in 30 (71.4%) patients. The tacrolimus trough level range was 0.5-15.20 ng/ml with a mean value of 4.68 ng/ml±2.85. Forty-one (97.6%) children showed complete response to treatment while one patient showed partial response. Conclusion: This study suggests that tacrolimus is an effective drug for treatment of SRNS in paediatric patients and there is no linear relationship between the drug dose, response and drug level. (author)

  1. Vitrification Studies with DOE Low-Level Mixed Waste Wastewater Treatment Sludges

    International Nuclear Information System (INIS)

    Cicero, C.A.; Andrews, M.K.; Bickford, D.F.; Hewlett, K.J.; Bennert, D.M.; Overcamp, T.J.

    1995-01-01

    Vitrification studies with simulated Low Level Mixed Waste (LLMW) sludges were performed at the Savannah River Technology Center (SRTC). These studies focused on finding the optimum glass compositions for four simulated LLMW wastewater treatment sludges and were based on both crucible-scale and pilot-scale studies. Optimum compositions were determined based on the maximum waste loading achievable without sacrificing glass integrity

  2. Environmental Assessment Offsite Thermal Treatment of Low-Level Mixed Waste

    Energy Technology Data Exchange (ETDEWEB)

    N/A

    1999-05-06

    The U.S. Department of Energy (DOE), Richland Operations Office (RL) needs to demonstrate the economics and feasibility of offsite commercial treatment of contact-handled low-level mixed waste (LLMW), containing polychlorinated biphenyls (PCBS) and other organics, to meet existing regulatory standards for eventual disposal.

  3. Statin use and 25-hydroxyvitamin D blood level response to vitamin D treatment of older adults

    Science.gov (United States)

    Objectives: To determine whether statin use alters response of 25-hydroxyvitamin D (25(OH)D) level to vitamin D treatment. Design: Pooled analysis. Setting: Three double-blind randomized controlled trials that tested different doses of vitamin D. Participants: Participants of three trials (N = 646; ...

  4. Levothyroxine treatment restored the decreased circulating fibroblast growth factor 21 levels in patients with hypothyroidism.

    Science.gov (United States)

    Wang, Guang; Liu, Jia; Yang, Ning; Hu, Yanjin; Zhang, Heng; Miao, Li; Yao, Zhi; Xu, Yuan

    2016-06-01

    Fibroblast growth factor 21 (FGF21) is an important endogenous regulator of energy metabolism. Thyroid hormone has been shown to regulate hepatic FGF21 expression in rodents. The goal of this study was to evaluate the plasma FGF21 levels in participants with normal thyroid function, subclinical hypothyroidism, or overt hypothyroidism and to investigate the change of plasma FGF21 levels in patients with overt hypothyroidism after levothyroxine treatment. A total of 473 drug-naive participants were recruited, including 250 healthy control subjects, 116 patients with subclinical hypothyroidism, and 107 patients with overt hypothyroidism. Thirty-eight patients with overt hypothyroidism were assigned to receive levothyroxine treatment. The overt hypothyroidism group had decreased FGF21 levels compared with the control and subclinical hypothyroidism groups (Ptreatment markedly attenuated the increased circulating levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), high-sensitivity C-reactive protein (hsCRP), and homeostasis model assessment index of insulin resistance (HOMA-IR) in patients with overt hypothyroidism. A significant increase in plasma FGF21 levels was observed after levothyroxine treatment (Ptreatment (FT3: r=0.44; FT4: r=0.53; all Ptreatment ameliorated metabolic disorders and restored the decreased circulating FGF21 levels in patients with overt hypothyroidism. The increase in FGF21 levels after levothyroxine treatment might be partly associated with the amelioration of metabolic disorders in patients with hypothyroidism. Copyright © 2016 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

  5. Low-Level Laser Therapy in the Treatment of Recurrent Aphthous Ulcers: A Systematic Review

    Directory of Open Access Journals (Sweden)

    Fernando Alves Vale

    2015-01-01

    Full Text Available Recurrent aphthous ulcers (RAUs are the most common lesion found in the oral cavity. There is no definitive cure for RAUs and current treatments are aimed at minimizing symptoms. Since low-level laser therapy (LLLT modulates inflammatory responses, and promotes pain reduction and cellular biostimulation, LLLT can be suggested as an alternative treatment for RAUs. The literature concerning the potential of LLLT in the treatment of RAUs was evaluated. A systematic literature review identified 22 publications, of which only 2 studies were adopted. The eligibility criteria consisted of randomized controlled trials (RCTs. Both RCTs achieved significant results concerning LLLT and pain-level reductions and reduced healing times. Despite the variance in irradiation conditions applied in both studies, very similar wavelengths were adopted. There is accordingly strong evidence that wavelength plays an important role in RAU treatment. Taking into account the different parameters applied by selected RCTs, it is not possible to suggest that a specific protocol should be used. However, in light of the significant results found in both studies, LLLT can be suggested as an alternative for RAU treatment. Additional RCTs should be performed in order to reach a clinical protocol and better understand the application of LLLT in RAU treatment.

  6. Ultraviolet-ozone treatment reduces levels of disease-associated prion protein and prion infectivity

    Science.gov (United States)

    Johnson, C.J.; Gilbert, P.; McKenzie, D.; Pedersen, J.A.; Aiken, Judd M.

    2009-01-01

    Background. Transmissible spongiform encephalopathies (TSEs) are a group of fatal neurodegenerative diseases caused by novel infectious agents referred to as prions. Prions appear to be composed primarily, if not exclusively, of a misfolded isoform of the cellular prion protein. TSE infectivity is remarkably stable and can resist many aggressive decontamination procedures, increasing human, livestock and wildlife exposure to TSEs. Findings. We tested the hypothesis that UV-ozone treatment reduces levels of the pathogenic prion protein and inactivates the infectious agent. We found that UV-ozone treatment decreased the carbon and prion protein content in infected brain homogenate to levels undetectable by dry-ashing carbon analysis or immunoblotting, respectively. After 8 weeks of ashing, UV-ozone treatment reduced the infectious titer of treated material by a factor of at least 105. A small amount of infectivity, however, persisted despite UV-ozone treatment. When bound to either montmorillonite clay or quartz surfaces, PrPTSE was still susceptible to degradation by UV-ozone. Conclusion. Our findings strongly suggest that UV-ozone treatment can degrade pathogenic prion protein and inactivate prions, even when the agent is associated with surfaces. Using larger UV-ozone doses or combining UV-ozone treatment with other decontaminant methods may allow the sterilization of TSE-contaminated materials. ?? 2009 Aiken et al; licensee BioMed Central Ltd.

  7. AERE contracts with DOE on the treatment and disposal of Intermediate Level Wastes

    International Nuclear Information System (INIS)

    Partridge, B.A.

    1985-07-01

    Individual summaries are provided for each contract report, under the titles: comparative evaluation of α and βγ irradiated medium level waste forms; modelling and characterisation of intermediate level waste forms based on polymers; optimisation of processing parameters for polymer and bitumen modified cements; α damage in non-reference matrix materials; leaching mechanisms and modelling; inorganic ion exchange treatment of medium active effluents; electrical processes for the treatment of medium active liquid waste; fast reactor fuel element cladding; dissolver residues; effects of radiation on the properties of cemented MTR waste forms; equilibrium leach testing of cemented MTR waste forms; radiolytic oxidation of radionuclides; immobilisation of liquid organic wastes; quality control, non-conformances and corrective action; application of gel processes in the treatment of actinide-containing liquid wastes; the role of colloids in the release of radionuclides from nuclear waste. (author)

  8. Effects of treatments for experimental bone tumor on prostaglandin E level and bone scintigrams

    Energy Technology Data Exchange (ETDEWEB)

    Otsuka, Nobuaki; Ito, Yasuhiko; Yoneda, Masaya; Muranaka, Akira; Nishishita, Soichi; Morita, Rikushi [Kawasaki Medical School, Kurashiki, Okayama (Japan)

    1983-10-01

    The role of Prostaglandin E (PgE) level was studied experimentally as follows: 1) intrahepatic implantation of VX-2, 2) intravenous injection of VX-2, 3) effect of treatments on intramedullary implanted VX-2. The levels of PgE in intrahepatic and intravenous transplantation were not higher than that of intramedullary transplantation. Mitomycin C (MMC) did not reduce the PgE level and appearance time of bone scan abnormality was the same as that of untreated animals. A combination of indomethacin and MMC caused a delay in appearance time of bone scan abnormalities.

  9. Treatment of labial adhesion with topical estrogen and correlation with serum estradiol level

    Directory of Open Access Journals (Sweden)

    Safaian B

    2013-05-01

    Full Text Available Background: Serum estradiol level is a controversial prognostic factor in the outcome of labial adhesion. The aim of this study was to evaluate serum estradiol levels and topical estrogen response in patients with labial adhesion.Methods: A prospective interventional study was conducted among girls with labial adhesion that referred to Pediatrics clinic in Taleghani University Hospital, Gorgan city, Iran in 2011. One hundred patients entered the study. The diagnosis was conducted by clinical examination of vestibule area. Inclusion criteria were, three months to eight years old prepuberty girls, no ambiguous genitalia, lack of vulvovaginitis symptoms, labial adhesion more than twenty five percent, no history of previous topical estrogen treatment since two weeks ago and previous incomplete treatment. The patients who did not use proper amount and duration of drug and also with adverse drug reactions during treatment period were excluded from the study. Results: The maximum frequency of labial adhesion was in the group of less than one year old. The minimum frequency of labial adhesion was in the 7-8 years old group. Eighty six patients had complete or partial remission. No evidence of an improvement was observed in fourteen children. Severity of adhesions did not worsen in our patients. Serum estradiol levels were lower in patients who had a positive response to treatment. There were significant differences in serum estradiol levels between full or relative improvement with no improvement groups (P=0.044.Conclusion: Findings of this study showed that the labial adhesion patients with low serum estradiol level had better treatment response after using topical estrogen.

  10. Plasma arc melting treatment of low level radioactive waste with centrifugal hearth

    International Nuclear Information System (INIS)

    Tsuji, Yukito

    1997-01-01

    Plasma Arc Melting technology may possible be able to treat various kinds of waste streams through volume reduction and stabilization into a disposal waste form. The ability of other melting technologies to convert inorganic material in a single step, however, varies according to the characteristics of the materials. Plasma technology also can treat organic waste by selecting the oxidation atmosphere. The Japan Atomic Power Company (JAPC) has decided to construct a low level radioactive waste treatment facility using the Plasma Arc Centrifugal Treatment (PACT) process with an 8 ft rotating hearth and 1.2 MW transferred torch developed by Retech (Ukiah, CA. USA) in the Tsuruga power station. In Japan, the plasma technology has been developed for incineration ash treatment, but the JAPC plant will be the first treatment system using plasma technology for solid waste with various characteristics and shapes. (author)

  11. FY 1995 separation studies for liquid low-level waste treatment at Oak Ridge National Laboratory

    International Nuclear Information System (INIS)

    Bostick, D.T.; Arnold, W.D.; Burgess, M.W.

    1995-01-01

    During FY 1995, studies were continued to develop improved methods for centralized treatment of liquid low-level waste (LLLW) at Oak Ridge National Laboratory (ORNL). Focus in this reporting period was on (1) identifying the parameters that affect the selective removal of 90 Sr and 137 Cs, two of the principal radioactive contaminants expected in the waste; (2) validating the effectiveness of the treatment methods by testing an ac Melton Valley Storage Tank (MVST) supernate; (3) evaluating the optimum solid/liquid separation techniques for the waste; (4) identifying potential treatment methods for removal of technetium from LLLW; and (5) identifying potential methods for stabilizing the high-activity secondary solid wastes generated by the treatment

  12. Response after Infection-Associated Rise in Clozapine Levels in Treatment-Resistant Schizoaffective Disorder

    Directory of Open Access Journals (Sweden)

    Nina H. Grootendorst-van Mil

    2018-01-01

    Full Text Available The clinical management of patients with treatment-resistant psychotic disorders is still challenging despite years of extensive research. If first-line antipsychotic treatment proves ineffective, clozapine is considered golden standard. Herein, we report on a patient with schizoaffective disorder that initially showed no response to treatment with clozapine and ECT and therefore reached a therapeutic dead end. After an unintentional exposure to supratherapeutic clozapine levels, related to a pneumonia, a significant and persistent reduction of psychotic symptoms occurred. The report suggests a careful reevaluation of the clozapine dose in cases of treatment-resistant psychotic disorders with failed trials of clozapine. Further increase of dose may prove efficacious, although side effects should be closely monitored. Research to determine the upper threshold of clozapine for antipsychotic efficacy is warranted.

  13. The clinical application of determination of plasma NPY levels for diagnosis and treatment of cardiovascular diseases

    International Nuclear Information System (INIS)

    Zheng Qing; Bao Yimin; Yang Yongqing

    2010-01-01

    Objective: To study the clinical usefulness of determination of plasma NPY levels for diagnosis and treatment of cardiovascular disease. Methods: Plasma levels of NPY were determined with RIA in 180 patients with heart failure from CHD, 89 patients with AMI, 58 patients with essential hypertension, 109 patients with PIH and 47 controls. Results: The plasma levels of NPY in 180 patients with heart failure were 206.37±40.1 pg/ml (I grade, P<0.05), 218.62±64.83 pg/ml (II grade, P<0.05), 269.16±56.57 pg/ml (III grade, P<0.01) and 314.82±56.73 pg/ml (IV grade, P<0.001), respectively. The plasma levels were 345.12±68.71 pg/ml and 191.46±38.92 pg/ml in patients with AMI and hypertension as a whole, respectively. All these levels were significantly higher than those in controls (P<0.05∼0.001). Among the patients, the plasma NPY levels increased along with advance of the disease process. Conclusion: Plasma NPY level was a useful marker for diagnosis and treatment of cardiovascular diseases. (authors)

  14. Effects of Metformin Treatment on Homocysteine Levels and Metabolic Parameters of Women With Polycystic Ovary Syndrome

    Directory of Open Access Journals (Sweden)

    Soheila Riahinejad

    2016-04-01

    Full Text Available Objective: Polycystic ovary syndrome (PCOS is one of the most common endocrine disorders in women. Metformin is a biguanide commonly used to improve PCOS symptoms. Effect of metformin on the levels of serum homocysteine (Hcy in PCOS women is unclear. The aim of this study is evaluating the effect of metformin administration on serum Hcy levels and metabolic parameters of PCOS patients.Materials and methods: Thirty three patients with PCOS were enrolled in this study who were selected randomly. All patients received metformin from the fifth day of menstrual cycle at a dose of 850 mg (one tablet daily for 3 months. Body mass index, Triglycerides, total cholesterol, high-density lipoprotein cholesterol (HDL-C, low-density lipoprotein cholesterol (LDL-C, fasting blood sugar and homocysteine levels were recorded at entry into the study and after 3 months treatment.Results: BMI, plasma Homocysteine concentrations and fasting blood sugar levels were significantly (p < 0.05 decreased after the treatment period. No significant changes were observed in the lipid profiles of patients. There was a weak negative correlation between homocysteine and LDL cholesterol serum levels (p = 0.04, r = -0.27.Conclusion: Treatment with metformin in PCOS women may lead to beneficial effects in terms of BMI, plasma homocysteine concentrations and fasting blood sugar with no remarkable effect on lipid profile. 

  15. Serum prolactin, leptin, lipids and lipoproteins levels during antipsychotics treatment in Parkinson's disease and related psychosis.

    Science.gov (United States)

    Rustembegovic, Avdo; Sofic, Emin; Wichart, Ildiko

    2006-01-01

    Weight gain is a common adverse effect associated with the use of most typical and atypical antipsychotic. Aim of this study was to investigate serum prolactin, leptin, cholesterol, triglyceride, lipoproteins, such high density lipoprotein (HDL), and low density lipoprotein (LDL) levels in patients with Parkinson's disease (PD)-related psychosis during long-term medication with atypical antipsychotic. The study population comprised 40 patients, who were divided into 4 groups: olanzapine (n=10), risperidone (n=10), seroquel (n=10) monotherapy, a group of 10 patients receiving only antiparkinson drugs and a control group of 8 healthy persons. The patients were evaluated at baseline and at the sixth and twelfth week according to the Positive and Negative Syndrome Scale (PANSS), body mass index (BMI), and fasting serum prolactin, leptin, lipids and lipoproteins levels. Treatment of patients with olanzapine caused marked increase of serum LDL, cholesterol, triglyceride, and leptin levels (prelationship between serum leptin, lipid levels and BMI. However, treatment of patients with seroquel did not cause changes in serum prolactin, leptin, lipids, and lipoproteins levels. Our results suggest that treatment of patients with PD-related psychosis with seroquel appears to have minimal influence on serum leptin, prolactin, lipids, lipoproteins and BMI compared with olanzapine and risperidone.

  16. [Influence of three-level collaboration network of pediatric burns treatment in Anhui province on treatment effects of burn children].

    Science.gov (United States)

    Xia, Z G; Zhou, X L; Kong, W C; Li, X Z; Song, J H; Fang, L S; Hu, D L; Cai, C; Tang, Y Z; Yu, Y X; Wang, C H; Xu, Q L

    2018-03-20

    Objective: To explore the influence of three-level collaboration network of pediatric burns in Anhui province on treatment effects of burn children. Methods: The data of medical records of pediatric burn children transferred from Lu'an People's Hospital and Fuyang People's Hospital to the First Affiliated Hospital of Anhui Medical University from January 2014 to December 2015 and January 2016 to September 2017 (before and after establishing three-level collaboration network of pediatric burns treatment) were analyzed: percentage of transferred burn children to hospitalized burn children in corresponding period, gender, age, burn degree, treatment method, treatment result, occurrence and treatment result of shock, and operative and non-operative treatment time and cost. Rehabilitation result of burn children transferred back to local hospitals in 2016 and 2017. Data were processed with t test, chi-square test, Mann-Whitney U test, and Fisher's exact test. Results: (1) Percentage of burn children transferred from January 2014 to December 2015 was 34.3% (291/848) of the total number of hospitalized burn children in the same period of time, which was close to 30.4% (210/691) of burn children transferred from January 2016 to September 2017 ( χ (2)=2.672, P >0.05). (2) Gender, age, burn degree, and treatment method of burn children transferred from the two periods of time were close ( χ (2)=3.382, Z =-1.917, -1.911, χ (2)=3.133, P >0.05). (3) Cure rates of children with mild, moderate, and severe burns transferred from January 2016 to September 2017 were significantly higher than those of burn children transferred from January 2014 to December 2015 ( χ (2)=11.777, 6.948, 4.310, P burns transferred from the two periods of time were close ( χ (2)=1.181, P >0.05). (4) Children with mild and moderate burns transferred from the two periods of time were with no shock. The incidence of shock of children with severe burns transferred from January 2014 to December 2015 was 6

  17. Variation of plasma cortisol levels in patients with depression after treatment with bilateral electroconvulsive therapy

    Directory of Open Access Journals (Sweden)

    Daniel Fortunato Burgese

    2015-03-01

    Full Text Available Introduction: More than 60 years after the introduction of modern psychopharmacology, electroconvulsive therapy (ECT continues to be an essential therapeutic modality in the treatment of mental disorders, but its mechanism of action remains unclear. Hormones play an essential role in the development and expression of a series of behavioral changes. One aspect of the influence of hormones on behavior is their potential contribution to the pathophysiology of psychiatric disorders and the mechanism of action of psychotropic drugs and ECT.Objective: We measured blood levels of the hormone cortisol in patients with unipolar depression according to the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV and compared results with levels found in healthy adults.Method: Blood cortisol levels were measured before the beginning of treatment with ECT, at the seventh session, and at the last session, at treatment completion. Depression symptoms were assessed using the Beck Depression Inventory (BDI.Results: Cortisol levels remained stable in both men and women between the seventh and the last sessions of ECT; values ranged from 0.686±9.6330 g/dL for women, and there was a mean decrease of 5.825±6.0780 g/dL (p = 0.024. Mean number of ECT sessions was 12. After the seventh and the last ECT sessions, patients with depression and individuals in the control group had similar cortisol levels, whereas BDI scores remained different.Conclusion: Cortisol levels decreased during ECT treatment. ECT seems to act as a regulator of the hypothalamic-pituitaryadrenal axis.

  18. Chronic lithium treatment increased intracellular S100ß levels in rat primary neuronal culture.

    Directory of Open Access Journals (Sweden)

    Masoumeh Emamghoreishi

    2015-02-01

    Full Text Available S100ß a neurotrophic factor mainly released by astrocytes, has been implicated in the pathogenesis of bipolar disorder. Thus, lithium may exert its neuroprotective effects to some extent through S100ß. Furthermore, the possible effects of lithium on astrocytes as well as on interactions between neurons and astrocytes as a part of its mechanisms of actions are unknown. This study was undertaken to determine the effect of lithium on S100β in neurons, astrocytes and a mixture of neurons and astrocytes. Rat primary astrocyte, neuronal and mixed neuro-astroglia cultures were prepared from cortices of 18-day's embryos. Cell cultures were exposed to lithium (1mM or vehicle for 1day (acute or 7 days (chronic. RT-PCR and ELISA determined S100β mRNA and intra- and extracellular protein levels. Chronic lithium treatment significantly increased intracellular S100β in neuronal and neuro-astroglia cultures in comparison to control cultures (P<0.05. Acute and chronic lithium treatments exerted no significant effects on intracellular S100β protein levels in astrocytes, and extracellular S100β protein levels in three studied cultures as compared to control cultures. Acute and chronic lithium treatments did not significantly alter S100β mRNA levels in three studied cultures, compared to control cultures. Chronic lithium treatment increased intracellular S100ß protein levels in a cell-type specific manner which may favor its neuroprotective action. The findings of this study suggest that lithium may exert its neuroprotective action, at least partly, by increasing neuronal S100ß level, with no effect on astrocytes or interaction between neurons and astrocytes.

  19. Can treatment of nocturia increase testosterone level in men with late onset hypogonadism?

    Science.gov (United States)

    Kim, Jong Wook; Chae, Ji Yun; Kim, Jin Wook; Yoon, Cheol Yong; Oh, Mi Mi; Park, Hong Seok; Kim, Je Jong; Moon, Du Geon

    2014-04-01

    To assess the effect of desmopressin on serum testosterone level in men with nocturia and late onset hypogonadism. We prospectively enrolled men with nocturia and symptoms of late onset hypogonadism. Desmopressin (0.1 mg) was administered once daily to patients for 12 weeks, and we then compared serum testosterone levels, electrolytes, frequency volume chart indices, and changes in the International Prostate Symptom Score (IPSS), International Index of Erectile Function, and Aging Male's Symptom scales before and after treatment. Patients with a history of cardiovascular disease or hyponatremia, those using hypnotics, and those who had primary hypogonadism or hypogonadotrophic hypogonadism were excluded from the study. Sixty-two men (mean age, 68.4 years) completed pre- and post-treatment questionnaires and underwent laboratory testing. At the end of the study, the testosterone levels in men with low testosterone levels (treatment (2.85 ± 0.58 to 3.97 ± 1.44 ng/mL; P = .001). Mean scores had decreased from 17.7 to 13.9 (IPSS), 3.8 to 3.2 (IPSS-Quality of Life), and 33.7 to 31.1 (Aging Male's Symptom). On the frequency volume chart, nocturnal urine volume, nocturnal polyuria index, actual number of nocturia events, nocturia index, and nocturnal bladder capacity index were significantly decreased. Desmopressin improved nocturia and other urinary symptoms. Moreover, serum testosterone levels increased significantly in men with low testosterone levels after 12-week desmopressin treatment. Copyright © 2014 Elsevier Inc. All rights reserved.

  20. Treatment of low level radioactive liquid waste containing appreciable concentration of TBP degraded products.

    Science.gov (United States)

    Valsala, T P; Sonavane, M S; Kore, S G; Sonar, N L; De, Vaishali; Raghavendra, Y; Chattopadyaya, S; Dani, U; Kulkarni, Y; Changrani, R D

    2011-11-30

    The acidic and alkaline low level radioactive liquid waste (LLW) generated during the concentration of high level radioactive liquid waste (HLW) prior to vitrification and ion exchange treatment of intermediate level radioactive liquid waste (ILW), respectively are decontaminated by chemical co-precipitation before discharge to the environment. LLW stream generated from the ion exchange treatment of ILW contained high concentrations of carbonates, tributyl phosphate (TBP) degraded products and problematic radio nuclides like (106)Ru and (99)Tc. Presence of TBP degraded products was interfering with the co-precipitation process. In view of this a modified chemical treatment scheme was formulated for the treatment of this waste stream. By mixing the acidic LLW and alkaline LLW, the carbonates in the alkaline LLW were destroyed and the TBP degraded products got separated as a layer at the top of the vessel. By making use of the modified co-precipitation process the effluent stream (1-2 μCi/L) became dischargeable to the environment after appropriate dilution. Based on the lab scale studies about 250 m(3) of LLW was treated in the plant. The higher activity of the TBP degraded products separated was due to short lived (90)Y isotope. The cement waste product prepared using the TBP degraded product was having good chemical durability and compressive strength. Copyright © 2011 Elsevier B.V. All rights reserved.

  1. Changes in blood lead levels associated with use of chloramines in water treatment systems.

    Science.gov (United States)

    Miranda, Marie Lynn; Kim, Dohyeong; Hull, Andrew P; Paul, Christopher J; Galeano, M Alicia Overstreet

    2007-02-01

    More municipal water treatment plants are using chloramines as a disinfectant in order to reduce carcinogenic by-products. In some instances, this has coincided with an increase in lead levels in drinking water in those systems. Lead in drinking water can be a significant health risk. We sought to test the potential effect of switching to chloramines for disinfection in water treatment systems on childhood blood lead levels using data from Wayne County, located in the central Coastal Plain of North Carolina. We constructed a unified geographic information system (GIS) that links blood lead screening data with age of housing, drinking water source, and census data for 7,270 records. The data were analyzed using both exploratory methods and more formal multivariate techniques. The analysis indicates that the change to chloramine disinfection may lead to an increase in blood lead levels, the impact of which is progressively mitigated in newer housing. Introducing chloramines to reduce carcinogenic by-products may increase exposure to lead in drinking water. Our research provides guidance on adjustments in the local childhood lead poisoning prevention program that should accompany changes in water treatment. As similar research is conducted in other areas, and the underlying environmental chemistry is clarified, water treatment strategies can be optimized across the multiple objectives that municipalities face in providing high quality drinking water to local residents.

  2. Effect of psoriasis activity and topical treatment on serum lipocalin-2 levels.

    Science.gov (United States)

    Baran, A; Świderska, M; Myśliwiec, H; Flisiak, I

    2017-03-01

    Psoriasis has been considered as systemic disorder. Lipocalin-2 might be a link between psoriasis and its comorbidities. Aim of the study was to investigate the associations between serum lipocalin-2 levels and the disease activity, markers of inflammation or metabolic disturbances and changes after topical treatment in psoriatic patients. Thirty-seven individuals with active plaque-type psoriasis and 15 healthy controls were recruited. Blood samples were collected before and after 14 days of therapy. Serum lipocalin-2 concentrations were examined by enzyme-linked immunosorbent assay. The results were correlated with Psoriasis Area and Severity Index (PASI), body mass index (BMI), inflammatory and biochemical markers, lipid profile and with effectiveness of topical treatment. Lipocalin-2 serum levels were significantly increased in psoriatic patients in comparison to the controls (p = 0.023). No significant correlations with indicators of inflammation, nor BMI or PASI were noted. A statistical association between lipocalin-2 and low-density lipoprotein-cholesterol was shown. After topical treatment serum lipocalin-2 level did not significantly change (p = 0.9), still remaining higher than in the controls, despite clinical improvement. Lipocalin-2 might be a marker of psoriasis and convey cardiovascular or metabolic risk in psoriatic patients, but may not be a reliable indicator of inflammation, severity of psoriasis nor efficacy of antipsoriatic treatment.

  3. Analytical characterization of high-level mixed wastes using multiple sample preparation treatments

    International Nuclear Information System (INIS)

    King, A.G.; Baldwin, D.L.; Urie, M.W.; McKinley, S.G.

    1994-01-01

    The Analytical Chemistry Laboratory at the Pacific Northwest Laboratory in Richland, Washington, is actively involved in performing analytical characterization of high-level mixed waste from Hanford's single shell and double shell tank characterization programs. A full suite of analyses is typically performed on homogenized tank core samples. These analytical techniques include inductively-coupled plasma-atomic emission spectroscopy, total organic carbon methods and radiochemistry methods, as well as many others, all requiring some type of remote sample-preparation treatment to solubilize the tank sludge material for analysis. Most of these analytical methods typically use a single sample-preparation treatment, inherently providing elemental information only. To better understand and interpret tank chemistry and assist in identifying chemical compounds, selected analytical methods are performed using multiple sample-preparation treatments. The sample preparation treatments used at Pacific Northwest Laboratory for this work with high-level mixed waste include caustic fusion, acid digestion, and water leach. The type of information available by comparing results from different sample-prep treatments includes evidence for the presence of refractory compounds, acid-soluble compounds, or water-soluble compounds. Problems unique to the analysis of Hanford tank wastes are discussed. Selected results from the Hanford single shell ferrocyanide tank, 241-C-109, are presented, and the resulting conclusions are discussed

  4. Particle count monitoring of reverse osmosis water treatment for removal of low-level radionuclides

    International Nuclear Information System (INIS)

    Moritz, E.J.; Hoffman, C.R.; Hergert, T.R.

    1995-01-01

    Laser diode particle counting technology and analytical measurements were used to evaluate a pilot-scale reverse osmosis (RO) water treatment system for removal of particulate matter and sub-picocurie low-level radionuclides. Stormwater mixed with Waste Water Treatment Plant (WWTP) effluent from the Rocky Flats Environmental Technology Site (RFETS), formerly a Department of Energy (DOE) nuclear weapons production facility, were treated. No chemical pretreatment of the water was utilized during this study. The treatment system was staged as follows: multimedia filtration, granular activated carbon adsorption, hollow tube ultrafiltration, and reverse osmosis membrane filtration. Various recovery rates and two RO membrane models were tested. Analytical measurements included total suspended solids (TSS), total dissolved solids (TDS), gross alpha (α) and gross beta (β) activity, uranium isotopes 233/234 U and 238 U, plutonium 239/240 Pu, and americium 241 Am. Particle measurement between 1--150 microns (μ) included differential particle counts (DPC), and total particle counts (TPC) before and after treatment at various sampling points throughout the test. Performance testing showed this treatment system produced a high quality effluent in clarity and purity. Compared to raw water levels, TSS was reduced to below detection of 5 milligrams per liter (mg/L) and TDS reduced by 98%. Gross α was essentially removed 100%, and gross β was reduced an average of 94%. Uranium activity was reduced by 99%. TPC between 1-150μ were reduced by an average 99.8% to less than 1,000 counts per milliliter (mL), similar in purity to a good drinking water treatment plant. Raw water levels of 239/240 Pu and 241 Am were below reliable quantitation limits and thus no removal efficiencies could be determined for these species

  5. Comparison of beta-endorphin and CGRP levels before and after treatment for severe schizophrenia

    Directory of Open Access Journals (Sweden)

    Urban-Kowalczyk M

    2016-04-01

    Full Text Available Małgorzata Urban-Kowalczyk,1 Janusz Śmigielski,2 Dominik Strzelecki1 1Department of Affective and Psychotic Disorders, 2Department of Geriatrics, Healthy Aging Research Centre (HARC, Medical University of Lodz, Lodz, Poland Objectives: Links between endorphins and dopaminergic transmission have not been fully explored in schizophrenia. Both endorphins excess and deficiency were postulated. CGRP is probably involved in dopaminergic transmission. The aim of this study was the evaluation of beta-endorphin (BE and CGRP blood concentrations before and after treatment of severe schizophrenia. Methods: Seventy patients treated with various antipsychotics, with severe symptoms of schizophrenia (51 with positive symptoms, 19 with negative symptoms, 15 first-degree relatives, and 44 healthy controls were included in the study. BE and CGRP blood concentrations were measured during patients severe schizophrenia and in their stable mental state after treatment. The results were compared with relatives and controls. Results: BE and CGRP concentrations in patients with negative symptoms were higher than in relatives and in controls. BE levels in patients with positive symptoms were lower than in patients with negative symptoms (P<0.0000 and controls (P<0.0006. No significant changes in CGRP concentration were found in patient samples. CGRP levels in these samples were independent of treatment, but they were significantly higher than in relatives and controls. After the treatment, BE level decreased in patients with negative symptoms (P<0.0001 and increased in patients with positive symptoms (P<0.0000. No differences in BE concentration between patients in stable mental state, their relatives, and controls were found. Conclusion: Effective antipsychotic treatment results in “normalization” of BE level. Specific changes in BE concentration could be involved in dopaminergic transmission and related to some symptoms of schizophrenia. Keywords

  6. Levels of interleukin-6 in tears before and after excimer laser treatment

    Directory of Open Access Journals (Sweden)

    Resan Mirko

    2015-01-01

    Full Text Available Background/Aim. Immune response and consequent inflammatory process which originate on ocular surface after a trauma are mediated by cytokines. Photoablation of corneal stroma performed by excimer laser causes surgically induced trauma. Interleukin-6 (IL-6 is mostly known as a proinflammatory cytokine. However, it also has regenerative and anti-inflammatory effects. It is supposed that this cytokine is likely to play a significant role in the process of corneal wound healing response after photoablation of stroma carried out by laser in situ keratomileusis (LASIK or photorefractive keratectomy (PRK methods. The aim of this study was to determine and compare the levels of IL-6 in tears before and after treatment with LASIK and PRK methods. Methods. The study included 68 shortsighted eyes up to -3.0 diopter sphere, i.e. 198 samples of tears (per three samples taken from each of the eyes, divided into two groups according to the kind of excimer laser intervention performed: the group 1 - eyes treated by LASIK method (n = 31, and the group 2 - eyes treated by the PRK method (n = 37. The samples of tears were taken from each eye at the following time points: before excimer laser treatment (0 h, the control group, 1 h after the treatment (1 h and 24 h after the treatment (24 h. The patients did not use anti-inflammatory therapy 24 h after the intervention. Tear samples were collected using microsurgical sponge. Level of IL-6 in tear fluid was determined by the flow cytometry method, applying a commercial test kit which allowed cytokine detection from a small sample volume. Results. The values of IL-6 were detectable in 16% of samples before LASIK treatment and in 30% of samples before PRK treatment. One h after the treatment IL-6 was detectable in 29% of samples for the LASIK group and 43% of samples for the PRK group, and 24 h after the treatment it was detectable in 19% of samples for the LASIK group and in 57% of samples for the PRK group. When we

  7. Levels of interleukin-6 in tears before and after excimer laser treatment.

    Science.gov (United States)

    Resan, Mirko; Stanojević, Ivan; Petković, Aleksandra; Pajić, Bojan; Vojvodić, Danilo

    2015-04-01

    Immune response and consequent inflammatory process which originate on ocular surface after a trauma are mediated by cytokines. Photoablation of corneal stroma performed by excimer laser causes surgically induced trauma. Interleukin-6 (IL-6) is mostly known as a proinflammatory cytokine. However, it also has regenerative and anti-inflammatory effects. It is supposed that this cytokine is likely to play a significant role in the process of corneal wound healing response after photoablation of stroma carried out by laser in situ keratomileusis (LASIK) or photorefractive keratectomy (PRK) methods. The aim of this study was to determine and compare the levels of IL-6 in tears before and after treatment with LASIK and PRK methods. The study included 68 shortsighted eyes up to -3.0 diopter sphere, i.e. 198 samples of tears (per three samples taken from each of the eyes), divided into two groups according to the kind of excimer laser intervention performed: the group 1--eyes treated by LASIK method (n=31), and the group 2--eyes treated by the PRK method (n=37). The samples of tears were taken from each eye at the following time points: before excimer laser treatment (0 h, the control group), 1 h after the treatment (1 h) and 24 h after the treatment (24 h). The patients did not use anti-inflammatory therapy 24 h after the intervention. Tear samples were collected using microsurgical sponge. Level of IL-6 in tear fluid was determined by the flow cytometry method, applying a commercial test kit which allowed cytokine detection from a small sample volume. Results. The values of IL-6 were detectable in 16% of samples before LASIK treatment and in 30% of samples before PRK treatment. One h after the treatment IL-6 was detectable in 29% of samples for the LASIK group and 43% of samples for the PRK group, and 24 h after the treatment it was detectable in 19% of samples for the LASIK group and in 57% of samples for the PRK group. When we analyzed the dynamics of IL76 production

  8. The need for the use of high-level radiation in water treatment and in waste-water (sewage) treatment

    International Nuclear Information System (INIS)

    Nielson, N.E.

    1975-01-01

    After excellent conventional primary, followed by the best possible conventional aerobic secondary and then chemical disinfection, significant quantities of contaminants are still present in sewage, especially pathogenic organisms and toxic or toxicity-causing long-chain-molecular forms. These contaminants are generally encountered in waste-waters with a seldom predictable, almost totally random frequency. Many of these chemical forms enter re-use situations where they can become toxic to man, or to wildlife, even in concentrations of a few parts per thousand million. It has been amply demonstrated that the long-held contention is no longer valid that dilution of these contaminants to an innocuous level is easily attained by their release into large bodies of water such as lakes, oceans and rivers. At the same time, a great deal of energy is required when using known techniques in highly reliable systems for removing or rendering innocuous a large portion of these contaminants. In the light of this new (to some people) information describing a much larger, more complex set of conditions which must be considered in effective water pollution elimination, high-level radiation becomes very attractive. There is a great need for high-level radiation in water treatment or waste-water treatment where the ultimate goal is a safe, clean, non-environmentally degrading, safely re-usable quality of water. Gamma radiation, used under the right circumstances, is the most reliable, most cost-effective, most generally efficient technique in the tertiary stages. With the addition of select chemicals to increase the number of ionizations realized and/or to capitalize upon surface charge phenomena, its effectiveness can be even further expanded. (author)

  9. Guideline for benchmarking thermal treatment systems for low-level mixed waste

    International Nuclear Information System (INIS)

    Hoffman, D.P.; Gibson, L.V. Jr.; Hermes, W.H.; Bastian, R.E.; Davis, W.T.

    1994-01-01

    A process for benchmarking low-level mixed waste (LLMW) treatment technologies has been developed. When used in conjunction with the identification and preparation of surrogate waste mixtures, and with defined quality assurance and quality control procedures, the benchmarking process will effectively streamline the selection of treatment technologies being considered by the US Department of Energy (DOE) for LLMW cleanup and management. Following the quantitative template provided in the benchmarking process will greatly increase the technical information available for the decision-making process. The additional technical information will remove a large part of the uncertainty in the selection of treatment technologies. It is anticipated that the use of the benchmarking process will minimize technology development costs and overall treatment costs. In addition, the benchmarking process will enhance development of the most promising LLMW treatment processes and aid in transferring the technology to the private sector. To instill inherent quality, the benchmarking process is based on defined criteria and a structured evaluation format, which are independent of any specific conventional treatment or emerging process technology. Five categories of benchmarking criteria have been developed for the evaluation: operation/design; personnel health and safety; economics; product quality; and environmental quality. This benchmarking document gives specific guidance on what information should be included and how it should be presented. A standard format for reporting is included in Appendix A and B of this document. Special considerations for LLMW are presented and included in each of the benchmarking categories

  10. Clinical significance of determination of changes of serum CA125, VEGF levels after treatment in patients with endometriosis

    International Nuclear Information System (INIS)

    Dong Yan; Zhou Dongxia

    2008-01-01

    Objective: To explore the significance of changes of serum CA125, VEGF levels after treatment in patients with endometriosis. Methods: Serum CA125 (with RIA) and VEGF (with ELISA) levels were determined in 36 patients with endometriosis both before and after treatment as well as in 30 controls. Results: Before treatment, the serum CA125, VEGF levels in the patients were significantly higher than those in the controls (P<0.01). After 3 months of treatment, the levels dropped markedly, but still remained significantly higher(P<0.05). Conclusion: Serum levels of CA125 and VEGF were closely related to the disease process in patients with ehdometriosis. (authors)

  11. Low Irisin Levels in Patients with Type 2 Diabetes Mellitus without Current Treatment: A Systematic Review

    Directory of Open Access Journals (Sweden)

    Jaqueline Pinheiro de Alencar

    2017-05-01

    Full Text Available Background: The Irisin is a myokine associated with the improvement on insulin resistance caused by diet and increased physical energy expenditure. Recent studies have shown that patients with Type 2 Diabetes Mellitus (T2DM have reduced levels of irisin, showing it as a potential marker for various endocrine and cardiovascular diseases. This study aimed to verify if T2DM patients never treated or without ongoing treatment have reduced levels of irisin when compared to individuals with other metabolic profiles. Methods and Findings: Systematic review of the literature, considering the primary studies published in 2012 to 2016, with the outcome Irisin levels in patients never treated or without current treatment in the ambience of Type 2 Diabetes Mellitus. The search was conducted through the electronic database Scopus (Elsevier, using the key words: "Irisin", "Human" and "Diabetes Mellitus". From the 91 studies found, 8 met the eligibility criteria. Significant differences were found on levels of irisin in patients with T2DM compared to normoglycemic individuals, obese and/or pre-diabetic. On average, there was a reduction of 15 pg/ml in plasma levels of irisin in diabetics. However, a minority of studies says that this relationship does not exist. Conclusion: Irisin reduced levels were found in patients with T2DM and is also related to lipid profile, with the risk of developing endocrine diseases, such as diabetes and obesity, and high risk for cardiovascular diseases because of its relationship with endothelial dysfunction. This generates the need for research in order to explore the isolation and clinical use of irisin for treatment of disorders related to imbalance in energy demand, obesity and diabetes. Descriptors: Irisin, Human, Diabetes Mellitus.

  12. Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels.

    Science.gov (United States)

    Cunningham, Glenn R; Stephens-Shields, Alisa J; Rosen, Raymond C; Wang, Christina; Bhasin, Shalender; Matsumoto, Alvin M; Parsons, J Kellogg; Gill, Thomas M; Molitch, Mark E; Farrar, John T; Cella, David; Barrett-Connor, Elizabeth; Cauley, Jane A; Cifelli, Denise; Crandall, Jill P; Ensrud, Kristine E; Gallagher, Laura; Zeldow, Bret; Lewis, Cora E; Pahor, Marco; Swerdloff, Ronald S; Hou, Xiaoling; Anton, Stephen; Basaria, Shehzad; Diem, Susan J; Tabatabaie, Vafa; Ellenberg, Susan S; Snyder, Peter J

    2016-08-01

    The Testosterone Trials are a coordinated set of seven trials to determine the efficacy of T in symptomatic men ≥65 years old with unequivocally low T levels. Initial results of the Sexual Function Trial showed that T improved sexual activity, sexual desire, and erectile function. To assess the responsiveness of specific sexual activities to T treatment; to relate hormone changes to changes in sexual function; and to determine predictive baseline characteristics and T threshold for sexual outcomes. A placebo-controlled trial. Twelve academic medical centers in the United States. A total of 470 men ≥65 years of age with low libido, average T sexual intercourse at least twice a month. Men were assigned to take T gel or placebo for 1 year. Sexual function was assessed by three questionnaires every 3 months: the Psychosexual Daily Questionnaire, the Derogatis Interview for Sexual Function, and the International Index of Erectile Function. Compared with placebo, T administration significantly improved 10 of 12 measures of sexual activity. Incremental increases in total and free T and estradiol levels were associated with improvements in sexual activity and desire, but not erectile function. No threshold T level was observed for any outcome, and none of the 27 baseline characteristics predicted responsiveness to T. In older men with low libido and low T levels, improvements in sexual desire and activity in response to T treatment were related to the magnitude of increases in T and estradiol levels, but there was no clear evidence of a threshold effect.

  13. Stathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancer.

    Directory of Open Access Journals (Sweden)

    Henrica M J Werner

    Full Text Available Stathmin is a prognostic marker in many cancers, including endometrial cancer. Preclinical studies, predominantly in breast cancer, have suggested that stathmin may additionally be a predictive marker for response to paclitaxel. We first evaluated the response to paclitaxel in endometrial cancer cell lines before and after stathmin knock-down. Subsequently we investigated the clinical response to paclitaxel containing chemotherapy in metastatic endometrial cancer in relation to stathmin protein level in tumors. Stathmin level was also determined in metastatic lesions, analyzing changes in biomarker status on disease progression. Knock-down of stathmin improved sensitivity to paclitaxel in endometrial carcinoma cell lines with both naturally higher and lower sensitivity to paclitaxel. In clinical samples, high stathmin level was demonstrated to be associated with poor response to paclitaxel containing chemotherapy and to reduced disease specific survival only in patients treated with such combination. Stathmin level increased significantly from primary to metastatic lesions. This study suggests, supported by both preclinical and clinical data, that stathmin could be a predictive biomarker for response to paclitaxel treatment in endometrial cancer. Re-assessment of stathmin level in metastatic lesions prior to treatment start may be relevant. Also, validation in a randomized clinical trial will be important.

  14. Design and construction of the low-level liquid waste treatment system

    International Nuclear Information System (INIS)

    Baker, M.N.; Mateer, W.E.; Metzler, G.H.; Reeves, S.R.; Rickettson, D.J.

    1989-03-01

    This report describes the design and construction of the Low-Level Liquid Waste Treatment System (LWTS). The LWTS is part of a system that will prepare High-Level Radioactive Waste for solidification in glass. This preparation includes removal of water and salts from the stored waste. The topics addressed are: the design objective to reuse the Process Building to contain LWTS, the special considerations that arise when building a new system inside a decontaminated facility, interface to existing plant systems, phased construction, and construction testing. 8 refs., 24 figs

  15. S-adenosylmethionine blood levels in major depression: changes with drug treatment.

    Science.gov (United States)

    Bell, K M; Potkin, S G; Carreon, D; Plon, L

    1994-01-01

    The relationship between plasma levels of S-adenosylmethionine (SAMe), an endogenous methyl donor, and clinical response were studied in patients with a DSM-III-R diagnosis of major depression. A double-blind randomized protocol comparing oral SAMe with oral desipramine, involving a total of 26 patients, was employed. At the end of the 4-week trial, 62% of the patients treated with SAMe and 50% of the patients treated with desipramine had significantly improved. Regardless of the type of treatment, patients with a 50% decrease in their Hamilton Depression Scale (HAM-D) score showed a significant increase in plasma SAMe concentration. The significant correlation between plasma SAMe levels and the degree of clinical improvement in depressed patients regardless of the type of treatment suggests that SAMe may play an important role in regulating mood.

  16. Optimizing Treatment with TNF Inhibitors in Inflammatory Bowel Disease by Monitoring Drug Levels and Antidrug Antibodies

    DEFF Research Database (Denmark)

    Steenholdt, Casper; Bendtzen, Klaus; Brynskov, Jørn

    2016-01-01

    costs. The objective is to review optimization of anti-TNF therapy by use of personalized treatment strategies based on circulating drug levels and antidrug antibodies (Abs), i.e. therapeutic drug monitoring (TDM). Furthermore, to outline TDM-related pitfalls and their prevention. METHODS: Literature...... inflammatory phenotype influencing the pharmacodynamic (PD) responses to TNF inhibitors also affect treatment outcomes. As an alternative to handling anti-TNF-treated patients by empiric strategies, TDM identifies underlying PK and PD-related reasons for treatment failure and aids decision making to secure...... of chronology between changes in PK versus symptomatic and objective disease activity manifestations. Biases can be accommodated by knowledgeable interpretation of results obtained by validated assays with clinically established thresholds, and by repeated assessments over time using complimentary techniques...

  17. Three-level multilevel growth models for nested change data: a guide for group treatment researchers.

    Science.gov (United States)

    Tasca, Giorgio A; Illing, Vanessa; Joyce, Anthony S; Ogrodniczuk, John S

    2009-07-01

    Researchers have known for years about the negative impact on Type I error rates caused by dependencies in hierarchically nested and longitudinal data. Despite this, group treatment researchers do not consistently use methods such as multilevel models (MLMs) to assess dependence and appropriately analyse their nested data. The goals of this study are to review some of the study design issues with regard to hierarchically nested and longitudinal data, discuss MLMs for assessing and handling dependence in data, and present a guide for developing a three-level growth MLM that is appropriate for group treatment data, design, and research questions. The authors present an example from group treatment research to illustrate these issues and methods.

  18. Mixed and low-level waste treatment project: Appendix C, Health and safety criteria for the mixed and low-level waste treatment facility at the Idaho National Engineering Laboratory. Part 1, Waste streams and treatment technologies

    Energy Technology Data Exchange (ETDEWEB)

    Neupauer, R.M.; Thurmond, S.M.

    1992-09-01

    This report describes health and safety concerns associated with the Mixed and Low-level Waste Treatment Facility at the Idaho National Engineering Laboratory. Various hazards are described such as fire, electrical, explosions, reactivity, temperature, and radiation hazards, as well as the potential for accidental spills, exposure to toxic materials, and other general safety concerns.

  19. Irisin levels increase after treatment in patients with newly diagnosed Hashimoto thyroiditis.

    Science.gov (United States)

    Uc, Z A; Gorar, S; Mizrak, S; Gullu, S

    2018-05-18

    Irisin is a newly identified myokine secreted by skeletal muscle and has significant effects on body metabolism. Thyroidal functional state has a profound influence on the metabolism of human body. Therefore, the aim of this study was to investigate the possible changes in serum irisin concentrations before and after treatment in hypothyroid subjects. The study included 26 patients with overt hypothyroidism due to Hashimoto thyroiditis and 19 healthy subjects. Baseline serum thyroid function tests and presence of thyroid autoantibodies and levels of creatine kinase (CK) and irisin were measured in both groups. All measurements in the hypothyroid group were repeated after euthyroidism was achieved. Serum irisin levels were significantly lower in the hypothyroid groups than the control group (p treatment (p hypothyroid patients were treated to achieve euthyroidism. To the best of our knowledge, this is the first study providing insight that low serum irisin levels significantly increased following treatment to euthyroid state in overt hypothyroid patients with Hashimoto thyroiditis. Larger scale studies are needed to confirm these results and to ensure irisin as a possible biomarker of Hashimoto's thyroiditis.

  20. The Effect of Provision of Information Regarding Infertility Treatment Strategies on Anxiety Level of Infertile Couples

    Directory of Open Access Journals (Sweden)

    Mustafa Hamdieh

    2009-01-01

    Full Text Available Background: Infertility may have many emotional and psychological implications on infertilecouples. So far, different methods for reducing anxiety in infertile couples have been evaluated. Thegoal of this study is to evaluate the effect of provision of information regarding infertility treatmentto infertile couples on their anxiety levels.Materials and Methods: This study was conducted as a before and after clinical trial. Forty-twoindividuals were considered as cases and 40 as controls. In order to evaluate anxiety and depressionin participants, the Hamilton Anxiety and Depression Scale (HADS questionnaire was used. Theintervention group received information about infertility treatment through a two hour face-to-facemeeting and was provided with a brochure. Anxiety level was assessed at the time of admission,immediately after the session and two weeks later. Assessment was performed twice for the controlgroup; once at the time of admission and secondly, two weeks later.Results: Our results show that receiving information about infertility treatment significantlydecreases anxiety among infertile couples two weeks post-training. This decline does not have asignificant correlation with age, sex, education level of the couple, and neither with the durationnor the cause of infertility. Providing information does not have any significant effect on the rate ofdepression among couples.Conclusion: It is recommended that provision of information regarding infertility treatmentmethods should be considered as a means of decreasing anxiety among infertile couples who referto infertility treatment centers.

  1. Inactivation of Escherichia coli by ozone treatment of apple juice at different pH levels.

    Science.gov (United States)

    Patil, S; Valdramidis, V P; Cullen, P J; Frias, J; Bourke, P

    2010-09-01

    This research investigated the efficacy of gaseous ozone on the inactivation of Escherichia coli ATCC 25922 and NCTC 12900 strains in apple juice of a range of pH levels, using an ozone bubble column. The pH levels investigated were 3.0, 3.5, 4.0, 4.5 and 5.0. Apple juice inoculated with E. coli strains (10(6)CFU/mL) was treated with ozone gas at a flow rate of 0.12L/min and ozone concentration of 0.048 mg/min/mL for up to 18 min. Results show that inactivation kinetics of E. coli by ozone were affected by pH of the juice. The ozone treatment duration required for achieving a 5-log reduction was faster (4 min) at the lowest pH than at the highest pH (18 min) studied. The relationship between time required to achieve 5log reduction (t(5d)) and pH for both strains was described mathematically by two exponential equations. Ozone treatment appears to be an effective process for reducing bacteria in apple juice and the required applied treatment for producing a safe apple juice is dependant on its acidity level. Copyright 2010 Elsevier Ltd. All rights reserved.

  2. Heightened systemic levels of neutrophil and eosinophil granular proteins in pulmonary tuberculosis and reversal following treatment.

    Science.gov (United States)

    Moideen, Kadar; Kumar, Nathella Pavan; Nair, Dina; Banurekha, Vaithilingam V; Bethunaickan, Ramalingam; Babu, Subash

    2018-04-09

    Granulocytes are activated during tuberculosis (TB) infection and act as immune effector cells and granulocyte responses are implicated in TB pathogenesis. Plasma levels of neutrophil and eosinophil granular proteins provide an indirect measure of degranulation. In this study, we wanted to examine the levels of neutrophil and eosinophil granular proteins in individuals with pulmonary tuberculosis (PTB) and to compare them with the levels in latent TB (LTB) individuals. Hence, we measured the plasma levels of myeloperoxidase (MPO), neutrophil elastase, and proteinase-3; major basic protein (MBP), eosinophil derived neurotoxin (EDN), eosinophil cationic protein (ECP) and eosinophil peroxidase (EPX) in these individuals. Finally, we also measured the levels of all of these parameters in PTB individuals following anti-tuberculosis (ATT) treatment. Our data reveal that PTB individuals are characterized by significantly higher plasma levels of MPO, elastase, human proteinase 3 as well as MBP and EDN in comparison to LTB individuals. Our data also reveal that ATT resulted in reversal of all of these changes, indicating an association with TB disease. Finally, our data show that the systemic levels of MPO and proteinase-3 can significantly discriminate PTB from LTB individuals. Thus, our data suggest that neutrophil and eosinophil granular proteins could play a potential role in the innate immune response and therefore, the pathogenesis of pulmonary TB. Copyright © 2018 American Society for Microbiology.

  3. Comparison of Serum Levels of Endothelin-1 in Chronic Periodontitis Patients Before and After Treatment

    Science.gov (United States)

    Varghese, Sheeja S; Sankari, M.; Jayakumar, ND.

    2017-01-01

    Introduction Endothelin-1 (ET-1) is a potent vasoconstrictive peptide with multi functional activity in various systemic diseases. Previous studies indicate the detection of ET-1 in gingival tissues and gingival crevicular fluid. Aim The aim of this study was to estimate the serum ET-1 levels in clinically healthy subjects and subjects with chronic periodontitis, before and after treatment, and correlate it with the clinical parameters. Materials and Methods A total of 44 patients were included in the study. Group I comprised of 20 subjects with clinically healthy periodontium. Group II comprised of 24 subjects with chronic periodontitis. Group III comprised of same Group II subjects following periodontal management. Serum samples were collected from the subjects and an Enzyme Linked Immunosorbent Assay (ELISA) was done to estimate the ET-1 levels. The ET-1 levels were then correlated among the three groups with the clinical parameters namely, Plaque Index (PI), Sulcus Bleeding Index (SBI), probing pocket depth, clinical attachment loss and Periodontally Inflamed Surface Area (PISA). The independent t-test and paired t-test were used for comparison of clinical parameters and Pearson’s correlation coefficient test was used for correlating the ET-1 levels. Results ET-1 levels in chronic periodontitis subjects were significantly higher compared to healthy subjects (p<0.001). However, the clinical parameters did not statistically correlate with the ET-1 levels. There was a significant decrease in ET-1 levels following treatment (p<0.001). Conclusion Serum ET-1 is increased in chronic periodontitis and reduces after periodontal therapy. Further studies are required to establish ET-1 as a biomarker for periodontal disease. PMID:28571268

  4. GLP-1 and GIP Levels in Patients With Hyperthyroidism: The Effect of Antithyroid Treatment.

    Science.gov (United States)

    Cira, Duygu Kalkan; Sari, Ramazan; Ozdem, Sebahat; Yilmaz, Nusret; Bozkurt, Selen

    2017-08-01

    Incretin hormones (glucagon-like peptide-1 [GLP-1] and gastric inhibitory polypeptide [GIP]) may play a role in the development of glucose intolerance and hyperglycemia in patients with hyperthyroidism. We aimed to assess both incretin levels and treatment-induced changes in incretin levels in those with hyperthyroidism. A total of 24 subjects (12 with hyperthyroidism and 12 healthy) were enrolled in the study. Oral glucose tolerance test was performed and serum glucose, insulin GLP1, and GIP levels were evaluated at 0 (baseline), 30, 60, 90, and 120 minutes using ELISA. Measurements were repeated after euthyroidism was reached in subjects with hyperthyroidism. The baseline glucose level was higher in those with hyperthyroidism compared with controls ( P = 0.03). GLP-1 and GIP responses to oral glucose load did not differ significantly between those with hyperthyroidism and controls. Peak GLP-1 and GIP levels were reached in both groups at 60 and 90 minutes, respectively. Areas under the curve (AUCs) for GLP1 and GIP were similar in those with hyperthyroidism and controls. Although GLP-1 and GIP levels did not change before and after antithyroid treatment in subjects with hyperthyroidism, time to peak GLP-1 and GIP levels were reached at 30 minutes after euthyroid state was achieved. Reversal of hyperthyroid to euthyroid status did not induce significant changes in AUCs for incretins. The findings of the present study suggest that the total incretin response to oral glucose load is preserved in patients with hypertyhroidism, but peak incretin responses may change after achieving euthyroid state.

  5. Assessment of the effectiveness of low level laser in the treatment of alveolar osteitis

    Directory of Open Access Journals (Sweden)

    Jovanović Goran

    2011-01-01

    Full Text Available Background/Aim. Alveolar osteitis (AO is the extraction wound healing disorder with a presence of severe pain. Low level laser therapy stimulates cell metabolism and microcirculation, have has pronounced analgesic, antiedematous and anti-inflammatory effect and speeds up wound healing process. The aim of this study was to present results of clinical research that examined the effectiveness of low level laser in pain relief and healing of extraction wounds with alveolar osteitis in the lower jaw which was formed on the second day after tooth extraction. Methods. The study was conducted on 60 subjects divided into the study and the control group. In both groups extraction wounds were processed in similar way, except that in the study group was applied daily treatment of low level laser with a total of eight sessions of radiation, while in the control group extraction wounds were dressed with zinc oxide eugenol paste, which was changed every 48 hours up to the pain cessation. Measurement of pain intensity was done with a visual analogue scale (VAS 10 min prior to processing of extraction wounds and daily for the next eight days. Assessment of the effectiveness of low level laser on healing of extraction wounds was performed on the day eight of the treatment. Results. On the day five after beginning of the treatment of extraction wounds with alveolar osteitis in the patients of the study group a lower average value of pain as compared to the control group was registered. This difference was increased within the following days. Extraction wounds healing in the study group was more successful and faster than in the control group. Conclusion. This study suggested that the reduction of pain was more pronounced in the patients with alveolar osteitis whose extraction wounds were subjected to low level laser radiation in comparison to those in which extraction wounds were treated with zinc oxide eugenol paste.

  6. Clinical significance of determination of changes of serum TSGF and plasma VEGF levels after treatment in patients with endometriosis

    International Nuclear Information System (INIS)

    Shi Shaohong; Tian Xiaoping

    2006-01-01

    Objective: To investigate the changes of serum TSGF and plasma VEGF levels after treatment in patients with endometriosis. Methods: Serum TSGF levels were determined with ELISA mad plasma VEGF levels with biochemistry in 31 patients with endometriosis both before and after treatment as well as in 30 controls. Results: Before treatment the serum TSGF and plasma VEGF levels in patients were significantly higher than those in the controls (P 0.05). Conclusion: Development of endometriosis were closely related to the plasma levels of VEGF and serum TSGF levels. (authors)

  7. Integrated process analysis of treatment systems for mixed low level waste

    International Nuclear Information System (INIS)

    Cooley, C.R.; Schwinkendorf, W.E.; Bechtold, T.E.

    1997-10-01

    Selection of technologies to be developed for treatment of DOE's mixed low level waste (MLLW) requires knowledge and understanding of the expected costs, schedules, risks, performance, and reliability of the total engineered systems that use these technologies. Thus, an integrated process analysis program was undertaken to identify the characteristics and needs of several thermal and nonthermal systems. For purposes of comparison, all systems were conceptually designed for a single facility processing the same amount of waste at the same rate. Thirty treatment systems were evaluated ranging from standard incineration to innovative thermal systems and innovative nonthermal chemical treatment. Treating 236 million pounds of waste in 20 years through a central treatment was found to be the least costly option with total life cycle cost ranging from $2.1 billion for a metal melting system to $3.9 billion for a nonthermal acid digestion system. Little cost difference exists among nonthermal systems or among thermal systems. Significant cost savings could be achieved by working towards maximum on line treatment time per year; vitrifying the final waste residue; decreasing front end characterization segregation and sizing requirements; using contaminated soil as the vitrifying agent; and delisting the final vitrified waste form from Resource Conservation and Recovery Act (RCRA) Land Disposal Restriction (LDR) requirements

  8. Decreased levels of matrix metalloproteinase-2 in root-canal exudates during root canal treatment.

    Science.gov (United States)

    Pattamapun, Kassara; Handagoon, Sira; Sastraruji, Thanapat; Gutmann, James L; Pavasant, Prasit; Krisanaprakornkit, Suttichai

    2017-10-01

    To determine the matrix metalloproteinase-2 (MMP-2) levels in root-canal exudates from teeth undergoing root-canal treatment. The root-canal exudates from six teeth with normal pulp and periradicular tissues that required intentional root canal treatment for prosthodontic reasons and from twelve teeth with pulp necrosis and asymptomatic apical periodontitis (AAP) were sampled with paper points for bacterial culture and aspirated for the detection of proMMP-2 and active MMP-2 by gelatin zymography and the quantification of MMP-2 levels by ELISA. By gelatin zymography, both proMMP-2 and active MMP-2 were detected in the first collection of root-canal exudates from teeth with pulp necrosis and AAP, but not from teeth with normal pulp, and their levels gradually decreased and disappeared at the last collection. Consistently, ELISA demonstrated a significant decrease in MMP-2 levels in the root-canal exudates of teeth with pulp necrosis and AAP following root canal procedures (papical lesions, similar to the clinical application of MMP-8 as a biomarker. Copyright © 2017 Elsevier Ltd. All rights reserved.

  9. Treatment and Storage of High-Level Radioactive Wastes. Proceedings of the Symposium on Treatment and Storage of High-Level Radioactive Wastes

    International Nuclear Information System (INIS)

    1963-01-01

    A variety of radioactive materials having no immediate use result from the utilization of atomic energy. The manner in which these materials are handled has repercussions on reactor economy and technology, on the health and safety of persons and populations and on atomic legislation. Excellent progress has been made in developing a technology capable of safely and economically dealing with these materials so that no immediate problems exist. The highly radioactive ''wastes'' arising from the reprocessing of irradiated fuel pose long-range problems, however, and methods for the ultimate disposal of these wastes must be developed and evaluated. Such development and evaluation can be materially assisted by providing the scientists doing the work with an opportunity of exchanging ideas and information on their experience. Therefore, the IAEA, as part of its programme of promoting nuclear technology, convened in Vienna from 8-12 October 1962 the Symposium on the Treatment and Storage of High-level Radioactive Wastes. The Symposium was attended by 130 scientists from 19 countries and two international organizations. Thirty-three papers were presented and discussed in full and formed a background for a panel discussion of chairmen near the end of the Symposium. The papers and a record of the discussions are published in this single volume. It is hoped that the information thus recorded will achieve the desired purpose of assisting the peaceful development of atomic energy

  10. The dynamics of histamine level in patients with chronic urticaria under the influence of different methods of treatment.

    Directory of Open Access Journals (Sweden)

    Dytyatkovska Ye.M.

    2014-11-01

    Full Text Available There was studied the efficiency of different methods of chronic urticaria treatment. All patients were divided into 2 groups depending on treatment scteme. The paper shows the dynamics of histamine level in blood plasma, intestine disbiosis in patients with chronic urticaria under the influence of different treatment complexes. It was proved that there exists the correlation between the serum histamine level and method of treatment. Intro¬ducing bionorm into the treatment allows to decrease histamine level and correspondingly to significantly improve clinical effect and patients’ life quality.

  11. Effect of thiazolidinedione treatment on resistin levels in insulin resistant sprague dawley rats

    International Nuclear Information System (INIS)

    Yousaf, I.; Hameed, W.; Rajput, T.A.

    2015-01-01

    Insulin resistance is manifested by decreased effect of fixed quantity of insulin on glucose metabolism leading to type 2 diabetes mellitus. Visceral obesity has been positively correlated with insulin resistance but its mechanism is not fully defined. Insulin resistance may be the consequence of adipocytokines including visfatin and resistin. This study was designed to see the effect of thiazolidinediones on levels of resistin in insulin resistant rats. Methods: Ninety Sprague Dawley rats were randomly divided into three groups. Group I served as control. Rats in Group II and III were made insulin resistant diabetics. Group III was treated with rosiglitazone after development of diabetes. Plasma glucose, serum triglycerides, HDL, TG:HDL ratio and serum resistin levels were analysed. Results: Body weight and plasma glucose were significantly increased (p<0.05) along with TG:HDL ratio (p<0.05) in group II and group III at the end of 4th week. Serum resistin levels also increased significantly (p<0.05) in group II and III at the end of 4th week. Treatment of group III with rosiglitazone led to improvement in insulin resistance with decrease in serum resistin levels (p<0.05). Conclusion: Increased serum resistin level indicates insulin resistance and impending hyperglycaemia. Thiazolidinediones augment sensitivity of insulin to restore normoglycaemia by decreasing serum resistin level. (author)

  12. Assess the knowledge level of POZ patients on the diagnosis and treatment of type 2 diabetes

    Directory of Open Access Journals (Sweden)

    Małgorzata Żebrowska

    2017-07-01

    Full Text Available Background: Diabetes is considered a civilization disease. It is now one of the major problems of the modern world. More than 123 million people suffer from it. About 3.5% of the general population suffer from this disease every year. This causes a huge health, social and economic problem. The reason for such a high incidence of illness is beyond the aging population, poor lifestyle: diet and low physical activity. Diabetes affects people of all ages. Having a disease means a very serious problem for the patient. It essentially changes its life, requires long-term treatment, proper care and lifestyle changes. Aim: Defining the knowledge level of POZ patients on the diagnosis and treatment of type 2 diabetes. Material and method: The study group consisted of patients reporting to the POZ clinic at the Independent Public Health Care Unit in Bychawa. The research group comprised 36 women and 37 men. The research tool was an author's questionnaire, which included a total of 47 questions, 11 of them metric, and the remaining 36 related to knowledge about diabetes. Questions were closed questions. The results of the study were statistically analyzed. The values of the measured measurable parameters are expressed by means of mean, standard deviation, minimum and maximum values, and non-measurable characteristics by means of numerical and interest. Standard deviation is a popular measure of dispersion reflecting the degree of dispersion of measurements around the arithmetic mean. The correlation between variables was used to correlate Sperman (R rankings. The significance level p <0.05 has been assumed to indicate the existence of statistically significant differences or dependencies. The database and statistical studies were based on Statistica 9.1 computer software. (StatSoft, Poland. Results: The knowledge of patients with type II diabetes mellitus is incomplete and high, and quite often they have knowledge in this field. Most respondents have

  13. Empiric 131I treatment of high thyroglobulin levels in differentiated thyroid carcinoma after remnant ablation

    International Nuclear Information System (INIS)

    Kalender, E.; Elboga, U.; Celen, Y.; Demir, H.; Yilmaz, M.; Sahin, E.

    2015-01-01

    Full text of publication follows. Objective: serum thyroglobulin (Tg) measurements are usually the best marker of residual or metastatic disease after the treatment of differentiated thyroid carcinoma (DTC). It is not rare to find patients with detectable serum Tg levels after ablative 131 I treatment (AIT). The objective of this study is to establish the efficacy of empiric 131 I treatment (EIT) given for patients whose Tg levels remained high after AIT. Materials and methods: 28 patients (23 women, 5 men; mean age 47.4 ± 16.8) without distant metastasis, who were treated empirically for high Tg levels after AIT in our clinic were studied retrospectively. In all patients stimulated Tg levels before AIT (Tg I) and 6 months after AIT (Tg II) were measured. The Tg cutoff level for EIT was accepted 10 ng/ml. After EIT, post-therapeutic whole-body scintigraphy (PWBS) was performed to all patients. 18 F-FDG PET CT was performed to patients who had negative PWBS but continued high Tg II levels. Results: PWBS was positive in 14 patients (50%) and negative in 14 patients (50%). 14 patients did not respond to EIT (50%), and 14 patients (50%) responded to EIT at different rates. Eight patients (28.6%) responded to EIT completely, and 6 patients (21.4%) responded to EIT partially. Tg I was 60.7 ± 40 ng/ml and Tg II was 31 ± 20.4 ng/ml in responded patients. Tg I was 87.6 ± 96 ng/ml and Tg II was 114.3 ± 106 ng/ml in non-responding patients. 18 F-FDG PET CT was performed to 14 patients who had negative PWBS. 18 F-FDG PET CT was positive in 11 patients and negative in 3 patients. 18 F-FDG PET CT positive patients were referred to surgery. Conclusion: Our findings, suggested that the EIT is not beneficial in patients who have higher Tg II than Tg I and the cure rate is low in increasing Tg levels. The patients who have high Tg II but lower than Tg I can be treated empirically with 131 I. In these patients EIT may be beneficial. (authors)

  14. Advances in technologies for the treatment of low and intermediate level radioactive liquid wastes

    International Nuclear Information System (INIS)

    1994-01-01

    In recent years the authorized maximum limits for radioactive discharges into the environment have been reduced considerably, and this, together with the requirement to minimize the volume of waste for storage or disposal and to declassify some wastes from intermediate to low level or to non-radioactive wastes, has initiated studies of ways in which improvements can be made to existing decontamination processes and also to the development of new processes. This work has led to the use of more specific precipitants and to the establishment of ion exchange treatment and evaporation techniques. Additionally, the use of combinations of some existing processes or of an existing process with a new technique such as membrane filtration is becoming current practice. New biotechnological, solvent extraction and electrochemical methods are being examined and have been proven at laboratory scale to be useful for radioactive liquid waste treatment. In this report an attempt has been made to review the current research and development of mature and advanced technologies for the treatment of low and intermediate level radioactive liquid wastes, both aqueous and non-aqueous. Non-aqueous radioactive liquid wastes or organic liquid wastes typically consist of oils, reprocessing solvents, scintillation liquids and organic cleaning products. A brief state of the art of existing processes and their application is followed by the review of advances in technologies, covering chemical, physical and biological processes. 213 refs, 33 figs, 3 tabs

  15. Non-Thermal Treatment of Hanford Site Low-Level Mixed Waste

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1998-09-01

    DOE proposes to transport contact-handled LLMW from the Hanford Site to the Allied Technology Group (ATG) Mixed Waste Facility (MWF) in Richland, Washington, for non-thermal treatment and to return the treated waste to the Hanford Site for eventual land disposal. Over a 3-year period the waste would be staged to the ATG MWF, and treated waste would be returned to the Hanford Site. The ATG MWF would be located on an 18 hectare (ha) (45 acre [at]) ATG Site adjacent to ATG's licensed low-level waste processing facility at 2025 Battelle Boulevard. The ATG MWF is located approximately 0.8 kilometers (km) (0.5 miles [mi]) south of Horn Rapids Road and 1.6 km (1 mi) west of Stevens Drive. The property is located within the Horn Rapids triangle in northern Richland (Figure 2.1). The ATG MWF is to be located on the existing ATG Site, near the DOE Hanford Site, in an industrial area in the City of Richland. The effects of siting, construction, and overall operation of the MWF have been evaluated in a separate State Environmental Policy Act (SEPA) EIS (City of Richland 1998). The proposed action includes transporting the LLMW from the Hanford Site to the ATG Facility, non-thermal treatment of the LLMW at the ATG MWF, and transporting the waste from ATG back to the Hanford Site. Impacts fi-om waste treatment operations would be bounded by the ATG SEPA EIS, which included an evaluation of the impacts associated with operating the non-thermal portion of the MWF at maximum design capacity (8,500 metric tons per year) (City of Richland 1998). Up to 50 employees would be required for non-thermal treatment portion of the MWF. This includes 40 employees that would perform waste treatment operations and 10 support staff. Similar numbers were projected for the thermal treatment portion of the MWF (City of Richland 1998).

  16. Treatment of low level radioactive wastewater by means of NF process

    Energy Technology Data Exchange (ETDEWEB)

    Chen, Ding; Zhao, Xuan, E-mail: zhxinet@tsinghua.edu.cn; Li, Fuzhi

    2014-10-15

    Highlights: • Nanofiltration can offer one of the approaches in optimizing membrane system. • Operation parameters especially the pressure affect nuclides’ removal efficiency. • Organic polyamide membrane shows radiation resistance. • A summary of DF and flux values can be taken as reference in designing the membrane system for LLRWs treatment. - Abstract: Membrane technology has been proved as an effective technology in the treatment of low level radioactive wastewaters (LLRWs). As ‘loose reverse osmosis’, nanofiltration can be integrated with RO and offers the high permeate flux at low pressure without obvious loss of decontamination efficiency. In the paper, three kinds of commercially available NF membrane materials were investigated by lab-scale experiment with respect to the nuclide rejection. The results demonstrate the efficient elimination. The membrane flux can be improved by the elevation of temperature and cross-flow velocity within the ranges of 20–30 °C and 0.4–1.0 m s{sup −1}. The radiation resistance test demonstrates no obvious loss of flux and nuclide rejection after a long term operation in the radioactive circumstance. A brief comparison of LLRWs treatment methods shows that NF can perform the pre-treatment of RO and optimize the entire membrane system with high flux and low pressure. In the paper, decontamination factor and flux values of the tested membranes at different operation condition are summarized as the reference for membrane selection and system design.

  17. Lacosamide reduces HDAC levels in the brain and improves memory: Potential for treatment of Alzheimer's disease.

    Science.gov (United States)

    Bang, Shraddha R; Ambavade, Shirishkumar D; Jagdale, Priti G; Adkar, Prafulla P; Waghmare, Arun B; Ambavade, Prashant D

    2015-07-01

    Lacosamide, a histone deacetylase (HDAC) inhibitor, has been approved for the treatment of epilepsy. Some HDAC inhibitors have been proven effective for the treatment of memory disorders. The present investigation was designed to evaluate the effect of lacosamide on memory and brain HDAC levels. The effect on memory was evaluated in animals with scopolamine-induced amnesia using the elevated plus maze, object recognition test, and radial arm maze. The levels of acetylcholinesterase and HDAC in the cerebral cortex were evaluated. Lacosamide at doses of 10 and 30mg/kg significantly reduced the transfer latency in the elevated plus maze. Lacosamide at a dose of 30mg/kg significantly increased the time spent with a familiar object in the object recognition test at the 24h interval and decreased the time spent in the baited arm. Moreover, at this dose, the number of errors in the radial arm maze at 3 and 24h intervals was minimized and a reduction in the level of HDAC1, but not acetylcholinesterase, was observed in the cerebral cortex. These effects of lacosamide are equivalent to those of piracetam at a dose of 300mg/kg. These results suggest that lacosamide at a 30mg/kg dose improves disrupted memory, possibly by inhibiting HDAC, and could be used to treat amnesic symptoms of Alzheimer's disease. Copyright © 2015 Elsevier Inc. All rights reserved.

  18. Effects of chlorhexidine (gel) application on bacterial levels and orthodontic brackets during orthodontic treatment.

    Science.gov (United States)

    Al-Bazi, Samar M; Abbassy, Mona A; Bakry, Ahmed S; Merdad, Leena A; Hassan, Ali H

    2016-01-01

    The objectives of this study were to evaluate the effects of applying 0.50% chlorhexidine (CHX) gel using the dental drug delivery system (3DS) on salivary Streptococcus mutans (S. mutans) and on the surface topography of metal and ceramic orthodontic brackets. The study involved 20 orthodontic patients with high levels of salivary S. mutans. The patients were treated with professional mechanical tooth cleaning followed by application of 0.50% CHX using individual trays (3DS). Salivary S. mutans levels were repeatedly measured 1, 2, 4, and 8 weeks post-treatment. In vitro study utilized forty ceramic and metallic brackets that were immersed in 0.50% CHX gel for 10 min, whereas another untreated forty brackets served as controls. The frictional resistances of stainless steel wires to the brackets before and after CHX treatment were recorded using a universal testing machine. Scanning electron microscopy was used to compare changes in the surface topography of brackets. Statistical analyses were used to determine the effect of CHX on bacterial count and to evaluate the effect of CHX on frictional resistance. According to the results of this study, S. mutans levels were reduced significantly (P brackets before or after application of CHX. (J Oral Sci 58, 35-42, 2016).

  19. Treatment methods for radioactive mixed wastes in commercial low-level wastes: technical considerations

    International Nuclear Information System (INIS)

    MacKenzie, D.R.; Kempf, C.R.

    1986-01-01

    Treatment options for the management of three generic categories of radioactive mixed waste in commercial low-level wastes (LLW) have been identified and evaluated. These wastes were characterized as part of a BNL study in which LLW generators were surveyed for information on potential chemical hazards in their wastes. The general treatment options available for mixed wastes are destruction, immobilization, and reclamation. Solidification, absorption, incineration, acid digestion, wet-air oxidation, distillation, liquid-liquid wastes. Containment, segregation, decontamination, and solidification or containment of residues, have been considered for lead metal wastes which have themselves been contaminated and are not used for purposes of waste disposal shielding, packaging, or containment. For chromium-containing wastes, solidification, incineration, wet-air oxidation, acid digestion, and containment have been considered. For each of these wastes, the management option evaluation has included an assessment of testing appropriate to determine the effect of the option on both the radiological and potential chemical hazards present

  20. Treatment methods for radioactive mixed wastes in commercial low-level wastes: technical considerations

    Energy Technology Data Exchange (ETDEWEB)

    MacKenzie, D.R.; Kempf, C.R.

    1986-01-01

    Treatment options for the management of three generic categories of radioactive mixed waste in commercial low-level wastes (LLW) have been identified and evaluated. These wastes were characterized as part of a BNL study in which LLW generators were surveyed for information on potential chemical hazards in their wastes. The general treatment options available for mixed wastes are destruction, immobilization, and reclamation. Solidification, absorption, incineration, acid digestion, wet-air oxidation, distillation, liquid-liquid wastes. Containment, segregation, decontamination, and solidification or containment of residues, have been considered for lead metal wastes which have themselves been contaminated and are not used for purposes of waste disposal shielding, packaging, or containment. For chromium-containing wastes, solidification, incineration, wet-air oxidation, acid digestion, and containment have been considered. For each of these wastes, the management option evaluation has included an assessment of testing appropriate to determine the effect of the option on both the radiological and potential chemical hazards present.

  1. Sea Level Rise Impacts on Wastewater Treatment Systems Along the U.S. Coasts

    Science.gov (United States)

    Hummel, Michelle A.; Berry, Matthew S.; Stacey, Mark T.

    2018-04-01

    As sea levels rise, coastal communities will experience more frequent and persistent nuisance flooding, and some low-lying areas may be permanently inundated. Critical components of lifeline infrastructure networks in these areas are also at risk of flooding, which could cause significant service disruptions that extend beyond the flooded zone. Thus, identifying critical infrastructure components that are exposed to sea level rise is an important first step in developing targeted investment in protective actions and enhancing the overall resilience of coastal communities. Wastewater treatment plants are typically located at low elevations near the coastline to minimize the cost of collecting consumed water and discharging treated effluent, which makes them particularly susceptible to coastal flooding. For this analysis, we used geographic information systems to assess the exposure of wastewater infrastructure to various sea level rise projections at the national level. We then estimated the number of people who would lose wastewater services, which could be more than five times as high as previous predictions of the number of people at risk of direct flooding due to sea level rise. We also performed a regional comparison of wastewater exposure to marine and groundwater flooding in the San Francisco Bay Area. Overall, this analysis highlights the widespread exposure of wastewater infrastructure in the United States and demonstrates that local disruptions to infrastructure networks may have far-ranging impacts on areas that do not experience direct flooding.

  2. Reduced plasma taurine level in Parkinson's disease: association with motor severity and levodopa treatment.

    Science.gov (United States)

    Zhang, Li; Yuan, Yongsheng; Tong, Qing; Jiang, Siming; Xu, Qinrong; Ding, Jian; Zhang, Lian; Zhang, Rui; Zhang, Kezhong

    2016-01-01

    This study aimed to evaluate the level of taurine in plasma, and its association with the severity of motor and non-motor symptoms (NMS) and chronic levodopa treatment in Parkinson's disease (PD). Plasma taurine level was measured in treated PD (tPD), untreated PD (ntPD) and control groups. Motor symptoms and NMS were assessed using the Unified Parkinson's Disease Rating Scale, the short form of the McGill Pain Questionnaire, the Hamilton Depression Scale, the Scale for Outcomes in Parkinson's disease for Autonomic Symptoms and the Pittsburgh Sleep Quality Index. Longtime exposure to levodopa was indicated by its approximate cumulative dosage. The plasma taurine levels of PD patients were decreased when compared with controls and negatively associated with motor severity but not NMS. Moreover, tPD patients exhibited lower levels of plasma taurine than ntPD patients. Interestingly, plasma taurine levels negatively correlated with cumulative levodopa dosage in tPD. After controlling for potential confounders, the association between taurine and levodopa remained significant. Our study supports that taurine may play important roles in the pathophysiology of PD and the disturbances caused by chronic levodopa administration.

  3. Sea level rise impacts on wastewater treatment systems along the U.S. coasts

    Science.gov (United States)

    Hummel, M.; Berry, M.; Stacey, M. T.

    2017-12-01

    As sea levels rise, coastal communities will experience more frequent and persistent nuisance flooding, and some low-lying areas may be permanently inundated. Critical components of lifeline infrastructure networks in these areas are also at risk of flooding, which could cause significant service disruptions that extend beyond the flooded zone. Thus, identifying critical infrastructure components that are vulnerable to sea level rise is an important first step in developing targeted investment in protective actions and enhancing the overall resilience of coastal communities. Wastewater treatment plants are typically located at low elevations near the coastline to minimize the cost of collecting consumed water and discharging treated effluent, which makes them particularly susceptible to coastal flooding. For this analysis, we used geographic information systems to assess the vulnerability of wastewater infrastructure to various sea level rise projections at the national level. We then estimated the number of people who would lose wastewater services, which could be more than three times as high as previous predictions of the number of people at risk of direct flooding due to sea level rise. We also considered several case studies of wastewater infrastructure in mid-sized cities to determine how topography and system configuration (centralized versus distributed) impact vulnerability. Overall, this analysis highlights the widespread vulnerability of wastewater infrastructure in the U.S. and demonstrates that local disruptions to infrastructure networks may have far-ranging impacts on areas that do not experience direct flooding.

  4. [Effect of anticancer treatment on leptin level, fat body mass (FM) and lean body mass (LBM)].

    Science.gov (United States)

    Krawczyk-Rybak, Maryna; Muszyńska-Rosłan, Katarzyna; Konstantynowicz, Jerzy; Solarz, Elzbieta; Wołczynski, Sławomir; Protas, Piotr

    2004-01-01

    Leptin plays an important role in the metabolism of adipose tissue. Considering that malignancy and its treatment cans affect normal development in childhood. We analysed the correlations between serum leptin levels and body composition after anticancer treatment. We studied 33 survivors (24 boys and 9 girls) who before our study, have been treated for acute lymphoblastic leukaemia (ALL) (n=23) and Hodgkin disease (n=10) after 7.15+/-3.5 years. Sixteen patients with ALL received cranial irradiation (12Gy). We measured body mass index (BM1) fat mass (FM) and lean body mass (LBM) using dual energy x-ray absorptiometry (DXA). We compared these results to the results obtained from reference values (SD score). Leptin levels were measured with the RIA method. 1. Mean leptin levels were higher in girls after puberty (10.93 ng/mL+/-8.9) than in boys (3.73 ng/mL+/-3. 7). In boys no differences were found in leptin levels between T2-4 and T5 stages. In girls the leptin values increased after puberty. Leptin SD score levels were higher in boys during (1.55 +/-1.0) and after puberty (1.46+/-0.75) and in girls - after puberty (1.19 +/-1.51). We did not find any influence of cranial irradiation (12Gy) or various methotrexate doses (5 g/m(2) vs. 19/m(2)) leptin values. 2. No difference in BMI SD score was found within the whole study group. 3. FM did not change ill boys during and after puberty, although FM SD score were higher during puberty (2.98 +/-4.8). In girls FM and FM SD score were higher after puberty. In boys and girls LBM augmented with pubertal development but LBM SD score in boys were lower after puberty (-1.67 +/-1.7) in comparison to puberty (0.2 +/-1.7). No differences were found between LBM SD score in girls during and after puberty. 4. We found a correlation between leptin levels and BMI (r=0.59 p=0.001) and FM (r=0.77 p=0.0001). 5. Relation of FM to LBM in boys remained unchanged, however in girls it increased within pubertal development. l. Anticancer

  5. Investigation of PON1 activity and MDA levels in patients with epilepsy not receiving antiepileptic treatment

    Directory of Open Access Journals (Sweden)

    Dönmezdil N

    2016-04-01

    Full Text Available Nilüfer Dönmezdil, Mehmet Uğur Çevik, Hasan Hüseyin Özdemir, Muhterem Taşin Department of Neurology, Dicle University, Diyarbakır, Turkey Purpose: There are many studies dedicated to researching the etiopathogenesis of epilepsy. In such research, oxidative and antioxidant indicators of etiopathogenesis have also been examined under the scope. Drawing on a group of patients with epilepsy who were receiving no treatment, we have tried to evaluate whether or not an increase in oxidative indicators is linked directly with the disorder, independent of epileptic medicaments.Methods: Thirty people in good health and 30 newly diagnosed with epilepsy and who received ambulatory treatment in the polyclinic of the Neurology Department took part in the study. The tests relating to serum malondialdehyde (MDA levels and paraoxonase 1 (PON1 activity were carried out in the biochemistry laboratory.Results: Even though the levels of MDA in the patient group (14.34±3.59 nmol/mL were found to be high compared to those of the control group, which consisted of people in good health (13.53±3.56 nmol/mL, there was no statistically significant difference. PON1 activity in the serum taken from people in the patient group (0.65±0.17 was lower in comparison to that observed in the serum of the control group (0.71±0.17 U/L. Nonetheless, it was not so low as to have significance from a statistical point of view.Conclusion: We conclude that such a high level of oxidative parameters should have been related to the disease and that statistically significant findings that emerged in some other studies could have been related to an antiepileptic treatment. Keywords: epilepsy, paraoxonase 1, malondialdehyde, oxidative stress, epilepsy, biochemical marker

  6. Treatment of burning mouth syndrome with a low-level energy diode laser.

    Science.gov (United States)

    Yang, Hui-Wen; Huang, Yu-Feng

    2011-02-01

    To test the therapeutic efficacy of low-level energy diode laser on burning mouth syndrome. Burning mouth syndrome is characterized by burning and painful sensations in the mouth, especially the tongue, in the absence of significant mucosal abnormalities. Although burning mouth syndrome is relatively common, little is known regarding its etiology and pathophysiology. As a result, no treatment is effective in all patients. Low-level energy diode laser therapy has been used in a variety of chronic and acute pain conditions, including neck, back and myofascial pain, degenerative osteoarthritis, and headache. A total of 17 patients who had been diagnosed with burning mouth syndrome were treated with an 800-nm wavelength diode laser. A straight handpiece was used with an end of 1-cm diameter with the fiber end standing 4 cm away from the end of handpiece. When the laser was applied, the handpiece directly contacted or was immediately above the symptomatic lingual surface. The output used was 3 W, 50 msec intermittent pulsing, and a frequency of 10 Hz, which was equivalent to an average power of 1.5 W/cm(2) (3 W × 0.05 msec × 10 Hz = 1.5 W/cm(2)). Depending on the involved area, laser was applied to a 1-cm(2) area for 70 sec until all involved area was covered. Overall pain and discomfort were analyzed with a 10-cm visual analogue scale. All patients received diode laser therapy between one and seven times. The average pain score before the treatment was 6.7 (ranging from 2.9 to 9.8). The results showed an average reduction in pain of 47.6% (ranging from 9.3% to 91.8%). The burning sensation remained unchanged for up to 12 months. Low-level energy diode laser may be an effective treatment for burning mouth syndrome.

  7. High level of oxygen treatment causes cardiotoxicity with arrhythmias and redox modulation

    Energy Technology Data Exchange (ETDEWEB)

    Chapalamadugu, Kalyan C.; Panguluri, Siva K. [Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL (United States); Bennett, Eric S. [Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa, FL (United States); Kolliputi, Narasaiah [Division of Allergy and Immunology, Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL (United States); Tipparaju, Srinivas M., E-mail: stippara@health.usf.edu [Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL (United States)

    2015-01-01

    Hyperoxia exposure in mice leads to cardiac hypertrophy and voltage-gated potassium (Kv) channel remodeling. Because redox balance of pyridine nucleotides affects Kv function and hyperoxia alters cellular redox potential, we hypothesized that hyperoxia exposure leads to cardiac ion channel disturbances and redox changes resulting in arrhythmias. In the present study, we investigated the electrical changes and redox abnormalities caused by 72 h hyperoxia treatment in mice. Cardiac repolarization changes were assessed by acquiring electrocardiogram (ECG) and cardiac action potentials (AP). Biochemical assays were employed to identify the pyridine nucleotide changes, Kv1.5 expression and myocardial injury. Hyperoxia treatment caused marked bradycardia, arrhythmia and significantly prolonged (ms) the, RR (186.2 ± 10.7 vs. 146.4 ± 6.2), PR (46.8 ± 3.1 vs. 39.3 ± 1.6), QRS (10.8 ± 0.6 vs. 8.5 ± 0.2), QTc (57.1 ± 3.5 vs. 40 ± 1.4) and JT (13.4 ± 2.1 vs. 7.0 ± 0.5) intervals, when compared with normoxia group. Hyperoxia treatment also induced significant increase in cardiac action potential duration (APD) (ex-APD{sub 90}; 73.8 ± 9.5 vs. 50.9 ± 3.1 ms) and elevated levels of serum markers of myocardial injury; cardiac troponin I (TnI) and lactate dehydrogenase (LDH). Hyperoxia exposure altered cardiac levels of mRNA/protein expression of; Kv1.5, Kvβ subunits and SiRT1, and increased ratios of reduced pyridine nucleotides (NADH/NAD and NADPH/NADP). Inhibition of SiRT1 in H9C2 cells using Splitomicin resulted in decreased SiRT1 and Kv1.5 expression, suggesting that SiRT1 may mediate Kv1.5 downregulation. In conclusion, the cardiotoxic effects of hyperoxia exposure involve ion channel disturbances and redox changes resulting in arrhythmias. - Highlights: • Hyperoxia treatment leads to arrhythmia with prolonged QTc and action potential duration. • Hyperoxia treatment alters cardiac pyridine nucleotide [NAD(P)H/NAD(P)] levels. • SiRT1 and Kv1.5 are co

  8. High level of oxygen treatment causes cardiotoxicity with arrhythmias and redox modulation

    International Nuclear Information System (INIS)

    Chapalamadugu, Kalyan C.; Panguluri, Siva K.; Bennett, Eric S.; Kolliputi, Narasaiah; Tipparaju, Srinivas M.

    2015-01-01

    Hyperoxia exposure in mice leads to cardiac hypertrophy and voltage-gated potassium (Kv) channel remodeling. Because redox balance of pyridine nucleotides affects Kv function and hyperoxia alters cellular redox potential, we hypothesized that hyperoxia exposure leads to cardiac ion channel disturbances and redox changes resulting in arrhythmias. In the present study, we investigated the electrical changes and redox abnormalities caused by 72 h hyperoxia treatment in mice. Cardiac repolarization changes were assessed by acquiring electrocardiogram (ECG) and cardiac action potentials (AP). Biochemical assays were employed to identify the pyridine nucleotide changes, Kv1.5 expression and myocardial injury. Hyperoxia treatment caused marked bradycardia, arrhythmia and significantly prolonged (ms) the, RR (186.2 ± 10.7 vs. 146.4 ± 6.2), PR (46.8 ± 3.1 vs. 39.3 ± 1.6), QRS (10.8 ± 0.6 vs. 8.5 ± 0.2), QTc (57.1 ± 3.5 vs. 40 ± 1.4) and JT (13.4 ± 2.1 vs. 7.0 ± 0.5) intervals, when compared with normoxia group. Hyperoxia treatment also induced significant increase in cardiac action potential duration (APD) (ex-APD 90 ; 73.8 ± 9.5 vs. 50.9 ± 3.1 ms) and elevated levels of serum markers of myocardial injury; cardiac troponin I (TnI) and lactate dehydrogenase (LDH). Hyperoxia exposure altered cardiac levels of mRNA/protein expression of; Kv1.5, Kvβ subunits and SiRT1, and increased ratios of reduced pyridine nucleotides (NADH/NAD and NADPH/NADP). Inhibition of SiRT1 in H9C2 cells using Splitomicin resulted in decreased SiRT1 and Kv1.5 expression, suggesting that SiRT1 may mediate Kv1.5 downregulation. In conclusion, the cardiotoxic effects of hyperoxia exposure involve ion channel disturbances and redox changes resulting in arrhythmias. - Highlights: • Hyperoxia treatment leads to arrhythmia with prolonged QTc and action potential duration. • Hyperoxia treatment alters cardiac pyridine nucleotide [NAD(P)H/NAD(P)] levels. • SiRT1 and Kv1.5 are co-regulated in

  9. The Effect of Growing Rod Treatment on Hemoglobin and Hematocrit Levels in Early-onset Scoliosis.

    Science.gov (United States)

    Barrett, Kody K; Lee, Christopher; Myung, Karen; Johnston, Charles; Shah, Suken A; Akbarnia, Behrooz A; Skaggs, David L

    2016-09-01

    This study examines preoperative hemoglobin (Hgb) and hematocrit (Hct) levels in a group of early-onset scoliosis (EOS) patients and the effect of distraction-based growing rods (GRs) on these levels. Children with EOS are at risk for respiratory insufficiency and chronic hypoxemia. Increased Hgb and Hct levels have been identified as surrogate markers for chronic hypoxemia. A study of patients who underwent VEPTR surgery showed a significant decrease in Hgb levels following surgery. Data were retrospectively collected on 66 EOS patients without confounding respiratory issues or oxygen dependence who were treated with GRs at 5 institutions. Average age at initial surgery was 5.5 years. Patients were followed for a minimum of 2 years (average 3.7 y). Preoperative and postoperative Hgb and Hct levels were converted to Z-scores based on age-adjusted mean blood indices and were compared using a paired t test. The prevalence of elevated Hgb and Hct levels (Z-score >2) preoperatively was 15% (10/66) and 19% (12/64), respectively. The average Hgb Z-score decreased from 0.20 to -0.31 (P=0.005) 6 to 24 months following surgery and the Hct Z-score decreased from 0.31 to -0.28 (P=0.002) 6 to 24 months following surgery. Following distraction-based GR treatment of children with EOS there was a significant decrease in both their Hgb and Hct. This is a physiological marker of decreased hypoxemia and improved pulmonary function. Level III-therapeutic study.

  10. Use of Eichornia crassipes for treatment of low level liquid radioactive waste

    Energy Technology Data Exchange (ETDEWEB)

    Hafez, N.; Ramadan, Y.S.; Hassanin, R.A.; Gafez, M.B. (Atomic Energy Authority, Hot Lab. Center, Cairo (Egypt))

    1993-01-01

    Radioactive and non-radioactive isotopes of cobalt, cerium and cesium were found to be accumulated inside Eichornia crassipes (the water hyacinth). The rate and extent of accumulation were dependent upon environmental parameters such as pH, temperature and interference by certain anions and cations. The accumulation rate of radioactive isotopes inside Eichornia crassipes, were more rapid than non-active ions. The results showed that accumulation of such metals inside the plant could be used successfully in the treatment of low-level liquid radioactive wastes. (author) 4 figs., 2 tabs., 15 refs.

  11. Use of Eichornia crassipes for treatment of low level liquid radioactive waste

    International Nuclear Information System (INIS)

    Hafez, N.; Ramadan, Y.S.; Hassanin, R.A.; Gafez, M.B.

    1993-01-01

    Radioactive and non-radioactive isotopes of cobalt, cerium and cesium were found to be accumulated inside Eichornia crassipes (the water hyacinth). The rate and extent of accumulation were dependent upon environmental parameters such as pH, temperature and interference by certain anions and cations. The accumulation rate of radioactive isotopes inside Eichornia crassipes, were more rapid than non-active ions. The results showed that accumulation of such metals inside the plant could be used successfully in the treatment of low-level liquid radioactive wastes. (author) 4 figs., 2 tabs., 15 refs

  12. Development of new treatment process for low level radioactive waste at Tokai reprocessing plant

    International Nuclear Information System (INIS)

    Horiguchi, Kenichi; Sugaya, Atsushi; Saito, Yasuo; Tanaka, Kenji; Akutsu, Shigeru; Hirata, Toshiaki

    2009-01-01

    The Low-level radioactive Waste Treatment Facility (LWTF) was constructed at the Tokai Reprocessing Plant (TRP) and cold testing has been carried out since 2006. The waste which will be treated in the LWTF is combustible/incombustible solid waste and liquid waste. In the LWTF, the combustible/incombustible solid waste will be incinerated. The liquid waste will be treated by a radio-nuclides removal process and subsequently solidified in cement. This report describes the essential technologies of the LWTF and results of R and D work for the nitrate-ion decomposition technology for the liquid waste. (author)

  13. SOLAR MIXTURE OPACITY CALCULATIONS USING DETAILED CONFIGURATION AND LEVEL ACCOUNTING TREATMENTS

    International Nuclear Information System (INIS)

    Blancard, Christophe; Cossé, Philippe; Faussurier, Gérald

    2012-01-01

    An opacity model (OPAS) combining detailed configuration and level accounting treatments has been developed to calculate radiative opacity of plasmas in local thermodynamic equilibrium. The model is presented and used to compute spectral opacities of a solar mixture. Various density-temperature couples have been considered from the solar center up to the vicinity of the radiative/convective zone interface. For a given solar thermodynamic path, OPAS calculations are compared to Opacity Project (OP) and OPAL data. Rosseland mean opacity values are in very good agreement over all the considered solar thermodynamic path, while OPAS and OP spectral opacities of each element may vary considerably. Main sources of discrepancy are discussed.

  14. Operating cost guidelines for benchmarking DOE thermal treatment systems for low-level mixed waste

    International Nuclear Information System (INIS)

    Salmon, R.; Loghry, S.L.; Hermes, W.H.

    1994-11-01

    This report presents guidelines for estimating operating costs for use in benchmarking US Department of Energy (DOE) low-level mixed waste thermal treatment systems. The guidelines are based on operating cost experience at the DOE Toxic Substances Control Act (TSCA) mixed waste incinerator at the K-25 Site at Oak Ridge. In presenting these guidelines, it should be made clear at the outset that it is not the intention of this report to present operating cost estimates for new technologies, but only guidelines for estimating such costs

  15. Study on the development of safeguards information treatment system at the facility level

    Energy Technology Data Exchange (ETDEWEB)

    Lee, B. D.; Song, D. Y.; So, D. S.; Kwak, E. H. [KAERI, Taejon (Korea, Republic of)

    2000-05-01

    Safeguards Information Treatment System(SITS) at the facility level is required to implement efficiently the obligations under the Korea-IAEA Safeguards Agreement, bilateral agreements with other countries and domestic law. In this paper, the requirements and major functions of SITS were considered, and the error checking methods and the relationships of safeguards information were reviewed. SITS will be developed to cover the different accounting procedures and methods applied at the various facilities under IAEA safeguards. Also, the resolved result of the Y2K problem in the existing nuclear material accounting program was described.

  16. Microwave energy for post-calcination treatment of high-level nuclear wastes

    International Nuclear Information System (INIS)

    Gombert, D.; Priebe, S.J.; Berreth, J.R.

    1980-01-01

    High-level radioactive wastes generated from nuclear fuel reprocessing require treatment for effective long-term storage. Heating by microwave energy is explored in processing of two possible waste forms: (1) drying of a pelleted form of calcined waste; and (2) vitrification of calcined waste. It is shown that residence times for these processes can be greatly reduced when using microwave energy rather than conventional heating sources, without affecting product properties. Compounds in the waste and in the glass frit additives couple very well with the 2.45 GHz microwave field so that no special microwave absorbers are necessary

  17. Crystal accumulation in the Hanford Waste Treatment Plant high level waste melter: Summary of 2017 experiments

    Energy Technology Data Exchange (ETDEWEB)

    Fox, K. [Savannah River Site (SRS), Aiken, SC (United States). Savannah River National Lab. (SRNL); Fowley, M. [Savannah River Site (SRS), Aiken, SC (United States). Savannah River National Lab. (SRNL)

    2018-01-11

    A full-scale, transparent mock-up of the Hanford Tank Waste Treatment and Immobilization Project High Level Waste glass melter riser and pour spout has been constructed to allow for testing with visual feedback of particle settling, accumulation, and resuspension when operating with a controlled fraction of crystals in the glass melt. Room temperature operation with silicone oil and magnetite particles simulating molten glass and spinel crystals, respectively, allows for direct observation of flow patterns and settling patterns. The fluid and particle mixture is recycled within the system for each test.

  18. EFFICACY OF LOW LEVEL LASER THERAPY IN THE TREATMENT OF ALOPECIA AREATA

    OpenAIRE

    Nermeen Mohamed Abdelhalim. PhD PT

    2014-01-01

    Background: Alopecia areata is a chronic inflammatory disease which affects the hair follicles and sometimes the nails. Purpose: The purpose of this study was to evaluate the efficacy of low level laser therapy in the treatment of alopecia areata of the scalp. Method: Twenty three patients (14 male and 9 female) had 2 or more patches of the scalp, one patch was left for comparison as a control patches. The age ranged from 22 to 39 years with 30 ± 6.09 years mean. The study p...

  19. Treatment of reactive process wastewater with high-level ammonia by blow-off method

    International Nuclear Information System (INIS)

    Chen Xiaotong; Quan Ying; Wang Yang; Fu Genna; Liu Bing; Tang Yaping

    2012-01-01

    The ceramic UO 2 kernels for nuclear fuel elements of high temperature gas cooled reactors were prepared through sol-gel process with uranyl nitrate, which produces process wastewater containing high-level ammonia and uranium. The blow-off method on a bench scale was investigated to remove ammonia from reactive wastewater. Under the optimized operating conditions, the ammonia can be removed by more than 95%, with little reactive uranium distilled. The effects of pH, heating temperature and stripping time were studied. Static tests with ion-exchange resin indicate that ammonia removal treatment increases uranium accumulation in anion exchange resin. (authors)

  20. Population-level differences in revascularization treatment and outcomes among various United States subpopulations

    Institute of Scientific and Technical Information of China (English)

    Garth Graham; Yang-Yu Karen Xiao; Dan Rappoport; Saima Siddiqi

    2016-01-01

    Despite recent general improvements in health care, significant disparities persist in the cardiovascular care of women and racial/ethnic minorities. This is true even when income, education level, and site of care are taken into consideration. Possible explanations for these disparities include socioeconomic considerations, elements of discrimination and racism that affect socioeconomic status, and access to adequate medical care. Coronary revascularization has become the accepted and recommended treatment for myocardial infarction(MI) today and is one of the most common major medical interventions in the United States, with more than 1 million procedures each year. This review discusses recent data on disparities in co-morbidities and presentation symptoms, care and access to medical resources, and outcomes in revascularization as treatment for acute coronary syndrome, looking especially at women and minority populations in the United States. The data show that revascularization is used less in both female and minority patients. We summarize recent data on disparities in co-morbidities and presentation symptoms related to MI; access to care, medical resources, and treatments; and outcomes in women, blacks, and Hispanics. The picture is complicated among the last group by the many Hispanic/Latino subgroups in the United States. Some differences in outcomes are partially explained by presentation symptoms and co-morbidities and external conditions such as local hospital capacity. Of particular note is the striking differential in both presentation co-morbidities and mortality rates seen in women, compared to men, especially in women ≤ 55 years of age. Surveillance data on other groups in the United States such as American Indians/Alaska Natives and the many Asian subpopulations show disparities in risk factors and co-morbidities, but revascularization as treatment for MI in these populations has not been adequately studied. Significant research is required to

  1. State-of-the-art report on low-level radioactive waste treatment

    International Nuclear Information System (INIS)

    Kibbey, A.H.; Godbee, H.W.

    1980-09-01

    An attempt is made to identify the main sources of low-level radioactive wastes that are generated in the United States. To place the waste problem in perspective, rough estimates are given of the annual amounts of each generic type of waste that is generated. Most of the wet solid wastes arise from the cleanup of gaseous and liquid radioactive streams prior to discharge or recycle. The treatment of the process streams and the secondary wet solid wastes thus generated is described for each type of government or fuel cycle installation. Similarly, the institutional wet wastes are also described. The dry wastes from all sources have smilar physical and chemical characteristics in that they can be classified as compactible, noncompactible, combustible, noncombustible, or combinations thereof. The various treatment options for concentrated or solid wet wastes and for dry wastes are discussed. Among the dry-waste treatment methods are compaction, baling, and incineration, as well as chopping, cutting, and shredding. Organic materials can usually be incinerated or, in some cases, biodegraded. The filter sludges, spent resins, incinerator ashes, and concentrated liquids are usually solidified in cement, urea-formaldehyde, or unsaturated polyester resins prior to burial. Asphalt has not yet been used as a solidificaton agent in the United States, but it probably will be used in the near future. The treatment of radioactive medical and bioresearch wastes is described, but the waste from radiochenmical, pharmaceutical, and other industries is not well defined at the present time. Recovery of waste metals and treatment of hazardous contaminated wastes are discussed briefly. Some areas appearing to need more research, development, and demonstration are specifically pointed out

  2. State-of-the-art report on low-level radioactive waste treatment

    Energy Technology Data Exchange (ETDEWEB)

    Kibbey, A.H.; Godbee, H.W.

    1980-09-01

    An attempt is made to identify the main sources of low-level radioactive wastes that are generated in the United States. To place the waste problem in perspective, rough estimates are given of the annual amounts of each generic type of waste that is generated. Most of the wet solid wastes arise from the cleanup of gaseous and liquid radioactive streams prior to discharge or recycle. The treatment of the process streams and the secondary wet solid wastes thus generated is described for each type of government or fuel cycle installation. Similarly, the institutional wet wastes are also described. The dry wastes from all sources have smilar physical and chemical characteristics in that they can be classified as compactible, noncompactible, combustible, noncombustible, or combinations thereof. The various treatment options for concentrated or solid wet wastes and for dry wastes are discussed. Among the dry-waste treatment methods are compaction, baling, and incineration, as well as chopping, cutting, and shredding. Organic materials can usually be incinerated or, in some cases, biodegraded. The filter sludges, spent resins, incinerator ashes, and concentrated liquids are usually solidified in cement, urea-formaldehyde, or unsaturated polyester resins prior to burial. Asphalt has not yet been used as a solidificaton agent in the United States, but it probably will be used in the near future. The treatment of radioactive medical and bioresearch wastes is described, but the waste from radiochenmical, pharmaceutical, and other industries is not well defined at the present time. Recovery of waste metals and treatment of hazardous contaminated wastes are discussed briefly. Some areas appearing to need more research, development, and demonstration are specifically pointed out.

  3. Pyrochemical treatment of Idaho Chemical Processing Plant high-level waste calcine

    International Nuclear Information System (INIS)

    Todd, T.A.; DelDebbio, J.A.; Nelson, L.O.; Sharpsten, M.R.

    1993-01-01

    The Idaho Chemical Processing Plant (ICPP), located at the Idaho National Engineering Laboratory (INEL), has reprocessed irradiated nuclear fuels for the US Department of Energy (DOE) since 1951 to recover uranium, krypton-85, and isolated fission products for interim treatment and immobilization. The acidic radioactive high-level liquid waste (HLLW) is routinely stored in stainless steel tanks and then, since 1963, calcined to form a dry granular solid. The resulting high-level waste (HLW) calcine is stored in seismically hardened stainless steel bins that are housed in underground concrete vaults. A research and development program has been established to determine the feasibility of treating ICPP HLW calcine using pyrochemical technology.This technology is described

  4. New treatment facility for low level process effluents at the Savannah River site

    International Nuclear Information System (INIS)

    Ebra, M.A.; Bibler, J.P.; Johnston, B.S.; Kilpatrick, L.L.; Poy, F.L.; Wallace, R.M.

    1987-01-01

    A new facility, the F/H Effluent Treatment Facility (F/H ETF) is under construction at the Savannah River site. It will decontaminate process effluents containing low levels of radionuclides and hazardous chemicals prior to discharge to a surface stream. These effluents, which are currently discharged to seepage basins, originate in the chemical separations and high-level radioactive waste processing areas, known as F-Area and H-Area. The new facility will allow closure of the basins in order to meet the provisions of the Resource Conservation and Recovery Act by November 1988. A high degree of reliability is expected from this design as a result of extensive process development work that has been conducted at the Savannah River Laboratory. This work has included both bench scale testing of individual unit operations and pilot scale testing of an integrated facility, 150 to 285 L/min (40 to 75 gpm), that contains the major operations

  5. Change in level of productivity in the treatment of schizophrenia with olanzapine or other antipsychotics

    Directory of Open Access Journals (Sweden)

    Osuntokun Olawale

    2011-05-01

    Full Text Available Abstract Background When treating schizophrenia, improving patients' productivity level is a major goal considering schizophrenia is a leading cause of functional disability. Productivity level has been identified as the most preferred treatment outcome by patients with schizophrenia. However, little has been done to systematically investigate productivity levels in schizophrenia. We set out to better understand the change in productivity level among chronically ill patients with schizophrenia treated with olanzapine compared with other antipsychotic medications. We also assessed the links between productivity level and other clinical outcomes. Methods This post hoc analysis used data from 6 randomized, double-blind clinical trials of patients with schizophrenia or schizoaffective disorder, with each trial being of approximately 6 months duration. Change in productivity level was compared between olanzapine-treated patients (HGBG, n = 172; HGHJ, n = 277; HGJB, n = 171; HGLB, n = 281; HGGN, n = 159; HGDH, n = 131 and patients treated with other antipsychotic medications (separately vs. haloperidol [HGGN, n = 97; HGDH, n = 132], risperidone [HGBG, n = 167; HGGN, n = 158], quetiapine [HGJB, n = 175], ziprasidone [HGHJ, n = 271] and aripiprazole [HGLB, n = 285]. Productivity was defined as functional activities/work including working for pay, studying, housekeeping and volunteer work. Productivity level in the prior 3 months was assessed on a 5-point scale ranging from no useful functioning to functional activity/work 75% to 100% of the time. Results Chronically ill patients treated with olanzapine (OLZ experienced significantly greater improvement in productivity when compared to patients treated with risperidone (RISP (OLZ = 0.22 ± 1.19, RISP = -0.03 ± 1.17, p = 0.033 or ziprasidone (ZIP (OLZ = 0.50 ± 1.38, ZIP = 0.25 ± 1.27, p = 0.026, but did not significantly differ from the quetiapine, aripiprazole or haloperidol treatment groups. Among

  6. Treatment with liraglutide may improve markers of CVD reflected by reduced levels of apoB

    Science.gov (United States)

    Engelbrechtsen, L.; Lundgren, J.; Wewer Albrechtsen, N. J.; Mahendran, Y.; Iepsen, E. W.; Finocchietto, P.; Jonsson, A. E.; Madsbad, S.; Holst, J. J.; Vestergaard, H.; Hansen, T.

    2017-01-01

    Summary Background Dislipidaemia and increased levels of apolipoprotein B (apoB) in individuals with obesity are risk factors for development of cardiovascular disease (CVD). The aim of this study was to investigate the effect of weight loss and weight maintenance with and without liraglutide treatment on plasma lipid profiles and apoB. Methods Fifty‐eight individuals with obesity (body mass index 34.5 ± 3.0 kg/m2 [mean ± SD]) were included in this study. After 8 weeks on a very low‐calorie diet (800 kcal/day), participants were randomized to weight maintenance with meal replacements with or without liraglutide (1.2 mg daily) for 1 year. Plasma samples from before and after weight loss and after 1 year of weight maintenance were subjected to nuclear magnetic resonance‐based lipidomics analysis. Results After an 8‐week low‐calorie diet, study participants lost 12.0 ± 2.9 kg (mean ± SD) of their body weight, which was reflected in their lipid profiles (80 out of 124 lipids changed significantly), including reduced levels of apoB, total cholesterol, free cholesterol, remnant cholesterol, triglycerides, low‐density lipoprotein and very low‐density lipoprotein subclasses. After 1 year of maintained weight loss, the majority of the lipids had returned to pre‐weight loss levels even though weight loss was successfully maintained in both groups. Interestingly, apoB levels remained low in the liraglutide treated group (apoB change: 0.03 ± 0.02 mmol/L, p = 0.4) in contrast to an increase in the control group (apoB change: 0.06 ± 0.07 mmol/L, p = 0.02). Conclusion An 8‐week low‐calorie diet, in individuals with obesity, reduced plasma levels of lipids and the atherogenic marker apoB. After 1 year of weight maintenance, only study participants treated with liraglutide maintained reduced levels of apoB, despite similar body weight maintenance. Treatment with liraglutide may therefore reduce apoB levels and thus reflect lower

  7. Treatment with liraglutide may improve markers of CVD reflected by reduced levels of apoB.

    Science.gov (United States)

    Engelbrechtsen, L; Lundgren, J; Wewer Albrechtsen, N J; Mahendran, Y; Iepsen, E W; Finocchietto, P; Jonsson, A E; Madsbad, S; Holst, J J; Vestergaard, H; Hansen, T; Torekov, S S

    2017-12-01

    Dislipidaemia and increased levels of apolipoprotein B (apoB) in individuals with obesity are risk factors for development of cardiovascular disease (CVD). The aim of this study was to investigate the effect of weight loss and weight maintenance with and without liraglutide treatment on plasma lipid profiles and apoB. Fifty-eight individuals with obesity (body mass index 34.5 ± 3.0 kg/m 2 [mean ± SD]) were included in this study. After 8 weeks on a very low-calorie diet (800 kcal/day), participants were randomized to weight maintenance with meal replacements with or without liraglutide (1.2 mg daily) for 1 year. Plasma samples from before and after weight loss and after 1 year of weight maintenance were subjected to nuclear magnetic resonance-based lipidomics analysis. After an 8-week low-calorie diet, study participants lost 12.0 ± 2.9 kg (mean ± SD) of their body weight, which was reflected in their lipid profiles (80 out of 124 lipids changed significantly), including reduced levels of apoB, total cholesterol, free cholesterol, remnant cholesterol, triglycerides, low-density lipoprotein and very low-density lipoprotein subclasses. After 1 year of maintained weight loss, the majority of the lipids had returned to pre-weight loss levels even though weight loss was successfully maintained in both groups. Interestingly, apoB levels remained low in the liraglutide treated group (apoB change: 0.03 ± 0.02 mmol/L, p = 0.4) in contrast to an increase in the control group (apoB change: 0.06 ± 0.07 mmol/L, p = 0.02). An 8-week low-calorie diet, in individuals with obesity, reduced plasma levels of lipids and the atherogenic marker apoB. After 1 year of weight maintenance, only study participants treated with liraglutide maintained reduced levels of apoB, despite similar body weight maintenance. Treatment with liraglutide may therefore reduce apoB levels and thus reflect lower CVD risk. Including apoB measurements in clinical practice when

  8. Changes of plasma VEGF levels and liver function in patients with liver cancer before and after interventional treatment

    International Nuclear Information System (INIS)

    Li Jia; Qi Jun; Gao Jia

    2011-01-01

    To explore the effect of the interventional treatment for the angiogenesis and liver function in patients with liver cancer within short time, enzyme linked immunosorbent assay was used to determine the level of VEGF in plasma. The level of liver function was measured through automatic biochemistry analyzer. The results indicated that the level of VEGF in patients with liver cancer decreased after interventional treatment than that of before treatment (P<0.05). The level of total protein, albumin, alkaline phosphatase and total bile acid decreased after interventional treatment (P<0.05). The level of alanine aminotransferase, aspartate aminotransferase, total bilirubin, direct bilirubin and indirect bilirubin were increased than before (P<0.05). The interventional treatment inhibit the expression of the VEGF in the tumor tissue and limited the angiogenesis within short time, but to some extent may caused the injury of the hepatocytes and the synthetic and excremental function in patients with liver cancer. (authors)

  9. Blood vitamin D levels in patients with fibromyalgia and the effectiveness of vitamin D treatment

    Directory of Open Access Journals (Sweden)

    Nurgül Köse

    2013-12-01

    Full Text Available Objective: The aim of this study was determination thelevel of vitamin D in patients diagnosed with fibromyalgiaand investigation the relationship with etiopathogenesisof the disease.Methods: In this study, between the months of Juneand December in 2012, Metin Sabancı Bone DiseasesTraining and Research Hospital, Physical Therapy OutpatientClinics, 141 patients diagnosed with fibromyalgiawere included. The patients were diagnosed accordingto American College of Rheumatology criteria. Levels ofC-reactive protein (CRP, serum calcium (Ca, phosphor(P, alkaline phosphatase (ALP, PTH, T3, T4, TSH, andvitamin D were analyzed in the blood of patients, for exclusionof a systemic illness. Deficiency of vitamin D isdetermined as ≤20 ng/ml and insufficiency of vitamin Dis determined 21-29 ng/ml. Normal level of vitamin D isaccepted as equal or ≥30 ng/ml.Results: The mean age of patients was found as45.70±14.10 years old. Mean vitamin D level was17.51±18.02 ng/ml. 76.6% (n=108 of all patients with fibromyalgiahad vitamin D deficiency and their mean vitaminD level was detected as 12.23±10.24 ng/ml. Twenty(14.2% of all patients had vitamin D insufficiency andtheir mean vitamin D level was found as 23.83±2.76 ng/ml. The lower vitamin D level was seen in patients withage less than 45 years-old and their mean vitamin D levelwas 14.91±10.75 ng/ml.Conclusion: Vitamin D deficiency is frequently seen inpatients diagnosed with fibromyalgia and treatment withvitamin D may cause regression of the disease.Key words: D vitamin, fibromyalgia, calcium

  10. Secular trends in lipid-lowering treatment and lipid levels after a first acute myocardial infarction

    Directory of Open Access Journals (Sweden)

    Lena Björck

    2008-01-01

    Full Text Available Lena Björck1, Catharina Welin2, Annika Rosengren11Department of medicine, Sahlgrenska University Hospital/Östra, Göteborg, Sweden; 2Institute of Health and Care Sciences, the Sahlgrenska Academy at Göteborg University, Göteborg, SwedenBackground: The beneficial effects of statins were unequivocally demonstrated in the Scandinavian Simvastatin Survival Study (4S in 1994, leading to an increase in the use of lipid-lowering drugs. However, to what extent this translates into serum cholesterol levels in a real-life setting has not been systematically investigated.Objective: To estimate secular trends from 1994 to 2002 in blood lipid levels among unselected younger patients after a first acute myocardial infarction (AMI.Method: Descriptive single centre study using consecutive data collection in 781 patients (aged <65 years hospitalized with a first AMI during the period 1994–2002.Results: From 1994–2002, the use of lipid-lowering drugs increased from 10% to 94% for men and from 23% to 90% for women. In 1994, the mean serum cholesterol levels were 6.53 mmol/l in men and 6.32 mmol/l in women, decreasing to 4.31 mmol/l and 5.13 mmol/l in men and women, respectively, in 2002. Still, only 56% of the men and 35% of the women had total serum cholesterol levels <4.5 mmol/l in 2002.Conclusion: Despite a marked increase in lipid-lowering drug treatment in which there was an increase from about 10% in 1994 to more than 90% in 2002, current target levels of <4.5 mmol/l for serum cholesterol were not achieved in a significant proportion of post-AMI patients.Keywords: lipid levels, lipid-lowering medication, myocardial infarction, risk factors

  11. Force systems in the initial phase of orthodontic treatment -- a comparison of different leveling arch wires.

    Science.gov (United States)

    Fuck, Lars-Michael; Drescher, Dieter

    2006-01-01

    The determination of orthodontically-effective forces and moments places great demands on the technical equipment. Many patients report severe pain after fixed appliance insertion. Since it is assumed that pain from orthodontic appliances is associated with the force and moment levels applied to the teeth and since the occurrence of root resorption is a common therapeutic side effect, it would seem important to know the actual magnitudes of the components of the active orthodontic force systems. The aim of the present study was therefore to measure initial force systems produced by different leveling arch-wires in a complete multi-bracket appliance and to assess whether force and moment levels can be regarded as biologically acceptable or not. The actual bracket position in 42 patients was transferred onto a measurement model. Forces and moments produced by a super-elastic nickel-titanium (NiTi) archwire, a 6-strand stainless steel archwire, and a 7-strand super-elastic NiTi archwire were determined experimentally on different teeth. Average forces and moments produced by the super-elastic NiTi arch wires were found to be the highest. In spite if their larger diameter, the stranded arch wires' average force and moment levels were lower, especially that of the stranded super-elastic archwire. Nevertheless, maximum force levels sometimes exceeded recommended values in the literature and must be considered as too high. The measured arch wires' initial force systems differed significantly depending on the type of archwire and its material structure. Stranded arch wires produced lower force and moment levels, and we recommend their use in the initial phase of orthodontic treatment.

  12. Pyrimethanil degradation by photo-Fenton process: Influence of iron and irradiance level on treatment cost.

    Science.gov (United States)

    Cabrera Reina, A; Miralles-Cuevas, S; Casas López, J L; Sánchez Pérez, J A

    2017-12-15

    This study evaluates the combined effect of photo-catalyst concentration and irradiance level on photo-Fenton efficiency when this treatment is applied to industrial wastewater decontamination. Three levels of irradiance (18, 32 and 46W/m 2 ) and three iron concentrations (8, 20 and 32mg/L) were selected and their influence over the process studied using a raceway pond reactor placed inside a solar box. For 8mg/L, it was found that there was a lack of catalyst to make use of all the available photons. For 20mg/L, the treatment always improved with irradiance indicating that the process was photo-limited. For 32mg/L, the excess of iron caused an excess of radicals production which proved to be counter-productive for the overall process efficiency. The economic assessment showed that acquisition and maintenance costs represent the lowest relative values. The highest cost was found to be the cost of the reagents consumed. Both sulfuric acid and sodium hydroxide are negligible in terms of costs. Iron cost percentages were also very low and never higher than 10.5% while the highest cost was always that of hydrogen peroxide, representing at least 85% of the reagent costs. Thus, the total costs were between 0.76 and 1.39€/m 3 . Copyright © 2017 Elsevier B.V. All rights reserved.

  13. The process of changing national malaria treatment policy: lessons from country-level studies.

    Science.gov (United States)

    Williams, Holly Ann; Durrheim, David; Shretta, Rima

    2004-11-01

    Widespread resistance of Plasmodium falciparum parasites to commonly used antimalarials, such as chloroquine, has resulted in many endemic countries considering changing their malaria treatment policy. Identifying and understanding the key influences that affect decision-making, and factors that facilitate or undermine policy implementation, is critical for improving the policy process and guiding resource allocation during this process. A historical review of archival documents from Malaŵi and data obtained from in-depth policy studies in four countries (Tanzania, South Africa, Kenya and Peru) that have changed malaria treatment policy provides important lessons about decision-making, the policy cycle and complex policy environment, while specifically identifying strategies successfully employed to facilitate policy-making and implementation. Findings from these country-level studies indicate that the process of malaria drug policy review should be institutionalized in endemic countries and based on systematically collected data. Key stakeholders need to be identified early and engaged in the process, while improved communication is needed on all levels. Although malaria drug policy change is often perceived to be a daunting task, using these and other proven strategies should assist endemic countries to tackle this challenge in a systematic fashion that ensures the development and implementation of the rational malaria drug policy.

  14. Greater-Than-Class C low-level radioactive waste treatment technology evaluation

    International Nuclear Information System (INIS)

    Garrison, T.W.; Fischer, D.K.

    1993-01-01

    This report was developed to provide the Greater-Than-Class C Low-Level Radioactive Waste Management Program with criteria and a methodology to select candidate treatment technologies for Greater-Than-Class C low-level radioactive waste (GTCC LLW) destined for dedicated storage and ultimately disposal. The technology selection criteria are provided in a Lotus spreadsheet format to allow the methodology to evolve as the GTCC LLW Program evolves. It is recognized that the final disposal facility is not yet defined; thus, the waste acceptance criteria and other facility-specific features are subject to change. The spreadsheet format will allow for these changes a they occur. As additional treatment information becomes available, it can be factored into the analysis. The technology selection criteria were established from program goals, draft waste acceptance criteria for dedicated storage (including applicable regulations), and accepted remedial investigation methods utilized under the Comprehensive Environmental Response, Compensation, and Liability Act. Kepner-Tregoe decisionmaking techniques are used to compare and rank technologies against the criteria

  15. Low-level laser therapy for the treatment of androgenic alopecia: a review.

    Science.gov (United States)

    Darwin, Evan; Heyes, Alexandra; Hirt, Penelope A; Wikramanayake, Tongyu Cao; Jimenez, Joaquin J

    2018-02-01

    There are many new low-level laser technologies that have been released commercially that claim to support hair regrowth. In this paper, we will examine the clinical trials to determine whether the body of evidence supports the use of low-level laser therapy (LLLT) to treat androgenic alopecia (AGA). A literature search was conducted through Pubmed, Embase, and Clinicaltrials.gov for clinical trials using LLLT to treat AGA. Thirteen clinical trials were assessed. Review articles were not included. Ten of 11 trials demonstrated significant improvement of androgenic alopecia in comparison to baseline or controls when treated with LLLT. In the remaining study, improvement in hair counts and hair diameter was recorded, but did not reach statistical significance. Two trials did not include statistical analysis, but showed marked improvement by hair count or by photographic evidence. Two trials showed efficacy for LLLT in combination with topical minoxidil. One trial showed efficacy when accompanying finasteride treatment. LLLT appears to be a safe, alternative treatment for patients with androgenic alopecia. Clinical trials have indicated efficacy for androgenic alopecia in both men and women. It may be used independently or as an adjuvant of minoxidil or finasteride. More research needs to be undertaken to determine the optimal power and wavelength to use in LLLT as well as LLLT's mechanism of action.

  16. LEVEL OF AWARENESS OF REPUBLIC BULGARIA'S POPULATION FOR TREATMENT OF ISCHEMIC STROKE VIA THROMBOLYSIS

    Directory of Open Access Journals (Sweden)

    GRETA KOLEVA

    2016-07-01

    Full Text Available The stroke is a socially significant disease that is characterized with high levels of morbidity and mortality, causing severe disability worldwide. It is the second most significant cause of death among the people in the western world, falling back only to the heart diseases and preceding the cancer, as it causes 10% of the mortal cases in the world. Since 2009 the Bulgarian association of neurosonology and cerebral hemodynamics(BANCH organizes different initiatives of training doctors to conduct a thrombolytic treatment to acute ischemic stroke(AIS. The intravenous thrombolysis has not been established as a leading differential treatment of AIS in Bulgaria, and the thrombolytic therapy is still not well developed in Bulgaria.The suport of national and local institutions is crucial for insuring and guarantee for a proper stroke treatment. Efforts are necessary for adequate financing of the health facilities, as well as professional preparation of the human resource, and training the population via creating an integrated national strategy for its application and control, which can underlie as a state politics in healthcare at optimal usage of public-private partnership.

  17. Clinical significance of determination of changes of serum TNF and SA levels after treatment in patients with gonorrhea

    International Nuclear Information System (INIS)

    Zhong Chengwu

    2005-01-01

    Objective: To investigate the changes of serum TNF and sialic acid (SA) levels after treatment in patients with gonorrhea. Methods: Serum TNF (with RIA) and SA (with spectrophotometer ) levels were measured both before and after treatment in 42 patients with gonorrhea as well as in 35 controls. Results: Before treatment, the serum levels of TNF and SA were significantly higher than those in the controls (P 0.05). Conclusion: Changes of serum levels of TNF and SA could reflect the severity of infection in patients with gonorrhea. (authors)

  18. Levels of Motivation and Readiness for Treatment Aligned With Criminal Justice Referral and Coercion Among Substance Users in England.

    Science.gov (United States)

    Jones, Andrew; Hayhurst, Karen Petra; Millar, Tim

    2017-11-01

    Motivation and readiness for substance misuse treatment predict treatment retention and successful treatment outcomes but may be lower among substance users coerced into treatment. We tested for differences associated with legal involvement and with client perceptions of coercion among individuals entering drug misuse treatment in England. Data collection involved 342 treatment agencies. Measures of motivation and readiness for treatment were taken from the Circumstances, Motivation, and Readiness (CMR) scale. Referral source was ordered to represent level of legal involvement and conditions. Perceived coercion was defined by a CMR item. Linear regression models, adjusting for client complexity, tested for differences in motivation and readiness by these measures. Levels of motivation and readiness did not differ according to level of legal conditions (coefficient = -0.38, 95% CI [-1.65, 0.88]). Motivation was inversely associated with perceived coercion (coefficient = -0.28, 95% CI [-0.05, -0.50], p = .014). At the point of treatment entry, criminal justice referral and aligned conditions have no impact on levels of motivation to achieve positive treatment outcomes. Concerns around lower levels of motivation are better focused on those who perceive themselves as coerced rather than on those whose referral carries a level of legal condition.

  19. Evaluation of dental students' perception and self-confidence levels regarding endodontic treatment.

    Science.gov (United States)

    Tanalp, Jale; Güven, Esra Pamukçu; Oktay, Inci

    2013-04-01

    The aim of this study was to obtain information about senior dental students' perceptions and self-confidence levels regarding endodontic practice. Anonymous survey forms were handed out to senior students at Yeditepe University, Faculty of Dentistry. The students were asked to score their level of confidence using a 5-point scale and comment about future practices. The response rate of the survey was 88%. 11.9% expressed endodontics as the first branch in terms of difficulty. The majority (90.5%) indicated they would perform root canal treatments within their expertise limit in the future but refer difficult cases to an endodontist. Bleaching of endodontically treated teeth, managing flare-ups, placement of a rubber dam were procedures in which students reported the lowest confidence (2.55 ± 1.17, 3.24 ± 0.96, 3.24 ± 1.19, respectively). On the other hand, students felt the lowest confidence in the treatment of maxillary molars followed by mandibular molars (3.43 ± 1.02 and 3.93 ± 0.97, respectively). Students also reported the lowest confidence in root resorptions, endo-perio lesions, traumas, retreatments and apexifications (2.93 ± 1.16, 3.07 ± 0.89, 3.24 ± 0.85, 3.33 ± 1.7 and 3.36 ± 1.1, respectively). The results showing students' lower confidence in more challenging aspects of dentistry may be related with the attitude of dental schools to refer these cases to post graduate students and instilling information about these cases on a theoretical basis only. Though there seems to be a tendency for students to refer challenging cases to a specialist in future, authorities should give priority to enhance the way information and experience is conveyed regarding various aspects of endodontic treatment.

  20. Evaluation of dental students’ perception and self-confidence levels regarding endodontic treatment

    Science.gov (United States)

    Tanalp, Jale; Güven, Esra Pamukçu; Oktay, Inci

    2013-01-01

    Objectives: The aim of this study was to obtain information about senior dental students’ perceptions and self-confidence levels regarding endodontic practice. Materials and Methods: Anonymous survey forms were handed out to senior students at Yeditepe University, Faculty of Dentistry. The students were asked to score their level of confidence using a 5-point scale and comment about future practices. Results: The response rate of the survey was 88%. 11.9% expressed endodontics as the first branch in terms of difficulty. The majority (90.5%) indicated they would perform root canal treatments within their expertise limit in the future but refer difficult cases to an endodontist. Bleaching of endodontically treated teeth, managing flare-ups, placement of a rubber dam were procedures in which students reported the lowest confidence (2.55 ± 1.17, 3.24 ± 0.96, 3.24 ± 1.19, respectively). On the other hand, students felt the lowest confidence in the treatment of maxillary molars followed by mandibular molars (3.43 ± 1.02 and 3.93 ± 0.97, respectively). Students also reported the lowest confidence in root resorptions, endo-perio lesions, traumas, retreatments and apexifications (2.93 ± 1.16, 3.07 ± 0.89, 3.24 ± 0.85, 3.33 ± 1.7 and 3.36 ± 1.1, respectively). Conclusions: The results showing students’ lower confidence in more challenging aspects of dentistry may be related with the attitude of dental schools to refer these cases to post graduate students and instilling information about these cases on a theoretical basis only. Though there seems to be a tendency for students to refer challenging cases to a specialist in future, authorities should give priority to enhance the way information and experience is conveyed regarding various aspects of endodontic treatment. PMID:24883030

  1. Clinical significance of determination of changes of serum APN, BNP and ANF levels after treatment in patients with heart failure

    International Nuclear Information System (INIS)

    Ge Hengsong; Hu Min; Gao Xinchun

    2011-01-01

    Objective: To explore the significance of changes on serum APN, BNP and ANF levels after treatment in patients with heart failure. Methods: Serum BNP, ANF(with RIA) serum APN (with ELISA) levels were determined in 30 patients with heart failure both before and after treatment as well as in 35 normal controls. Results: Before treatment, serum APN level was significantly lower than those in controls (P<0.01), but serum BNP, ANF levels were apparently higher (P<0.01). After 1 month of treatment, the levels dropped markedly, but still remained obviously higher (P<0.05). Conclusion: Serum APN, BNP and ANF levels were closely related to the process of heart failure and were of clinical value of monitoring therapeutic effect and prognosis. (authors)

  2. MWIP: Surrogate formulations for thermal treatment of low-level mixed waste

    International Nuclear Information System (INIS)

    Bostick, W.D.; Hoffmann, D.P.; Stevenson, R.J.; Richmond, A.A.; Bickford, D.F.

    1994-01-01

    The category of sludges, filter cakes, and other waste processing residuals represent the largest volume of low-level mixed (hazardous and radioactive) wastes within the US Department of Energy (DOE) complex. Treatment of these wastes to minimize the mobility of contaminants, and to eliminate the presence of free water, is required under the Federal Facility Compliance Act agreements between DOE and the Environmental Protection Agency. In the text, we summarize the currently available data for several of the high priority mixed-waste sludge inventories within DOE. Los Alamos National Laboratory TA-50 Sludge and Rocky Flats Plant By-Pass Sludge are transuranic (TRU)-contaminated sludges that were isolated with the use of silica-based filter aids. The Oak Ridge Y-12 Plant West End Treatment Facility Sludge is predominantly calcium carbonate and biomass. The Oak Ridge K-25 Site Pond Waste is a large-volume waste stream, containing clay, silt, and other debris in addition to precipitated metal hydroxides. We formulate ''simulants'' for the waste streams described above, using cerium oxide as a surrogate for the uranium or plutonium present in the authentic material. Use of nonradiological surrogates greatly simplifies material handling requirements for initial treatability studies. The use of synthetic mixtures for initial treatability testing will facilitate compositional variation for use in conjunction with statistical design experiments; this approach may help to identify any ''operating window'' limitations. The initial treatability testing demonstrations utilizing these ''simulants'' will be based upon vitrification, although the materials are also amenable to testing grout-based and other stabilization procedures. After the feasibility of treatment and the initial evaluation of treatment performance has been demonstrated, performance must be verified using authentic samples of the candidate waste stream

  3. Do drug treatment facilities increase clients' exposure to potential neighborhood-level triggers for relapse? A small-area assessment of a large, public treatment system.

    Science.gov (United States)

    Jacobson, Jerry O

    2006-03-01

    Research on drug treatment facility locations has focused narrowly on the issue of geographic proximity to clients. We argue that neighborhood conditions should also enter into the facility location decision and illustrate a formal assessment of neighborhood conditions at facilities in a large, metropolitan area, taking into account conditions clients already face at home. We discuss choice and construction of small-area measures relevant to the drug treatment context, including drug activity, disadvantage, and violence as well as statistical comparisons of clients' home and treatment locations with respect to these measures. Analysis of 22,707 clients discharged from 494 community-based outpatient and residential treatment facilities that received public funds during 1998-2000 in Los Angeles County revealed no significant mean differences between home and treatment neighborhoods. However, up to 20% of clients are exposed to markedly higher levels of disadvantage, violence, or drug activity where they attend treatment than where they live, suggesting that it is not uncommon for treatment locations to increase clients' exposure to potential environmental triggers for relapse. Whereas on average both home and treatment locations exhibit higher levels of these measures than the household locations of the general population, substantial variability in public treatment clients' home neighborhoods calls into question the notion that they hail exclusively from poor, high drug activity areas. Shortcomings of measures available for neighborhood assessment of treatment locations and implications of the findings for other areas of treatment research are also discussed.

  4. Comparison of the pain levels of computer-controlled and conventional anesthesia techniques in prosthodontic treatment

    Directory of Open Access Journals (Sweden)

    Murat Yenisey

    2009-10-01

    Full Text Available OBJECTIVE: The objective of this study was to compare the pain levels on opposite sides of the maxilla at needle insertion during delivery of local anesthetic solution and tooth preparation for both conventional and anterior middle superior alveolar (AMSA technique with the Wand computer-controlled local anesthesia application. MATERIAL AND METHODS: Pain scores of 16 patients were evaluated with a 5-point verbal rating scale (VRS and data were analyzed nonparametrically. Pain differences at needle insertion, during delivery of local anesthetic, and at tooth preparation, for conventional versus the Wand technique, were analyzed using the Mann-Whitney U test (p=0.01. RESULTS: The Wand technique had a lower pain level compared to conventional injection for needle insertion (p0.05. CONCLUSIONS: The AMSA technique using the Wand is recommended for prosthodontic treatment because it reduces pain during needle insertion and during delivery of local anaesthetic. However, these two techniques have the same pain levels for tooth preparation.

  5. Salicylic Acid Treatment Increases the Levels of Triterpene Glycosides in Black Cohosh (Actaea Racemosa) Rhizomes.

    Science.gov (United States)

    De Capite, Annette; Lancaster, Tyler; Puthoff, David

    2016-01-01

    Black cohosh (Actaea racemosa) serves as the host plant for the Appalachian azure butterfly, Celastrina neglectamajor. Overharvesting of Black cohosh for the dietary supplement industry may result in its extirpation, and may also cause the elimination of the dependent butterfly. One way to increase or maintain the number of host plants in forested environments would be to reduce the number harvested, for example by increasing the levels of the desired metabolites in Black cohosh rhizomes. The secondary metabolites actein and deoxyactein are triterpene glycosides and are among the compounds associated with the putative activity of Black cohosh extracts. Acetein and deoxyacetein are used to standardize Black cohosh supplements. To gain an understanding of mechanisms that may control actein and deoxyactein accumulation, Black cohosh rhizomes were treated with exogenous salicylic acid, jasmonic acid, or ethylene, or were mechanically wounded. Salicylic acid treatment significantly increased the levels of actein and deoxyactein in the rhizome of Black cohosh, suggesting that the synthesis of triterpene glycosides is controlled in part by salicylic acid. Using salicylic acid or related chemicals to increase the levels of actein and deoxyactein in rhizomes may help supply the supplement industry and, simultaneously, help conserve Black cohosh and species dependent upon it.

  6. Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma.

    Science.gov (United States)

    Vuolo, Francieli; Petronilho, Fabricia; Sonai, Beatriz; Ritter, Cristiane; Hallak, Jaime E C; Zuardi, Antonio Waldo; Crippa, José A; Dal-Pizzol, Felipe

    2015-01-01

    Asthma represents a public health problem and traditionally is classified as an atopic disease, where the allergen can induce clinical airway inflammation, bronchial hyperresponsiveness, and reversible obstruction of airways. Studies have demonstrated the presence of T-helper 2 lymphocytes in the lung of patients with asthma. These cells are involved in cytokine production that regulates immunoglobulin synthesis. Recognizing that T cell interaction with antigens/allergens is key to the development of inflammatory diseases, the aim of this study is to evaluate the anti-inflammatory potential of cannabidiol (CBD) in this setting. Asthma was induced in 8-week-old Wistar rats by ovalbumin (OVA). In the last 2 days of OVA challenge animals received CBD (5 mg/kg, i.p.) and were killed 24 hours after. The levels of IL-4, IL-5, IL-13, IL-6, IL-10, and TNF-α were determinate in the serum. CBD treatment was able to decrease the serum levels of all analyzed cytokines except for IL-10 levels. CBD seems to be a potential new drug to modulate inflammatory response in asthma.

  7. Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma

    Directory of Open Access Journals (Sweden)

    Francieli Vuolo

    2015-01-01

    Full Text Available Asthma represents a public health problem and traditionally is classified as an atopic disease, where the allergen can induce clinical airway inflammation, bronchial hyperresponsiveness, and reversible obstruction of airways. Studies have demonstrated the presence of T-helper 2 lymphocytes in the lung of patients with asthma. These cells are involved in cytokine production that regulates immunoglobulin synthesis. Recognizing that T cell interaction with antigens/allergens is key to the development of inflammatory diseases, the aim of this study is to evaluate the anti-inflammatory potential of cannabidiol (CBD in this setting. Asthma was induced in 8-week-old Wistar rats by ovalbumin (OVA. In the last 2 days of OVA challenge animals received CBD (5 mg/kg, i.p. and were killed 24 hours after. The levels of IL-4, IL-5, IL-13, IL-6, IL-10, and TNF-α were determinate in the serum. CBD treatment was able to decrease the serum levels of all analyzed cytokines except for IL-10 levels. CBD seems to be a potential new drug to modulate inflammatory response in asthma.

  8. BDNF serum levels in schizophrenic patients during treatment augmentation with sarcosine (results of the PULSAR study).

    Science.gov (United States)

    Strzelecki, Dominik; Kałużyńska, Olga; Wysokiński, Adam

    2016-08-30

    Finding a relationship between schizophrenia symptoms severity and initial level of BDNF and its changes during augmentation of antipsychotic treatment with sarcosine. 57 individuals with schizophrenia with predominantly negative symptoms completed a 6-month RCT prospective study. The patients received 2g of sarcosine (n=27) or placebo (n=30) daily. At the beginning, after 6 weeks and 6 months BDNF levels were measured. Severity of symptoms was assessed using the Positive and Negative Syndrome Scale (PANSS) and Calgary Depression Scale for Schizophrenia (CDSS). BDNF serum levels were stable after 6 weeks and 6 months in both groups. We noted improvement in negative symptoms, general psychopathology and total PANSS score in sarcosine group comparing to placebo, however there was no correlations between serum BDNF concentrations and PANSS scores in all assessments. Initial serum BDNF concentrations cannot be used as a predictor of the improvement resulting from adding sarcosine. Our results indicate that either BDNF is not involved in the NMDA-dependent mechanism of sarcosine action or global changes in BDNF concentrations induced by amino-acid cannot be detected in blood assessments. Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

  9. Effect of Technological Treatments on Human-Like Leptin Level in Bovine Milk for Human Consumption

    Directory of Open Access Journals (Sweden)

    Damiano Magistrelli

    2014-07-01

    Full Text Available In this experiment, raw milk and commercially available full-cream UHT milk, semi-skimmed UHT milk, skimmed UHT milk, full-cream pasteurized milk, semi-skimmed pasteurized milk and infant formulas for babies between 6 and 12 months of age were analyzed by RIA, with a method using an antibody directed against human leptin and human leptin as reference standard. Raw milk and full-cream UHT milk did not differ for human-like leptin. Leptin content of full-cream pasteurized milk was not different to that of full-cream UHT milk, but it was 14% lower (p < 0.05 than that observed in raw milk. Human-like leptin level of semi-skimmed UHT milk was not different to that of semi-skimmed pasteurized milk, but it was 30% lower (p < 0.0001 than those of full-cream UHT and full-cream pasteurized milks. In skimmed UHT milk, leptin was 40% lower (p < 0.0001 than in full-cream UHT milk. Leptin was correlated (p < 0.001 with lipid content. Leptin level of infant formulas was not different to that of skimmed milks. Results suggest that the heat treatment (pasteurization or UHT is not a modifier of human-like leptin content of edible commercial bovine milks, whereas the skimming process significantly reduces milk leptin level.

  10. Evaluating non-incinerative treatment of organically contaminated low level mixed waste

    International Nuclear Information System (INIS)

    Shuck, D.L.; Wade, J.F.

    1993-01-01

    This investigation examines the feasibility of using non-incinerator technologies effectively to treat organically contaminated mixed waste. If such a system is feasible now, it would be easier to license because it would avoid the stigma that incineration has in the publics' perception. As other DOE facilities face similar problems, this evaluation is expected to be of interest to both DOE and the attendees of WM'93. This investigation considered treatment to land disposal restriction (LDR) standards of 21 different low level mixed (LLM) waste streams covered by the Rocky Flats Federal Facilities Compliance Agreement (FFCA) agreement with the Environmental Protection Agency (EPA). Typically the hazardous components consists of organic solvent wastes and the radioactive component consists of uranic/transuranic wastes. Limited amounts of cyanide and lead wastes are also involved. The primary objective of this investigation was to identify the minimum number of non-thermal unit processes needed to effectively treat this collection of mixed waste streams

  11. Abnormal levels of histone methylation in the retinas of diabetic rats are reversed by minocycline treatment

    DEFF Research Database (Denmark)

    Wang, Wenjun; Sidoli, Simone; Zhang, Wenquan

    2017-01-01

    67% of these marks had their relative abundance restored to non-diabetic levels after minocycline treatment. Mono-and di-methylation states of histone H4 lysine 20 (H4K20me1/me2), markers related to DNA damage response, were found to be up-regulated in the retinas of diabetic rats and restored......In this study we quantified the alterations of retinal histone post-translational modifications (PTMs) in diabetic rats using a liquid chromatography-tandem mass spectrometry (LC-MS/MS) approach. Some diabetic rats were subsequently treated with minocycline, a tetracycline antibiotic, which has...... been shown to inhibit the diabetes-induced chronic inflammation in the retinas of rodents. We quantified 266 differentially modified histone peptides, including 48 out of 83 methylation marks with significantly different abundancein retinas of diabetic rats as compared to non-diabetic controls. About...

  12. Application of chitin and zeolite adsorbents for treatment of low level radioactive liquid wastes

    International Nuclear Information System (INIS)

    Moattar, F.; Hayeripour, S.

    2004-01-01

    Two types of shrimp chitin derivatives and two types of Iranian natural zeolite derivates were studied for adsorption and treatment of low-level radioactive liquid waste. Chitin with lowers than 10% and chitosan with higher than 90% deacetylation factor were selected as neutral organic adsorbents. Natural clinoptilolite of Firuzkooh area and Na from derivates of it were selected as natural inorganic adsorbents. The static and dynamic ion exchange experimental results show that the ad adsorption efficiency depend on particle size, Ph, adsorbent type, deacetylation factor ( in chitin adsorbents) and cation type. The best Cs adsorption occurred in Na from clinoptilolite. Nevertheless chitin derivatives, particularly chitosan, are more efficient than zeolite adsorbents for removing of radionuclides such as 137 Cs, 54 Mn, 90 Sr and 60 Co. Adsorption performance was discussed and compared with each other

  13. Study on the treatment of low-level radioactive wastewater by ultrasound

    International Nuclear Information System (INIS)

    You Zhi; He Bin; Zhang Quanhu; Du Qianwei

    2010-01-01

    By simulating the trajectory of one single suspended radioactive particle subjected to ultrasonic standing wave, the principle of the treatment of low-level radioactive wastewater by ultrasound was analyzed. The result show that under the action of ultrasonic standing wave, the particle will move toward the pressure node plane and the time of particle reached the plane became shorter when the radium of particle and the frequency and power of ultrasound was enlarged. The mathematic equation represent the change of the number of the suspended particles was built and the decontamination efficiency was calculated. The result shows that under the condition of T=80 min, f=50 kHz and P=71.09 w, the radioactive concentration of wastewater could be reduced from 400 Bq/L to 9.295 Bq/L and the decontamination efficiency was 97.68%. The decontamination efficiency could not be obviously improved by further increasing the treating time. (authors)

  14. Low Level Laser Therapy for the Treatment of Diabetic Foot Ulcers: A Critical Survey

    Directory of Open Access Journals (Sweden)

    Kathrin H. Beckmann

    2014-01-01

    Full Text Available Diabetic foot ulcers as one of the most common complications of diabetes mellitus are defined as nonhealing or long-lasting chronic skin ulcers in diabetic patients. Multidisciplinary care for the diabetic foot is common, but treatment results are often unsatisfactory. Low level laser therapy (LLLT on wound areas as well as on acupuncture points, as a noninvasive, pain-free method with minor side effects, has been considered as a possible treatment option for the diabetic foot syndrome. A systematic literature review identified 1764 articles on this topic. Finally, we adopted 22 eligible references; 8 of them were cell studies, 6 were animal studies, and 8 were clinical trials. Cell studies and animal studies gave evidence of cellular migration, viability, and proliferation of fibroblast cells, quicker reepithelization and reformed connective tissue, enhancement of microcirculation, and anti-inflammatory effects by inhibition of prostaglandine, interleukin, and cytokine as well as direct antibacterial effects by induction of reactive oxygen species (ROS. The transferral of these data into clinical medicine is under debate. The majority of clinical studies show a potential benefit of LLLT in wound healing of diabetic ulcers. But there are a lot of aspects in these studies limiting final evidence about the actual output of this kind of treatment method. In summary, all studies give enough evidence to continue research on laser therapy for diabetic ulcers, but clinical trials using human models do not provide sufficient evidence to establish the usefulness of LLLT as an effective tool in wound care regimes at present. Further well designed research trials are required to determine the true value of LLLT in routine wound care.

  15. New Treatment Applying Low Level Laser Therapy for Acute Dehiscence Saphenectomy in Post Myocardial Revascularization.

    Science.gov (United States)

    Pinto, Nathali Cordeiro; Shoji, Nara; Junior, Mauro Favoretto; Muramatso, Mikiya; Chavantes, Maria Cristina; Stolf, Noedir A. G.

    2008-04-01

    Introduction: In Brazil, the main cause of death is the coronary heart disease and the surgical treatment applied in such cases is the Myocardial Revascularization (MR). Patients undergoing to MR through saphenous vein bypass development dehiscence in 10% of the cases. Dehiscence of surgical incision through Biomodulation treatment with Low Level Laser Therapy (LLLT) in patients who underwent to MR seems to be an unprecedented new therapy and a less invasive technique, which can benefit patients and Institutions, reducing costs. Methodology: It was analyzed 7 diabetic patients, mean age 51, 8 years old that post MR surgery presented dehiscence of the saphenectomy incision on lower limb with erithema, edema and pain. The wounds area varies from 2,2 until 34,8 cm and deep from 0,1 until 1,1 cm. It was used only Diode Laser C.W. (655 nm wavelength), Power = 25 mW, Time = 30 s, Fluence = 4 J/cm2 applied punctually around surgical wound's sore, by 2 cm distance. Results: It was observed granulated tissue all around the incision, as well as decreased inflammatory process, reduction fibrin and wound's size, besides analgesic effect since the first application. It was required in superficial wounds only 3 applications, while in the extensive wounds 8-10 applications were necessary. The LLLT has shown a remarkable role as a wound healing facilitated agent, reflecting the reduction of inflammatory process and improving analgesia. Conclusion: LLLT assisted dehiscence post saphenectomy showed a substantial improvement to the patient's quality of life, with a cost-effectiveness treatment that can benefit both patients and Institutions as an effective and less invasive therapy.

  16. Alternative high-level radiation sources for sewage and waste-water treatment

    International Nuclear Information System (INIS)

    Ballantine, D.S.

    1975-01-01

    The choice of an energy source for the radiation treatment of waste-water or sludge is between an electron accelerator or a gamma-ray source of radioactive cobalt or caesium. A number of factors will affect the ultimate choice and the potential future adoption of radiation as a treatment technique. The present and future availability of radioactive sources of cobalt and caesium is closely linked to the rate of nuclear power development and the assumption by uranium fuel reprocessors of a role as radioactive caesium suppliers. Accelerators are industrial machines which could be readily produced to meet any conceivable market demand. For energy sources in the 20-30 kW range, electron accelerators appear to have an initial capital cost advantage of about seven and an operating cost advantage of two. While radioisotope sources are inherently more reliable, accelerators at voltages to 3 MeV have achieved a reliability level adequate to meet the demands of essentially continuous operations with moderate maintenance requirements. The application of either energy source to waste-water treatment will be significantly influenced by considerations of the relative penetration capability, energy density and physical geometrical constraints of each option. The greater range of the gamma rays and the lower energy density of the isotopic sources permit irradiation of a variety of target geometrics. The low penetration of electrons and the high-energy density of accelerators limit application of the latter to targets presented as thin films of several centimetres thickness. Any potential use of radiation must proceed from a clear definition of process objectives and critical comparison of the radiation energy options for that specific objective. (Author)

  17. Feasible modifications for the low-level waste treatment plant at Oak Ridge National Laboratory

    International Nuclear Information System (INIS)

    Chilton, J.M.

    1984-06-01

    Aqueous, low-level, radioactive wastes at Oak Ridge National Laboratory (ORNL) contain small amounts of 60 Co, 90 Sr, 137 Cs, and trace amounts of other radionuclides. These wastes are processed by passage through beds of a strong-acid cation exchange resin, and the treated water is then discharged to the environment. Studies show that pretreatment of the waste with a weak-acid cation exchange resin would result in a significant decrease in regeneration reagents and a saving of manpower. This can be accomplished in the present plant by piping changes on the existing columns. The effluent from the cation treatment process contains all of the radionuclides that are present in anionic form. Routinely, this consists only of approximately one-half of the 60 Co. Under certain conditions, other anions (such as 131 I) could be present. Studies show that these can be removed by use of an anion exchange resin bed at the end of the process. This would require the construction of an additional column, if the head-end treatment described above is also installed. 2 references, 2 figures, 2 tables

  18. Treatment options of low level liquid waste of ETP origin by synthetic zeolites

    International Nuclear Information System (INIS)

    Singh, I.J.; Jain, Savita; Sathi Sasidharan, N.; Deshingkar, D.S.

    2001-08-01

    Mixture of synthetic zeolites, AR1, 4A and 13X of Indian origin were tested in a single fixed bed column operation for the treatment of low level liquid waste received at Effluents Treatment Plant (ETP) Trombay, under dynamic conditions. The mixed bed of zeolites was highly effective in decontaminating thousands of bed volumes of waste stream from radio cesium, radio strontium and gross beta gamma activity. High volume reduction factors, upwards of 10,000 are available in this process compared to less than 100 available with chemical precipitation process, currently followed. Containment of entrapped activity in zeolite bed was studied by solidifying them in Portland cement matrix as stable waste form. Incorporation of minerals like vermiculite as minor additive for improving the leaching characteristics of the final waste form was evaluated. Zeolite incorporated cement blocks were subjected to leach tests in distilled water for over 200 days to assess the incremental and cumulative leach rates of individual activity components. Leachability index of radio cesium and strontium were computed, which indicated the suitability of the matrix for safe shallow land burial. (author)

  19. Treatment of low-level radioactive waste liquid by reverse osmosis

    International Nuclear Information System (INIS)

    Buckley, L.P.; Sen Gupta, S.K.; Slade, J.A.

    1995-01-01

    The processing of low-level radioactive waste (LLRW) liquids that result from operation of nuclear power plants with reverse osmosis systems is not common practice. A demonstration facility is operating at Chalk River Laboratories (of Atomic Energy of Canada Limited), processing much of the LLRW liquids generated at the site from a multitude of radioactive facilities, ranging from isotope production through decontamination operations and including chemical laboratory drains. The reverse osmosis system comprises two treatment steps--spiral wound reverse osmosis followed by tubular reverse osmosis--to achieve an average volume reduction factor of 30:1 and a removal efficiency in excess of 99% for most radioactive and chemical species. The separation allows the clean effluent to be discharged without further treatment. The concentrated waste stream of 3 wt% total solids is further processed to generate a solid product. The typical lifetimes of the membranes have been nearly 4000 hours, and replacement was required based on increased pressure drops and irreversible loss of permeate flux. Four years of operating experience with the reverse osmosis system, to demonstrate its practicality and to observe and record its efficiency, maintenance requirements and effectiveness, have proven it to be viable for volume reduction and concentration of LLRW liquids generated from nuclear-power-plant operations

  20. Efficacy of low level laser therapy in the treatment of burning mouth syndrome: A systematic review.

    Science.gov (United States)

    Al-Maweri, Sadeq Ali; Javed, Fawad; Kalakonda, Butchibabu; AlAizari, Nader A; Al-Soneidar, Walid; Al-Akwa, Ameen

    2017-03-01

    Burning mouth syndrome (BMS) is a chronic pain condition with indefinite cure, predominantly affecting post-menopausal women. The aim of this study was to systematically review the efficacy of low level laser therapy in the treatment of burning mouth syndrome (BMS). PubMed, Embase and Scopus were searched from date of inception till and including October 2016 using various combinations of the following keywords: burning mouth syndrome, BMS, stomatodynia, laser therapy, laser treatment and phototherapy. The inclusion criteria were: Prospective, retrospective and case series studies. Letter to editors, reviews, experimental studies, studies that were not published in English, theses, monographs, and abstracts presented in scientific events were excluded. Due to heterogeneity of data no statistical analyses were performed. Ten clinical studies fulfilled the eligibility criteria, five of which were randomized clinical trials. In these studies, the laser wavelengths, power output and duration of irradiation ranged between 630-980nm, 20-300mW, 10s-15min, respectively. Most of studies reported laser to be an effective therapy strategy for management of BMS. Majority of the studies showed that laser therapy seemed to be effective in reducing pain in BMS patients. However, due to the varied methodologies and substantial variations in laser parameters among these studies, more clinical trials are required to ascertain the efficacy of laser for treating BMS. Copyright © 2016 Elsevier B.V. All rights reserved.

  1. Treatment methods for radioactive mixed wastes in commercial low-level wastes - technical considerations

    International Nuclear Information System (INIS)

    MacKenzie, D.R.; Kempf, C.R.

    1986-01-01

    Treatment options for the management of three generic categories of radioactive mixed waste in commercial low-level wastes (LLW) have been identified and evaluated. These wastes were characterized as part of a BNL study in which LLW generators were surveyed for information on potential chemical hazards in their wastes. The general treatment options available for mixed wastes are destruction, immobilization, and reclamation. Solidification, absorption, incineration, acid digestion, wet-air oxidation, distillation, liquid-liquid solvent extraction, and specific chemical destruction techniques have been considered for organic liquid wastes. Containment, segregation, decontamination, and solidification or containment of residues, have been considered for lead metal wastes which have themselves been contaminated and are not used for purposes of waste disposal shielding, packaging, or containment. For chromium-containing wastes, solidification, incineration, wet-air oxidation, acid digestion, and containment have been considered. Fore each of these wastes, the management option evaluation has included an assessment of testing appropriate to determine the effect of the option on both the radiological and potential chemical hazards present

  2. Low-level laser (light) therapy (LLLT) for treatment of hair loss.

    Science.gov (United States)

    Avci, Pinar; Gupta, Gaurav K; Clark, Jason; Wikonkal, Norbert; Hamblin, Michael R

    2014-02-01

    Alopecia is a common disorder affecting more than half of the population worldwide. Androgenetic alopecia, the most common type, affects 50% of males over the age of 40 and 75% of females over 65. Only two drugs have been approved so far (minoxidil and finasteride) and hair transplant is the other treatment alternative. This review surveys the evidence for low-level laser therapy (LLLT) applied to the scalp as a treatment for hair loss and discusses possible mechanisms of actions. Searches of PubMed and Google Scholar were carried out using keywords alopecia, hair loss, LLLT, photobiomodulation. Studies have shown that LLLT stimulated hair growth in mice subjected to chemotherapy-induced alopecia and also in alopecia areata. Controlled clinical trials demonstrated that LLLT stimulated hair growth in both men and women. Among various mechanisms, the main mechanism is hypothesized to be stimulation of epidermal stem cells in the hair follicle bulge and shifting the follicles into anagen phase. LLLT for hair growth in both men and women appears to be both safe and effective. The optimum wavelength, coherence and dosimetric parameters remain to be determined. © 2013 Wiley Periodicals, Inc.

  3. Regional waste treatment with monolith disposal for low-level radioactive waste

    International Nuclear Information System (INIS)

    Forsberg, C.W.

    1983-01-01

    An alternative system is proposed for the disposal of low-level radioactive waste. This system, called REgional Treatment with MOnolith Disposal (RETMOD), is based on integrating three commercial technologies: automated package warehousing, whole-barrel rotary kiln incineration, and cement-based grouts for radioactive waste disposal. In the simplified flowsheet, all the sludges, liquids, resins, and combustible wastes are transported to regional facilities where they are incinerated. The ash is then mixed with special cement-based grouts, and the resulting mixture is poured into trenches to form large waste-cement monoliths. Wastes that do not require treatment, such as damaged and discarded equipment, are prepositioned in the trenches with the waste-cement mixture poured on top. The RETMOD system may provide higher safety margins by conversion of wastes into a solidified low-leach form, creation of low-surface area waste-cement monoliths, and centralization of waste processing into a few specialized facilities. Institutional problems would be simplified by placing total responsibility for safe disposal on the disposal site operator. Lower costs may be realized through reduced handling costs, the economics of scale, simplified operations, and less restrictive waste packaging requirements

  4. Comparing cluster-level dynamic treatment regimens using sequential, multiple assignment, randomized trials: Regression estimation and sample size considerations.

    Science.gov (United States)

    NeCamp, Timothy; Kilbourne, Amy; Almirall, Daniel

    2017-08-01

    Cluster-level dynamic treatment regimens can be used to guide sequential treatment decision-making at the cluster level in order to improve outcomes at the individual or patient-level. In a cluster-level dynamic treatment regimen, the treatment is potentially adapted and re-adapted over time based on changes in the cluster that could be impacted by prior intervention, including aggregate measures of the individuals or patients that compose it. Cluster-randomized sequential multiple assignment randomized trials can be used to answer multiple open questions preventing scientists from developing high-quality cluster-level dynamic treatment regimens. In a cluster-randomized sequential multiple assignment randomized trial, sequential randomizations occur at the cluster level and outcomes are observed at the individual level. This manuscript makes two contributions to the design and analysis of cluster-randomized sequential multiple assignment randomized trials. First, a weighted least squares regression approach is proposed for comparing the mean of a patient-level outcome between the cluster-level dynamic treatment regimens embedded in a sequential multiple assignment randomized trial. The regression approach facilitates the use of baseline covariates which is often critical in the analysis of cluster-level trials. Second, sample size calculators are derived for two common cluster-randomized sequential multiple assignment randomized trial designs for use when the primary aim is a between-dynamic treatment regimen comparison of the mean of a continuous patient-level outcome. The methods are motivated by the Adaptive Implementation of Effective Programs Trial which is, to our knowledge, the first-ever cluster-randomized sequential multiple assignment randomized trial in psychiatry.

  5. Treatment of complementary events in event trees in constructing linked fault trees for level 1 and level 2 PRA

    International Nuclear Information System (INIS)

    Jo, Y. G.

    2008-01-01

    Complementary events in the event trees for a PRA model should be treated properly in order to evaluate plant risk correctly. In this study, the characteristics of the following three different cut-set generation methods were investigated first in order to find the best practical way for treating complementary events: 1) exact method which treats complementary events logically, 2) no-delete term method which does not treat complementary events at all, and 3) delete term method which treats complementary events by deleting nonsense cut-sets which are generated as a result of ignoring complementary events. Then, practical methods for treating complementary events in constructing linked fault trees for level 1 and level 2 PRA in EPRI R and R workstation software environment, where CAFTA is the fault tree editor and FORTE is the cut-set engine, were suggested and demonstrated. The suggested methods deal with the following selected four typical cases: Case 1: an event tree event (E) is represented by a fault tree gate whose inputs consist of only fault tree gates, Case 2: E is represented by a single basic event, Case 3: E is represented by an OR fault tree gate which has a single basic event and a fault tree gate as inputs, and Case 4: E is represented by an AND fault tree gate which has a single basic event and a fault tree gate as inputs. In the suggested methods, first the high level logic structures of event tree events are examined and restructured, if needed. Then, the delete term method, the exact method, and the combination of the two methods are applied to Case 1, Case 2, and Cases 3 and 4, respectively. Also, it is recommended to treat complementary events, using the suggested methods, before level 1 and level 2 PRA fault trees are coupled. It should be noted that the selected four typical cases may not cover all different cases encountered in level 1 and level 2 PRA modeling. However, a process similar to the one suggested in this study may be used to find

  6. Oral Magnesium Treatment Reduces Anemia and Levels of Inflammatory Markers in Experimental Diabetes.

    Science.gov (United States)

    Ige, A O; Adewoye, E O

    2016-07-26

    Magnesium has been reported to improve glucose utilization in diabetes mellitus. However, information on its effects on anemic and inflammatory markers in diabetes mellitus is limited. This study investigated the effect of oral magnesium (Mg) treatment on some markers of anemia and inflammation in 25 male Wistar rats. Rats (200 ± 15 g) were randomly divided into five groups (n = 5). Group 1 was control (received orally 0.2 mL distilled water daily), group 2 (Diabetic Untreated), group 3 (Diabetic Mg treated-100 mg/kg bw), group 4 (Diabetic Mg treated-250 mg/kg bw), group 5 (Diabetic Insulin treated-1 IU/kg bw). Diabetes was induced with a single dose of alloxan (100 mg/kg intraperitoneal (i.p.)). All treatments were done for 14 days. Anemic and inflammatory markers were investigated on blood samples obtained from each animal using standard laboratory methods. Significant increase (p DMg 100 (5.86 ± 0.74 × 10 9 /L) and DMg 250 (5.06 ± 0.78 × 10 9 /L). Hemoglobin concentration, packed cell volume (PCV) and red blood cell (RBC) count was decreased (p DMg 100, and DI rats. Erythrocyte sedimentation rate (ESR) was significantly increased (p DMg 100, DMg 250, and DI groups. Fibrinogen level was increased (p DMg 100 (0.30 ± 0.03 g/dL), DMg 250 (0.22 ± 0.04 g/dL), and DI (0.36 ± 0.02 g/dL) rats were comparable to control (0.26 ± 0.02 g/dL). Total protein, albumin, and globulin levels were decreased in DU rats compared to normal control, DMg 100, DMg 250, and DI rats. In conclusion, anemia and increased hematologic and metabolic inflammatory markers may be associated with untreated diabetes mellitus. Treatment of alloxan-induced diabetic rats with magnesium improved the anemic state and reduced hematologic and metabolic inflammatory markers.

  7. Treatment of radioactive mixed wastes in commercial low-level wastes

    International Nuclear Information System (INIS)

    Kempf, C.R.; MacKenzie, D.R.

    1985-01-01

    Management options for three generic categories of radioactive mixed waste in commercial low-level wastes have been identified and evaluated. These wastes were characterized as part of a BNL study in which a large number of generators were surveyed for information on potentially hazardous low-level wastes. The general management targets adopted for mixed wastes are immobilization, destruction, and reclamation. It is possible that these targets may not be practical for some wastes, and for these, goals of stabilization or reduction of hazard are addressed. Solidification, absorption, incineration, acid digestion, segregation, and substitution have been considered for organic liquid wastes. Containment, segregation, and decontamination and re-use have been considered for lead metal wastes which have themselves been contaminated and are not used for purposes of waste disposal shielding, packaging, or containment. For chromium-containing wastes, solidification, incineration, containment, substitution, chemical reduction, and biological removal have been considered. For each of these wastes, the management option evaluation has necessarily included assessment/estimation of the effect of the treatment on both the radiological and potential chemical hazards present. 10 refs

  8. Effect of Technological Treatments on Human-Like Leptin Level in Bovine Milk for Human Consumption.

    Science.gov (United States)

    Magistrelli, Damiano; Rosi, Fabia

    2014-07-23

    In this experiment, raw milk and commercially available full-cream UHT milk, semi-skimmed UHT milk, skimmed UHT milk, full-cream pasteurized milk, semi-skimmed pasteurized milk and infant formulas for babies between 6 and 12 months of age were analyzed by RIA, with a method using an antibody directed against human leptin and human leptin as reference standard. Raw milk and full-cream UHT milk did not differ for human-like leptin. Leptin content of full-cream pasteurized milk was not different to that of full-cream UHT milk, but it was 14% lower ( p raw milk. Human-like leptin level of semi-skimmed UHT milk was not different to that of semi-skimmed pasteurized milk, but it was 30% lower ( p pasteurized milks. In skimmed UHT milk, leptin was 40% lower ( p milk. Leptin was correlated ( p milks. Results suggest that the heat treatment (pasteurization or UHT) is not a modifier of human-like leptin content of edible commercial bovine milks, whereas the skimming process significantly reduces milk leptin level.

  9. Multi-level computational chemistry study on hydrogen recombination catalyst of off-gas treatment system

    International Nuclear Information System (INIS)

    Hatakeyama, Nozomu; Ise, Mariko; Inaba, Kenji

    2011-01-01

    In order to reveal the deactivation mechanism of the hydrogen recombination catalyst of off-gas treatment system, we investigate by using multi-level computational chemistry simulation methods. The recombiner apparatus is modeled by the numerical mesh system in the axial coordinates, and unsteady, advection and reaction rate equations are solved by using a finite difference method. The chemical reactions are formulated to represent adsorption-desorption of hydrogen and oxygen on Pt catalyst, and time developments of the coverage factors of Pt are solved numerically. The computational simulations successfully reproduce the very similar behaviors observed by experiments, such as increasing of the inversion rates of H 2 to H 2 O, the temperatures distributions along the flow direction, dependencies of experimental condition, and so on. Thus Pt poisoning is considered to cause the deactivation of the hydrogen recombination catalyst. To clarify the poisoning mechanism, the molecular level simulation is applied to the system of Pt on boehmite attacked by a cyclic siloxane which has been detected by experiments and considered as one of poisoning spices. The simulation shows ring-opening reaction of the cyclic siloxane on Pt, then attachment of two ends of the chain-like siloxane to Pt and boehmite, respectively, and that finally the recombination reaction is prevented. This may be the first study to find out the detailed dynamical mechanism of hydrogen recombination catalyst poisoning with cyclic siloxane. (author)

  10. Evaluation of isometamidium levels in the serum of sheep and goats after prophylactic treatment against trypanosomosis

    Directory of Open Access Journals (Sweden)

    J.O. Wesongah

    2004-11-01

    Full Text Available years, but recently there have been reports of prophylaxis failure under natural conditions. In this study, use of the drug for prophylactic purpose against trypanosomosis in small ruminants was investigated. Forty-two sheep and 44 goats were divided into four treatment groups. Groups 1 and 2 were treated with isometamidium chloride (Samorin(R, Rhone Merieux, Lyon, France at 3-month intervals while groups 3 and 4 were used as controls. All the animals were exposed to natural tsetse challenge and monitored for serum isometamidium levels and anti-trypanosome antibodies. Seven days after drug administration, isometamidium levels were significantly higher in goats 13.7 + 0.07 ng/mℓ than in sheep 6.2 + 0.06 ng/mℓ. However, the elimination half-life in the sheep was 14.2 + 0.92 days and was significantly higher (P > 0.05 than that of the goats 12 + 0.5 days. This study established that isometamidium metabolism differs between sheep and goats and this difference may have important implications in high tsetse challenge areas.

  11. Development of safeguards information treatment system at facility level in Korea

    International Nuclear Information System (INIS)

    So, D.S.; Lee, B.D.; Song, D.Y.

    2001-01-01

    Safeguards Information Treatment System (SITS) at Facility level was developed to implement efficiently the obligations under IAEA comprehensive Safeguards Agreement, bilateral nuclear cooperation Agreements with other countries and domestic law, and to manage efficiently the information related to safeguards implementation at facility level in Korea. Nuclear facilities in Korea are categorized into 8 types based on its accounting characteristics as follows: (1) Item counting facility or bulk handling facility; (2) Batch follow-up facility or not; (3) MUF (Material Unaccounted For) occurrence or not; (4) Nuclear production facility or not; (5) Operation status of facility; (6) Information management of nuclear material transfer status between KMPs or not; (7) Indication of inventory KMP on the inventory change of nuclear material is required or not. Hardware and Software for SITS can be loaded on a personal computer under operation system of Window 2000 or Window NT. MS SQL server 7 and MS Internet Information Server were adopted for database management system and Web server, respectively. Network environment of SITS was designed to include nuclear research institute, nuclear power plants of PWR and CANDU, nuclear fuel fabrication facilities and other facilities. SITS can be operated standalone or under the client-server system if intranet exists. More detailed contents of SITS are described elsewhere. Each module of SITS will be tested during incorporation of existing data into SITS and SITS will be distributed to nuclear facilities in Korea

  12. Medication adherence levels and differential use of mental-health services in the treatment of schizophrenia

    Directory of Open Access Journals (Sweden)

    Furiak Nicolas M

    2009-01-01

    Full Text Available Abstract Background Adherence to antipsychotics for schizophrenia is associated with favorable clinical outcomes. This study compared annual mental-health service utilization by recent medication adherence levels for patients treated for schizophrenia, and assessed whether adherence levels change from pre- to post-psychiatric hospitalization. Methods We analyzed data from a large prospective, non-interventional study of patients treated for schizophrenia in the United States, conducted between 7/1997 and 9/2003. Detailed mental-health resource utilization was systematically abstracted from medical records and augmented with patients' self report. Medication possession ratio (MPR with any antipsychotic in the 6 months prior to enrollment was used to categorize patients as: adherent (MPR ≥ 80%, N = 1758, partially adherent (MPR ≥ 60% Results Adherent patients had a lower rate of psychiatric hospitalization compared with partially adherent and non-adherent patients (p Conclusion Adherence is associated with lower utilization of acute care services and greater engagement in outpatient mental-health treatment. Adherence is a potentially dynamic phenomenon, which may improve, at least temporarily, following patients' psychiatric hospitalizations.

  13. [2,3-diphosphoglycerate level during the active and maintenance treatment of iron-deficiency anemia patients].

    Science.gov (United States)

    Iordanova, E; Dosheva, I; Lulcheva, F; Tsvetkova, N; Dobrev, K

    1985-01-01

    The objective of the present study was to obtain information about the duration of tissue hypoxia in patients with iron deficiency anemia. That fact is of importance for the determination of the duration of maintenance iron therapy. The level of 2,3-diphosphoglycerate was studied during the treatment, after the correction of anemic syndrome and after 60-day out-patient department treatment. The data obtained revealed that the level of 2,3-diphosphoglycerate was considerably elevated, as compared with the norm, before the treatment. After the active treatment and correction of anemic syndrome it was decreased, but remaining above the norm. By the 60th day of the out-patient department treatment the decrease continued and the level of 2,3-diphosphoglycerate approached the norm.

  14. The Department of Energy's National Disposition Strategy for the Treatment and Disposal of Low Level and Mixed Low Level Waste

    International Nuclear Information System (INIS)

    Peterson, G.R.; Tonkay, D.W.

    2006-01-01

    The U.S. Department of Energy's (DOE) Environmental Management (EM) program is committed to the environmental remediation of DOE sites. This cleanup mission will continue to produce large amounts of Low Level Waste (LLW) and Mixed Low-Level Waste (MLLW). This paper reports on the development of the DOE LLW/MLLW National Disposition Strategy that maps the Department's long-range strategy to manage LLW and MLLW. Existing corporate LLW and MLLW data proved insufficient to develop this strategy. Therefore, new data requirements were developed in conjunction with waste managers. The paper will report on the results of this data collection effort, which will result in development of DOE LLW/MLLW disposition maps. (authors)

  15. Clinical significance of changes of serum gas, IL-6 and IL-10 levels after treatment in patients with peptic ulcer

    International Nuclear Information System (INIS)

    Ye Yuexian

    2009-01-01

    Objective: To explore the clinical significance of changes of serum Gas, Interleukin-6(IL-6) and Interleukin-10(IL-10) levels in patients with peptic ulcer. Methods: Serum Gas, IL-6 and IL-10 (with RIA) levels were determined in 61 patients with peptic ulcer both before and after treatment as well as in 35 controls. Results: Before treatment the serum Gas, IL-6 and IL-10 levels were significantly higher in the patients with peptic ulcer than those in controls (P 0.05). Conclusion: Serum Gas, IL-6 and IL-10 levels were closely related to the diseases process of peptic ulcer and were of prognostic values. (authors)

  16. Clinical significance of determination of serum TNF-α, VEGF and TSGF levels after treatment in patients with aplastic anemia

    International Nuclear Information System (INIS)

    Hu Mingqiu; Xu Yanli

    2009-01-01

    Objective: To explore the clinical significance changes of serum TNF-α, VEGF and TSGF levels after treatment in patients with aplastic Anemia. Methods: Serum TNF-α(with RIA), VEGF(with ELISA) and TSGF(with biochemistry) levels were determined in 33 patients with aplastic anemia both before and after treatment and 35 controls. Results: Before treatment, the serum TNF-α, TSGF levels were significantly higher in the patients than those in controls (P<0.01), but serum VEGF levels were significantly lower in the patients (P<0.01). Serum TNF-α, TSGF levels were negatively correlated with levels of VEGF(r=-0.5192, -0.6018, P<0.01). After a course of treatment, the serum TNF-α, VEGF and TSGF levels, though corrected markedly, remained significantly different from those in controls (P<0.05). Conclusion: Determination of serum TNF-α, VEGF and TSGF levels after treatment might be of prognostic importance in patients with aplastic anemia. (authors)

  17. Leptin and adiponectin levels in girls with central precocious puberty before and during GnRH agonist treatment

    Directory of Open Access Journals (Sweden)

    Jae Won Yoo

    2016-12-01

    Full Text Available PurposeThe effects of gonadotropin-releasing hormone agonist (GnRHa treatment on the energy metabolism in girls with central precocious puberty (CPP are controversial. We focused the changes and related factors of serum levels of leptin and adiponectin in girls with CPP before and during GnRHa treatment.MethodsThirty girls with idiopathic CPP were enrolled in the study. Their auxological data and fasting blood were collected at the baseline and after six months of GnRHa treatment.ResultsAfter treatment, height (P<0.001, weight (P<0.001, and serum leptin levels (P=0.033 were significantly increased, whereas body mass index (BMI, homeostasis model of assessment-insulin resistance, serum adiponectin levels, and adiponectin/leptin ratio exhibited no significant changes. A Pearson correlation analysis showed that height, weight, BMI, and their standard deviation scores (SDSs, but not basal LH, FSH, and estradiol, were significantly correlated with serum leptin levels before and after GnRHa treatment. After a multiple linear regression analysis, only BMI was associated with serum leptin levels. Moreover, leptin SDSs adjusted for BMI were not significantly different before and after GnRHa. The Δ leptin levels (r2=0.207, P=0.012, but not with Δ leptin SDS (r2=0.019, P=0.556, during GnRHa treatment were positively correlated with Δ BMI.ConclusionThese results suggest that GnRHa treatment in girls with CPP does not affect serum levels of leptin and adiponectin and insulin resistance. Serum leptin levels were depend on the changes in BMI during GnRHa treatment.

  18. A survey of low-level radioactive waste treatment methods and problem areas associated with commercial nuclear power plants

    International Nuclear Information System (INIS)

    Jolley, R.L.; Rodgers, B.R.

    1987-01-01

    A survey was made (June 1985) of technologies that were currently being used, those that had been discontinued, and those that were under consideration for treatment of low-level radioactive waste from the commercial nuclear power plants in the United States. The survey results included information concerning problems areas, areas needing research and development, and the use of mobile treatment facilities

  19. The Treatment of Low Level Radioactive Liquid Waste Containing Detergent by Biological Activated Sludge Process

    International Nuclear Information System (INIS)

    Zainus Salimin

    2002-01-01

    The treatment of low level radioactive liquid waste containing persil detergent from laundry operation of contaminated clothes by activated sludge process has been done, for alternative process replacing the existing treatment by evaporation. The detergent concentration in water solution from laundry operation is 14.96 g/l. After rinsing operation of clothes and mixing of laundry water solution with another liquid waste, the waste water solution contains about ≤ 1.496 g/l of detergent and 10 -3 Ci/m 3 of Cs-137 activity. The simulation waste having equivalent activity of Cs-137 10 -3 Ci/m 3 , detergent content (X) 1.496, 0.748, 0.374, 0.187, 0.1496 and 0.094 g/l on BOD value respectively 186, 115, 71, 48, 19, and 16 ppm was processed by activated sludge in reactor of 18.6 l capacity on ambient temperature. It is used Super Growth Bacteria (SGB) 102 and SGB 104, nitrogen and phosphor nutrition, and aeration. The result show that bacteria of SGB 102 and SGB 104 were able to degrade the persil detergent for attaining standard quality of water release category B in which BOD values 6 ppm. It was need 30 hours for X ≤ 0.187 g/l, 50 hours for 0.187 < X ≤ 0.374 g/l, 75 hours for 0.374 < X ≤ 0.748, and 100 hours for 0.748 < X ≤ 1.496 g/l. On the initial period the bacteria of SGB 104 interact most quickly to degrade the detergent comparing SGB 102. Biochemical oxidation process decontaminate the solution on the decontamination factor of 350, Cs-137 be concentrate in sludge by complexing with the bacteria wall until the activity of solution be become very low. (author)

  20. The effect of drawing and writing technique on the anxiety level of children undergoing cancer treatment.

    Science.gov (United States)

    Altay, Naime; Kilicarslan-Toruner, Ebru; Sari, Çigdem

    2017-06-01

    To determine the effect of the drawing and writing technique on the anxiety level of children undergoing cancer treatment in hospital. Research was conducted in the haematology-oncology clinic of a university hospital, using a quasi-experimental design (pre-and-post intervention evaluations of a single group). The sample comprised 30 hospitalised children aged 9-16 years. Data were collected with Socio-demographic form, clinical data form, and the State Anxiety Inventory. The institution gave written approval for the study and parents provided written consent. Drawing, writing and mutual story-telling techniques were used as part of a five-day programme. Children were asked to draw a picture of a hospitalised child and write a story about this drawing. After drawing and writing, mutual storytelling were used to more constructive story with positive feelings. The drawing, writing techniques was implemented on the first and third days of the programme and mutual storytelling was implemented on the second and fourth days. Data were reported as percentages and frequencies and the intervention effect analysed with the Wilcoxon test. The average age of children was 12.56 years ± 2.67 and 76.7% were girls. The mean age diagnosis and mean treatment duration were 11.26 years ± 3.17 and 16.56 months ± 20.75 respectively. Most of the children (50%) had leukaemia and were receiving chemotherapy (66.7%). In most cases (76.7%) the mother was the primary caregiver. Scores on the State Anxiety Inventory were lower-indicating lower anxiety-after the intervention (36.86 ± 4.12 than before it (40.46 ± 4.51) (p < 0.05). The therapeutic intervention reduced children's state anxiety. Copyright © 2017 Elsevier Ltd. All rights reserved.

  1. RNA-SEQ reveals transcriptional level changes of poplar roots in different forms of nitrogen treatments

    Directory of Open Access Journals (Sweden)

    Chunpu eQu

    2016-02-01

    Full Text Available Poplar has emerged as a model plant for understanding molecular mechanisms of tree growth, development and response to environment. Long-term application of different forms of nitrogen (such as NO3--N and NH4+-N may cause morphological changes of poplar roots; however, the molecular level changes are still not well known. In this study, we analyzed the expression profiling of poplar roots treated by three forms of nitrogen: S1 (NH4+, S2 (NH4NO3 and S3 (NO3- by using RNA-SEQ technique. We found 463 genes significantly differentially expressed in roots by different N treatments, of which a total of 116 genes were found to differentially express between S1 and S2, 173 genes between S2 and S3, and 327 genes between S1 and S3. A cluster analysis shows significant difference in many transcription factor families and functional genes family under different N forms. Through an analysis of Mapman metabolic pathway, we found that the significantly differentially expressed genes are associated with fermentation, glycolysis and tricarboxylic acid cycle (TCA, secondary metabolism, hormone metabolism, and transport processing. Interestingly, we did not find significantly differentially expressed genes in N metabolism pathway, mitochondrial electron transport / ATP synthesis and mineral nutrition. We also found abundant candidate genes (20 transcription factors and 30 functional genes regulating morphology changes of poplar roots under the three N forms. The results obtained are beneficial to a better understanding of the potential molecular and cellular mechanisms regulating root morphology changes under different N treatments.

  2. Low-level laser therapy as a treatment for androgenetic alopecia.

    Science.gov (United States)

    Afifi, Ladan; Maranda, Eric L; Zarei, Mina; Delcanto, Gina M; Falto-Aizpurua, Leyre; Kluijfhout, Wouter P; Jimenez, Joaquin J

    2017-01-01

    Androgenetic alopecia (AGA) affects 50% of males by age 50 and 50% of females by age 80. Recently, the use of low-level laser therapy (LLLT) has been proposed as a treatment for hair loss and to stimulate hair regrowth in AGA. This paper aims to review the existing research studies to determine whether LLLT is an effective therapy for AGA based on objective measurements and patient satisfaction. A systematic literature review was done to identify articles on Medline, Google Scholar, and Embase that were published between January 1960 and November 2015. All search hits were screened by two reviewers and examined for relevant abstracts and titles. Articles were divided based on study design and assessed for risk of bias. Eleven studies were evaluated, which investigated a total of 680 patients, consisting of 444 males and 236 females. Nine out of 11 studies assessing hair count/hair density found statistically significant improvements in both males and females following LLLT treatment. Additionally, hair thickness and tensile strength significantly improved in two out of four studies. Patient satisfaction was investigated in five studies, and was overall positive, though not as profound as the objective outcomes. The majority of studies covered in this review found an overall improvement in hair regrowth, thickness, and patient satisfaction following LLLT therapy. Although we should be cautious when interpreting these findings, LLLT therapy seems to be a promising monotherapy for AGA and may serve as an effective alternative for individuals unwilling to use medical therapy or undergo surgical options. Lasers Surg. Med. 49:27-39, 2017. © 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

  3. Comparison of alternative treatment systems for DOE mixed low-level waste

    International Nuclear Information System (INIS)

    Schwinkendorf, W.E.

    1997-03-01

    From 1993 to 1996, the Department of Energy, Environmental Management, Office of Science and Technology (OST), has sponsored a series of systems analyses to guide its future research and development (R ampersand D) programs for the treatment of mixed low-level waste (MLLW) stored in the DOE complex. The two original studies were of 20 mature and innovative thermal systems. As a result of a technical review of these thermal system studies, a similar study of five innovative nonthermal systems was conducted in which unit operations are limited to temperatures less than 350 degrees C to minimize volatilization of heavy metals and radionuclides, and de novo production of dioxins and furans in the offgas. Public involvement in the INTS study was established through a working group of 20 tribal and stakeholder representatives to provide input to the INTS studies and identify principles against which the systems should be designed and evaluated. Pre-conceptual designs were developed for all systems to treat the same waste input (2927 lbs/hr) in a single centralized facility operating 4032 hours per year for 20 years. This inventory consisted of a wide range of combustible and non-combustible materials such as paper, plastics, metals, concrete, soils, sludges, liquids, etc., contaminated with trace quantities of radioactive materials and RCRA regulated wastes. From this inventory, an average waste profile was developed for simulated treatment using ASPEN PLUS copyright for mass balance calculations. Seven representative thermal systems were selected for comparison with the five nonthermal systems. This report presents the comparisons against the TSWG principles, of total life cycle cost (TLCC), and of other system performance indicators such as energy requirements, reagent requirements, land use, final waste volume, aqueous and gaseous effluents, etc

  4. Clinical significance of measurement of serum NO/NOS and TNF-α levels after treatment in patients with schizophrenia

    International Nuclear Information System (INIS)

    Nan Deqi; Du Liang; Yang Sixue; Qin Yong

    2007-01-01

    Objective: To explore the significance of changes of serum NO/NOS and TNF-α levels in patients with schizophrenia. Methods: Serum TNF-α (with R/A) and NO/NOS (with bio-chemistry) levels were determined in 41 patients with schizophrenia both before and after treatment as well as in 35 controls. Results:Before treatment the serum NOS, TNF-α levels in the patients were significantly higher than those in controls (P <0.01 ). After six weeks treatment, the levels in patients, though dropped markedly, remained significantly higher (P<0.05). Conclusion: Serum NO/NOS and TNF-α levels were closely related to the diseases process of schizophrenia and were of prognostic values. (authors)

  5. Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome

    DEFF Research Database (Denmark)

    Glintborg, D; Hermann, Pernille; Rasmussen, Lars Melholt

    2013-01-01

    in polycystic ovary syndrome (PCOS). Research design and methods Plasma OPG levels were measured in 30 PCOS patients before and after randomized treatment with 30 mg pioglitazone/placebo for 16 weeks. Fourteen age and BMI matched healthy women were included as controls. Clinical and hormonal evaluations......Objective Increased osteoprotegerin (OPG) levels are associated with increased cardiovascular risk and decreased bone resorption. Pioglitazone treatment reduces the inflammatory state but may decrease bone mineral density. OPG levels during pioglitazone treatment have not previously been evaluated...... and whole body DXA-scans were performed in all participants. Results OPG levels were comparable in PCOS patients [12.0 (10.5 - 14.6) ng/ml] and controls [12.9 (11.7 - 14.9) ng/ml]. In PCOS patients (n=30), OPG levels were positively associated with testosterone (r= 0.43), prolactin (r= 0.47), ICTP (r= 0...

  6. LOW LEVEL LIQUID RADIOACTIVE WASTE TREATMENT AT MURMANSK, RUSSIA: FACILITY UPGRADE AND EXPANSION

    International Nuclear Information System (INIS)

    BOWERMAN, B.; CZAJKOWSKI, C.; DYER, R.S.; SORLIE, A.

    2000-01-01

    Today there exist many almost overfilled storage tanks with liquid radioactive waste in the Russian Federation. This waste was generated over several years by the civil and military utilization of nuclear power. The current waste treatment capacity is either not available or inadequate. Following the London Convention, dumping of the waste in the Arctic seas is no longer an alternative. Waste is being generated from today's operations, and large volumes are expected to be generated from the dismantling of decommissioned nuclear submarines. The US and Norway have an ongoing co-operation project with the Russian Federation to upgrade and expand the capacity of a treatment facility for low level liquid waste at the RTP Atomflot site in Murmansk. The capacity will be increased from 1,200 m 3 /year to 5,000 m 3 /year. The facility will also be able to treat high saline waste. The construction phase will be completed the first half of 1998. This will be followed by a start-up and a one year post-construction phase, with US and Norwegian involvement for the entire project. The new facility will consist of 9 units containing various electrochemical, filtration, and sorbent-based treatment systems. The units will be housed in two existing buildings, and must meet more stringent radiation protection requirements that were not enacted when the facility was originally designed. The US and Norwegian technical teams have evaluated the Russian design and associated documentation. The Russian partners send monthly progress reports to US and Norway. Not only technical issues must be overcome but also cultural differences resulting from different methods of management techniques. Six to eight hour time differentials between the partners make real time decisions difficult and relying on electronic age tools becomes extremely important. Language difficulties is another challenge that must be solved. Finding a common vocabulary, and working through interpreters make the process very

  7. Pulmonary tuberculous: Symptoms, diagnosis and treatment. 19-year experience in a third level pediatric hospital.

    Science.gov (United States)

    González Saldaña, Napoleón; Macías Parra, Mercedes; Hernández Porras, Marte; Gutiérrez Castrellón, Pedro; Gómez Toscano, Valeria; Juárez Olguin, Hugo

    2014-07-19

    Pulmonary tuberculosis (PTB) is an infectious disease that involves the lungs and can be lethal in many cases. Tuberculosis (TB) in children represents 5 to 20% of the total TB cases. However, there are few updated information on pediatric TB, reason why the objective of the present study is to know the real situation of PTB in the population of children in terms of its diagnosis and treatment in a third level pediatric hospital. A retrospective study based on a revision of clinical files of patients less than 18 years old diagnosed with PTB from January 1994 to January 2013 at Instituto Nacional de Pediatria, Mexico City was carried out. A probable diagnosis was based on 3 or more of the following: two or more weeks of cough, fever, tuberculin purified protein derivative (PPD) +, previous TB exposure, suggestive chest X-ray, and favorable response to treatment. Definitive diagnosis was based on positive acid-fast bacilli (AFB) or culture. In the 19-year period of revision, 87 children were diagnosed with PTB; 57 (65.5%) had bacteriologic confirmation with ZN staining or culture positive (in fact, 22 were ZN and culture positive), and 30 (34.5%) had a probable diagnosis; 14(16.1%) were diagnosed with concomitant disease, while 69/81 were immunized. Median evolution time was 21 days (5-150). Fever was found in 94.3%, cough in 77%, and weight loss in 55.2%. History of contact with TB was established in 41.9%. Chest X-ray showed consolidation in 48.3% and mediastinal lymph node in 47.1%. PPD was positive in 59.2%, while positive AFB was found in 51.7% cases. Culture was positive in 24/79 patients (30.4%), PCR in 20/27 (74.1%). 39 (44.8%) patients were treated with rifampin, isoniazid, and pyrazinamide while 6 (6.9%) received the former drugs plus streptomycin and 42 (48.3%) the former plus ethambutol. There were three deaths. PTB in pediatric population represents a diagnostic challenge for the fact that clinical manifestations are unspecific and the diagnosis is not

  8. LOW LEVEL LIQUID RADIOACTIVE WASTE TREATMENT AT MURMANSK, RUSSIA: FACILITY UPGRADE AND EXPANSION

    Energy Technology Data Exchange (ETDEWEB)

    BOWERMAN,B.; CZAJKOWSKI,C.; DYER,R.S.; SORLIE,A.

    2000-03-01

    Today there exist many almost overfilled storage tanks with liquid radioactive waste in the Russian Federation. This waste was generated over several years by the civil and military utilization of nuclear power. The current waste treatment capacity is either not available or inadequate. Following the London Convention, dumping of the waste in the Arctic seas is no longer an alternative. Waste is being generated from today's operations, and large volumes are expected to be generated from the dismantling of decommissioned nuclear submarines. The US and Norway have an ongoing co-operation project with the Russian Federation to upgrade and expand the capacity of a treatment facility for low level liquid waste at the RTP Atomflot site in Murmansk. The capacity will be increased from 1,200 m{sup 3}/year to 5,000 m{sup 3} /year. The facility will also be able to treat high saline waste. The construction phase will be completed the first half of 1998. This will be followed by a start-up and a one year post-construction phase, with US and Norwegian involvement for the entire project. The new facility will consist of 9 units containing various electrochemical, filtration, and sorbent-based treatment systems. The units will be housed in two existing buildings, and must meet more stringent radiation protection requirements that were not enacted when the facility was originally designed. The US and Norwegian technical teams have evaluated the Russian design and associated documentation. The Russian partners send monthly progress reports to US and Norway. Not only technical issues must be overcome but also cultural differences resulting from different methods of management techniques. Six to eight hour time differentials between the partners make real time decisions difficult and relying on electronic age tools becomes extremely important. Language difficulties is another challenge that must be solved. Finding a common vocabulary, and working through interpreters make the

  9. Clinical significance of measurement of serum NO, IL-6 and IL-8 levels after treatment in patients with schizophrenia

    International Nuclear Information System (INIS)

    Gao Wanqin

    2010-01-01

    Objective: To study the significance of changes of serum NO, IL-6 and IL-8 levels after treatment in patients with schizophrenia. Methods: Serum IL-6, IL-8 (with RIA) and NO (with bio-chemistry) levels were determined in 37 patients with schizophrenia both before and after treatment as well as in 35 controls. Results: Before treatment, the serum IL-6, IL-8 levels in the patients were significantly higher than those in controls (P<0.01). While the serum NO levels were significantly lower (P<0.01). After six weeks' treatment, the levels of IL-6, IL-8 in the patients, though dropped markedly still remained significantly higher (P<0.05) than those in controls. The serum NO levels, though markedly increased after treatment, were still remained significantly lower than those in the controls (P<0.05). Conclusion: Serum NO, IL-6 and IL-8 levels were closely related to the diseases process of schizophrenia and were of prognostic values. (authors)

  10. Low-level radioactive waste from commercial nuclear reactors. Volume 2. Treatment, storage, disposal, and transportation technologies and constraints

    Energy Technology Data Exchange (ETDEWEB)

    Jolley, R.L.; Dole, L.R.; Godbee, H.W.; Kibbey, A.H.; Oyen, L.C.; Robinson, S.M.; Rodgers, B.R.; Tucker, R.F. Jr.

    1986-05-01

    The overall task of this program was to provide an assessment of currently available technology for treating commercial low-level radioactive waste (LLRW), to initiate development of a methodology for choosing one technology for a given application, and to identify research needed to improve current treatment techniques and decision methodology. The resulting report is issued in four volumes. Volume 2 discusses the definition, forms, and sources of LLRW; regulatory constraints affecting treatment, storage, transportation, and disposal; current technologies used for treatment, packaging, storage, transportation, and disposal; and the development of a matrix relating treatment technology to the LLRW stream as an aid for choosing methods for treating the waste. Detailed discussions are presented for most LLRW treatment methods, such as aqueous processes (e.g., filtration, ion exchange); dewatering (e.g., evaporation, centrifugation); sorting/segregation; mechanical treatment (e.g., shredding, baling, compaction); thermal processes (e.g., incineration, vitrification); solidification (e.g., cement, asphalt); and biological treatment.

  11. Low-level radioactive waste from commercial nuclear reactors. Volume 2. Treatment, storage, disposal, and transportation technologies and constraints

    International Nuclear Information System (INIS)

    Jolley, R.L.; Dole, L.R.; Godbee, H.W.; Kibbey, A.H.; Oyen, L.C.; Robinson, S.M.; Rodgers, B.R.; Tucker, R.F. Jr.

    1986-05-01

    The overall task of this program was to provide an assessment of currently available technology for treating commercial low-level radioactive waste (LLRW), to initiate development of a methodology for choosing one technology for a given application, and to identify research needed to improve current treatment techniques and decision methodology. The resulting report is issued in four volumes. Volume 2 discusses the definition, forms, and sources of LLRW; regulatory constraints affecting treatment, storage, transportation, and disposal; current technologies used for treatment, packaging, storage, transportation, and disposal; and the development of a matrix relating treatment technology to the LLRW stream as an aid for choosing methods for treating the waste. Detailed discussions are presented for most LLRW treatment methods, such as aqueous processes (e.g., filtration, ion exchange); dewatering (e.g., evaporation, centrifugation); sorting/segregation; mechanical treatment (e.g., shredding, baling, compaction); thermal processes (e.g., incineration, vitrification); solidification (e.g., cement, asphalt); and biological treatment

  12. An optimized approach towards the treatment of high level liquid waste in the nuclear cycle

    International Nuclear Information System (INIS)

    Maio, V.; Todd, T.; Law, J.; Roach, J.; Sabharwall, P.

    2006-01-01

    Full text: One key long-standing issue that must be overcome to realize the successful growth of nuclear power is an economical, politically acceptable, stakeholder-compatible, and technically feasible resolution pertaining to the safe treatment and disposal of high-level liquid radioactive waste (HLLW). In addition to spent nuclear reactor fuel, HLLW poses a unique challenge in regard to environmental and security concerns, since future scenarios for a next generation of domestic and commercialized nuclear fuel cycle infrastructures must include reprocessing - the primary source of HLLW-to ensure the cost effectiveness of nuclear power as well as mitigate any threats as related to proliferation. Past attempts to immobilize HLLW - generated by both the weapons complex and the commercial power sector-have been plagued by an inability to convince the public and some technical peer reviewers that any proposed geological disposal sites (e.g., Yucca Mountain) can accommodate and contain the HLLW for a period of geological time equivalent to ten fold the radiological half-life of the longest lived of the actinides remaining after reprocessing. The paper explores combined equipment and chemical processing approaches for advancing and economizing the immobilization of high level liquid waste to ensure its long term durability, its decoupling from the unknown behavior of the repository over long geological time periods, and its economical formulation as required for the nuclear fuel cycle of the future. One approach involves the investigation of crystalline based waste forms as opposed to the glass/amorphous based waste forms, and how recent developments in crystalline forms show promise in sequestering the long lived actinides for over tens of millions of years. Another approach -compatible with the first- involves the use of an alternative melter technology-the Cold Crucible Induction Melter (CCIM)- to overcome the engineering material problems of Joule Heated Meters (JHM

  13. Immobilization of high level nuclear wastes in sintered glasses. Devitrification evaluation produced with different thermal treatments

    International Nuclear Information System (INIS)

    Messi de Bernasconi, N.B.; Russo, D.O.; Bevilacqua, M.E.; Sterba, M.E.; Heredia, A.D.; Audero, M.A.

    1990-01-01

    This work describes immobilization of high level nuclear wastes in sintered glass, as alternative way to melting glass. Different chemical compositions of borosilicate glass with simulate waste were utilized and satisfactory results were obtained at laboratory scale. As another contribution to the materials studies by X ray powder diffraction analysis, the devitrification produced with different thermal treatments, was evaluated. The effect of the thermal history on the behaviour of fission products containing glasses has been studied by several working groups in the field of high level waste fixation. When the glass is cooled through the temperature range from 800 deg C down to less than 400 deg C (these temperatures are approximates) nucleation and crystal growth can take place. The rate of crystallization will be maximum near the transformation point but through this rate may be low at lower temperatures, devitrification can still occur over long periods of time, depending on the glass composition. It was verified that there can be an appreciable increase in leaching in some waste glass compositions owing to the presence of crystalline phases. On the other hand, other compositions show very little change in leachability and the devitrified product is often preferable as there is less tendency to cracking, particularly in massive blocks of glass. A borosilicate glass, named SG7, which was developed specially in the KfK for the hot pressing of HLW with glass frit was studied. It presents a much enhanced chemical durability than borosolicate glass developed for the melting process. The crystallization behaviour of SG7 glass products was investigated in our own experiments by annealing sintered samples up to 3000 h at temperatures between 675 and 825 deg C. The samples had contained simulated waste with noble metals, since these might act as foreign nuclei for crystallization. Results on the extent of devitrification and time- temperature- transformation curves are

  14. Surrogate formulations for thermal treatment of low-level mixed waste, Part II: Selected mixed waste treatment project waste streams

    Energy Technology Data Exchange (ETDEWEB)

    Bostick, W.D.; Hoffmann, D.P.; Chiang, J.M.; Hermes, W.H.; Gibson, L.V. Jr.; Richmond, A.A. [Martin Marietta Energy Systems, Inc., Oak Ridge, TN (United States); Mayberry, J. [Science Applications International Corp., Idaho Falls, ID (United States); Frazier, G. [Univ. of Tennessee, Knoxville, TN (United States)

    1994-01-01

    This report summarizes the formulation of surrogate waste packages, representing the major bulk constituent compositions for 12 waste stream classifications selected by the US DOE Mixed Waste Treatment Program. These waste groupings include: neutral aqueous wastes; aqueous halogenated organic liquids; ash; high organic content sludges; adsorbed aqueous and organic liquids; cement sludges, ashes, and solids; chloride; sulfate, and nitrate salts; organic matrix solids; heterogeneous debris; bulk combustibles; lab packs; and lead shapes. Insofar as possible, formulation of surrogate waste packages are referenced to authentic wastes in inventory within the DOE; however, the surrogate waste packages are intended to represent generic treatability group compositions. The intent is to specify a nonradiological synthetic mixture, with a minimal number of readily available components, that can be used to represent the significant challenges anticipated for treatment of the specified waste class. Performance testing and evaluation with use of a consistent series of surrogate wastes will provide a means for the initial assessment (and intercomparability) of candidate treatment technology applicability and performance. Originally the surrogate wastes were intended for use with emerging thermal treatment systems, but use may be extended to select nonthermal systems as well.

  15. Surrogate formulations for thermal treatment of low-level mixed waste, Part II: Selected mixed waste treatment project waste streams

    International Nuclear Information System (INIS)

    Bostick, W.D.; Hoffmann, D.P.; Chiang, J.M.; Hermes, W.H.; Gibson, L.V. Jr.; Richmond, A.A.; Mayberry, J.; Frazier, G.

    1994-01-01

    This report summarizes the formulation of surrogate waste packages, representing the major bulk constituent compositions for 12 waste stream classifications selected by the US DOE Mixed Waste Treatment Program. These waste groupings include: neutral aqueous wastes; aqueous halogenated organic liquids; ash; high organic content sludges; adsorbed aqueous and organic liquids; cement sludges, ashes, and solids; chloride; sulfate, and nitrate salts; organic matrix solids; heterogeneous debris; bulk combustibles; lab packs; and lead shapes. Insofar as possible, formulation of surrogate waste packages are referenced to authentic wastes in inventory within the DOE; however, the surrogate waste packages are intended to represent generic treatability group compositions. The intent is to specify a nonradiological synthetic mixture, with a minimal number of readily available components, that can be used to represent the significant challenges anticipated for treatment of the specified waste class. Performance testing and evaluation with use of a consistent series of surrogate wastes will provide a means for the initial assessment (and intercomparability) of candidate treatment technology applicability and performance. Originally the surrogate wastes were intended for use with emerging thermal treatment systems, but use may be extended to select nonthermal systems as well

  16. Documentation of currently operating low-level radioactive waste treatment systems: Shredder/compactor report

    International Nuclear Information System (INIS)

    1987-04-01

    The report documents a volume reduction waste treatment system for dry active waste, a shredder/compactor, and includes specifics on system selection, system descriptions, and detailed system performance data from three operational nuclear power plants. Data gathered from the plants have shown the ability to increase the density (thereby reducing the volume) of dry active waste to /approximately/50 pounds per cubic foot when using shredder/compactors and/approximately/80 to 100 pounds per cubic foot for shredder/high pressure compactors depending on reactor type and plant specific waste characteristics. An economic evaluation of various alternative volume reduction systems for dry active waste is also presented. The report presents a method on calculating the associated costs and paybacks achieved using various volume reduction alternatives. A 10 year cost (operating expenses and capital outlay for equipment) for a shredder/high pressure compactor is 1.85 million dollars for a BWR as compared to /approximately/3 million for a conventional drum compactor. The resulting payback for the shredder/compactor is as low as 1.7 years. The report provides generators of low level waste additional information to understand the nuances of shredder/compactor systems to select a system which best suits their individual needs. 4 refs., 6 figs., 10 tabs

  17. Treatment of bronchial asthma with low-level laser in attack-free period at children

    Science.gov (United States)

    Ailioaie, C.; Ailioaie, Laura

    2000-06-01

    Bronchial asthma is a common disease in both the pediatric and adult populations, characterized by wide variations over short periods of time in resistance to airflow in intrapulmonary airways. A primary goal in the use of low- level laser therapy (LLLT) was the safe, effective and rapid palliation of symptoms owing to tracheal or bronchial obstruction. We have investigated the effects of LLLT comparatively with other modality trials in children's asthma. In the study were included 98 patients aged 10-18 years diagnosed with moderate or severe asthma, in attack- free period. The patients were divided into 3 groups. Group 1 received only laser therapy using extra meridian acupuncture points and scanning technique. Group 2 was treated only with inhaled Serevent 2 X 25 micrometers , two times daily, 3 months. Group 3 was tread with Theophylline retard in dosage of 15-mg/kg/12 h, 3 months. At the end of treatment we remarked a noticeable improvement of the clinical, functional and immunological characteristics at 83 percent of patients in group 1, comparatively with only 70 percent (group 2) and 53 percent (group 3). The LLLT had a very good action on bronchial patency , displayed an immunocorrecting action and is recommended in attack-free periods at children.

  18. Capacity of textile filters for wastewater Treatment at changeable wastewater level – a hydraulic model

    Directory of Open Access Journals (Sweden)

    Marcin Spychała

    2016-12-01

    Full Text Available The aim of the study was to describe in a mathematical manner the hydraulic capacity of textile filters for wastewater treatment at changeable wastewater levels during a period between consecutive doses, taking into consideration the decisive factors for flow-conditions of filtering media. Highly changeable and slightly changeable flow-conditions tests were performed on reactors equipped with non-woven geo-textile filters. Hydraulic conductivity of filter material coupons was determined. The dry mass covering the surface and contained in internal space of filtering material was then indicated and a mathematical model was elaborated. Flow characteristics during the highly changeable flow-condition test were sensitivity to differentiated values of hydraulic conductivity in horizontal zones of filtering layer. During the slightly changeable flow-conditions experiment the differences in permeability and hydraulic conductivity of different filter (horizontal zones height regions were much smaller. The proposed modelling approach in spite of its simplicity provides a satisfactory agreement with empirical data and therefore enables to simulate the hydraulic capacity of vertically oriented textile filters. The mathematical model reflects the significant impact of the filter characteristics (textile permeability at different filter height and operational conditions (dosing frequency on the textile filters hydraulic capacity.

  19. Effects of short- and long-term risperidone treatment on prolactin levels in children with autism.

    Science.gov (United States)

    Anderson, George M; Scahill, Lawrence; McCracken, James T; McDougle, Christopher J; Aman, Michael G; Tierney, Elaine; Arnold, L Eugene; Martin, Andrés; Katsovich, Liliya; Posey, David J; Shah, Bhavik; Vitiello, Benedetto

    2007-02-15

    The effects of short- and long-term risperidone treatment on serum prolactin were assessed in children and adolescents with autism. Patients with autism (N = 101, 5-17 years of age) were randomized to an 8-week trial of risperidone or placebo and 63 then took part in a 4-month open-label follow-up phase. Serum samples were obtained at Baseline and Week-8 (N = 78), and at 6-month (N = 43) and 22-month (N = 30) follow-up. Serum prolactin was determined by immunoradiometric assay; dopamine type-2 receptor (DRD2) polymorphisms were genotyped. Baseline prolactin levels were similar in the risperidone (N = 42) and placebo (N = 36) groups (9.3 +/- 7.5 and 9.3 +/- 7.6 ng/ml, respectively). After 8 weeks of risperidone, prolactin increased to 39.0 +/- 19.2 ng/ml, compared with 10.1 +/- 8.8 ng/ml for placebo (p autism. Although risperidone-induced increases tended to diminish with time, further research on the consequences of long-term prolactin elevations in children and adolescents is needed.

  20. [Costs of appendicitis treatment by diagnosis-related groups in a third-level pediatric hospital].

    Science.gov (United States)

    Tlacuilo-Parra, Alberto; Hernández-Hernández, Araceli; Venegas-Dávalos, Martha; Gutiérrez-Hermosillo, Violeta; Guevara-Gutiérrez, Elizabeth; Ambriz-González, Gabriela

    2014-01-01

    Diagnosis-related groups (DRGs) are widely used in Europe. They allow performing comparisons in hospitals and incurrent hospital payment systems, defining the payment categories. We undertook this study to classify children who underwent appendectomy according to DRGs. Cross-sectional study. Comorbidities, length of hospitalization, histopathologic classification, and DRG classifications were analyzed. We included 313 patients, 62% males, with an average age of 8 ± 3 years; 91% were referred by another hospital and 67% were treated at night. Average length of hospitalization was 4 ± 3 days. There were comorbidities in 8% and surgical complications in 11%. According to histopathology, appendicitis was edematous (11%), suppurative (36%), gangrenous (22%), perforated (29%), and abscessed (2%). At discharge, 97% of the patients were healthy. Total cost for DRG 343 was $10,470,173.00 (Mexican pesos), DRG 342 was $1,227,592.00 and DRG 340 was $511,521.00. The global amount was $12,209,286.00 (Mexican pesos). The unitary cost for treatment of appendectomy for DRG 343 was $37,935.00, for DRG 342 was $49,103.00 and for DRG 340 was $42,626.00 (Mexican pesos). Because 88% of the cases of appendicitis were uncomplicated, this amount of money could be spent to treat these patients in a second-level hospital, using reimbursement 343 without generating additional expenses.

  1. Contemporary Directions in Theories and Psychotherapeutic Strategies in Treatment of Personality Disorders: Relation to Level of Personality Functioning

    DEFF Research Database (Denmark)

    Simonsen, Sebastian; Simonsen, Erik

    2014-01-01

    In this commentary on treatment strategies for personality disorders, we analyze each of the cases and the problem of low motivation in terms of how they fit with the Level of Personality Functioning scale. We then show how patients vary in terms of both level and breadth of pathology. Three...

  2. Communication subjective assessments of patients undergoing compulsory treatment with the severity of negative symptoms and cognitive functioning level

    Directory of Open Access Journals (Sweden)

    Kabanov T.N.

    2015-04-01

    Full Text Available The article presents the results of studies on the relationship of subjective assessments of the mentally ill with the severity of negative symptoms and cognitive functioning level. The features of patients perception of various aspects of compulsory treatment and subjective satisfaction with treatment. In a study of 94 male patients with a diagnosis of organic mental disorder and schizophrenia was used diagnostic system, consisting of patopsihologicheskogo study, formal survey map, the scale of assessment of negative symptoms SANS, questionnaire symptom levels SCL-90, self-existing problems, as well as - in Test authoring tool sheet to treatment and hospital stay (VG Bulygin, Kabanov, TN, 2011. The differences in subjective assessments of aspects of compulsory treatment and social functioning of patients with varying degrees of severity of negative symptoms and dependence of subjective assessments of the level of cognitive functioning.

  3. Dynamic changes of serum thyroid-related hormones levels after 131I treatment in patients with Graves' disease

    International Nuclear Information System (INIS)

    Zhou Feihua; Zhou Runsuo; Tong Guanghuan; Xu Haifeng

    2007-01-01

    Objective: To investigate the clinical significance of changes of serum thyroid-related hormones (FT 3 , FT 4 , TSH, TGA, TMA) after 131 I therapy in patients with Graves' disease. Methods: Serum levels of thyroid-related hormones were measured with RIA both before and 3, 6, 12 months after 131 I therapy in 92 patients with Graves' disease and once in 80 controls. Results: Se- mm FT 3 and FT 4 levels were significantly higher in the patients before treatment than those in controls. At 3 months after treatment, the levels were still much higher, but were not much different from those on controls by 6 and 12 months (P>0.05). TSH remained slightly lower than those in controls at 3 months but reached a high level at 6 months and dropped again at 12 months. Positive rate of serum TGA and TMA was 38.0% and 32.6% respectively before treatment, it dropped by 3 months, reached a peak by 6 months and dropped again to slightly lower than those before treatment but not significant. Conclusion: If FT 3 and FT 4 levels were not normal by 6 months after mi therapy, a second course of treatment might be necessary. Higher TGA and TMA levels before therapy predisposed to development of hypothyroidism afterwards. (authors)

  4. Prognostic Significance of Pre-treatment Serum C-Reactive Protein Level in Patients with Adenocarcinoma of the Uterine Cervix.

    Science.gov (United States)

    Bodner-Adler, Barbara; Kimberger, Oliver; Schneidinger, Cora; Kölbl, Heinz; Bodner, Klaus

    2016-09-01

    To evaluate pre-treatment serum C-reactive protein (CRP) level as a prognostic parameter in patients with adenocarcinoma of the uterine cervix. Pre-treatment CRP levels were analyzed to determine potential associations with clinicopathological parameters and to assess prognostic value in 46 patients with sole adenocarcinoma of the uterine cervix. The mean (±SD) pre-treatment serum CRP level was 5.82 (7.21) mg/l. Serum CRP concentration significantly correlated positively with age at diagnosis (p=0.001), lymphovascular space invasion (p=0.0026), recurrent disease (p=0.0001) and International Federation of Gynecology and Obstetrics (FIGO) stage (p=0.0002). In multivariate Cox regression models with age, FIGO stage, histological grade and lymph node status, elevated CRP and cancer antigen 125 levels were associated with shortened survival (pcervix. Copyright© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

  5. Does smoking affect gingival crevicular fluid LL-37 levels following non-surgical periodontal treatment in chronic periodontitis?

    Science.gov (United States)

    Türkoğlu, Oya; Eren, Gülnihal; Emingil, Gülnur; Azarsız, Elif; Kutukculer, Necil; Atilla, Gül

    2016-01-01

    LL-37 contributes to maintaining the balance between health and disease. Smoking is a risk factor for periodontitis that impairs neutrophil functions. The aim of the present study was to comparatively evaluate gingival crevicular fluid (GCF) LL-37 levels in smoker and non-smoker chronic periodontitis (CP) patients and controls, as well as the effect of non-surgical periodontal treatment on GCF LL-37 levels. Thirty-one CP patients (16 smokers, 15 non-smokers) and thirty-one controls (16 smokers, 15 non-smokers) were included in the study. CP patients received non-surgical treatment. GCF LL-37 levels and periodontal parameters were assessed at baseline, 1 and 3 months after completion of non-surgical periodontal treatment. GCF LL-37 levels were analyzed by ELISA. No significant difference was observed in GCF LL-37 levels between smoker and non-smoker controls (p>0.05). Smoker CP group had significantly lower GCF LL-37 level than non-smoker CP group at baseline (pnon-smoker CP group at first week, 1 and 3 months after completion of non-surgical periodontal treatment (psmoker CP group (p>0.05). Periodontal parameters were correlated with GCF LL-37 levels in non-smoker CP group (psmoker CP group (p>0.05). GCF LL-37 levels do not seem to be affected from smoking in periodontal health. However, smoking might have a suppressive effect on GCF LL-37 levels in CP. Non-surgical treatment is effective in decreasing GCF LL-37 levels in non-smoker CP patients but not in smokers with CP. Copyright © 2015. Published by Elsevier Ltd.

  6. Environmental assessment for the treatment of Class A low-level radioactive waste and mixed low-level waste generated by the West Valley Demonstration Project

    International Nuclear Information System (INIS)

    1995-11-01

    The U.S. Department of Energy (DOE) is currently evaluating low-level radioactive waste management alternatives at the West Valley Demonstration Project (WVDP) located on the Western New York Nuclear Service Center (WNYNSC) near West Valley, New York. The WVDP's mission is to vitrify high-level radioactive waste resulting from commercial fuel reprocessing operations that took place at the WNYNSC from 1966 to 1972. During the process of high-level waste vitrification, low-level radioactive waste (LLW) and mixed low-level waste (MILLW) will result and must be properly managed. It is estimated that the WVDP's LLW storage facilities will be filled to capacity in 1996. In order to provide sufficient safe storage of LLW until disposal options become available and partially fulfill requirements under the Federal Facilities Compliance Act (FFCA), the DOE is proposing to use U.S. Nuclear Regulatory Commission-licensed and permitted commercial facilities in Oak Ridge, Tennessee; Clive, Utah; and Houston, Texas to treat (volume-reduce) a limited amount of Class A LLW and MLLW generated from the WVDP. Alternatives for ultimate disposal of the West Valley LLW are currently being evaluated in an environmental impact statement. This proposed action is for a limited quantity of waste, over a limited period of time, and for treatment only; this proposal does not include disposal. The proposed action consists of sorting, repacking, and loading waste at the WVDP; transporting the waste for commercial treatment; and returning the residual waste to the WVDP for interim storage. For the purposes of this assessment, environmental impacts were quantified for a five-year operating period (1996 - 2001). Alternatives to the proposed action include no action, construction of additional on-site storage facilities, construction of a treatment facility at the WVDP comparable to commercial treatment, and off-site disposal at a commercial or DOE facility

  7. Evaluation of Blood Pressure Control Levels and Treatment Compliances of Hypertensive Patients

    Directory of Open Access Journals (Sweden)

    Cenk Aypak

    2013-04-01

    Full Text Available Purpose: The aim of the study is to evaluate the knowledge of patients about hypertension (HT, compliance with lifestyle changes and to determine their blood pressure levels under antihypertensive therapy. Method: Hypertensive patients that applied to Family medicine outpatient clinics of Diskapi Yildirim Beyazit Education and Research Hospital for the first time, in 2012 (between February 1 to April 30, were included in our cross-sectional study. Patients are evaluated primarily for the control and the factors that can affect high blood pressure and the rate on achieving treatment goals. Results: Three hundred and forty patients were included in the study. The mean age of the patients was 60.5±10.7 years and 222 of them (65.3% were female. The blood pressure was not under control in 108 (31.8% patients. The mean body weight of male patients was statistically higher than females (p=0.015. The number of the patients that knew the normal blood pressure value was 249 (73.2%. Among those 155 (62.2% were women and 179 (71.9% were younger than 65 years of age (p=0.0001. Forty one patients (12.1% were still smoking, 46 (13.5% patients were exercising regularly and 32 (9.4% were consuming regular diet. Blood pressure was better controlled in the group that was exercising regularly (p=0.001. The rate of male patients that were on regular exercise and diet, were higher than females (p=0.09. Only 86 patients (25.3% knew the name of their antihypertensive medication and 65 of patients (19.1% knew the dose of their medication. Female patients knew the name of their medication better than males (p=0.002. 156 patients (45.9% were using two kinds of antihypertensive medication. 58 patients (17.1% were skipping doses a few times a week. Conclusion: The knowledge of hypertensive patients on their illness and their compliance on non-drug treatments were inadequate. The compliance of patients should be improved by development of patient-doctor should be improved

  8. Changes of blood levels of LPO, SOD and GSH-Px after endovenous laser treatment of varicose greater saphenous vein

    International Nuclear Information System (INIS)

    Han Li'na; Gu Ying; Liu Fanguang

    2004-01-01

    Objective: To investigate the changes of the blood levels of lipid peroxide (LPO), superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) after treatment of varicose greater saphenous vein with either endovenous laser or conventional surgery (high ligation plus stripping). Methods: Thirty-seven patients with varicose greater saphenous vein were treated with endovenous laser and another 33 patients were treated with conventional surgery. Levels of LPO (serum, with TBA fluorescein), SOD (whole blood, with RIA) and GSH-Px (whole blood, with direct DTNB) were determined in these patients both before and 1, 3, 5, 7, 10, 15 days after treatment. Levels in 30 controls were also measured. Results: The levels of LPO were higher and levels of SOD, GSH-Px lower in the patients than those in the controls. After either form of therapy, the levels LPO rose and levels of SOD, GSH-Px dropped immediately but gradually approached the control values by the 15 th day (slower with SOD and GSH-Px). However, the early increase of LPO levels were less and recovery sooner in the group of patients treated with laser. Conclusion: Changes of levels of LPO, SOD and GSH-Px were closely related to the degree of stress and recovery condition after the treatment

  9. Feasibility study for private-sector treatment services for alpha-contaminated low-level mixed wastes

    International Nuclear Information System (INIS)

    Bloom, R.R.; Rodriguez, R.R.

    1995-01-01

    Rust Federal Services, under contract to the United States Department of Energy (DOE), Idaho Operations Office, performed a study to develop and evaluate the feasibility of a suggested private sector solution for the treatment of alpha-contaminated low-level mixed waste (ALLMW) stored or produced at the Idaho National Engineering Laboratory (INEL). The feasibility study is an initial step in the potential procurement of privatized treatment services for these wastes. Rust's derived objective of the feasibility study was to define an optimal treatment system and analyze the feasibility of that system for accomplishing the processing objectives specified by DOE. All aspects of the selected treatment system were addressed in the feasibility study, including technical, regulatory, public involvement, and financial considerations. Two central elements of the study were a technology screening task to select the optimal treatment system and an analysis of the institutional, business, financial, and contractual issues that are likely to accompany the privatization of treatment services for DOE

  10. HIGH ALUMINUM HLW (HIGH LEVEL WASTE) GLASSES FOR HANFORD'S WTP (WASTE TREATMENT PROJECT)

    International Nuclear Information System (INIS)

    Kruger, A.A.; Bowan, B.W.; Joseph, I.; Gan, H.; Kot, W.K.; Matlack, K.S.; Pegg, I.L.

    2010-01-01

    This paper presents the results of glass formulation development and melter testing to identify high waste loading glasses to treat high-Al high level waste (HLW) at Hanford. Previous glass formulations developed for this HLW had high waste loadings but their processing rates were lower that desired. The present work was aimed at improving the glass processing rate while maintaining high waste loadings. Glass formulations were designed, prepared at crucible-scale and characterized to determine their properties relevant to processing and product quality. Glass formulations that met these requirements were screened for melt rates using small-scale tests. The small-scale melt rate screening included vertical gradient furnace (VGF) and direct feed consumption (DFC) melter tests. Based on the results of these tests, modified glass formulations were developed and selected for larger scale melter tests to determine their processing rate. Melter tests were conducted on the DuraMelter 100 (DMIOO) with a melt surface area of 0.11 m 2 and the DuraMelter 1200 (DMI200) HLW Pilot Melter with a melt surface area of 1.2 m 2 . The newly developed glass formulations had waste loadings as high as 50 wt%, with corresponding Al 2 O 3 concentration in the glass of 26.63 wt%. The new glass formulations showed glass production rates as high as 1900 kg/(m 2 .day) under nominal melter operating conditions. The demonstrated glass production rates are much higher than the current requirement of 800 kg/(m 2 .day) and anticipated future enhanced Hanford Tank Waste Treatment and Immobilization Plant (WTP) requirement of 1000 kg/(m 2 .day).

  11. REMARKS ON THE ACCOUNTING TREATMENT OF GOODWILL AT THE LEVEL OF BLOCKS OF TRADING COMPANIES

    Directory of Open Access Journals (Sweden)

    Violeta Isai

    2015-05-01

    Full Text Available This paper presents the accounting treatment of goodwill, namely, its recognition, assessment and accounting, as part of the patrimonial assets of an economic entity. Specific, due to its structure, to any blocks of companies, the goodwill represents the cost surplus of an active block to the market value of the net purchased assets. Why would anyone pay for a company more than its actual accounting worth? Because the extra price is usually attributed to those intangible elements that cannot be assessed separately but whose horizon of expectation is usually related to prospective economic advantages such as the clientele, the top commercial location, the employees' level of training, market shares, good relationships with the employees, the suppliers, the banks etc. Many of the Romanian economic entities were sold at a price that was inferior to their accounting value because, following their assessment, the experts were able to ascertain the following: the existence of fixed assets that needed to be scrapped; the existence of stocks that were either depreciated or difficult to sell; the existence of outstanding debts that were either uncertain of lost for good; the existence of major debts carrying interest. The effect of such assessments led to a reduced marked value of all assets and an increased market value of the debts, or in other words, the possibility of a badwill occurrence. The relationship goodwill – badwill, specific to the blocks of trading companies, represents a current challenge in the recognition and evaluation of the goodwill in compliance with the current Romanian legislation as harmonized with the international accountancy standards.

  12. [Clinical significance of calcitonin gene-related peptide level before and after treatment in patients with chronic periodontitis].

    Science.gov (United States)

    Yan, Ying; Xiang, Xue-Rong; Wang, Chun; Ye, Guo; Fan, Xiao-Ping

    2016-08-01

    To explore the clinical significance of calcitonin gene-related peptide (CGRP) levels in patients with chronic periodontitis before and after treatment, and to detect the calcitonin gene-related peptide content in human venous blood. Thirty healthy controls and thirty patients with mild, moderate, severe periodontitis were enrolled from August 2014 to June 2015.CGRP level in the patients' peripheral blood was detected by ELISA. Three months after periodontal treatment, CGRP level in mild, moderate, severe periodontitis patients' peripheral blood was re-examined by ELISA. Then the correlation between calcitonin gene-related peptide and inflammation of chronic periodontitis was analyzed with SPSS 22.0 software package. The content of CGRP in healthy controls was significantly higher than that in patients with periodontitis. With the aggravation of periodontal inflammation, blood level of CGRP decreased gradually, and the lowest was in patients with severe periodontitis (Pperiodontal treatment, CGRP content was significantly higher compared with that before treatment (Pperiodontitis (P>0.05). The level of CGRP in venous blood decreased with the increasing severity of chronic periodontitis, and CGRP was negatively correlated with the degree of inflammation of chronic periodontitis. CGRP may be involved in the occurrence and development of chronic periodontitis. CGRP content in serum of patients with chronic periodontitis after treatment was significantly increased, CGRP may be used as the basis for clinical detection of chronic periodontitis.

  13. An assessment of individual-level factors associated with alcohol treatment utilization among Mexican Americans.

    Science.gov (United States)

    Reingle Gonzalez, Jennifer M; Caetano, Raul; Mills, Britain A; Vaeth, Patrice A C

    2014-01-01

    The purpose of this study is to identify enabling factors for treatment utilization for alcohol-related problems, and to evaluate how enabling factors vary by need for treatment, among two samples of Mexican American adults. These two distinct samples included 2,595 current and former drinkers (one sample included 787 U.S./Mexico border residents; the other sample included 740 Mexican Americans living in U.S. cities not proximal to the border). Need for treatment (alcohol disorder severity) and (male) gender were the primary correlates of treatment utilization; and there was no moderation in the enabling factors by need for treatment as "enablers" of utilization. Further theoretical and empirical research is necessary to determine which mechanisms are driving disparities in treatment utilization across racial/ethnic groups generally, and Hispanic national groups specifically. Copyright © 2014 Elsevier Inc. All rights reserved.

  14. Mixed and Low-Level Treatment Facility Project. Appendix B, Waste stream engineering files, Part 1, Mixed waste streams

    Energy Technology Data Exchange (ETDEWEB)

    1992-04-01

    This appendix contains the mixed and low-level waste engineering design files (EDFS) documenting each low-level and mixed waste stream investigated during preengineering studies for Mixed and Low-Level Waste Treatment Facility Project. The EDFs provide background information on mixed and low-level waste generated at the Idaho National Engineering Laboratory. They identify, characterize, and provide treatment strategies for the waste streams. Mixed waste is waste containing both radioactive and hazardous components as defined by the Atomic Energy Act and the Resource Conservation and Recovery Act, respectively. Low-level waste is waste that contains radioactivity and is not classified as high-level waste, transuranic waste, spent nuclear fuel, or 11e(2) byproduct material as defined by DOE 5820.2A. Test specimens of fissionable material irradiated for research and development only, and not for the production of power or plutonium, may be classified as low-level waste, provided the concentration of transuranic is less than 100 nCi/g. This appendix is a tool that clarifies presentation format for the EDFS. The EDFs contain waste stream characterization data and potential treatment strategies that will facilitate system tradeoff studies and conceptual design development. A total of 43 mixed waste and 55 low-level waste EDFs are provided.

  15. C-reactive protein levels and treatment resistance in schizophrenia - A Danish population-based cohort study

    DEFF Research Database (Denmark)

    Horsdal, Henriette Thisted; Wimberley, Theresa; Benros, Michael Eriksen

    2017-01-01

    -time schizophrenia diagnosis and a baseline C-reactive protein measurement (a commonly available marker of systemic inflammation) from 2000 to 2012. We defined treatment resistance as the earliest observed instance of either clozapine initiation or hospital admission due to schizophrenia after having received......OBJECTIVE: Schizophrenia is associated with increased levels of inflammatory markers. However, it remains unclear whether inflammatory markers are associated with treatment-resistant schizophrenia. METHODS: We conducted a population-based follow-up study among individuals with a first...... (4.0 vs. 3.1 mg/L, p = .13) was observed among the 52 (13.3%) treatment-resistant individuals. Increased levels of C-reactive protein (above 3 mg/L) at baseline were not associated with treatment resistance (adjusted hazard ratio = 0.99, 95% confidence interval [0.56, 1.73]). CONCLUSIONS: C...

  16. Lipid profile and levels of homocysteine, leptin, fibrinogen and C-reactive protein in hyperthyroid patients before and after treatment

    Directory of Open Access Journals (Sweden)

    Emine Sütken

    2010-03-01

    Full Text Available Objectives: The present study was carried out to determine whether thyroid hormones affect lipid profile and levels of erithrocyte sedimentation rate (ESR, serum total homocysteine (t-hcy, leptin, fibrinogen, C-reactive protein (CRP in patients with hyperthyroidism.Materials and methods: This study was carried out on 23 hyperthroid subjects (3 men / 20 women, mean age 41.8 ± 2.4 years. Serum levels of homocysteine, leptin, fibrinogen, CRP, total cholesterol (TC, high-density lipoprotein cholesterol (HDL-C, low-density lipoprotein cholesterol (LDL-C and ESR were measured and body mass index (BMI were calculated before and after treatment of hyperthyroidism.Results: Pretreatment t-hcy, TC, LDL-C, HDL-C levels and BMI of patients were significantly lower than those of the post-treatment (p<0.001, for each variable. However, fibrinogen and ESR decreased after the treatment (p<0.001 and p<0.05, respectively. There were no differences in leptin and CRP levels between pre- and post-treatment periods. Pre and post treatment TC and LDL-C levels were negatively correlated with free triiodothyronine (fT3 levels (r=-0.588, p<0.01; r=-0.534, p<0.01; r=-0.543, p<0.01 and r =-0.653, p<0.01, respectively. Pre-treatment HDL-C was inversely correlated with TSH (r=-0.423, p<0.05. Pre-post- treatment LDL-C was negatively correlated with free thyroxine (fT4 levels (r=-0.536, p<0.001 and r=- 0.422, p<0.05 respectively. Pre-treatment TC was inversely correlated with fT4 (r=-0.590, p<0.01.Conclusion: Hyperthyroidism is associated with high plasma fibrinogen and ESR levels. Elevated plasma fibrinogen and ESR levels may be a possible explanation for the high cardiovascular morbidity among hyperthyroidic subjects. These changes may reflect low-grade inflammation or disturbances in coagulation in hyperthyroidism.

  17. Plaque, caries level and oral hygiene habits in young patients receiving orthodontic treatment

    DEFF Research Database (Denmark)

    Martignon, S; Ekstrand, K R; Lemos, M I

    2010-01-01

    To assess plaque, caries, and oral hygiene habits amongst patients receiving fixed-orthodontic treatment at the Dental-Clinic, Universidad-El-Bosque, Bogotá, Colombia.......To assess plaque, caries, and oral hygiene habits amongst patients receiving fixed-orthodontic treatment at the Dental-Clinic, Universidad-El-Bosque, Bogotá, Colombia....

  18. Design and operational experience of the centre for the collection treatment and storage of low level radioactive wastes

    International Nuclear Information System (INIS)

    Zorrilla, S.

    1986-01-01

    The activities of the Centre for Collection, Treatment and Storage of Low-Level Radioactive Wastes (CRTADRBN) are presented. The objective of this centre is the final storage of radioactive waste and radiation sources generated by medicine, industry teaching and research. Safety, storage capacity and economy are considered in the design. The types of treatment for liquid wastes are described and the containement system is specified. (M.C.K.) [pt

  19. Metagenomics shows that low-energy anaerobic-aerobic treatment reactors reduce antibiotic resistance gene levels from domestic wastewater.

    Science.gov (United States)

    Christgen, Beate; Yang, Ying; Ahammad, S Z; Li, Bing; Rodriquez, D Catalina; Zhang, Tong; Graham, David W

    2015-02-17

    Effective domestic wastewater treatment is among our primary defenses against the dissemination of infectious waterborne disease. However, reducing the amount of energy used in treatment processes has become essential for the future. One low-energy treatment option is anaerobic-aerobic sequence (AAS) bioreactors, which use an anaerobic pretreatment step (e.g., anaerobic hybrid reactors) to reduce carbon levels, followed by some form of aerobic treatment. Although AAS is common in warm climates, it is not known how its compares to other treatment options relative to disease transmission, including its influence on antibiotic resistance (AR) in treated effluents. Here, we used metagenomic approaches to contrast the fate of antibiotic-resistant genes (ARG) in anaerobic, aerobic, and AAS bioreactors treating domestic wastewater. Five reactor configurations were monitored for 6 months, and treatment performance, energy use, and ARG abundance and diversity were compared in influents and effluents. AAS and aerobic reactors were superior to anaerobic units in reducing ARG-like sequence abundances, with effluent ARG levels of 29, 34, and 74 ppm (198 ppm influent), respectively. AAS and aerobic systems especially reduced aminoglycoside, tetracycline, and β-lactam ARG levels relative to anaerobic units, although 63 persistent ARG subtypes were detected in effluents from all systems (of 234 assessed). Sulfonamide and chloramphenicol ARG levels were largely unaffected by treatment, whereas a broad shift from target-specific ARGs to ARGs associated with multi-drug resistance was seen across influents and effluents. AAS reactors show promise for future applications because they can reduce more ARGs for less energy (32% less energy here), but all three treatment options have limitations and need further study.

  20. Level of agreement among Latin American glaucoma subspecialists on the diagnosis and treatment of glaucoma: results of an online survey

    OpenAIRE

    Daniel E. Grigera; Paulo Augusto Arruda Mello; Wilma Lelis Barbosa; Javier Fernando Casiraghi; Rodolfo Perez Grossmann; Alejo Peyret

    2013-01-01

    PURPOSE: The aim of this research was to assess the level of agreement among glaucoma experts in Latin America on key practices related to treatment and diagnosis of glaucoma. METHODS: An online questionnaire was sent to a multinational panel of glaucoma experts. The questionnaire contained 107 statements on the medical treatment (Part 1) and diagnosis (Part 2) of glaucoma, and was developed in Spanish and translated into English. Agreement was defined as >70% of respondents. RESULTS: Fifty p...

  1. Effect of switching to risperidone after unsuccessful treatment with aripiprazole on plasma monoamine metabolites level in the treatment of acute schizophrenia.

    Science.gov (United States)

    Miura, Itaru; Takeuchi, Satoshi; Katsumi, Akihiko; Kanno, Keiko; Watanabe, Kenya; Mashiko, Hirobumi; Niwa, Shin-Ichi

    2012-09-01

    In the treatment of acute schizophrenia, risperidone and aripiprazole are both placed the first line antipsychotics. These two antipsychotics have different pharmacological effects. We investigated the effects of risperidone on plasma levels of homovanillic acid (HVA) and 3-methoxy-4hydroxyphenylglycol after unsuccessful aripiprazole treatment in acute schizophrenia. Ten Japanese patients with acute schizophrenia were enrolled to this study. Plasma levels of monoamine metabolites were analyzed with high-performance liquid chromatography with electrochemical detection. Risperidone improved the symptoms and 4 of 10 patients were responders. Risperidone showed a tendency to decrease plasma HVA (pHVA) levels in responders (p = 0.068), but not in non-responders (p = 1.0). At baseline, pHVA levels of responders were significantly higher than that of non-responders (p = 0.033). A trend for negative correlation was found between pHVA at baseline and the changes in Positive and Negative Syndrome Scale-Total (p = 0.061, r = -0.61). Our results suggest that high pHVA level before switching may predict good response to the second line antipsychotics after unsuccessful first antipsychotic treatment. If aripiprazole is not effective in acute schizophrenia, switching to risperidone may be effective and reasonable strategy for improving symptoms. Copyright © 2012 John Wiley & Sons, Ltd.

  2. Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes

    DEFF Research Database (Denmark)

    Lund, S.S.; Tarnow, L.; Astrup, A.S.

    2009-01-01

    BACKGROUND: In addition to its glucose-lowering effect, metformin treatment has been suggested to improve lipidaemia in patients with type 2 diabetes. In contrast, in patients with type 1 diabetes (T1DM), information about the effect of metformin treatment on lipidaemia is limited. In this study......, we report the effect of a 1-year treatment with metformin vs. placebo on plasma lipids in T1DM patients and persistent poor glycaemic control. METHODS: One hundred T1DM patients with haemoglobinA(1c) (HbA(1c)) > or =8.5% during the year before enrolment entered a 1-month run-in period on placebo...... treatment. Thereafter, patients were randomized (baseline) to treatment with either metformin (1000 mg twice daily) or placebo for 12 months (double masked). Patients continued ongoing insulin therapy and their usual outpatient clinical care. Outcomes were assessed at baseline and after 1 year. RESULTS...

  3. Changes in urinary Cu, Zn, and Se levels in cancer patients after treatment with Sha Shen Mai Men Dong Tang

    Directory of Open Access Journals (Sweden)

    Tung-Yuan Lai

    2016-04-01

    Full Text Available Sha Shen Mai Men Dong Tang (SMD-2; 沙參麥冬湯 shā shēn mài dōng tāng is a Chinese medicinal herb (CMH; 中草藥 zhōng cǎo yào used to treat symptoms associated with cancer therapy. The objective of this study was to assess the effect of SMD-2 on the levels of urinary copper (Cu, zinc (Zn, and selenium (Se in lung cancer patients and head and neck cancer patients receiving chemoradiotherapy. Forty-two head and neck cancer patients and 10 lung cancer patients participated in our clinical trial. Each patient received chemoradiotherapy for 4 weeks. In addition, each patient was treated with SMD-2 for 8 weeks, including 2 weeks prior to and after the chemoradiotherapy treatment. Comparison of urinary Cu, Zn, and Se levels and the ratios of Zn to Cu and Se to Cu at three time points in the two types of cancer were assessed using the generalized estimating equations (GEEs. After the patients received chemoradiotherapy for 4 weeks, SMD-2 treatment was found to be associated with a significant decrease in urinary Cu levels, whereas urinary Zn and Se levels increased significantly. In addition, the ratios of Zn to Cu and Se to Cu in the urine samples of these patients also increased significantly. Both the urinary Zn levels and the ratio of Zn to Cu in head and neck cancer patients were significantly higher than in lung cancer patients. Urinary Zn and Se levels and the ratios of Zn to Cu and Se to Cu, but not urinary Cu levels, increased significantly during and after treatment when assessed using the GEE model. The SMD-2 treatments significantly increased Zn and Se levels in the urine of head and neck cancer patients. Increased Zn and Se levels in urine strengthened immune system.

  4. Treatment response in Kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin G.

    Science.gov (United States)

    Ogata, Shohei; Shimizu, Chisato; Franco, Alessandra; Touma, Ranim; Kanegaye, John T; Choudhury, Biswa P; Naidu, Natasha N; Kanda, Yutaka; Hoang, Long T; Hibberd, Martin L; Tremoulet, Adriana H; Varki, Ajit; Burns, Jane C

    2013-01-01

    Although intravenous immunoglobulin (IVIG) is highly effective in Kawasaki disease (KD), mechanisms are not understood and 10-20% of patients are treatment-resistant, manifesting a higher rate of coronary artery aneurysms. Murine models suggest that α2-6-linked sialic acid (α2-6Sia) content of IVIG is critical for suppressing inflammation. However, pro-inflammatory states also up-regulate endogenous levels of β-galactoside:α2-6 sialyltransferase-I (ST6Gal-I), the enzyme that catalyzes addition of α2-6Sias to N-glycans. We asked whether IVIG failures correlated with levels of α2-6Sia on infused IVIG or on the patient's own endogenous IgG. We quantified levels of α2-6Sia in infused IVIG and endogenous IgG from 10 IVIG-responsive and 10 resistant KD subjects using multiple approaches. Transcript levels of ST6GAL1, in patient whole blood and B cell lines were evaluated by RT-PCR. Plasma soluble (s)ST6Gal-I levels were measured by ELISA. There was no consistent difference in median sialylation levels of infused IVIG between groups. However, α2-6Sia levels in endogenous IgG, ST6GAL1 transcript levels, and ST6Gal-I protein in serum from IVIG-resistant KD subjects were lower than in responsive subjects at both pre-treatment and one-year time points (p treatment response in KD. Rather, lower sialylation of endogenous IgG and lower blood levels of ST6GALI mRNA and ST6Gal-I enzyme predict therapy resistance. These differences were stable over time, suggesting a genetic basis. Because IVIG-resistance increases risk of coronary artery aneurysms, our findings have important implications for the identification and treatment of such individuals.

  5. Research and development on low level liquid waste treatment in Thailand

    International Nuclear Information System (INIS)

    Yamkate, P.; Sinakhom, F.; Punnachaiya, M.; Chantaraprachoom, N.; Srisorn, S.

    1996-01-01

    The studies have been directed towards several subjects concerning the treatment technologies of low level waste. The simple physico-chemical method has been studied for applying to many kind of waste streams such as reactor waste, isotope production waste and liquid waste from the hospital. The characterization of inorganic ion-exchangers including the effect of pH, equilibrium time, temperature and concentration of such ion-exchangers were tested and the optimum condition of the sorption of C x on the exchangers are reported. The results from the investigation on the efficiencies of detergents in the radioactive decontamination reveal that the local simple brand machine-washed detergents. which is very cheap, can be best used as the decontaminating agent instead of the more expensive imported one. It is found that chemical precipitation methods i.e. phosphate coagulation, copper ferrocyanide coagulation and cobalt precipitation method can be used for treating of the waste stream arising successfully. In considering of the immobilizing process of treated waste, cementation is advised to be used and, therefore, subjects to be evaluated. The basic properties of cement-waste products as well the leachability of a particular types of sludge waste at 15-40% waste loading were investigated. The result reveals that, cement waste forms of inorganic ion-exchanger and of sludge waste from chemical precipitation of decontamination waste, exhibit high compressive strength and a low leach rates. The compressive strength of 118-207 Kg/cm 2 were found for the optimum waste products originated from various exchangers and 15-20% loading of sludge waste. The leachability of Co-60, Cs-134 and Sr-85 from 15-40% loading of cement waste for 30 days were studied. The cumulative fraction leached rate of Cs-134 from sludge-cement wastes was found to be about 17 x 10 - 3 g/cm 2 for 25 degree C and 50 degree C at 30 days leaching time respectively, while there were no leaching of Sr-85 and

  6. The Effect of Fertilizer Treatments at Three Compactness Levels on Qualitative Traits of Sport Lawn in Winter Season

    Directory of Open Access Journals (Sweden)

    Soheila Javahery

    2012-01-01

    Full Text Available Lawn quality, which introduces by good color, density, uniformity and texture varies depending on the species, maintenance operation, and time of the year. In the current study, the effect of organic fertilizers containing Leaf Mold (LM, Rice Husk (RH, manure, Spent Mushroom Compost (SMC, a mixture of LM, RH and SMC (mixture 1, a mixture of LM, RH and manure (mixture 2, with the ratio of 1:1:1 and control (no fertilizer at three levels of soil compactness including roller weights of 36, 56, 76 kilograms on qualitative traits of sport lawn were investigated in winter season. Treatments were applied in a strip plot design with three replications, in research farm of Gorgan University of Agricultural Sciences and Natural Resources during fall 2008-2009. According to achieved results, manure and RH treatments in first and second compaction and manure treatment in third compaction level showed the highest amount of chlorophyll content. In visual assessment, the highest and lowest of lawn quality was observed in the manure and the control treatment respectively. In first and second compaction, the maximum height was observed in manure treatment. Control and LM treatments showed the minimum height. In third compaction, maximum and minimum heights were associated with manure and control treatment respectively.

  7. The motivation paradox: higher psychosocial problem levels in severely mentally ill patients are associated with less motivation for treatment.

    Science.gov (United States)

    Mulder, Cornelis L; Jochems, E; Kortrijk, H E

    2014-04-01

    Lack of motivation for treatment makes a subgroup of patients with severe mental illness (SMI) difficult to engage in psychiatric treatment. Such difficult-to-engage patients may also be the most in need of treatment. We hypothesized that the level of psychosocial problems would be inversely related to motivation for treatment. Cross-sectional study in two independent samples. The first sample (n = 294) included SMI patients who participated in a randomized controlled trial and were assessed using the Health of the Nation Outcome Scales (HoNOS) and self-rated and clinician-rated motivation-for-treatment scales. The second sample (n = 1,170) included SMI patients who were treated in Assertive Outreach Teams and were routinely assessed with the HoNOS and a motivation-for-treatment scale. In both samples, patients also self-rated their quality of life. In both samples, patients with HoNOS scores of 16 and higher had lower motivation scores on all motivation scales than patients with lower HoNOS scores, and also a lower quality of life. A motivation paradox seems inherent to this association between higher psychosocial problems levels, less motivation for treatment, and lower quality of life. Such a paradox has clinical relevance, as it may provide an ethical basis for outreach services which aim to engage marginally motivated SMI patients with severe psychosocial problems into mental health care.

  8. Development of plasma melting technology for treatment of low level radioactive waste. Pt. 9. Treatment method for combustible wastes

    International Nuclear Information System (INIS)

    Yasui, Shinji; Adachi, Kazuo; Amakawa, Masashi

    1996-01-01

    This paper describes the incineration method for the miscellaneous solid waste containing the low level radioactive combustibles (wood, PE, PVC) in a plasma furnace. The maximum weights of the respective combustibles to be fed into the plasma furnace and the incineration conditions for continuous feeding of the respective combustibles were examined experimentally. As a result, a experimental equation which expresses the maximum weights of the respective combustibles to be fed in reference to the residence time in the plasma furnace was obtained by using apparent reaction rate constants. Furthermore, a calculation method for the feeding intervals in reference to the weights of the combustibles fed each time was obtained for the continuous feeding in the plasma furnace, and the method was found to be consistent with experimental results. (author)

  9. Mixed and low-level waste treatment project: Appendix C, Health and safety criteria for the mixed and low-level waste treatment facility at the Idaho National Engineering Laboratory

    International Nuclear Information System (INIS)

    Neupauer, R.M.; Thurmond, S.M.

    1992-09-01

    This report describes health and safety concerns associated with the Mixed and Low-level Waste Treatment Facility at the Idaho National Engineering Laboratory. Various hazards are described such as fire, electrical, explosions, reactivity, temperature, and radiation hazards, as well as the potential for accidental spills, exposure to toxic materials, and other general safety concerns

  10. Mixed and low-level waste treatment project: Appendix C, Health and safety criteria for the mixed and low-level waste treatment facility at the Idaho National Engineering Laboratory

    Energy Technology Data Exchange (ETDEWEB)

    Neupauer, R.M.; Thurmond, S.M.

    1992-09-01

    This report describes health and safety concerns associated with the Mixed and Low-level Waste Treatment Facility at the Idaho National Engineering Laboratory. Various hazards are described such as fire, electrical, explosions, reactivity, temperature, and radiation hazards, as well as the potential for accidental spills, exposure to toxic materials, and other general safety concerns.

  11. Conceptual Evaluation for the Installation of Treatment Capability for Mixed Low-Level Waste at the Nevada National Security Site

    International Nuclear Information System (INIS)

    2010-01-01

    National Security Technologies, LLC, initiated an evaluation of treatment technologies that they would manage and operate as part of the mixed low-level waste (MLLW) disposal facilities at the Nevada National Security Site (NNSS). The NNSS Disposal Facility has been receiving radioactive waste from the U.S. Department of Energy (DOE) complex since the 1960s, and since 2005 the NNSS Disposal Facility has been receiving radioactive and MLLW for disposal only. In accordance with the Resource Conservation and Recovery Act (RCRA), all mixed waste must meet land disposal restrictions (LDRs) prior to disposal. Compliance with LDRs is attained through treatment of the waste to mitigate the characteristics of the listed waste hazard. Presently, most generators utilize commercial capacity for waste treatment prior to shipment to the NNSS Disposal Facility. The objectives of this evaluation are to provide a conceptual study of waste treatment needs (i.e., demand), identify potential waste treatment technologies to meet demand, and analyze implementation considerations for initiating MLLW treatment capacity at the NNSS Disposal Facility. A review of DOE complex waste generation forecast data indicates that current and future Departmental demand for mixed waste treatment capacity will remain steady and strong. Analysis and screening of over 30 treatment technologies narrowed the field of treatment technologies to four: (1) Macroencapsulation; (2) Stabilization/microencapsulation; (3) Sort and segregation; and (4) Bench-scale mercury amalgamation. The analysis of treatment technologies also considered existing permits, current the NNSS Disposal Facility infrastructure such as utilities and procedures, and past experiences such as green-light and red-light lessons learned. A schedule duration estimate has been developed for permitting, design, and construction of onsite treatment capability at the NNSS Disposal Facility. Treatment capability can be ready in 20 months.

  12. Conceptual Evaluation for the Installation of Treatment Capability for Mixed Low Level Waste at the Nevada National Security Site

    Energy Technology Data Exchange (ETDEWEB)

    NSTec Environmental Management

    2010-11-24

    National Security Technologies, LLC, initiated an evaluation of treatment technologies that they would manage and operate as part of the mixed low-level waste (MLLW) disposal facilities at the Nevada National Security Site (NNSS). The NNSS Disposal Facility has been receiving radioactive waste from the U.S. Department of Energy (DOE) complex since the 1960s, and since 2005 the NNSS Disposal Facility has been receiving radioactive and MLLW for disposal only. In accordance with the Resource Conservation and Recovery Act (RCRA), all mixed waste must meet land disposal restrictions (LDRs) prior to disposal. Compliance with LDRs is attained through treatment of the waste to mitigate the characteristics of the listed waste hazard. Presently, most generators utilize commercial capacity for waste treatment prior to shipment to the NNSS Disposal Facility. The objectives of this evaluation are to provide a conceptual study of waste treatment needs (i.e., demand), identify potential waste treatment technologies to meet demand, and analyze implementation considerations for initiating MLLW treatment capacity at the NNSS Disposal Facility. A review of DOE complex waste generation forecast data indicates that current and future Departmental demand for mixed waste treatment capacity will remain steady and strong. Analysis and screening of over 30 treatment technologies narrowed the field of treatment technologies to four: • Macroencapsulation • Stabilization/microencapsulation • Sort and segregation • Bench-scale mercury amalgamation The analysis of treatment technologies also considered existing permits, current the NNSS Disposal Facility infrastructure such as utilities and procedures, and past experiences such as green-light and red-light lessons learned. A schedule duration estimate has been developed for permitting, design, and construction of onsite treatment capability at the NNSS Disposal Facility. Treatment capability can be ready in 20 months.

  13. Treatment of renal osteopathy by Rocaltrol, with special reference to parathormone levels and X-ray examinations

    Energy Technology Data Exchange (ETDEWEB)

    Schmitt, R.L.

    The effects of treatment of renal osteopathy with 1.25 (OH)/sub 2/D/sub 3/ was evaluated in 24 chronic hemodialysis patients. The best results of treatment were displayed in patients in whom 1.25 (OH)/sub 2/D/sub 3/ determined only a slow rise in plasma calcium levels. In these patients iPTH, alkaline phosphatase levels, and osteoblast counts in bone biopsies were initially high. Definite improvement of bone resorption was found on X-ray examination. In contrast in patients with low iPTH, low alkaline phosphatase levels, and low osteoblast counts, administration of 1.25 (OH)/sub 2/D/sub 3/ determined a fast rise of plasma calcium levels. No X-ray modifications could be detected.

  14. Treatment of renal osteopathy by Rocaltrol, with special reference to parathormone levels and X-ray examinations

    International Nuclear Information System (INIS)

    Schmitt, R.L.

    1981-01-01

    The effects of treatment of renal osteopathy with 1.25 (OH) 2 D 3 was evaluated in 24 chronic hemodialysis patients. The best results of treatment were displayed in patients in whom 1.25 (OH) 2 D 3 determined only a slow rise in plasma calcium levels. In these patients iPTH, alkaline phosphatase levels, and osteoblast counts in bone biopsies were initially high. Definite improvement of bone resorption was found on X-ray examination. In contrast in patients with low iPTH, low alkaline phosphatase levels, and low osteoblast counts, administration of 1.25 (OH) 2 D 3 determined a fast rise of plasma calcium levels. No X-ray modifications could be detected. (orig.) [de

  15. Clinical significance of changes of serum Hcy and IGF-I levels after treatment in patients with acute cerebral infarction

    International Nuclear Information System (INIS)

    Wang Yuezhou

    2011-01-01

    Objective: To investigate the clinical significance of serum Hcy and IGF-I levels in patients with acute cerebral infarction. Methods: Serum IGF-I (with RIA), Hcy (with ELISA)levels were measured in 32 patients with acute cerebral infarction both before and after treatment as well as in 35 normal controls. Results: Before treatment, the serum Hcy level was remarkably higher than that in controls (P 0.05). Conclusion: The level of Hcy increased and IGF-I decreased in the patients with acute cerebral infarction which closely to the severity of acute cerebral infarction and may be taken as a sensitive biochemical indicator for predicting pathogenesis and progress of ACI. (authors)

  16. Etiological periodontal treatment with and without low-level laser therapy on IL-1β level in gingival crevicular fluid: an in vivo multicentric pilot study.

    Science.gov (United States)

    Mastrangelo, F; Dedola, A; Cattoni, F; Ferrini, F; Bova, F; Tatullo, M; Gherlone, E; Lo Muzio, L

    2018-01-01

    Cytokine proteins may have important roles during different human physiological and pathological processes. In the oral cavity, the bone loss and periodontal tissue pathology was related to inflammatory process activation. The aim of the present study was to assess the effects of etiological periodontal therapy with and without the use of Low Level Laser Therapy (LLLT) on clinical periodontal parameters and interleukin (IL)-1β level in gingival crevicular fluid (GCF) from chronic periodontitis (CP) patients. Thirty non-smoker CP patients were selected from the Foggia University Dental Clinic and other 2 private dental clinics. All patients were divided into two homogeneous randomized groups: 15 patients were treated with only scaling and root planing (group 1) and 15 patients with scaling and root planing etiological treatment and LLLT (group 2). In all sites, at baseline before treatment, the periodontal pocket depth (PPD) and bleeding on probing (BOP) were measured. In the PPD sites, the GCF samples were collected from 30 deep (≥5 mm) and shallow (≤3 mm) sites and IL-1β were evaluated at baseline, after 10 days and 1 month. In all the samples at baseline, the IL-1β concentration in GCF and BOP rate were significantly higher at deep PPD sites than at the shallow ones. After 10 days in all samples no PPD improvement was observed in the BOP rate but the IL-1 β level was statistically significantly improved (pdeep PPD sites, PPD and BOP improvements were observed. At same time, IL-1β levels were lower and statistically significantly (pdeep PPD sites with or with-out associated LLLT promotes periodontal health. Etiological treatment associated with LLLT, improves BOP and inflammation in periodontal disease. Moreover, the IL-1β concentration changes in GCF suggest these cytokines as a predictable marker of gingival inflammation in chronic periodontitis patients.

  17. Evaluation of waste treatment technologies by LLWDDD [Low-Level Waste Disposal Development and Demonstration] Programs

    International Nuclear Information System (INIS)

    Kennerly, J.M.; Williams, L.C.; Dole, L.R.; Genung, R.K.

    1987-01-01

    Waste treatments are divided into four categories: (1) volume reduction; (2) conditioning to improve waste form performance; (3) segregation to achieve waste reduction; and (4) separation to remove radioactive (or hazardous) constituents. Two waste treatment demonstrations are described. In the first, volume reduction by mechanical means was achieved during the supercompaction of 300 55-gal drums of solid waste at ORNL. In the second demonstration, conditioning of waste through immobilization and packaging to improve the performance of the waste form is being evaluated. The final section of this paper describes potential scenarios for the management of uranium-contaminated wastes at the Y-12 Plant in Oak Ridge and emphasizes where demonstrations of treatment technology will be needed to implement the scenarios. Separation and thermal treatment are identified as the principal means for treating these wastes. 15 figs

  18. Serum NT-proCNP levels increased after initiation of GH treatment in patients with achondroplasia/hypochondroplasia.

    Science.gov (United States)

    Kubota, Takuo; Wang, Wei; Miura, Kohji; Nakayama, Hirofumi; Yamamoto, Keiko; Fujiwara, Makoto; Ohata, Yasuhisa; Tachibana, Makiko; Kitaoka, Taichi; Takakuwa, Satoshi; Miyoshi, Yoko; Namba, Noriyuki; Ozono, Keiichi

    2016-06-01

    Serum amino-terminal propeptide of C-type natriuretic peptide (NT-proCNP) levels have been proposed as a biomarker of linear growth in healthy children. The usefulness of NT-proCNP in patients with achondroplasia (ACH)/hypochondroplasia (HCH) remains to be elucidated. The objective was to study whether serum NT-proCNP level is a good biomarker for growth in ACH/HCH and other patients of short stature. This was a longitudinal cohort study. Sixteen children with ACH (aged 0·4-4·3 years), six children with HCH (2·7-6·3 years), 23 children with idiopathic short stature (ISS) (2·2-9·0 years), eight short children with GH deficiency (GHD) (2·9-6·8 years) and five short children born small for gestational age (SGA) (2·0-6·6 years). Patients with ACH/HCH received GH treatment for 1 year. Serum NT-proCNP levels and height were measured. NT-proCNP levels positively correlated with height velocity in these short children (P < 0·05, r = 0·27). NT-proCNP levels inversely correlated with age in children with ISS alone (P < 0·01, r = -0·55). Serum NT-proCNP levels in patients with ACH/HCH were increased 3 months following the initiation of GH treatment (P < 0·05). Height SDS gain during GH treatment for 1 year was positively correlated with the changes in NT-proCNP levels after the initiation of GH (P < 0·01, r = 0·72). Serum NT-proCNP levels may be a good biomarker to indicate the effect of GH treatment on growth in patients with ACH/HCH at least in the first year and height velocity in short stature patients. © 2016 John Wiley & Sons Ltd.

  19. Blood-ACTH, cortisole and aldosterone levels following complex radiation treatment for cancer of the uterine cervix

    International Nuclear Information System (INIS)

    Modnikov, O.P.

    1984-01-01

    Blood-ACTH, cortisole and aldosterone levels in patients with cancer of the uterine cervix were measured radioimmunologically prior to complex radiotherapy, following a half-dose exposure of tumor focus and immediately on completion of the treatment course. Patients showed a rise in cortisole and aldosterone levels and a slight increase in ACTH. Radiation therapy inhibited production of cortisole and aldosterone matched by a rise in ACTH output

  20. Treatment of low-and intermediate-level radioactive waste concentrates

    International Nuclear Information System (INIS)

    1968-01-01

    The report of a panel convened by the IAEA in Vienna, 2-6 May 1966. Thirteen experts from eight countries and one international organization attended the meeting. This report is related to treatment and radioactive sludges or residues resulting from treatment and purification of radioactive wastes. It includes: (i) concentration by evaporation; (ii) filtration; (iii) insolubilization by means of bitumen; (iv) use of cement or cement-vermiculite. 31 refs, 34 figs, 14 tabs

  1. Centralized treatment facility for low level radioactive waste produced in Belgium. The CILVA project

    International Nuclear Information System (INIS)

    Renard, Cl.; Detilleux, M.; Debieve, P.

    1993-01-01

    Due to rather limited amount of waste produced and the small size of the Belgian territory (30 x 10 3 km 2 ), ONDRAF/NIRAS strategy aims at centralizing treatment conditioning and storage of radioactive waste. ONDRAF/NTRAS has decided to set up a new infrastructure: the CILVA unit. The CILVA facility is focused on the supercompaction and the incineration treatment, so that ONDRAF/NIRAS can safely manage all radioactive wastes produced in Belgium. (2 figs.)

  2. Beta-amyloid deposition in patients with major depressive disorder with differing levels of treatment resistance: a pilot study.

    Science.gov (United States)

    Li, Peng; Hsiao, Ing-Tsung; Liu, Chia-Yih; Chen, Chia-Hsiang; Huang, She-Yao; Yen, Tzu-Chen; Wu, Kuan-Yi; Lin, Kun-Ju

    2017-12-01

    Lack of treatment response in patients with late-life depression is common. The role of brain beta-amyloid (Aβ) deposition in treatment outcome in subjects with late-life depression remains unclear. The present study aimed to investigate brain Aβ deposition in patients with major depressive disorder (MDD) with differing treatment outcomes in vivo using 18 F-florbetapir imaging. This study included 62 MDD patients and 18 healthy control subjects (HCs).We first employed the Maudsley staging method (MSM) to categorize MDD patients into two groups according to treatment response: mild treatment resistance (n = 29) and moderate-to-severe treatment resistance (n = 33).The standard uptake value ratio (SUVR) of each volume of interest was analysed, and voxel-wise comparisons were made between the MDD patients and HCs. Vascular risk factors, serum homocysteine level, and apolipoprotein E (ApoE) genotype were also determined. The MDD patients with moderate-to-severe treatment resistance had higher 18 F-florbetapir SUVRs than the HCs in the parietal region (P depressive symptoms may represent prodromal manifestations of Alzheimer's disease (AD). Depressive symptomatology in old age, particularly in subjects with a poor treatment response, may underscore early changes of AD-related pathophysiology.

  3. Periodontal treatment decreases levels of antibodies to Porphyromonas gingivalis and citrulline in patients with rheumatoid arthritis and periodontitis.

    Science.gov (United States)

    Okada, Moe; Kobayashi, Tetsuo; Ito, Satoshi; Yokoyama, Tomoko; Abe, Asami; Murasawa, Akira; Yoshie, Hiromasa

    2013-12-01

    Porphyromonas gingivalis has been implicated as an etiologic agent of rheumatoid arthritis (RA) because of the expression of peptidylarginine deiminase. The present study evaluates whether periodontal treatment may affect serum antibodies to P. gingivalis and citrulline levels in relation to disease activity of RA. Fifty-five patients with RA were randomly assigned to receive oral hygiene instruction and supragingival scaling (treatment group, n = 26) or no periodontal treatment (control group, n = 29). Periodontal and rheumatologic parameters and serum levels of cytokine and inflammatory markers citrulline and immunoglobulin (Ig)G to P. gingivalis were examined at baseline and 8 weeks later. Both groups did not differ statistically in any parameters except percentage of sites with probing depth and clinical attachment level ≥ 4 mm at baseline. The treatment group exhibited a significantly greater decrease in disease activity score including 28 joints using C-reactive protein (DAS28-CRP) (P = 0.02), serum levels of IgG to P. gingivalis hemin binding protein (HBP)35 (P = 0.04), and citrulline (P = 0.02) than the control group. Serum levels of IgG to P. gingivalis HBP35 were significantly correlated positively with those of anti-cyclic citrullinated peptide antibodies (P = 0.0002). The same correlation was obtained between serum levels of IgG to P. gingivalis-sonicated extracts and those of rheumatoid factor (P = 0.02). These results suggest that supragingival scaling decreases DAS28-CRP and serum levels of IgG to P. gingivalis HBP35 and citrulline in patients with RA. These observations may reflect a role of P. gingivalis in the protein citrullination, which is related to the pathogenesis of RA.

  4. Motivation for orthognathic treatment and anticipated satisfaction levels-a two-centre cross-national audit.

    Science.gov (United States)

    Patcas, Raphael; Cunningham, Susan J; Shute, Justin; Lloyd, Timothy; Obwegeser, Joachim A; Arjomand, Lida; Sharma, Sujata

    2017-06-01

    This audit investigated factors which motivate patients to seek orthognathic treatment, assessed how confident patients were that they would be satisfied with the outcome of treatment, and explored possible influencing factors. Questionnaires were distributed to pre-surgical patients at two centres (United Kingdom and Switzerland); questions asked what patients wished to gain from orthognathic treatment and how confident they were that they would be satisfied with treatment outcome. Gender, age and location were recorded as demographic variables, and type of malocclusion was also recorded. A total of 202 questionnaires were returned (UK, n = 149; Switzerland, n = 53). Reported motivating factors focused on improvements in aesthetics (specified and unspecified) (UK vs. Switzerland: 91.3% vs. 83.0%), function (72.5% vs. 66.0%), psychosocial health (51.7% vs. 20.8%), speech (4.0% vs. 7.5%), alleviation of pain (5.4% vs. 17%) and normalization of breathing (1.3% vs. 7.5%). No significant relationships were observed relative to patient age, gender or malocclusion. The anticipated satisfaction levels were generally high (86.5% vs. 89.9%). Although the distribution of motivational factors varied between the two sites, it did not affect the anticipated satisfaction level. Patients were generally confident that they would be satisfied with their treatment outcome and that their reasons for seeking treatment would be addressed. Copyright © 2017 European Association for Cranio-Maxillo-Facial Surgery. All rights reserved.

  5. Dentinal hypersensitivity following scaling and root planing: comparison of low-level laser and topical fluoride treatment.

    Science.gov (United States)

    Pesevska, Snezana; Nakova, Marija; Ivanovski, Kiro; Angelov, Nikola; Kesic, Ljiljana; Obradovic, Radmila; Mindova, Sonja; Nares, Salvador

    2010-09-01

    The aim of this study is to compare the effectiveness of low-level laser irradiation to traditional topical fluoride treatment for treatment choices of dentinal hypersensitivity following scaling and root planing. The experimental group (15 patients) was treated with low-energy-level diode laser at each site of dentinal hypersensitivity following scaling and root planning. The control group (15 patients) received topical fluoride treatment (protective varnish for desensitization). All the patients were treated at baseline visit, and then at day 2 and 4 after the initial treatment; the pain was subjectively assessed by the patients as strong, medium, medium low, low, or no pain. Total absence of the dental hypersensitivity was reported in 26.66% of the examined group even after the second visit, compared to the control group where complete resolution of the hypersensitivity was not present after the second visit in any of the treated cases. Complete absence of pain was achieved in 86.6% of patients treated with laser and only in 26.6% in the fluoride treated group, after the third visit. Based on our findings, we conclude that low-energy biostimulative laser treatment can be successfully used for treatment of dental hypersensitivity following scaling and root planing.

  6. Efficacy of a multidisciplinary fibromyalgia treatment adapted for women with low educational levels: a randomized controlled trial.

    Science.gov (United States)

    Castel, Antoni; Fontova, Ramon; Montull, Salvador; Periñán, Rocío; Poveda, Maria José; Miralles, Iris; Cascón-Pereira, Rosalia; Hernández, Pilar; Aragonés, Natalia; Salvat, Isabel; Castro, Sonia; Monterde, Sonia; Padrol, Anna; Sala, José; Añez, Cristóbal; Rull, Maria

    2013-03-01

    Multidisciplinary treatments of fibromyalgia (FM) have demonstrated efficacy. Nevertheless, they have been criticized for not maintaining their benefits and for not being studied for specific populations. Our objectives were to determine the efficacy of a multidisciplinary treatment for FM adapted for patients with low educational levels and to determine the maintenance of its therapeutic benefits during a long-term followup period. Inclusion criteria consisted of female sex, a diagnosis of FM (using American College of Rheumatology criteria), age between 18 and 60 years, and between 3 and 8 years of schooling. Patients were randomly assigned to 1 of the 2 treatment conditions: conventional pharmacologic treatment or multidisciplinary treatment. Outcome measures were functionality, sleep disturbances, pain intensity, catastrophizing, and psychological distress. Analysis was by intent-to-treat and missing data were replaced following the baseline observation carried forward method. One hundred fifty-five participants were recruited. No statistically significant differences regarding pretreatment measures were found between the 2 experimental groups. Overall statistics comparison showed a significant difference between the 2 groups in all of the variables studied (P educational levels is effective in reducing key symptoms of FM. Some improvements were maintained 1 year after completing the multidisciplinary treatment. Copyright © 2013 by the American College of Rheumatology.

  7. High levels of psychosocial readiness for ART in an African population at the onset of treatment.

    Science.gov (United States)

    Wolff, Brent; Mbonye, Martin; Coutinho, Aartin; Amuron, Barbara; Nkabala, Robert; Jaffar, Shabbar; Grosskurth, Heiner

    2009-12-01

    Adherence at the earliest stages of treatment is likely to be influenced by prior illness trajectories and future expectations, best captured (and addressed) before treatment begins. We examined the influence of illness trajectories and treatment expectations on psychosocial readiness to start antiretroviral therapy (ART) in Jinja, Uganda. In-depth interviews were conducted between October 2005 and April 2006 with 41 members of an AIDS support organisation on their first day of treatment. Transcribed texts were translated, coded and analysed thematically using NVIVO-7 software. Results indicated that acute fear of death and progressive withdrawal from social, economic and sexual roles narrowed focus on survival, while efficacy-enhancing experiences with septrin prophylaxis and trust in counsellors reinforced belief in HIV diagnosis and importance of adherence. Most enjoyed supportive home environments after disclosing their serostatus. Lack of money for food and transport was anticipated as the main barriers to future adherence, particularly among women. Integrating strong counselling support with ART provision helped channel the power of shared illness experience into positive motivation to adhere at the onset of treatment.

  8. A formal treatment of uncertainty sources in a level 2 PSA

    International Nuclear Information System (INIS)

    Ahn, Kwang Il; Yang, Joon Eon

    2003-01-01

    The methodological framework of the level 2 PSA appears to be currently standardized in a formalized fashion, but there have been different opinions on the way the sources of uncertainty are characterized and treated. This is primarily because the level 2 PSA deals with complex phenomenological processes that are deterministic in nature rather than random processes, and there are no probabilistic models characterizing them clearly. As a result, the probabilistic quantification of the level 2 PSA is often subjected to two sources of uncertainty: (a) incomplete modeling of accident pathways or different predictions for the behavior of phenomenological events and (b) expert-to-expert variation in estimating the occurrence probability of phenomenological events. While a clear definition of the two sources of uncertainty involved in the level 2 PSA makes it possible to treat an uncertainty in a consistent manner, careless application of these different sources of uncertainty may produce different conclusions in the decision-making process. The primary purpose of this paper is to characterize typical sources of uncertainty that would often be addressed in the level 2 PSA and their impacts on the PSA level 2 risk results. An additional purpose of this paper is to give a formal approach on how to combine random uncertainties addressed in the level 1 PSA with subjectivistic uncertainties addressed in the level 2 PSA

  9. Glucocorticoid treatment earlier in childhood and adolescence show dose-response associations with diurnal cortisol levels

    DEFF Research Database (Denmark)

    Vestergaard, Martin; Holm, Sara K; Uldall, Peter

    2017-01-01

    or diurnal cortisol output; however, sex-dependent group differences were observed. Specifically, female patients had a higher CAR relative to female controls, while male patients had higher daily cortisol levels compared to male controls. Notably, CAR in female patients and daily cortisol levels in male...... for males and females....

  10. Treatment of Electronic Energy Level Transition and Ionization Following the Particle-Based Chemistry Model

    Science.gov (United States)

    Liechty, Derek S.; Lewis, Mark

    2010-01-01

    A new method of treating electronic energy level transitions as well as linking ionization to electronic energy levels is proposed following the particle-based chemistry model of Bird. Although the use of electronic energy levels and ionization reactions in DSMC are not new ideas, the current method of selecting what level to transition to, how to reproduce transition rates, and the linking of the electronic energy levels to ionization are, to the author s knowledge, novel concepts. The resulting equilibrium temperatures are shown to remain constant, and the electronic energy level distributions are shown to reproduce the Boltzmann distribution. The electronic energy level transition rates and ionization rates due to electron impacts are shown to reproduce theoretical and measured rates. The rates due to heavy particle impacts, while not as favorable as the electron impact rates, compare favorably to values from the literature. Thus, these new extensions to the particle-based chemistry model of Bird provide an accurate method for predicting electronic energy level transition and ionization rates in gases.

  11. Influence of surface pre-treatment on the electronic levels in silicon MaWCE nanowires.

    Science.gov (United States)

    Venturi, Giulia; Castaldini, Antonio; Schleusener, Alexander; Sivakov, Vladimir; Cavallini, Anna

    2015-05-15

    Deep level transient spectroscopy (DLTS) was performed on n-doped silicon nanowires grown by metal-assisted wet chemical etching (MaWCE) with gold as the catalyst in order to investigate the energetic scheme inside the bandgap. To observe the possible dependence of the level scheme on the processing temperature, DLTS measurements were performed on the nanowires grown on a non-treated Au/Si surface and on a thermally pre-treated Au/Si surface. A noticeable modification of the configuration of the energy levels was observed, induced by the annealing process. Based on our results on these MaWCE nanowires and on literature data about deep levels in bulk silicon, some hypotheses were advanced regarding the identification of the defects responsible of the energy levels revealed.

  12. Radiological, physical, and chemical characterization of additional alpha contaminated and mixed low-level waste for treatment at the advanced mixed waste treatment project

    International Nuclear Information System (INIS)

    Hutchinson, D.P.

    1995-07-01

    This document provides physical, chemical, and radiological descriptive information for a portion of mixed waste that is potentially available for private sector treatment. The format and contents are designed to provide treatment vendors with preliminary information on the characteristics and properties for additional candidate portions of the Idaho National Engineering Laboratory (INEL) and offsite mixed wastes not covered in the two previous characterization reports for the INEL-stored low-level alpha-contaminated and transuranic wastes. This report defines the waste, provides background information, briefly reviews the requirements of the Federal Facility Compliance Act (P.L. 102-386), and relates the Site Treatment Plans developed under the Federal Facility Compliance Act to the waste streams described herein. Each waste is summarized in a Waste Profile Sheet with text, charts, and tables of waste descriptive information for a particular waste stream. A discussion of the availability and uncertainty of data for these waste streams precedes the characterization descriptions

  13. Radiological, physical, and chemical characterization of additional alpha contaminated and mixed low-level waste for treatment at the advanced mixed waste treatment project

    Energy Technology Data Exchange (ETDEWEB)

    Hutchinson, D.P.

    1995-07-01

    This document provides physical, chemical, and radiological descriptive information for a portion of mixed waste that is potentially available for private sector treatment. The format and contents are designed to provide treatment vendors with preliminary information on the characteristics and properties for additional candidate portions of the Idaho National Engineering Laboratory (INEL) and offsite mixed wastes not covered in the two previous characterization reports for the INEL-stored low-level alpha-contaminated and transuranic wastes. This report defines the waste, provides background information, briefly reviews the requirements of the Federal Facility Compliance Act (P.L. 102-386), and relates the Site Treatment Plans developed under the Federal Facility Compliance Act to the waste streams described herein. Each waste is summarized in a Waste Profile Sheet with text, charts, and tables of waste descriptive information for a particular waste stream. A discussion of the availability and uncertainty of data for these waste streams precedes the characterization descriptions.

  14. Withdrawal of immunomodulators after co-treatment does not reduce trough level of infliximab in patients with Crohn's disease.

    Science.gov (United States)

    Drobne, David; Bossuyt, Peter; Breynaert, Christine; Cattaert, Tom; Vande Casteele, Niels; Compernolle, Griet; Jürgens, Matthias; Ferrante, Marc; Ballet, Vera; Wollants, Willem-Jan; Cleynen, Isabelle; Van Steen, Kristel; Gils, Ann; Rutgeerts, Paul; Vermeire, Severine; Van Assche, Gert

    2015-03-01

    The addition of immunomodulators increases the efficacy of maintenance therapy with infliximab for up to 1 year in patients with Crohn's disease who have not been previously treated with immunomodulators. However, there are questions about the effect of withdrawing immunomodulator therapy from these patients. We studied the effects of treatment with infliximab and immunomodulators (co-treatment) and then immunomodulator withdrawal on long-term outcomes of patients, as well as trough levels of infliximab and formation of anti-infliximab antibodies (ATI). In a retrospective study with the median follow-up period of 34 months (interquartile range, 19-58 months), we analyzed data from 223 patients treated for Crohn's disease between May 1999 and December 2010 at the University Hospitals, Leuven, Belgium (65 received infliximab monotherapy, 158 received infliximab and an immunomodulator). Trough levels of infliximab and levels of ATI were measured in blood samples collected from 117 patients throughout co-treatment, as well as the time of immunomodulator withdrawal and after withdrawal. Patients receiving co-treatment had higher trough levels of infliximab (adjusted mean increase, 1.44-fold) than those receiving infliximab monotherapy (95% confidence interval [CI], 1.07-1.92; P = .02). A smaller percentage of patients receiving co-treatment developed ATI (35 of 158, 22%) than those receiving infliximab monotherapy (25 of 65, 38%; P = .01). Among co-treated patients, levels of infliximab remained stable after immunomodulators were withdrawn (before: 3.2 μg/mL; 95% CI, 1.6-5.8 μg/mL and after: 3.7 μg/mL; 95% CI, 1.3-6.3 μg/mL; P = .70). After withdrawal of immunomodulators, 45 of 117 patients (38%) required increasing doses of infliximab, and 21 of 117 (18%) discontinued infliximab. At the time of immunomodulator withdrawal, trough levels of infliximab and C-reactive protein were most strongly associated with response to infliximab thereafter. In a retrospective

  15. The sodium level. An inconspicuous but very important parameter in all-volatile treatment

    Energy Technology Data Exchange (ETDEWEB)

    Bursik, Albert [PowerPlant Chemistry GmbH, Neulussheim (Germany)

    2011-07-15

    Boiler tube failure due to ''lack of sodium''? This is certainly not a common concern, yet this contribution stresses the importance of the presence of sodium in the boiler water even when applying all-volatile treatment (AVT) as a method of boiler water treatment. Sodium in the cycle (either unintentionally via sodium-contaminated makeup or intentionally through sodium hydroxide additions) may neutralize the possible acidic contaminations and help to avoid boiler tube failures due to hydrogen damage. (orig.)

  16. Molecular-level removal of proteinaceous contamination from model surfaces and biomedical device materials by air plasma treatment.

    Science.gov (United States)

    Banerjee, K K; Kumar, S; Bremmell, K E; Griesser, H J

    2010-11-01

    Established methods for cleaning and sterilising biomedical devices may achieve removal of bioburden only at the macroscopic level while leaving behind molecular levels of contamination (mainly proteinaceous). This is of particular concern if the residue might contain prions. We investigated at the molecular level the removal of model and real-life proteinaceous contamination from model and practical surfaces by air plasma (ionised air) treatment. The surface-sensitive technique of X-ray photoelectron spectroscopy (XPS) was used to assess the removal of proteinaceous contamination, with the nitrogen (N1s) photoelectron signal as its marker. Model proteinaceous contamination (bovine serum albumin) adsorbed on to a model surface (silicon wafer) and the residual proteinaceous contamination resulting from incubating surgical stainless steel (a practical biomaterial) in whole human blood exhibited strong N1s signals [16.8 and 18.5 atomic percent (at.%), respectively] after thorough washing. After 5min air plasma treatment, XPS detected no nitrogen on the sample surfaces, indicating complete removal of proteinaceous contamination, down to the estimated XPS detection limit 10ng/cm(2). Applying the same plasma treatment, the 7.7at.% nitrogen observed on a clinically cleaned dental bur was reduced to a level reflective of new, as-received burs. Contact angle measurements and atomic force microscopy also indicated complete molecular-level removal of the proteinaceous contamination upon air plasma treatment. This study demonstrates the effectiveness of air plasma treatment for removing proteinaceous contamination from both model and practical surfaces and offers a method for ensuring that no molecular residual contamination such as prions is transferred upon re-use of surgical and dental instruments. Crown Copyright © 2010. Published by Elsevier Ltd. All rights reserved.

  17. Preliminary siting criteria for the proposed mixed and low-level waste treatment facility at the Idaho National Engineering Laboratory

    International Nuclear Information System (INIS)

    Jorgenson-Waters, M.

    1992-09-01

    The Mixed and Low-Level Waste Treatment Facility project was established in 1991 by the US Department of Energy Idaho Field Office. This facility will provide treatment capabilities for Idaho National Engineering Laboratory (INEL) low-level mixed waste and low-level waste. This report identifies the siting requirements imposed on facilities that treat and store these waste types by Federal and State regulatory agencies and the US Department of Energy. Site selection criteria based on cost, environmental, health and safety, archeological, geological and service, and support requirements are presented. These criteria will be used to recommend alternative sites for the new facility. The National Environmental Policy Act process will then be invoked to evaluate the alternatives and the alternative sites and make a final site determination

  18. State-level prevalence of cigarette smoking and treatment advice, by disability status, United States, 2004.

    Science.gov (United States)

    Armour, Brian S; Campbell, Vincent A; Crews, John E; Malarcher, Ann; Maurice, Emmanuel; Richard, Roland A

    2007-10-01

    To our knowledge, no study has determined whether smoking prevalence is higher among people with disabilities than among people without disabilities across all U.S. states. Neither do we know whether people with disabilities and people without disabilities receive the same quality of advice about tobacco-cessation treatment from medical providers. We analyzed data from the 2004 Behavioral Risk Factor Surveillance System to estimate differences between people with and people without disabilities in smoking prevalence and the receipt of tobacco-cessation treatment advice from medical providers. We found that smoking prevalence for people with disabilities was approximately 50% higher than for people without disabilities. Smokers with disabilities were more likely than smokers without disabilities to have visited a medical provider at least once in the previous 12 months and to have received medical advice to quit. More than 40% of smokers with disabilities who were advised to quit, however, reported not being told about the types of tobacco-cessation treatment available. Ensuring that people with disabilities are included in state-based smoking cessation programs gives states an opportunity to eliminate health disparities and to improve the health and wellness of this group. Ways to reduce unmet preventive health care needs of people with disabilities include provider adoption of the Public Health Service's clinical practice guideline for treating tobacco use and dependence and the provision of smoking cessation services that include counseling and effective pharmaceutical treatment.

  19. The Level of Alexithymia in Alcohol-Dependent Patients Does Not Influence Outcomes after Inpatient Treatment

    NARCIS (Netherlands)

    Haan, H.A. de; Schellekens, A.F.A.; Palen, J.A.M. van der; Verkes, R.J.; Buitelaar, J.K.; Jong, C.A.J. de

    2012-01-01

    Background: The inability of individuals with Alcohol Use Disorders (AUD) to recognize and describe their feelings and cravings may be due to alexithymia. Previous researches have shown evidence for a negative influence of alexithymia on treatment outcomes in patients with AUD. Therefore, it was

  20. The level of alexithymia in alcohol-dependent patients does not influence outcomes after inpatient treatment.

    NARCIS (Netherlands)

    Haan, H.A. de; Schellekens, A.F.A.; Palen, J.A.M. van der; Verkes, R.J.; Buitelaar, J.K.; Jong, C.A.J. de

    2012-01-01

    BACKGROUND: The inability of individuals with Alcohol Use Disorders (AUD) to recognize and describe their feelings and cravings may be due to alexithymia. Previous researches have shown evidence for a negative influence of alexithymia on treatment outcomes in patients with AUD. Therefore, it was

  1. Surrogate formulations for thermal treatment of low-level mixed waste

    International Nuclear Information System (INIS)

    Stockdale, J.A.D.; Bostick, W.D.; Hoffmann, D.P.; Lee, H.T.

    1994-01-01

    The evaluation and comparison of proposed thermal treatment systems for mixed wastes can be expedited by tests in which the radioactive components of the wastes are replaced by surrogate materials chosen to mimic, as far as is possible, the chemical and physical properties of the radioactive materials of concern. In this work, sponsored by the Mixed Waste Integrated Project of the US Department of Energy, the authors have examined reported experience with such surrogates and suggest a simplified standard list of materials for use in tests of thermal treatment systems. The chief radioactive nuclides of concern in the treatment of mixed wastes are 239 Pu, 238 U, 235 U, 137 Cs, 103 Ru, 99 Tc, and 90 Sr. These nuclides are largely by-products of uranium enrichment, reactor fuel reprocessing, and weapons program activities. Cs, Ru, and Sr all have stable isotopes that can be used as perfect surrogates for the radioactive forms. Technetium exists only in radioactive form, as do plutonium and uranium. If one wishes to preclude radioactive contamination of the thermal treatment system under trial burn, surrogate elements must be chosen for these three. For technetium, the authors suggest the use of natural ruthenium, and for both plutonium and uranium, they recommend cerium. The seven radionuclides listed can therefore be simulated by a surrogate package containing stable isotopes of ruthenium, strontium, cesium, and cerium

  2. The level of Alexithymia in alcohol-dependent patients does not influence outcomes after inpatient treatment

    NARCIS (Netherlands)

    de Haan, Hein A.; Schellekens, Arnt F.A.; van der Palen, Jacobus Adrianus Maria; Verkes, Robbert-Jan; Buitelaar, Jan K.; de Jong, Cor A.J.

    2012-01-01

    Background: The inability of individuals with Alcohol Use Disorders (AUD) to recognize and describe their feelings and cravings may be due to alexithymia. Previous researches have shown evidence for a negative influence of alexithymia on treatment outcomes in patients with AUD. Therefore, it was

  3. Treatment of External Levels in Neutron Resonance Fitting: Application to the Nonfissile Nuclide 52Cr

    International Nuclear Information System (INIS)

    Froehner, Fritz H.; Bouland, Olivier

    2001-01-01

    Measured neutron resonance cross sections are usually analyzed and parametrized by fitting theoretical curves to high-resolution point data. Theoretically, the cross sections depend mainly on the 'internal' levels inside the fitted energy range but also on the 'external' levels outside. Although the external levels are mostly unknown, they must be accounted for. If they are simply omitted, the experimental data cannot be fitted satisfactorily. Especially with elastic scattering and total cross-section data, one gets troublesome edge effects and difficulties with the potential cross section between resonances. Various ad hoc approaches to these problems are still being used, involving replacement of the unknown levels by equidistant ('picket fence') or Monte Carlo-sampled resonance sequences, or replication of the internal level sequence; however, more convenient, better working, and theoretically sound techniques have been available for decades. These analytical techniques are reviewed. They describe the contribution of external levels to the R matrix concisely in terms of average resonance parameters (strength function, effective radius, etc.). A more recent, especially convenient approximation accounts for the edge effects by just one fictitious pair of very broad external resonances. Fitting the thermal region, including accurately known thermal cross sections, is often done by adjusting a number of bound levels by trial and error, although again a simple analytical recipe involving just one bound level has been available for a long time. For illustration, these analytical techniques are applied to the resolved resonance region of 52 Cr. The distinction between channel radii and effective radii, crucial in the present context, is emphasized

  4. Treatment response in Kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin G.

    Directory of Open Access Journals (Sweden)

    Shohei Ogata

    Full Text Available Although intravenous immunoglobulin (IVIG is highly effective in Kawasaki disease (KD, mechanisms are not understood and 10-20% of patients are treatment-resistant, manifesting a higher rate of coronary artery aneurysms. Murine models suggest that α2-6-linked sialic acid (α2-6Sia content of IVIG is critical for suppressing inflammation. However, pro-inflammatory states also up-regulate endogenous levels of β-galactoside:α2-6 sialyltransferase-I (ST6Gal-I, the enzyme that catalyzes addition of α2-6Sias to N-glycans. We asked whether IVIG failures correlated with levels of α2-6Sia on infused IVIG or on the patient's own endogenous IgG.We quantified levels of α2-6Sia in infused IVIG and endogenous IgG from 10 IVIG-responsive and 10 resistant KD subjects using multiple approaches. Transcript levels of ST6GAL1, in patient whole blood and B cell lines were evaluated by RT-PCR. Plasma soluble (sST6Gal-I levels were measured by ELISA.There was no consistent difference in median sialylation levels of infused IVIG between groups. However, α2-6Sia levels in endogenous IgG, ST6GAL1 transcript levels, and ST6Gal-I protein in serum from IVIG-resistant KD subjects were lower than in responsive subjects at both pre-treatment and one-year time points (p <0.001, respectively.Our data indicate sialylation levels of therapeutic IVIG are unrelated to treatment response in KD. Rather, lower sialylation of endogenous IgG and lower blood levels of ST6GALI mRNA and ST6Gal-I enzyme predict therapy resistance. These differences were stable over time, suggesting a genetic basis. Because IVIG-resistance increases risk of coronary artery aneurysms, our findings have important implications for the identification and treatment of such individuals.

  5. Effects of barium chloride treatment of uranium mill tailings and ore on radon emanation and 226Ra levels. Progress report

    International Nuclear Information System (INIS)

    Ibrahim, S.A.; Flot, S.L.

    1983-01-01

    The purpose of this study was to investigate the effect of barium chloride treatments on: reduction of 222 Rn emanation from mill wastes; reduction of 226 Ra levels in wastewater; and decreased leachability of 226 Ra from mill wastes. Baseline 226 Ra concentrations were determined for ore and tailings as well as radon emanation fractions. Uranium ore was treated with soluble barium at concentrations of 10, 25, 50, and 100 mg per litre of slurry. The leach-liquor declined in 226 Ra concentration by as much as 50%. When soluble potassium as well as barium was used in the treatment process at equal concentrations of 10, 25, 50, and 100 mg per litre of slurry, a similar reduction was observed. No significant difference was noted between the two treatment regimes. An accelerated leaching experiment was performed on the ore treated with barium chloride. All treatment groups except that treated with 10 mg of soluble barium per litre of slurry showed significant decreases in leachability. Available 222 Rn (corresponds with radon emanation fraction) was measured in treated and untreated ore. Ore treated with concentrations of Ba ++ up to 1.00 mg per gram of ore did not show a statistically significant reduction in available 222 Rn, however when potassium sulfate was also added, a significant decline was noted. This study suggests that barium chloride treatments reduce radon emanation from mill wastes and reduce 226 Ra levels in wastewater. Leachability of 226 Ra from treated samples decreased markedly. 19 references, 8 figures, 7 tables

  6. Use of low-level laser therapy in treatment of the androgenic alopecia, the first systematic review.

    Science.gov (United States)

    Najem, Ibrahim; Chen, Hongxiang

    2017-12-11

    Alopecia is a common disease affecting more than half of the world total number of people. Alopecia exists in different types, but one of the most common of these types is the Androgenic Alopecia which has affected approximately 51% of the total number of males ranging between the age bracket of 40 years and 75 years. This type of alopecia is more common in females who are above the age of 65 years and above. Despite this widespread effect, much has not been done regarding identifying the possible drugs for treating this disease. At present, there exist only two possible medications that have been scientifically approved to cure this disease, include finasteride and minoxidil. Also, another possible form of treatment has been the case of hair transplantation. Despite the new possible treatment options available for treatment of different types of hair loss, there is a need for the invention for more efficient management and treatment options that are less costly, environmentally friendly, and most importantly human consumption friendly. Due to the recent evaluation that low-level laser therapy stimulated hair growth. This systematic review and meta-analysis was to determine whether the use of low-level laser therapy is an effective therapy for treatment of the Androgenic alopecia and also to some degree we reviewed the level of the patient's satisfaction. Some earlier studies had shown that the use of low-level laser therapy stimulated the hair growth when mice were treated with chemotherapy which was induced by the alopecia and also the other type of alopecia called alopecia areata. The researchers hypothesized that the primary mechanism of treating Androgenic alopecia to be the stimulation of the epidermal stem cells which are in the hair follicle making them bulge and shift the follicles into the anagen phase.

  7. Levels and treatment options for enteric and antibiotic resistant bacteria in sewage from Sisimiut, Greenland

    DEFF Research Database (Denmark)

    Jensen, Pernille Erland; Gunnarsdottir, Ragnhildur; Andersen, Henrik Rasmus

    2013-01-01

    Sewage treatment in Arctic towns is inadequate. Sewage contains pathogenic microorganisms, parasites, antibiotic resistant bacteria, and toxic compounds. Discharging of untreated sewage can thus have a negative effect on people’s health and the aquatic environment in the receiving water bodies....... Conventional treatment is challenging and expensive to implement in Arctic communities due to the cold climate and scattered population. In addition, advanced removal of nutrients may in many cases be overstated due to the low population density and large receiving water bodies. In this work we investigated......, the wastewater is very strong, suggesting a potential hygienic risk. In addition, a high fraction of antibiotic resistant bacteria and an increased toxicity in the sub-stream from the hospital, suggest that this stream contains toxic compounds, possibly antibiotic of nature that may affect the local Arctic...

  8. Acupuncture treatment for sleep disturbances patients: A case report with inflammatory cytokine levels evaluation

    Directory of Open Access Journals (Sweden)

    Yun Jin Kim

    2018-01-01

    Full Text Available Sleep disturbance is one of the more common risk factors, numerous other negative physical health outcomes, and it is defined as self-reported poor quality of sleep, short sleep duration, daytime sleepiness, and insomnia symptoms. It is a common risk factor for depression and anxiety. Here, a case of sleep disturbance that received 72 sessions of acupuncture treatment delivered is reported. After acupuncture treatment, the patient’s PSQI, HDRS, and SAS score decreased, as well as the plasma TNF-α, and IL-6 being reduced. No adverse effects were observed. The clinical studies findings provide evidence supporting the acupuncture aimed at the cause of sleep disturbance symptoms can also be useful.

  9. [Beclobrate (Turec) in the treatment of primary hyperlipoproteinemia. I. Effect on cholesterol, lipid and apoprotein levels].

    Science.gov (United States)

    Sznajd, J; Idzior-Waluś, B; Zabiński, J; Wybrańska, I; Korzus, G; Iwanejko, J

    1990-01-01

    The effects of a new fibric acid derivative--beclobrate (Turec, Zyma) on serum lipid and apoprotein concentrations in 63 patients with primary hyperlipoproteinemia were examined. Beclobrate was given in the evening, 100 mg, once daily. After 3 months of beclobrate treatment mean total cholesterol concentration in serum decreased from 9.35 to 7.73 mmol/l (17.3%), mean LDL-cholesterol concentration from 6.32 to 5.38 mmol/l (14.9%), mean HDL-cholesterol concentration increased by 0.21 mmol/l (15.3% of initial value). The greatest decrease was observed in triglyceride concentration--by 50% of the initial value. Apoprotein B concentration decreased by 19.7%, apoprotein A1 and A2 concentration increased by 20.3% and 26.8% respectively. Higher initial values of total cholesterol and triglyceride concentration in serum were associated with greater concentration decrease after beclobrate treatment.

  10. Eccentric Exercise in Treatment of Patellar Tendinopathy in High Level Basketball Players. A Randomized Clinical Trial.

    OpenAIRE

    Sosa, Carlos; Lorenzo Calvo, Alberto; Jiménez, Sergio L.; Bonfanti, Noelia

    2014-01-01

    Chronic patellar tendinopathy is a common pathology in sporting population. To date, there is no agreed upon protocol as election treatment. Eccentric exercises have been used with satisfactory outcomes. The purpose of this trial is compare the effects of two eccentric exercise protocols. 0.146 SJR (2014) Q4, 199/231 Health (social science), 131/169 Physical therapy, sports therapy and rehabilitation, 119/128 Sports sciences UEM

  11. Treatment of Navy Landfill Leachate Contaminated with Low Levels of Priority Pollutants

    Science.gov (United States)

    1991-10-01

    nitrogen, and in another study lignins and tannins . Sulfate to chloride ratio, oxidation reduction pctential (ORP), and pH reflect the degree of...from the treatment system. The contaminants are identified in the groundwater through laboratory analysis . The design goal is to use the properties of...materials management 1 H Structural analysis and design (including numerical and 4C Waterwaste management and sanitary engineering computer techniques

  12. LONG-TERM TREATMENT RESULTS OF BONE SARCOMA PATIENTS WITH CONSIDERATION OF SERUM METALLOPROTEINASE LEVELS

    Directory of Open Access Journals (Sweden)

    I. V. Babkina

    2015-01-01

    Full Text Available Background: Bone sarcomas are extremely malignant prone to rapid hematogenic metastasing. Evaluation of biological marker expression by the tumor is important not only for the search of new potential chemotherapy targets, but for the assessment of the disease prognosis.Aim: A comparative evaluation of matrix metalloproteinases (MMP-2, -7, -9 and tissue inhibitor of metalloproteinase-1 (TIMP-1 in the serum of patients with primary bone tumors and in healthy people to identify their potential association with the histological characteristics of the tumor and the disease prognosis.Materials and methods: A comparative study of serum MMP-2, -7, -9, and TIMP-1 levels was performed in 54 patients with primary bone tumors (malignant, 45 patients, including central osteosarcoma in 21, periosteal osteosarcoma in 4, Ewing's sarcoma in 11, primary chondrosarcoma in 6, undifferentiated pleomorphic sarcoma in 3, and borderline giant cell tumors in 9 and in 26 healthy individuals with the use of the immunoenzyme technique (Biosource, USA, for TIMP-1 and R&D, USA, for MMP-2, -7, and -9. Results: The TIMP-1 levels in the serum of patients with central and periosteal osteosarcomas were significantly higher than in the serum of healthy controls (р = 0.038 and p = 0.007, respectively. The MMP-9 levels in patients with bone malignancies were significantly lower than that in the normal controls (p < 0.05. There was a positive correlation between serum TIMP-1 and MMP-9 levels in patients with central, periosteal and Ewing's sarcomas (r = 0.37, p = 0.024. No significant differences in the 5-year survival rates related to serum TIMP-1, MMP-2, -7, -9 levels were found in patients with bone sarcomas. However, in those with osteosarcoma and serum MMP-2 > 160 ng/ml, the overall 5-year survival rate was 1.6-fold higher than in those with lower MMP-2 levels, and in those with ММP-9 levels < 377 ng/ml, the 5-year survival rate was 1.4-fold higher than in patients with

  13. Fats, oils, and grease : options for plant-level treatment of a national problem

    Energy Technology Data Exchange (ETDEWEB)

    Miles, E.; Scherffius, B. [EcoPlus Inc. Charlotte, NC (United States)

    2007-09-15

    Fats, oils, and grease from restaurants and homes can congeal in sewers and result in damaging runoff into rivers and streams. A growing number of food service establishments are now producing increasing amounts of a specific grease product called brown grease, which is sticky and difficult to remove. Regulations now require haulers to remove the waste and dispose of it. However, many local treatment plants cannot accept or dispose of the amounts of grease currently being produced. A total of volume of 3 to 10 billion gallons per year of contaminated water have been accidentally discharged from sanitary sewers as a result of brown grease accumulations. This paper provided details of the EcoPlus Final Treatment Facility, which can be set up at waste water treatment plants and is able to process brown grease and discharge supernatant water from its process back into city sewers. The EcoPlus process produces 2 waste streams: (1) a low strength aqueous solution that can be disposed of in a sanitary sewer tap; and (2) a granular material that can be disposed of in a landfill for use as a soil conditioner. It was concluded that the granular material can also be used facilitate the incineration of sewage sludge, or burned as an alternative green fuel for power generation. 4 figs.

  14. Time and motion study for alternative mixed low-level waste treatment systems

    International Nuclear Information System (INIS)

    Biagi, C.; Vetromile, J.; Teheranian, B.

    1997-02-01

    The time and motion study was developed to look at time-related aspects of the technologies and systems studied in the Integrated Thermal Treatment Systems (ITTS) and Integrated Nonthermal Treatment Systems (INTS) studies. The INTS and ITTS studies combined technologies into systems and subsystems for evaluation. The system approach provides DOE a method of measuring advantages and disadvantages of the many technologies currently being researched. For example, technologies which are more likely to create secondary waste or require extensive pretreatment handling may be less desirable than technologies which require less support from other processes. The time and motion study was designed to address the time element in the INTS and ITTS systems studies. Previous studies have focused on material balance, cost, technical effectiveness, regulatory issues, community acceptance, and operability. This study looks at system dynamics by estimating the treatment time required for a unit of waste, from receipt to certification for shipping. Labor estimates are also developed, based on the time required to do each task for each process. This focus on time highlights critical path processes and potential bottlenecks in the INTS and ITTS systems

  15. National procurement of private-sector treatment for U.S. Department of Energy mixed low-level wastes

    International Nuclear Information System (INIS)

    Berry, J.B.; Jones, D.W.; Seeker, W.R.; Alex, L.J.

    1995-01-01

    The cost of bringing DOE into compliance with the Federal Facilities Compliance Act may be dramatically reduced if the private sector treats DOE mixed low level waste. If the DOE clearly defines this market by using national procurement contracts, the private sector will be able to decide if investing in DOE waste treatment contracts is good business. DOE can structure the mixed waste treatment market to influence the profitability of the contracts and to influence the quality of private sector responses. National procurement contracts will incorporate advice from the private sector so that issues of concern to industry are adequately incorporated

  16. National procurement of private-sector treatment for U.S. Department of Energy mixed low-level wastes

    Energy Technology Data Exchange (ETDEWEB)

    Berry, J.B.; Jones, D.W. [Oak Ridge National Lab., TN (United States); Seeker, W.R. [Energy and Environmental Research Corp., Irvine, CA (United States); Alex, L.J. [Committee for Environmental Management, Washington (United States)

    1995-12-31

    The cost of bringing DOE into compliance with the Federal Facilities Compliance Act may be dramatically reduced if the private sector treats DOE mixed low level waste. If the DOE clearly defines this market by using national procurement contracts, the private sector will be able to decide if investing in DOE waste treatment contracts is good business. DOE can structure the mixed waste treatment market to influence the profitability of the contracts and to influence the quality of private sector responses. National procurement contracts will incorporate advice from the private sector so that issues of concern to industry are adequately incorporated.

  17. Dynamic PET evaluation of elevated FLT level after sorafenib treatment in mice bearing human renal cell carcinoma xenograft.

    Science.gov (United States)

    Ukon, Naoyuki; Zhao, Songji; Yu, Wenwen; Shimizu, Yoichi; Nishijima, Ken-Ichi; Kubo, Naoki; Kitagawa, Yoshimasa; Tamaki, Nagara; Higashikawa, Kei; Yasui, Hironobu; Kuge, Yuji

    2016-12-01

    Sorafenib, an oral multikinase inhibitor, has anti-proliferative and anti-angiogenic activities and is therapeutically effective against renal cell carcinoma (RCC). Recently, we have evaluated the tumor responses to sorafenib treatment in a RCC xenograft using [Methyl- 3 H(N)]-3'-fluoro-3'-deoxythythymidine ([ 3 H]FLT). Contrary to our expectation, the FLT level in the tumor significantly increased after the treatment. In this study, to clarify the reason for the elevated FLT level, dynamic 3'-[ 18 F]fluoro-3'-deoxythymidine ([ 18 F]FLT) positron emission tomography (PET) and kinetic studies were performed in mice bearing a RCC xenograft (A498). The A498 xenograft was established in nude mice, and the mice were assigned to the control (n = 5) and treatment (n = 5) groups. The mice in the treatment group were orally given sorafenib (20 mg/kg/day p.o.) once daily for 3 days. Twenty-four hours after the treatment, dynamic [ 18 F]FLT PET was performed by small-animal PET. Three-dimensional regions of interest (ROIs) were manually defined for the tumors. A three-compartment model fitting was carried out to estimate four rate constants using the time activity curve (TAC) in the tumor and the blood clearance rate of [ 18 F]FLT. The dynamic pattern of [ 18 F]FLT levels in the tumor significantly changed after the treatment. The rate constant of [ 18 F]FLT phosphorylation (k 3 ) was significantly higher in the treatment group (0.111 ± 0.027 [1/min]) than in the control group (0.082 ± 0.009 [1/min]). No significant changes were observed in the distribution volume, the ratio of [ 18 F]FLT forward transport (K 1 ) to reverse transport (k 2 ), between the two groups (0.556 ± 0.073 and 0.641 ± 0.052 [mL/g] in the control group). Our dynamic PET studies indicated that the increase in FLT level may be caused by the phosphorylation of FLT in the tumor after the sorafenib treatment in the mice bearing a RCC xenograft. Dynamic PET studies with kinetic

  18. Effect of high-dose lidocaine treatment on superoxide dismutase and malon dialdehyde levels in seven diabetic patients.

    Science.gov (United States)

    Celebi, H; Bozkirli, F; Günaydin, B; Bilgihan, A

    2000-01-01

    We report on the use of intravenous (IV) high-dose lidocaine to relieve diabetic neuropathic pain, and the technique's effects on clinical measures of lipid peroxidation. Under continuous electrocardiogram monitoring, IV lidocaine (5 mg kg(-1) in 100 mL saline) was administered over 30 minutes to 7 non-insulin-dependent diabetic patients suffering from neuropathic pain who reported increased pain within the preceding 6 months. This treatment was performed once a week for 1 month. Blood samples were collected from the contralateral limb to determine plasma superoxide dismutase (SOD) and malondialdehyde (MDA) levels on admission and following the final lidocaine administration. Plasma MDA concentrations significantly decreased after the final IV lidocaine treatment (P < .05, paired t-test), whereas SOD levels did not show a statistically significant difference compared with baseline levels. High-dose lidocaine treatment lessens MDA levels, a marker of free-radical-mediated cell damage. This suggests that one of lidocaine's mechanism of action may be its effect on oxygen free radicals, which in turn impacts lipid peroxidation.

  19. Perinatal nicotine treatment induces transient increases in NACHO protein levels in the rat frontal cortex

    DEFF Research Database (Denmark)

    Wichern, Franziska; Jensen, Majbrit M; Christensen, Ditte Z

    2017-01-01

    The nicotinic acetylcholine receptor (nAChR) regulator chaperone (NACHO) was recently identified as an important regulator of nAChR maturation and surface expression. Here we show that NACHO levels decrease during early postnatal development in rats. This decrease occurs earlier and to a greater...... degree in the frontal cortex (FC) compared with the hippocampus (HIP). We further show that rats exposed to nicotine during pre- and postnatal development exhibit significantly higher NACHO levels in the FC at postnatal day (PND) 21, but not at PND60. Repeated exposure to nicotine selectively during...... a single exposure to a combination of nicotine and the type II α7 nAChR positive allosteric modulator (PAM) PNU-120596, but not the type I PAM AVL-3288. These findings suggest that exposure to nAChR agonism affects NACHO protein levels, and that this effect is more pronounced during pre- or early postnatal...

  20. Vitamin D Levels in Children and Adolescents with Antiepileptic Drug Treatment

    Science.gov (United States)

    Baek, Jung-Hyun; Seo, Young-Ho; Kim, Gun-Ha; Kim, Mi-Kyung

    2014-01-01

    Purpose This study was to evaluate the relationship of 25(OH)D3 levels with anticonvulsant use and other possible factors in epileptic children and adolescents. Materials and Methods We studied 143 patients with epilepsy (90 boys, 53 girls; 11.21±4.49 years), who had been treated with anticonvulsants for more than 1 year. Patients who had taken multiple vitamins before the blood test and those who have the limitation of physical activity (wheelchair-bound) were excluded from the study. We evaluated the difference in vitamin D status according to the type and number of anticonvulsants taken and other factors such as gender, age, intelligence and seizure variables. Results For patients with mental retardation or developmental delay, 25(OH)D3 levels were lower than the levels in patients with normal intelligence quotient levels (p=0.03). 25(OH)D3 levels were lower in patients who had taken anticonvulsants for more than 2 years as compared to those who had taken them for less than 2 years (p=0.03). Those taking oxcarbazepine had significantly lower vitamin D levels than patients taking valproic acid (p=0.01). However, no effects of number of anticonvulsants taken were detectable. More than two-thirds of the patients were diagnosed with osteopenia or osteoporosis in patients showing either vitamin D insufficiency or deficiency. Conclusion The possibility of vitamin D deficiency can be considered in pediatric patients taking anticonvulsants if they have mental retardation or developmental delay or if they have been taking anticonvulsants for more than 2 years or taking hepatic enzyme inducing drugs. PMID:24532512

  1. Solvent extraction in the treatment of acidic high-level liquid waste : where do we stand?

    International Nuclear Information System (INIS)

    Horwitz, E. P.; Schulz, W. W.

    1998-01-01

    During the last 15 years, a number of solvent extraction/recovery processes have been developed for the removal of the transuranic elements, 90 Sr and 137 Cs from acidic high-level liquid waste. These processes are based on the use of a variety of both acidic and neutral extractants. This chapter will present an overview and analysis of the various extractants and flowsheets developed to treat acidic high-level liquid waste streams. The advantages and disadvantages of each extractant along with comparisons of the individual systems are discussed

  2. Review of private sector and Department of Energy treatment, storage, and disposal capabilities for low-level and mixed low-level waste

    International Nuclear Information System (INIS)

    Willson, R.A.; Ball, L.W.; Mousseau, J.D.; Piper, R.B.

    1996-03-01

    Private sector capacity for treatment, storage, and disposal (TSD) of various categories of radioactive waste has been researched and reviewed for the Idaho National Engineering Laboratory (INEL) by Lockheed Idaho Technologies Company, the primary contractor for the INEL. The purpose of this document is to provide assistance to the INEL and other US Department of Energy (DOE) sites in determining if private sector capabilities exist for those waste streams that currently cannot be handled either on site or within the DOE complex. The survey of private sector vendors was limited to vendors currently capable of, or expected within the next five years to be able to perform one or more of the following services: low-level waste (LLW) volume reduction, storage, or disposal; mixed LLW treatment, storage, or disposal; alpha-contaminated mixed LLW treatment; LLW decontamination for recycling, reclamation, or reuse; laundering of radioactively-contaminated laundry and/or respirators; mixed LLW treatability studies; mixed LLW treatment technology development. Section 2.0 of this report will identify the approach used to modify vendor information from previous revisions of this report. It will also illustrate the methodology used to identify any additional companies. Section 3.0 will identify, by service, specific vendor capabilities and capacities. Because this document will be used to identify private sector vendors that may be able to handle DOE LLW and mixed LLW streams, it was decided that current DOE capabilities should also be identified. This would encourage cooperation between DOE sites and the various states and, in some instances, may result in a more cost-effective alternative to privatization. The DOE complex has approximately 35 sites that generate the majority of both LLW and mixed LLW. Section 4.0 will identify these sites by Operations Office, and their associated LLW and mixed LLW TSD units

  3. Review of private sector and Department of Energy treatment, storage, and disposal capabilities for low-level and mixed low-level waste

    Energy Technology Data Exchange (ETDEWEB)

    Willson, R.A.; Ball, L.W.; Mousseau, J.D.; Piper, R.B.

    1996-03-01

    Private sector capacity for treatment, storage, and disposal (TSD) of various categories of radioactive waste has been researched and reviewed for the Idaho National Engineering Laboratory (INEL) by Lockheed Idaho Technologies Company, the primary contractor for the INEL. The purpose of this document is to provide assistance to the INEL and other US Department of Energy (DOE) sites in determining if private sector capabilities exist for those waste streams that currently cannot be handled either on site or within the DOE complex. The survey of private sector vendors was limited to vendors currently capable of, or expected within the next five years to be able to perform one or more of the following services: low-level waste (LLW) volume reduction, storage, or disposal; mixed LLW treatment, storage, or disposal; alpha-contaminated mixed LLW treatment; LLW decontamination for recycling, reclamation, or reuse; laundering of radioactively-contaminated laundry and/or respirators; mixed LLW treatability studies; mixed LLW treatment technology development. Section 2.0 of this report will identify the approach used to modify vendor information from previous revisions of this report. It will also illustrate the methodology used to identify any additional companies. Section 3.0 will identify, by service, specific vendor capabilities and capacities. Because this document will be used to identify private sector vendors that may be able to handle DOE LLW and mixed LLW streams, it was decided that current DOE capabilities should also be identified. This would encourage cooperation between DOE sites and the various states and, in some instances, may result in a more cost-effective alternative to privatization. The DOE complex has approximately 35 sites that generate the majority of both LLW and mixed LLW. Section 4.0 will identify these sites by Operations Office, and their associated LLW and mixed LLW TSD units.

  4. Pioglitazone treatment increases spontaneous growth hormone (GH) secretion and stimulated GH levels in polycystic ovary syndrome

    DEFF Research Database (Denmark)

    Glintborg, Dorte; Støving, René Klinkby; Hagen, Claus

    2005-01-01

    BACKGROUND: Low GH levels, probably due to insulin resistance and increased abdominal fat mass, are well described in polycystic ovary syndrome (PCOS). GH acts as an important ovarian cogonadotropin, and GH disturbances may be an additional pathogenic factor in PCOS. Decreased abdominal fat mass...

  5. Recent developments in the extraction separation method for treatment of high-level liquid waste

    International Nuclear Information System (INIS)

    Jiao Rongzhou; Song Chongli; Zhu Yongjun

    2000-01-01

    A description and review of the recent developments in the extraction separation method for partitioning transuranium elements from high-level liquid waste (HLLW) is presented. The extraction separation processes such as TRUEX process, DIAMEX process, DIDPA process, CTH process, TRPO process are briefly discussed

  6. Effects of intensive atorvastatin and rosuvastatin treatment on apolipoprotein B-48 and remnant lipoprotein cholesterol levels

    Science.gov (United States)

    Atorvastatin and rosuvastatin at maximal doses are both highly effective in lowering low-density lipoprotein cholesterol (LDL-C) and triglyceride (TG) levels. Rosuvastatin has been shown to be more effective than atorvastatin in lowering LDL-C, small dense LDL-C and in raising high-density lipoprote...

  7. Aerated biofilters with multiple-level air injection configurations to enhance biological treatment of methane emissions.

    Science.gov (United States)

    Farrokhzadeh, Hasti; Hettiaratchi, J Patrick A; Jayasinghe, Poornima; Kumar, Sunil

    2017-09-01

    Aiming to improve conventional methane biofilter performance, a multiple-level aeration biofilter design is proposed. Laboratory flow-through column experiments were conducted to evaluate three actively-aerated methane biofilter configurations. Columns were aerated at one, two, and three levels of the bed depth, with air introduced at flow rates calculated from methane oxidation reaction stoichiometry. Inlet methane loading rates were increased in five stages between 6 and 18mL/min. The effects of methane feeding rate, levels of aeration, and residence time on methane oxidation rates were determined. Samples collected after completion of flow-through experiments were used to determine methane oxidation kinetic parameters, V max , K m , and methanotrophic community distribution across biofilter columns. Results obtained from mixed variances analysis and response surfaces, as well as methanotrophic activity data, suggested that, biofilter column with two aeration levels has the most even performance over time, maintaining 85.1% average oxidation efficiency over 95days of experiments. Copyright © 2017 Elsevier Ltd. All rights reserved.

  8. Sustainability of High-Level Isolation Capabilities among US Ebola Treatment Centers.

    Science.gov (United States)

    Herstein, Jocelyn J; Biddinger, Paul D; Gibbs, Shawn G; Le, Aurora B; Jelden, Katelyn C; Hewlett, Angela L; Lowe, John J

    2017-06-01

    To identify barriers to maintaining and applying capabilities of US high-level isolation units (HLIUs) used during the Ebola virus disease outbreak, during 2016 we surveyed HLIUs. HLIUs identified sustainability challenges and reported the highly infectious diseases they would treat. HLIUs expended substantial resources in development but must strategize models of sustainability to maintain readiness.

  9. Parallel increases in sister chromatid exchanges at base level and with UV treatment in human opiate users

    International Nuclear Information System (INIS)

    Shafer, D.A.; Falek, A.; Madden, J.J.; Tadayon, F.; Pline, M.; Kuehnle, J.C.; Mendelson, J.

    1983-01-01

    The SCE base level frequency and SCE levels induced by far-UV (254 nm) treatment of cells in early G 1 and early S phases of the cell cycle were significantly higher in leukocytes from heroin addicts as compared to controls. The increased SCE levels in addicts was greatest at base level and smallest after UV irradiation of cells in S phase. These results corrobate and extend our previous findings of increased chromosome damage and reduced DNA-repair synthesis in heroin users. Since opiates do not directly damage DNA, the elevated cytogenetic effects associated with opiate use probably arise from secondary promotional effects related to opiate-mediated alterations in leukocyte metabolism. (orig.)

  10. Alendronate treatment alters bone tissues at multiple structural levels in healthy canine cortical bone.

    Science.gov (United States)

    Acevedo, Claire; Bale, Hrishikesh; Gludovatz, Bernd; Wat, Amy; Tang, Simon Y; Wang, Mingyue; Busse, Björn; Zimmermann, Elizabeth A; Schaible, Eric; Allen, Matthew R; Burr, David B; Ritchie, Robert O

    2015-12-01

    Bisphosphonates are widely used to treat osteoporosis, but have been associated with atypical femoral fractures (AFFs) in the long term, which raises a critical health problem for the aging population. Several clinical studies have suggested that the occurrence of AFFs may be related to the bisphosphonate-induced changes of bone turnover, but large discrepancies in the results of these studies indicate that the salient mechanisms responsible for any loss in fracture resistance are still unclear. Here the role of bisphosphonates is examined in terms of the potential deterioration in fracture resistance resulting from both intrinsic (plasticity) and extrinsic (shielding) toughening mechanisms, which operate over a wide range of length-scales. Specifically, we compare the mechanical properties of two groups of humeri from healthy beagles, one control group comprising eight females (oral doses of saline vehicle, 1 mL/kg/day, 3 years) and one treated group comprising nine females (oral doses of alendronate used to treat osteoporosis, 0.2mg/kg/day, 3 years). Our data demonstrate treatment-specific reorganization of bone tissue identified at multiple length-scales mainly through advanced synchrotron x-ray experiments. We confirm that bisphosphonate treatments can increase non-enzymatic collagen cross-linking at molecular scales, which critically restricts plasticity associated with fibrillar sliding, and hence intrinsic toughening, at nanoscales. We also observe changes in the intracortical architecture of treated bone at microscales, with partial filling of the Haversian canals and reduction of osteon number. We hypothesize that the reduced plasticity associated with BP treatments may induce an increase in microcrack accumulation and growth under cyclic daily loadings, and potentially increase the susceptibility of cortical bone to atypical (fatigue-like) fractures. Published by Elsevier Inc.

  11. Implementation of laser technology and treatment at county level in the Swedish Public Dental Service.

    Science.gov (United States)

    Bergholm, Åsa; Östberg, Anna-Lena; Gabre, Pia

    2014-01-01

    The aim of this study was to obtain an understanding of the factors that affected the way new technology and methods were used in dentistry after a training program. A qualitative research method was used to collect data. Nine dentists working in the Public Dental Service (PDS) in Uppsala County in Sweden agreed to be interviewed in the study. They worked in five different clinics, all with laser equipment, and had received training in the use of lasers. The interviews were tape recorded and transcribed, and were analysed using manifest and latent qualitative content analysis. The categories in this study were identified as "Prerequisites and obstacles to imple- mentation", "Attitudes to laser technology and treatments" and "Laser technology in the future'". The dentists described working with lasers as complicated and problematic. They had concerns about the method relating to the working environment, evidence of efficacy of treatment, costs, and benefits for patients and dentists. The main finding was that the decision to adopt the technology seemed to be based on individual perceptions of the value of lasers compared to other ways of achieving the same goal. They provided uniform proposals regarding how an organization should implement new methods, including an emphasis on the importance of preparation and having opportunities to be able to test and evaluate the technology. Another important factor was support from surrounding staff, colleagues and management. Despite all the barriers, the respondents were positive about working with lasers in the future, mainly due to their belief that patients would demand laser treatment. In conclusion both individual and organizational factors affected the extent to which the respondents used the laser. The main finding was the individual perception of the value of lasers compared to other methods which could achieve the same goal.

  12. Adalimumab for Treatment of Noninfectious Uveitis: Immunogenicity and Clinical Relevance of Measuring Serum Drug Levels and Antidrug Antibodies.

    Science.gov (United States)

    Cordero-Coma, Miguel; Calleja-Antolín, Sara; Garzo-García, Irene; Nuñez-Garnés, Ana M; Álvarez-Castro, Carolina; Franco-Benito, Manuel; Ruiz de Morales, Jose G

    2016-12-01

    To evaluate the rate of immunogenicity induced by adalimumab and its relationship with drug serum levels and clinical responses in patients with noninfectious uveitis. Prospective observational study. Consecutive patients from 1 referral center who initiated treatment with adalimumab for active noninfectious uveitis resistant to conventional therapy. All patients received 40 mg adalimumab every other week. Patients were evaluated clinically and immunologically before and after 4, 8, and 24 weeks of treatment. Clinical evaluation included assessment of changes in visual acuity, degree of inflammation in the anterior chamber and vitreous cavity, central macular thickness, and retinal angiographic leakage. Immunologic evaluation included assessment of serum trough adalimumab and antibodies against adalimumab (AAA) levels and class II HLA typing. Twenty-five patients were enrolled. Overall, 18 of 25 patients (72%) showed a favorable clinical response to adalimumab therapy. Eleven patients (44%) achieved a complete response and 7 (28%) achieved a partial response. However, 7 of 25 patients (28%) were considered nonresponders. Median trough adalimumab serum levels were higher in responders than in nonresponders (P uveitis outcome was observed only in patients with permanent AAA+, which correlated with undetectable adalimumab trough levels (P = 0.014). Treatment of noninfectious uveitis with adalimumab is associated with high rates of favorable clinical response. Overall, adalimumab trough levels were higher in responder patients. Development of permanent AAA was associated with undetectable trough adalimumab levels and worse uveitis outcome. Immunogenicity was more common in patients in whom uveitis was associated with a systemic disease and was not influenced by concomitant immunosuppressors. Copyright © 2016 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

  13. Methodology development for radioactive waste treatment of CDTN/BR - liquid low-level radioactive wastes

    International Nuclear Information System (INIS)

    Morais, Carlos Antonio de

    1996-01-01

    The radioactive liquid wastes generated in Nuclear Technology Development Centre (CDTN) were initially treated by precipitation/filtration and then the resulting wet solid wastes were incorporated in cement. These wastes were composed of different chemicals and different radioactivities and were generated by different sectors. The objective of the waste treatment method was to obtain minimum wet solid waste volume and decontamination and minimum operational cost. The composition of the solid wastes were taken into consideration for compatible cementation process. Approximately 5,400 litres of liquid radioactive wastes were treated by this process during 1992-1995. The volume reduction was 1/24 th and contained 20% solids. (author)

  14. Low-level laser treatment accelerated hair regrowth in a rat model of chemotherapy-induced alopecia (CIA).

    Science.gov (United States)

    Wikramanayake, Tongyu Cao; Villasante, Alexandra C; Mauro, Lucia M; Nouri, Keyvan; Schachner, Lawrence A; Perez, Carmen I; Jimenez, Joaquin J

    2013-05-01

    Chemotherapy-induced alopecia (CIA) is one of the most distressing side effects of antineoplastic chemotherapy for which there is no effective interventional approach. A low-level laser (LLL) device, the HairMax LaserComb®, has been cleared by the FDA to treat androgenetic alopecia. Its effects may be extended to other settings; we have demonstrated that LaserComb treatment induced hair regrowth in a mouse model for alopecia areata. In the current study, we tested whether LLL treatment could promote hair regrowth in a rat model for CIA. Chemotherapy agents cyclophosphamide, etoposide, or a combination of cyclophosphamide and doxorubicin were administered in young rats to induce alopecia, with or without LLL treatment. As expected, 7-10 days later, all the rats developed full body alopecia. However, rats receiving laser treatment regrew hair 5 days earlier than rats receiving chemotherapy alone or sham laser treatment (with the laser turned off). The accelerated hair regrowth in laser-treated rats was confirmed by histology. In addition, LLL treatment did not provide local protection to subcutaneously injected Shay chloroleukemic cells. Taken together, our results demonstrated that LLL treatment significantly accelerated hair regrowth after CIA without compromising the efficacy of chemotherapy in our rat model. Our results suggest that LLL should be explored for the treatment of CIA in clinical trials because LLL devices for home use (such as the HairMax LaserComb®) provide a user-friendly and noninvasive approach that could be translated to increased patient compliance and improved efficacy.

  15. [Clinical evaluation of flomoxef in the treatment of chorioamnionitis and changes in the fetal fibronectin level in vaginal secretion].

    Science.gov (United States)

    Chimura, T; Hirayama, T; Oda, T; Saitou, N; Morisaki, N

    1993-02-01

    Flomoxef (FMOX) was administered as an initial treatment for chorioamnionitis complicating possible spontaneous abortion or premature delivery and preterm PROM (premature rupture of the membranes), and the clinical effectiveness of the drug, and the usefulness of fetal fibronectin (FFN) as a diagnostic marker of premature delivery were evaluated. 1. Clinical effects of drip infusion of FMOX (2-4 g/day) with and without tocolysis for the treatment of chorioamnionitis were evaluated in 43 patients with possible spontaneous abortion or premature delivery and those with preterm PROM (n = 43). Changes in the FFN level in the vaginal secretion were also studied in 11 patients. 2. It was possible to prevent premature delivery in 7 (26.9%) of 26 patients, and the latent period of preterm PROM was longer than 8 days in 6 (46.2%) of 13 patients. 3. The FFN level decreased slightly in patients for whom FMOX was effective, and the outcome was satisfactory in those whose FFN levels were less than 200 ng/ml. However, the outcome was poor in those whose FFN levels were higher than 1,000 ng/ml. These findings suggest that changes in the FFN level in the vaginal secretion reflect the clinical course of chorioamnionitis as do changes in CRP.

  16. The optimal cutoff serum level of human chorionic gonadotropin for efficacy of methotrexate treatment in women with extrauterine pregnancy.

    Science.gov (United States)

    Sagiv, Ron; Debby, Abraham; Feit, Hagit; Cohen-Sacher, Bina; Keidar, Ran; Golan, Abraham

    2012-02-01

    To evaluate the efficacy of methotrexate treatment for extrauterine pregnancy and define criteria for prediction of success. Of 829 patients with an ectopic pregnancy admitted to E. Wolfson Medical Center, Holon, Israel, from January 1997 through December 2009, 238 had asymptomatic tubal pregnancies and increasing serum β-human chorionic gonadotropin (βhCG) levels. These patients were treated with a single intramuscular injection of 50mg of methotrexate (MTX) per square meter of body surface. Success was defined as undetectable βhCG levels without the need for a surgical intervention. The groups of patients successfully treated (n=167 [70%]) and unsuccessfully treated (n=71 [30%]) were compared. They were similar regarding age and gravidity. The initial serum βhCG level was significantly higher in the latter group than in the former (3798 mIU/mL vs. 1601 mIU/mL, Pinitial βhCG levels were less than 1000 mIU/mL, 71% when they were between 1000 and 2000 mIU/mL, and only 59% when they were between 2000 and 3000 mIU/mL. Methotrexate treatment is a safe and effective alternative to surgery. However, patients with initial βhCG levels higher than 2000 mIU/mL should only be offered the surgical approach. Copyright © 2011. Published by Elsevier Ireland Ltd.

  17. Hepatic cysteamine and non-protein sulfhydryl levels following cystamine or cysteamine treatment of galactosamine-poisoned rats

    International Nuclear Information System (INIS)

    MacDonald, J.R.; Gandolfi, A.J.; Sipes, I.G.

    1985-01-01

    Hepatic cysteamine and non-protein sulfhydryl (NPSH) levels were determined in galactosamine (GAL)-poisoned rats following hepatoprotective cystamine or cysteamine treatments to determine whether alterations of hepatic NPSH status could contribute to their observed protective actions. D(+)-Galactosamine HC1 (400 mg/kg, ip) was administered to male Sprague-Dawley rats at 8 pm. Cystamine diHC1 (300 mg/kg, po) or cysteamine HC1 (170 mg/kg, ip) were administered 12 hr after GAL. Hepatic NPSH levels were determined using Ellman's reagent. Hepatic cysteamine levels were determined by separating NPSH Ellman's derivatives by reversed phase HPLC. Cystamine and cysteamine caused transient elevation of NPSH levels of 1-2 nanomoles/mg liver which correlated with the presence of 1-2 nanomoles of cysteamine/mg liver. However, neither cystamine nor cysteamine prevented NPSH levels from falling to 3 nanomoles/mg tissue 24 hr after GAL. Hepatoprotective treatments did not affect long term NPSH status in GAL-poisoned rats. However, transient NPSH increases, due to the intrahepatic presence of cysteamine, may contribute to the therapeutic effects of these hepatoprotective agents

  18. Elevated Systemic Levels of Eosinophil, Neutrophil, and Mast Cell Granular Proteins in Strongyloides Stercoralis Infection that Diminish following Treatment.

    Science.gov (United States)

    Rajamanickam, Anuradha; Munisankar, Saravanan; Bhootra, Yukthi; Dolla, Chandra Kumar; Nutman, Thomas B; Babu, Subash

    2018-01-01

    Infection with the helminth parasite Strongyloides stercoralis ( Ss ) is commonly clinically asymptomatic that is often accompanied by peripheral eosinophilia. Granulocytes are activated during helminth infection and can act as immune effector cells. Plasma levels of eosinophil and neutrophil granular proteins convey an indirect measure of granulocyte degranulation and are prominently augmented in numerous helminth-infected patients. In this study, we sought to examine the levels of eosinophil, neutrophil, and mast cell activation-associated granule proteins in asymptomatic Ss infection and to understand their kinetics following anthelmintic therapy. To this end, we measured the plasma levels of eosinophil cationic protein, eosinophil-derived neurotoxin, eosinophil peroxidase, eosinophil major basic protein, neutrophil elastase, myeloperoxidase, neutrophil proteinase-3, mast cell tryptase, leukotriene C4, and mast cell carboxypeptidase-A3 in individuals with asymptomatic Ss infection or without Ss infection [uninfected (UN)]. We also estimated the levels of all of these analytes in infected individuals following definitive treatment of Ss infection. We demonstrated that those infected individuals have significantly enhanced plasma levels of eosinophil cationic protein, eosinophil-derived neurotoxin, eosinophil peroxidase, eosinophil major basic protein, elastase, myeloperoxidase, mast cell tryptase, leukotriene C4, and carboxypeptidase-A3 compared to UN individuals. Following the treatment of Ss infection, each of these granulocyte-associated proteins drops significantly. Our data suggest that eosinophil, neutrophil, and mast cell activation may play a role in the response to Ss infection.

  19. Independent peer review panel report on the integrated nonthermal treatment systems study and the comparison of integrated thermal and integrated nonthermal treatment systems for mixed low level waste

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1996-08-01

    The US Department of Energy`s (DOE) Office of Environmental Management (EM) Office of Science and Technology (OST) has conducted studies of integrated thermal treatment systems and integrated nonthermal treatment systems (INTS) for treating contact handled, alpha and non-alpha mixed low level radioactive waste (MLLW). The MLLW in the DOE complex consists of a wide variety of organic and inorganic solids and liquids contaminated with radioactive substances. Treatment systems are needed to destroy organic material and stabilize residues prior to land disposal. In May 1996 the Deputy Assistant Secretary for OST appointed an Independent Peer Review Panel to: (1) review and comment on the INTS Study; (2) make recommendations on the most promising thermal and nonthermal treatment systems; (3) make recommendations on research and development necessary to prove the performance of nonthermal and thermal technologies; and (4) review and comment on the preliminary draft of the ITTS/INTS Comparison Report. This report presents the primary conclusions and recommendations based on the review of the INTS study and the comparison report. System selection, overviews, comparisons, cost estimations and sensitivity analyses, and recommended R and D engineering needs are then described and discussed.

  20. Independent peer review panel report on the integrated nonthermal treatment systems study and the comparison of integrated thermal and integrated nonthermal treatment systems for mixed low level waste

    International Nuclear Information System (INIS)

    1996-08-01

    The US Department of Energy's (DOE) Office of Environmental Management (EM) Office of Science and Technology (OST) has conducted studies of integrated thermal treatment systems and integrated nonthermal treatment systems (INTS) for treating contact handled, alpha and non-alpha mixed low level radioactive waste (MLLW). The MLLW in the DOE complex consists of a wide variety of organic and inorganic solids and liquids contaminated with radioactive substances. Treatment systems are needed to destroy organic material and stabilize residues prior to land disposal. In May 1996 the Deputy Assistant Secretary for OST appointed an Independent Peer Review Panel to: (1) review and comment on the INTS Study; (2) make recommendations on the most promising thermal and nonthermal treatment systems; (3) make recommendations on research and development necessary to prove the performance of nonthermal and thermal technologies; and (4) review and comment on the preliminary draft of the ITTS/INTS Comparison Report. This report presents the primary conclusions and recommendations based on the review of the INTS study and the comparison report. System selection, overviews, comparisons, cost estimations and sensitivity analyses, and recommended R and D engineering needs are then described and discussed

  1. Application of DOE prescribed guides to the evaluation of Hanford's Mixed Low Level Solid Waste Treatment Options

    International Nuclear Information System (INIS)

    Campbell, B.F.; Nash, C.R.

    1994-10-01

    A recent Westinghouse Hanford Company report (WHC-SD-W100-ES-008, February, 1994), compared a Vitrification process to the WRAP-2A Grout/PE process for the treatment of Mixed Low Level Waste (MLLW). This comparison applied a limited scope numerical evaluation to compare technology complexity of the two processes, but focused primarily on capital and operating costs. The work reported here is supplementary to WHC-SD-Wl00-ES-008. It provides a record of the application of the more formal DOE-prescribed criteria (Treatment Selection Guides for Federal Facility Compliance Act Draft Site Treatment Plans) to the Vitrification and Grout/PE processes previously evaluated. Results of the evaluation favored the Grout/PE process by a weighted score of 83 to 78 over the Plasma arc vitrification process

  2. Assessment of Changes in Nickel and Chromium Levels in the Gingival Crevicular Fluid during Fixed Orthodontic Treatment.

    Science.gov (United States)

    Bhasin, Vinny; Pustake, Swati J; Joshi, Viprat; Tiwari, Anil; Bhasin, Meenakshi; Punia, Ramandeep S

    2017-08-01

    Various components of appliances used in fixed orthodontic treatment are fabricated from materials that are highly resistant in nature and have high strength and biocompatibility. Corrosion of materials occurs inside the oral cavity due to numerous environmental or oral factors that act on them. These factors include temperature, pH variation, salivary conditions, mechanical loads, microbiological and enzymatic activity, and various food components. Gingival crevicular fluid (GCF) is the material obtained from the gingival sulcus and might act as a potential source for various biomarkers in the orthodontic setup because inflammatory-induced response is directly related to orthodontic forces in GCF. In the light of above-mentioned data, we planned this study to assess and evaluate the changes occurring in nickel and chromium levels in the GCF during fixed orthodontic treatment. This study included assessment of 30 patients who underwent fixed orthodontic treatment. Three samples were taken from the GCF of the patients giving a total of 90 samples. The samples were collected at the following time intervals: At baseline (pretreatment time), 1 month after the start of orthodontic treatment, and at 6 months after the commencement of orthodontic treatment. Cellulose strips were used for isolation of the tooth region. For GCF collection, a standardized cellulose acetate absorbent strip was used. Placement of the strips was done in the sulcus for 60 seconds for the collection of the samples. Refrigeration of the specimen bottles was done for a minimum of 7 days and was then sent to a laboratory where specimens were transferred for atomic absorption spectrophotometry. All the results were analyzed by Statistical Package for the Social Sciences software. At 1 month, the mean value of nickel and chromium in GCF was found to be 4.5 and 4.9 ug/gm of GCF respectively. While comparing the mean nickel levels between 1 and 6 months and between baseline and 6 months, significant

  3. Advanced waste form and melter development for treatment of troublesome high-level wastes

    Energy Technology Data Exchange (ETDEWEB)

    Marra, James [Savannah River Site (SRS), Aiken, SC (United States). Savannah River National Lab. (SRNL); Kim, Dong -Sang [Pacific Northwest National Lab. (PNNL), Richland, WA (United States); Maio, Vincent [Idaho National Lab. (INL), Idaho Falls, ID (United States)

    2015-09-02

    A number of waste components in US defense high level radioactive wastes (HLW) have proven challenging for current Joule heated ceramic melter (JHCM) operations and have limited the ability to increase waste loadings beyond already realized levels. Many of these "troublesome" waste species cause crystallization in the glass melt that can negatively impact product quality or have a deleterious effect on melter processing. Recent efforts at US Department of Energy laboratories have focused on understanding crystallization behavior within HLW glass melts and investigating approached to mitigate the impacts of crystallization so that increases in waste loading can be realized. Advanced glass formulations have been developed to highlight the unique benefits of next-generation melter technologies such as the Cold Crucible Induction Melter (CCIM). Crystal-tolerant HLW glasses have been investigated to allow sparingly soluble components such as chromium to crystallize in the melter but pass out of the melter before accumulating.

  4. Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial

    DEFF Research Database (Denmark)

    Goldstein, L.B.; Amarenco, P.; Zivin, J.

    2009-01-01

    BACKGROUND AND PURPOSE: Laboratory experiments suggest statins reduce stroke severity and improve outcomes. The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial was a placebo-controlled, randomized trial designed to determine whether treatment with atorvastatin reduces...... or 4), moderate (modified Rankin Scale score 3 or 2), and mild (modified Rankin Scale score 1 or 0) outcome ischemic strokes and transient ischemic attacks and an increase in the proportion of event-free subjects randomized to atorvastatin (P

  5. Evaluation of RNFL thickness and serum cytokine levels after retinal photocoagulation combined with intravitreous Conbercept injection treatment of diabetic retinopathy

    Institute of Scientific and Technical Information of China (English)

    Luo Na

    2016-01-01

    Objective:To evaluate the effect of retinal photocoagulation combined with intravitreous Conbercept injection in RNFL thickness, serum cytokine levels and other aspects of diabetic retinopathy.Methods:A total of 92 patients with diabetic retinopathy (126 eyes) who received inpatient treatment in our hospital from December, 2013 to December 2015 were included in the study and divided into observation group 46 cases (62 eyes) and control group 46 cases (64 eyes) according to random number table, control group received retinal photocoagulation therapy alone, observation group received retinal photocoagulation combined with intravitreous Conbercept injection treatment, and then differences in RNFL thickness, hemodynamic indexes, serum levels of cytokines and others were compared between two groups after treatment.Results: Average RNFL thickness of inner optic disc top, bottom, bitamporal and nasal ring area as well as the average full-cycle 360° RNFL thickness of observation group after treatment was less than those of control group; PSV and EDV values of CRA were higher than those of control group while RI value was lower than that of control group, and PSV, EDV and RI values of CRV were lower than those of control group; serumβ2-GPⅠ, Hcy, VEGF and SDF-1 levels were lower than those of control group while C-peptide and APN levels were higher than those of control group.Conclusion: Retinal photocoagulation combined with intravitreous Conbercept injection can significantly reduce the RNFL thickness of the patients with diabetic retinopathy and optimize the retinal hemodynamic status, and helps to improve patients’ overall conditions.

  6. Optimization of the dose level for a given treatment plan to maximize the complication-free tumor cure

    International Nuclear Information System (INIS)

    Lind, B.K.; Mavroidis, P.; Hyoedynmaa, S.; Kappas, C.

    1999-01-01

    During the past decade, tumor and normal tissue reactions after radiotherapy have been increasingly quantified in radiobiological terms. For this purpose, response models describing the dependence of tumor and normal tissue reactions on the irradiated volume, heterogeneity of the delivered dose distribution and cell sensitivity variations can be taken into account. The probability of achieving a good treatment outcome can be increased by using an objective function such as P + , the probability of complication-free tumor control. A new procedure is presented, which quantifies P + from the dose delivery on 2D surfaces and 3D volumes and helps the user of any treatment planning system (TPS) to select the best beam orientations, the best beam modalities and the most suitable beam energies. The final step of selecting the prescribed dose level is made by a renormalization of the entire dose plan until the value of P + is maximized. The index P + makes use of clinically established dose-response parameters, for tumors and normal tissues of interest, in order to improve its clinical relevance. The results, using P + , are compared against the assessments of experienced medical physicists and radiation oncologists for two clinical cases. It is observed that when the absorbed dose level for a given treatment plan is increased, the treatment outcome first improves rapidly. As the dose approaches the tolerance of normal tissues the complication-free curve begins to drop. The optimal dose level is often just below this point and it depends on the geometry of each patient and target volume. Furthermore, a more conformal dose delivery to the target results in a higher control rate for the same complication level. This effect can be quantified by the increased value of the P + parameter. (orig.)

  7. Proton therapy for prostate cancer treatment employing online image guidance and an action level threshold.

    Science.gov (United States)

    Vargas, Carlos; Falchook, Aaron; Indelicato, Daniel; Yeung, Anamaria; Henderson, Randall; Olivier, Kenneth; Keole, Sameer; Williams, Christopher; Li, Zuofeng; Palta, Jatinder

    2009-04-01

    The ability to determine the accuracy of the final prostate position within a determined action level threshold for image-guided proton therapy is unclear. Three thousand one hundred ten images for 20 consecutive patients treated in 1 of our 3 proton prostate protocols from February to May of 2007 were analyzed. Daily kV images and patient repositioning were performed employing an action-level threshold (ALT) of > or = 2.5 mm for each beam. Isocentric orthogonal x-rays were obtained, and prostate position was defined via 3 gold markers for each patient in the 3 axes. To achieve and confirm our action level threshold, an average of 2 x-rays sets (median 2; range, 0-4) was taken daily for each patient. Based on our ALT, we made no corrections in 8.7% (range, 0%-54%), 1 correction in 82% (41%-98%), and 2 to 3 corrections in 9% (0-27%). No patient needed 4 or more corrections. All patients were treated with a confirmed error of < 2.5 mm for every beam delivered. After all corrections, the mean and standard deviations were: anterior-posterior (z): 0.003 +/- 0.094 cm; superior-inferior (y): 0.028 +/- 0.073 cm; and right-left (x) -0.013 +/- 0.08 cm. It is feasible to limit all final prostate positions to less than 2.5 mm employing an action level image-guided radiation therapy (IGRT) process. The residual errors after corrections were very small.

  8. Reducing uranium and thorium level in Zircon: effect of heat treatment on rate of leaching

    International Nuclear Information System (INIS)

    Meor Yusoff Meor Sulaiman

    2002-01-01

    Considerable amount of uranium and thorium are found in Malaysian zircon and the level is much higher than the minimum value adopted by many importing countries. Selective leaching had been applied as an important technique to reduce these elements. An initial study was carried out using hydrochloric acid leaching system but the result was not favourable. The rate of uranium and thorium leached can be further improved by introducing a heat pretreatment process prior to leaching (Author)

  9. Increased thiol levels in antimony-resistant Leishmania infantum isolated from treatment-refractory visceral leishmaniasis in Brazil.

    Science.gov (United States)

    Magalhães, Lucas S; Bomfim, Lays Gs; Mota, Sthefanne G; Cruz, Geydson S; Corrêa, Cristiane B; Tanajura, Diego M; Lipscomb, Michael W; Borges, Valéria M; Jesus, Amélia R de; Almeida, Roque P de; Moura, Tatiana R de

    2018-02-01

    BACKGROUND Treatment-refractory visceral leishmaniasis (VL) has become an important problem in many countries. OBJECTIVES We evaluated the antimony-resistance mechanisms of Leishmania infantum isolated from VL patients refractory or responsive to treatment with pentavalent antimony. METHODS Strains isolated from antimony-refractory patients (in vitro antimony-resistant isolates) and antimony-responsive patients (in vitro antimony-sensitive isolates) were examined. Morphological changes were evaluated by transmission electron microscopy after trivalent antimony exposure. P-glycoprotein (P-gp) efflux pump activity was evaluated using the pump-specific inhibitor verapamil hydrochloride, and the role of thiol in trivalent antimony resistance was investigated using the enzymatic inhibitor L-buthionine sulfoximine. FINDINGS Antimony treatment induced fewer alterations in the cellular structure of L. infantum resistant isolates than in that of sensitive isolates. P-gp efflux activity was not involved in antimony resistance in these isolates. Importantly, the resistant isolates contained higher levels of thiol compared to the sensitive isolates, and inhibition of thiol synthesis in the resistant isolates recovered their sensitivity to trivalent antimony treatment, and enhanced the production of reactive oxygen species in promastigotes exposed to the drug. MAIN CONCLUSIONS Our results demonstrate that isolates from patients with antimony-refractory VL exhibited higher thiol levels than antimony-sensitive isolates. This indicates that redox metabolism plays an important role in the antimony-resistance of New World VL isolates.

  10. Performance Improvement Of Cross-Flow Filtration For High Level Waste Treatment

    International Nuclear Information System (INIS)

    Duignan, M.; Nash, C.; Poirier, M.

    2011-01-01

    In the interest of accelerating waste treatment processing, the DOE has funded studies to better understand filtration with the goal of improving filter fluxes in existing cross-flow equipment. The Savannah River National Laboratory (SRNL) was included in those studies, with a focus on start-up techniques, filter cake development, the application of filter aids (cake forming solid precoats), and body feeds (flux enhancing polymers). This paper discusses the progress of those filter studies. Cross-flow filtration is a key process step in many operating and planned waste treatment facilities to separate undissolved solids from supernate slurries. This separation technology generally has the advantage of self-cleaning through the action of wall shear stress created by the flow of waste slurry through the filter tubes. However, the ability of filter wall self-cleaning depends on the slurry being filtered. Many of the alkaline radioactive wastes are extremely challenging to filtration, e.g., those containing compounds of aluminum and iron, which have particles whose size and morphology reduce permeability. Unfortunately, low filter flux can be a bottleneck in waste processing facilities such as the Savannah River Modular Caustic Side Solvent Extraction Unit and the Hanford Waste Treatment Plant. Any improvement to the filtration rate would lead directly to increased throughput of the entire process. To date increased rates are generally realized by either increasing the cross-flow filter axial flowrate, limited by pump capacity, or by increasing filter surface area, limited by space and increasing the required pump load. SRNL set up both dead-end and cross-flow filter tests to better understand filter performance based on filter media structure, flow conditions, filter cleaning, and several different types of filter aids and body feeds. Using non-radioactive simulated wastes, both chemically and physically similar to the actual radioactive wastes, the authors performed

  11. PERFORMANCE IMPROVEMENT OF CROSS-FLOW FILTRATION FOR HIGH LEVEL WASTE TREATMENT

    Energy Technology Data Exchange (ETDEWEB)

    Duignan, M.; Nash, C.; Poirier, M.

    2011-01-12

    In the interest of accelerating waste treatment processing, the DOE has funded studies to better understand filtration with the goal of improving filter fluxes in existing cross-flow equipment. The Savannah River National Laboratory (SRNL) was included in those studies, with a focus on start-up techniques, filter cake development, the application of filter aids (cake forming solid precoats), and body feeds (flux enhancing polymers). This paper discusses the progress of those filter studies. Cross-flow filtration is a key process step in many operating and planned waste treatment facilities to separate undissolved solids from supernate slurries. This separation technology generally has the advantage of self-cleaning through the action of wall shear stress created by the flow of waste slurry through the filter tubes. However, the ability of filter wall self-cleaning depends on the slurry being filtered. Many of the alkaline radioactive wastes are extremely challenging to filtration, e.g., those containing compounds of aluminum and iron, which have particles whose size and morphology reduce permeability. Unfortunately, low filter flux can be a bottleneck in waste processing facilities such as the Savannah River Modular Caustic Side Solvent Extraction Unit and the Hanford Waste Treatment Plant. Any improvement to the filtration rate would lead directly to increased throughput of the entire process. To date increased rates are generally realized by either increasing the cross-flow filter axial flowrate, limited by pump capacity, or by increasing filter surface area, limited by space and increasing the required pump load. SRNL set up both dead-end and cross-flow filter tests to better understand filter performance based on filter media structure, flow conditions, filter cleaning, and several different types of filter aids and body feeds. Using non-radioactive simulated wastes, both chemically and physically similar to the actual radioactive wastes, the authors performed

  12. Treatment of self-poisoning at a tertiary level hospital in Bangladesh

    DEFF Research Database (Denmark)

    Verma, Vasundhara; Paul, Sujat; Ghose, Aniruddha

    2017-01-01

    OBJECTIVES: Approximately 10,000 people die from suicide annually in Bangladesh, many from pesticide poisoning. We aimed to estimate financial costs to patients and health services of treating patients with self-poisoning. METHODS: Data on direct costs to families, sources of funds for treatment...... and family wealth were collected prospectively over a one-month period in 2016 at the tertiary Chittagong Medical College Hospital, Bangladesh. Aggregate operational costs to the government were calculated using annual budget, bed occupancy and length-of-stay data. RESULTS: Agrochemicals were the most common...... as organophosphorus poisoning in 17(.) 0% of agrochemical cases resulted in increased cost to patients. Only 51(.) 9% of patients had indicators of wealth; 78(.) 1% borrowed money to cover costs. Conservatively estimated median healthcare costs (US$ 21(.) 30 per patient) were markedly lower than costs to patients...

  13. Fractional treatment of spent scintillation cocktail with low level tritium by azeotropic distillation

    International Nuclear Information System (INIS)

    Nishikawa, Masabumi; Kotoh, Kenji; Koga, Keisuke; Katase, Akira

    1982-01-01

    Among various waste from RI laboratories, one of the most troublesome wastes is the spent liquid scintillation cocktail, because there are no good disposal way but to store in each laboratories. The fractionation of tritiated water, solvent and alkyl detergent from the spent scintillation cocktail by the azeotropic distillation method is examined in this study, and it has been concluded that this method is applicable, It is also found in this study that removal of tritiated water from distilled solvent can be conducted by using adsorption tower with Molecular sieve 3A. Treatment of the spent scintillation cocktail within 3 months after use is recomended because no isotope exchange reaction with solvent or detergent is observed within 3 months after use in this study. No isotope effects are observed in the zeotropic distillation process. (author)

  14. The effects of systemic, topical, and intralesional steroid treatments on apoptosis level of nasal polyps.

    Science.gov (United States)

    Kapucu, Burak; Cekin, Engin; Erkul, Bulent Evren; Cincik, Hakan; Gungor, Atila; Berber, Ufuk

    2012-09-01

    The purpose of this study was to compare the apoptotic responses to systemic, topical, and intrapolyp injection of glucocorticoid with no treatment in nasal polyps. Prospective, randomized controlled study. Tertiary training hospital. The study was performed on 48 patients with nasal polyposis in the Department of Otorhinolaryngology between 2008 and 2009. Patients were assigned to 1 of 4 groups of 12 patients. Group A was treated with oral methylprednisolone 1 mg/kg/d, and the dose was tapered gradually. Group B received 0.3 mL triamcinolone acetonide (40 mg/mL), which was injected into polyp tissue. Group C was treated with topical 55 µg triamcinolone acetonide 2 times daily for 1 month. Group D received no medication. Samples were collected endoscopically after the seventh day for groups A and B, the first month for group C, and the first visit for group D. Apoptotic indexes were determined using the terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling method. Statistically significant differences in apoptotic index were found between each steroid-medicated group and the control group (P (D-A) = .0001; P (D-B) = .003; P (D-C) = .026) and between groups A and C (P (A-C) = .012). Group B did not differ significantly from either group A or C (P (A-B) = .11; P (B-C) = .75). The apoptotic index in nasal polyps treated with systemic, topical, and intrapolyp injection forms of glucocorticoids was higher than that in the control group. Systemic steroid treatment induced the most apoptosis.

  15. Fragile X and autism: Intertwined at the molecular level leading to targeted treatments

    Directory of Open Access Journals (Sweden)

    Hagerman Randi

    2010-09-01

    Full Text Available Abstract Fragile X syndrome (FXS is caused by an expanded CGG repeat (> 200 repeats in the 5' untranslated portion of the fragile mental retardation 1 gene (FMR1, leading to deficiency or absence of the FMR1 protein (FMRP. FMRP is an RNA carrier protein that controls the translation of several other genes that regulate synaptic development and plasticity. Autism occurs in approximately 30% of FXS cases, and pervasive developmental disorder, not otherwise specified (PDD-NOS occurs in an additional 30% of cases. Premutation repeat expansions (55 to 200 CGG repeats may also give rise to autism spectrum disorders (ASD, including both autism and PDD-NOS, through a different molecular mechanism that involves a direct toxic effect of the expanded CGG repeat FMR1 mRNA. RNA toxicity can also lead to aging effects including tremor, ataxia and cognitive decline, termed fragile X-associated tremor ataxia syndrome (FXTAS, in premutation carriers in late life. In studies of mice bearing premutation expansions, there is evidence of early postnatal neuronal cell toxicity, presenting as reduced cell longevity, decreased dendritic arborization and altered synaptic morphology. There is also evidence of mitochondrial dysfunction in premutation carriers. Many of the problems with cellular dysregulation in both premutation and full mutation neurons also parallel the cellular abnormalities that have been documented in autism without fragile X mutations. Research regarding dysregulation of neurotransmitter systems in FXS, including the metabotropic glutamate receptor (mGluR1/5 pathway and γ aminobutyric acid (GABAA pathways, have led to new targeted treatments for FXS. Preliminary evidence suggests that these new targeted treatments will also be beneficial in non-fragile X forms of autism.

  16. Formation and filtration characteristics of solids generated in a high level liquid waste treatment process. Solids formation behavior from simulated high level liquid waste

    International Nuclear Information System (INIS)

    Kondo, Y.; Kubota, M.

    1997-01-01

    The solids formation behavior in a simulated high level liquid waste (HLLW) was experimentally examined, when the simulated HLLW was treated in the ordinary way of actual HLLW treatment process. Solids formation conditions and mechanism were closely discussed. The solids formation during a concentration step can be explained by considering the formation of zirconium phosphate, phosphomolybdic acid and precipitation of strontium and barium nitrates and their solubilities. For the solids formation during the denitration step, at least four courses were observed; formation of an undissolved material by a chemical reaction with each other of solute elements (zirconium, molybdenum, tellurium) precipitation by reduction (platinum group metals) formation of hydroxide or carbonate compounds (chromium, neodymium, iron, nickel, strontium, barium) and a physical adsorption to stable solid such as zirconium molybdate (nickel, strontium, barium). (author)

  17. Regulatory T cell levels and cytokine production in active non-infectious uveitis: in-vitro effects of pharmacological treatment.

    Science.gov (United States)

    Molins, B; Mesquida, M; Lee, R W J; Llorenç, V; Pelegrín, L; Adán, A

    2015-03-01

    The aim of this study was to quantify the proportion of regulatory T cells (Treg ) and cytokine expression by peripheral blood mononuclear cells (PBMCs) in patients with active non-infectious uveitis, and to evaluate the effect of in-vitro treatment with infliximab, dexamethasone and cyclosporin A on Treg levels and cytokine production in PBMCs from uveitis patients and healthy subjects. We included a group of 21 patients with active non-infectious uveitis and 18 age-matched healthy subjects. The proportion of forkhead box protein 3 (FoxP3)(+) Treg cells and intracellular tumour necrosis factor (TNF)-α expression in CD4(+) T cells was determined by flow cytometry. PBMCs were also either rested or activated with anti-CD3/anti-CD28 and cultured in the presence or absence of dexamethasone, cyclosporin A and infliximab. Supernatants of cultured PBMCs were collected and TNF-α, interleukin (IL)-10, IL-17 and interferon (IFN)-γ levels were measured by enzyme-linked immunosorbent assay (ELISA). No significant differences were observed in nTreg levels between uveitis patients and healthy subjects. However, PBMCs from uveitis patients produced significantly higher amounts of TNF-α and lower amounts of IL-10. Dexamethasone treatment in vitro significantly reduced FoxP3(+) Treg levels in PBMCs from both healthy subjects and uveitis patients, and all tested drugs significantly reduced TNF-α production in PBMCs. Dexamethasone and cyclosporin A significantly reduced IL-17 and IFN-γ production in PBMCs and dexamethasone up-regulated IL-10 production in activated PBMCs from healthy subjects. Our results suggest that PBMCs from patients with uveitis express more TNF-α and less IL-10 than healthy subjects, and this is independent of FoxP3(+) Treg levels. Treatment with infliximab, dexamethasone and cyclosporin A in vitro modulates cytokine production, but does not increase the proportion of FoxP3(+) Treg cells. © 2014 British Society for Immunology.

  18. Association of Serum Uric Acid Levels with Leg Ischemia in Patients with Peripheral Arterial Disease after Treatment.

    Science.gov (United States)

    Sotoda, Yoko; Hirooka, Shigeki; Orita, Hiroyuki; Wakabayashi, Ichiro

    2017-07-01

    We investigated the relationships of serum uric acid levels with the progression of atherosclerosis in patients with peripheral arterial disease (PAD) after treatment. Subjects were male patients diagnosed with PAD. Atherosclerosis at the common carotid artery was evaluated based on its intima-media thickness (IMT). Leg arterial flow was evaluated by measuring ankle-brachial index (ABI) and exercise-induced decrease in ABI. Among various risk factors including age, blood pressure, adiposity, estimated glomerular filtration rate, and blood lipid, blood glucose, uric acid, fibrinogen and C-reactive protein levels, only uric acid levels showed significant correlations with ABI [Pearson's correlation coefficient, -0.292 (p<0.01)] and leg exercise-induced decrease in ABI [Pearson's correlation coefficient, 0.236 (p< 0.05)]. However, there was no significant correlation between uric acid levels and maximum or mean IMT. Odds ratios of subjects with the 3rd tertile versus subjects with the 1st tertile for uric acid levels were significantly higher than the reference level of 1.00 for low ABI [4.44 (95% confidence interval, 1.45-13.65, p<0.01)] and for high % decrease in ABI after exercise [4.31 (95% confidence interval, 1.34-13.82, p<0.05)]. The associations of uric acid levels with the indicators of leg ischemia were also found after adjustment for age, history of revascularization therapy, diabetes, smoking, alcohol consumption, body mass index, triglyceride levels, and renal function. Uric acid levels are associated with the degree of leg ischemia in patients with PAD. Further interventional studies are needed to determine whether the correction of uric acid levels is effective in preventing the progression of PAD.

  19. Analysis of the suitability of DOE facilities for treatment of commercial low-level radioactive mixed waste

    International Nuclear Information System (INIS)

    1996-02-01

    This report evaluates the capabilities of the United States Department of Energy's (DOE's) existing and proposed facilities to treat 52 commercially generated low-level radioactive mixed (LLMW) waste streams that were previously identified as being difficult-to-treat using commercial treatment capabilities. The evaluation was performed by comparing the waste matrix and hazardous waste codes for the commercial LLMW streams with the waste acceptance criteria of the treatment facilities, as identified in the following DOE databases: Mixed Waste Inventory Report, Site Treatment Plan, and Waste Stream and Technology Data System. DOE facility personnel also reviewed the list of 52 commercially generated LLMW streams and provided their opinion on whether the wastes were technically acceptable at their facilities, setting aside possible administrative barriers. The evaluation tentatively concludes that the DOE is likely to have at least one treatment facility (either existing or planned) that is technically compatible for most of these difficult-to-treat commercially generated LLMW streams. This conclusion is tempered, however, by the limited amount of data available on the commercially generated LLMW streams, by the preliminary stage of planning for some of the proposed DOE treatment facilities, and by the need to comply with environmental statutes such as the Clean Air Act

  20. Extending an evidence hierarchy to include topics other than treatment: revising the Australian 'levels of evidence'

    Directory of Open Access Journals (Sweden)

    Merlin Tracy

    2009-06-01

    Full Text Available Abstract Background In 1999 a four-level hierarchy of evidence was promoted by the National Health and Medical Research Council in Australia. The primary purpose of this hierarchy was to assist with clinical practice guideline development, although it was co-opted for use in systematic literature reviews and health technology assessments. In this hierarchy interventional study designs were ranked according to the likelihood that bias had been eliminated and thus it was not ideal to assess studies that addressed other types of clinical questions. This paper reports on the revision and extension of this evidence hierarchy to enable broader use within existing evidence assessment systems. Methods A working party identified and assessed empirical evidence, and used a commissioned review of existing evidence assessment schema, to support decision-making regarding revision of the hierarchy. The aim was to retain the existing evidence levels I-IV but increase their relevance for assessing the quality of individual diagnostic accuracy, prognostic, aetiologic and screening studies. Comprehensive public consultation was undertaken and the revised hierarchy was piloted by individual health technology assessment agencies and clinical practice guideline developers. After two and a half years, the hierarchy was again revised and commenced a further 18 month pilot period. Results A suitable framework was identified upon which to model the revision. Consistency was maintained in the hierarchy of "levels of evidence" across all types of clinical questions; empirical evidence was used to support the relationship between study design and ranking in the hierarchy wherever possible; and systematic reviews of lower level studies were themselves ascribed a ranking. The impact of ethics on the hierarchy of study designs was acknowledged in the framework, along with a consideration of how harms should be assessed. Conclusion The revised evidence hierarchy is now widely

  1. Extending an evidence hierarchy to include topics other than treatment: revising the Australian 'levels of evidence'

    Science.gov (United States)

    2009-01-01

    Background In 1999 a four-level hierarchy of evidence was promoted by the National Health and Medical Research Council in Australia. The primary purpose of this hierarchy was to assist with clinical practice guideline development, although it was co-opted for use in systematic literature reviews and health technology assessments. In this hierarchy interventional study designs were ranked according to the likelihood that bias had been eliminated and thus it was not ideal to assess studies that addressed other types of clinical questions. This paper reports on the revision and extension of this evidence hierarchy to enable broader use within existing evidence assessment systems. Methods A working party identified and assessed empirical evidence, and used a commissioned review of existing evidence assessment schema, to support decision-making regarding revision of the hierarchy. The aim was to retain the existing evidence levels I-IV but increase their relevance for assessing the quality of individual diagnostic accuracy, prognostic, aetiologic and screening studies. Comprehensive public consultation was undertaken and the revised hierarchy was piloted by individual health technology assessment agencies and clinical practice guideline developers. After two and a half years, the hierarchy was again revised and commenced a further 18 month pilot period. Results A suitable framework was identified upon which to model the revision. Consistency was maintained in the hierarchy of "levels of evidence" across all types of clinical questions; empirical evidence was used to support the relationship between study design and ranking in the hierarchy wherever possible; and systematic reviews of lower level studies were themselves ascribed a ranking. The impact of ethics on the hierarchy of study designs was acknowledged in the framework, along with a consideration of how harms should be assessed. Conclusion The revised evidence hierarchy is now widely used and provides a common

  2. Disposal of low-level radioactive wastes. Plasma furnace for the treatment of low-level radwastes in Switzerland. Plasma furnace for the treatment of low-level radwastes in Switzerland

    International Nuclear Information System (INIS)

    Hoffelner, W.; Mueller, T.; Fuenfschilling, M.R.; Jacobi, A.; Eschenbach, R.; Lutz, H.R.; Vuilleumier, C.

    1994-01-01

    The treatment method to be applied consists of thermal decomposition and vitrification. The facility to be constructed at the Zwilag is a plasma-arc furnace, and planning activities are heading towards the final phase. There will be only this one facility for treating in only one process step solid, mixed wastes, liquid wastes, sludges, metals, and inorganic wastes, producing vitrified waste packages ready for ultimate storage as 200-l waste drums. The main features of the plasma-arc furnace are explained. (orig./HP) [de

  3. Comparison of high-sensitivity C-reactive protein and fetuin-A levels before and after treatment for subjects with subclinical hyperthyroidism.

    Science.gov (United States)

    Bilgir, Oktay; Bilgir, Ferda; Topcuoglu, Tuba; Calan, Mehmet; Calan, Ozlem

    2014-03-01

    This study was designed to show the effect of propylthiouracil treatment on sCD40L, high-sensitivity C-reactive protein, and fetuin-A levels on subjects with subclinical hyperthyroidism. After checking sCD40L, high-sensitivity C-reactive protein, and fetuin-A levels of 35 patients with subclinical hyperthyroidism, each was given 50 mg tablets of propylthiouracil three times daily. After 3 months, sCD40L, high-sensitivity C-reactive protein, and fetuin-A levels were then compared to the levels before treatment. Although high-sensitivity C-reactive protein and sCD40L levels were normal in the subclinical hyperthyroidism patients compared to the healthy controls, fetuin-A levels were statistically significantly higher (*p = 0.022). After treatment, fetuin-A levels of subclinical hyperthyroidism patients decreased statistically significantly compared to the levels before treatment (**p = 0.026). sCD40L and high-sensitivity C-reactive protein levels did not have a statistically significant difference compared to the control group and post-propylthiouracil treatment. In subclinical hyperthyroidism patients, high fetuin-A levels before propylthiouracil treatment and decreases in these levels after treatment in cases with subclinical hyperthyroidism indicated the possibility of preventing long-term cardiac complications with propylthiouracil treatment.

  4. Dietary calcium levels and chemical treatments influencing radiostrontium uptake and release in mammalian bones

    International Nuclear Information System (INIS)

    Roushdy, H.M.; Moloukhia, M.K.; Abdel-Fattah, A.T.

    1979-01-01

    Data obtained from in vivo studies on rats suggest that the rate of administered radiostrontium uptake and deposition in bones shows a negative correlation with the levels of dietary calcium in the following order: CR, CN, CP, CDP, where CR stands for calcium-rich diet (Ca% 1.728), CN for calcium-normal ( Ca% 1.442), CP for calcium-poor (Ca% 0.347(and CDP for both calcium-poor (Ca% 0.135) and vitamin D deficient. The uptake values for the administered radiostrontium were affected by the duration of the experimental feeding time in the following order: 10, 50 and 120 days. Administration of MgSO 4 or SrCl 2 experimentally fed animals showed a decrease in the magnitude of radiostrontium uptake, the effect being more pronounced with MgSO, whereas CaCl 2 showed an increase in the rate of uptake of the radionuclide. It has been also found that increasing the level of dietary calcium as well as administration of stable strontium or magnesium favoured more rapid elimination of the radiostrontium from the bones and helped the animals to discriminate more significantly against radiostrontium uptake. The data obtained were statistically evaluated and the results discussed in view of the relevant literature. (author)

  5. FERRATE TREATMENT FOR REMOVING CHROMIUM FROM HIGH-LEVEL RADIOACTIVE TANK WASTE

    International Nuclear Information System (INIS)

    Sylvester, Paul; Rutherford, Andy; Gonzalez-Martin, Anuncia; Kim, J.; Rapko, Brian M.; Lumetta, Gregg J.

    2000-01-01

    A method has been developed for removing chromium from alkaline high-level radioactive tank waste. Removing chromium from these wastes is critical in reducing the volume of waste requiring expensive immobilization and deep geologic disposition. The method developed is based on the oxidation of insoluble chromium(III) compounds to soluble chromate using ferrate. The tests conducted with a simulated Hanford tank sludge indicate that the chromium removal with ferrate is more efficient at 5 M NaOH than at 3 M NaOH. Chromium removal increases with increasing Fe(VI)/Cr(III) molar ratio, but the chromium removal tends to level out for Fe(VI)/Cr(III) greater than 10. Increasing temperature leads to better chromium removal, but higher temperatures also led to more rapid ferrate decomposition. Tests with radioactive Hanford tank waste generally confirmed the simulant results. In all cases examined, ferrate enhanced the chromium removal, with a typical removal of around 60-70% of the total chromium present in the washed sludge solids. The ferrate leachate solutions did not contain significant concentrations of transuranic elements, so these solutions could be handled as low-activity waste

  6. Ferrate treatment for removing chromium from high-level radioactive tank waste.

    Science.gov (United States)

    Sylvester, P; Rutherford, L A; Gonzalez-Martin, A; Kim, J; Rapko, B M; Lumetta, G J

    2001-01-01

    A method has been developed for removing chromium from alkaline high-level radioactive tank waste. Removing chromium from these wastes is critical in reducing the volume of waste requiring expensive immobilization and deep geologic disposition. The method developed is based on the oxidation of insoluble chromium(III) compounds to soluble chromate using ferrate. This method could be generally applicable to removing chromium from chromium-contaminated solids, when coupled with a subsequent reduction of the separated chromate back to chromium(III). The tests conducted with a simulated Hanford tank sludge indicate that the chromium removal with ferrate is more efficient at 5 M NaOH than at 3 M NaOH. Chromium removal increases with increasing Fe(VI)/Cr(II) molar ratio, but the chromium removal tends to level out for Fe(VI)/ Cr(III) greaterthan 10. Increasingtemperature leadsto better chromium removal, but higher temperatures also led to more rapid ferrate decomposition. Tests with radioactive Hanford tank waste generally confirmed the simulant results. In all cases examined, ferrate enhanced the chromium removal, with a typical removal of around 60-70% of the total chromium present in the washed sludge solids. The ferrate leachate solutions did not contain significant concentrations of transuranic elements, so these solutions could be disposed as low-activity waste.

  7. Biochemical and neurochemical effects in rats following Iow-level chronic moniliformin mycotoxin treatment

    International Nuclear Information System (INIS)

    Adam, Y.M.; Abdel-Kader, S.M.

    2000-01-01

    An investigation was conducted to study the biochemical and neurochemical effects of moniliformin mycotoxins in rats. Moniliformin was extracted from fusarium oxysporum and injected intraperitoneally to male albino rats at a dose level 225 magaa g/kg (1/220 LD 5 0) daily for three weeks. The results. The results revealed a decrease in body weight of treated animals, in addition to alteration in the weights of some selected organs. A significant increase of serum ALT, AST and ALP were observed, indicating changes in liver function. Kidney function of treated rats as determined by alteration creatinine and blood urea also was affected. On the other hand the data obtained revealed a dramatic decrease in brain acetylcholinesterase activity. In addition, moniliformin exhibited alteration in the total content of catecholamines, dopamine (DA), norepinephrine (NE), serotonine (5-HT), 5-hydroxyindoleacetic acid (5-HIAA), free inorganic phosphate (Pi) and gamma-aminobutyric acid (GABA) in rat brain of treated animals. Also, profound decline in serum testosterone level was observed. No pathological changes were detected. Hormonal assays were performed using radioimmunoassay techniques

  8. Levels of Stress among General Practitioners, Students and Specialists In Pediatric Dentistry during Dental Treatment.

    Science.gov (United States)

    Davidovich, E; Pessov, Y; Baniel, A; Ram, D

    2015-01-01

    To assess self-reported stress during the performance of different procedures in pediatric dentistry, according to the professional experience of the dentists. During the years 2010 to 2011, an anonymous survey was administered by means of an internet link, and by distribution at professional meetings of dentists . No statistically significant differences in stress were reported for maxilla and mandibular procedures. Placement of a rubber dam was rated as the most stressful procedure among dental students. For general practitioners and specialists, injection of local anesthesia to an anxious child was the most stressful procedure, regardless of age, sex, or years of professional experience. A negative correlation was found between years of experience and level of stress for all the procedures surveyed, but not for the use of nitrous oxide. No differences were found between male and female dentists in stress scores for any of the procedures. Higher rates of stress during operative procedures were reported among dental students than among experienced dentists. Anxiety of the pediatric patients, but not the location of the procedure: maxillary or mandibular, affected the dentists' reported level of stress.

  9. Evaluation of prospective hazardous waste treatment technologies for use in processing low-level mixed wastes at Rocky Flats

    International Nuclear Information System (INIS)

    McGlochlin, S.C.; Harder, R.V.; Jensen, R.T.; Pettis, S.A.; Roggenthen, D.K.

    1990-01-01

    Several technologies for destroying or decontaminating hazardous wastes were evaluated (during early 1988) as potential processes for treating low-level mixed wastes destined for destruction in the Fluidized Bed Incinerator. The processes that showed promise were retained for further consideration and placed into one (or more) of three categories based on projected availability: short, intermediate, and long-term. Three potential short-term options were identified for managing low-level mixed wastes generated or stored at the Rocky Flats Plant (operated by Rockwell International in 1988). These options are: (1) Continue storing at Rocky Flats, (2) Ship to Nevada Test Site for landfill disposal, or (3) Ship to the Idaho National Engineering Laboratory for incineration in the Waste Experimental Reduction Facility. The third option is preferable because the wastes will be destroyed. Idaho National Engineering Laboratory has received interim status for processing solid and liquid low-level mixed wastes. However, low-level mixed wastes will continue to be stored at Rocky Flats until the Department of Energy approval is received to ship to the Nevada Test Site or Idaho National Engineering Laboratory. Potential intermediate and long-term processes were identified; however, these processes should be combined into complete waste treatment ''systems'' that may serve as alternatives to the Fluidized Bed Incinerator. Waste treatment systems will be the subject of later work. 59 refs., 2 figs

  10. Application of Monoclonal Antibodies to Detect and Compare the Levels of Streptococcus mutans in Adolescents Undergoing Orthodontic Treatment with Those Not Undergoing Treatment.

    Science.gov (United States)

    Kim, Jae Hwan; Kim, Mi Ah; Kim, Jae Gon

    2016-10-01

    The purpose of this study was to detect Streptococcus mutans by using monoclonal antibodies (mAbs) against S. mutans that cause dental caries and compare the levels of the bacterium between the saliva of adolescents undergoing orthodontic treatment (OT) and those not undergoing treatment (NT). Saliva samples, collected from 25 OT adolescents (with a mean age of 12.84 years) and 25 NT adolescents (mean age of 12.4 years), were analyzed by Dentocult-SM and enzyme-linked immunosorbent assay using mAbs against Ag I/II (ckAg I/II) and GTF B (ckGTF B), GTF C (ckGTF C), and GTF D (ckGTF D) of S. mutans. The DMFT index was slightly higher in the OT group (5.12 in OT and 4.96 in NT) and the level of S. mutans (≥10 5 CFU/mL) was higher in OT (72%) than in NT (56%). The detected levels of ckAg I/II, ckGTF B, ckGTF C, and ckGTF D were slightly higher in OT than in NT. The results of this study indicate that use of mAbs against S. mutans yields sensitive detection for the bacterium in saliva samples and shows that it has a reliable connection to the number of S. mutans and decayed, missing, filled teeth (DMFT), suggesting that the levels of S. mutans in saliva can be defined and compared by the application of the mAbs.

  11. Patient- and population-level health consequences of discontinuing antiretroviral therapy in settings with inadequate HIV treatment availability

    Directory of Open Access Journals (Sweden)

    Kimmel April D

    2012-09-01

    Full Text Available Abstract Background In resource-limited settings, HIV budgets are flattening or decreasing. A policy of discontinuing antiretroviral therapy (ART after HIV treatment failure was modeled to highlight trade-offs among competing policy goals of optimizing individual and population health outcomes. Methods In settings with two available ART regimens, we assessed two strategies: (1 continue ART after second-line failure (Status Quo and (2 discontinue ART after second-line failure (Alternative. A computer model simulated outcomes for a single cohort of newly detected, HIV-infected individuals. Projections were fed into a population-level model allowing multiple cohorts to compete for ART with constraints on treatment capacity. In the Alternative strategy, discontinuation of second-line ART occurred upon detection of antiretroviral failure, specified by WHO guidelines. Those discontinuing failed ART experienced an increased risk of AIDS-related mortality compared to those continuing ART. Results At the population level, the Alternative strategy increased the mean number initiating ART annually by 1,100 individuals (+18.7% to 6,980 compared to the Status Quo. More individuals initiating ART under the Alternative strategy increased total life-years by 15,000 (+2.8% to 555,000, compared to the Status Quo. Although more individuals received treatment under the Alternative strategy, life expectancy for those treated decreased by 0.7 years (−8.0% to 8.1 years compared to the Status Quo. In a cohort of treated patients only, 600 more individuals (+27.1% died by 5 years under the Alternative strategy compared to the Status Quo. Results were sensitive to the timing of detection of ART failure, number of ART regimens, and treatment capacity. Although we believe the results robust in the short-term, this analysis reflects settings where HIV case detection occurs late in the disease course and treatment capacity and the incidence of newly detected patients are

  12. Clinical significance of measurement of plasma leptin and serum IL-6, IL-18 levels after treatment in patients with children nephrotic syndrome

    International Nuclear Information System (INIS)

    Wang Xiaoyan

    2011-01-01

    Objective: To explore the clinical significance of changes of plasma leptin and serum IL-6, IL-18 levels after treatment in patients with children nephrotic syndrome. Methods: Plasma leptin (with RIA) serum IL-6, IL-18 (with ELISA) levels were measured in 31 patients with children nephrotic syndrome both before and after treatment as well as in 30 controls. Results: Before treatment,the plasma leptin and serum IL-6, IL-18 levels were significantly higher than those in controls(P <0.01). After treatment for 3 months, the levels in patients though dropped markedly remained significantly higher than those in controls (P<0.05). Plasma leptin levels were positively correlated with IL-6, IL-18 levels (r=0.6138, 0.5784, P<0.01). Conclusion: Changes of plasma leptin and serum IL-6, IL-18 levels after treatment might be of prognostic importance in patients with children nephrotic syndrome. (authors)

  13. Role Of SYNBIOTICS And Low Level GAMMA Irradiation Treatments In Improving Performance Of Japanese Quails

    International Nuclear Information System (INIS)

    ABU-TALEB, A.M.

    2009-01-01

    A total number of 800 Japanese quail eggs were obtained from a parent flock maintained the poultry research unit of the Biological Application Department, Nuclear Research Centre at Inshas, Egypt, and used in the present study. Before incubating the eggs, they were divided into two equal groups of 400 eggs each; the 1 st group was exposed to a low level of gamma irradiation at 50 rad before sitting while the 2 nd group did not exposed to gamma irradiation. After hatching of the two groups, fertility, hatchability, embryonic mortality and hatching weight were determined. Hatched quail chicks from each group (1 and 2) were divided into four identical subgroups and all fed the basal diet but with a different supplement. The diet of the 1 st subgroup was supplemented with 2.5% Lactobacilli, the 2 nd with 1.5% lactose, the 3 rd with 2.5% Lactobacilli plus 1.5% lactose, while the 4 th subgroup was fed the basal diet only and served as control. The results showed decreased embryonic mortality and increased hatchability and hatching weight due to exposing quail eggs to low level of gamma radiation as compared to non-exposed eggs. The average body weight and the relative weights of carcass, testis and oviduct, egg production, egg weight, serum total protein, albumin, globulins, RBC, WBC and Hb values were increased significantly (P th week due to adding Lactobacilli and lactose to the basal diet. Significant reduction (P<0.05) in the intestinal wall index was observed due to adding Lactobacilli and lactose to the basal diet of hatched quails. In conclusion, adding Lactobacilli and/or lactose to the basal diet of hatched Japanese quails improved performance as well as blood constituents and intestinal wall index. The magnitude of this improvement was even greater when both supplements were combined. In addition, the exposure of eggs to low level of gamma radiation (50 rad) improved hatchability and hatching weight of Japanese quail eggs, but no relationship to dietary

  14. The influence of single whole body cryostimulation treatment on the dynamics and the level of maximal anaerobic power.

    Science.gov (United States)

    Klimek, Andrzej T; Lubkowska, Anna; Szyguła, Zbigniew; Frączek, Barbara; Chudecka, Monika

    2011-06-01

    The objective of this work was to determine the dynamics of maximal anaerobic power (MAP) of the lower limbs, following a single whole body cryostimulation treatment (WBC), in relation to the temperature of thigh muscles. The subjects included 15 men and 15 women with an average age (± SD) of 21.6 ± 1.2 years. To evaluate the level of anaerobic power, the Wingate test was applied. The subjects were submitted to 6 WBC treatments at -130°C once a day. After each session they performed a single Wingate test in the 15, 30, 45, 60, 75 and 90th min after leaving the cryogenic chamber. The order of the test was randomized. All Wingate tests were preceded by an evaluation of thigh surface temperature with the use of a thermovisual camera. The average thigh surface temperature (T(av)) in both men and women dropped significantly after the whole body cryostimulation treatment, and next increased gradually. In women T(av) remained decreased for 75 min, whereas in men it did not return to the basal level until 90th min. A statistically insignificant decrease in MAP was observed in women after WBC. On the contrary, a non-significant increase in MAP was observed in men. The course of changes in MAP following the treatment was similar in both sexes to the changes in thigh surface temperature, with the exception of the period between 15th and 30th min. The shorter time to obtain MAP was observed in women till 90th min and in men till 45 min after WBC compared to the initial level. A single whole body cryostimulation may have a minor influence on short-term physical performance of supramaximal intensity, but it leads to improvement of velocity during the start as evidenced by shorter time required to obtain MAP.

  15. Treatment of high-level wastes from the IFR fuel cycle

    International Nuclear Information System (INIS)

    Johnson, T.R.; Lewis, M.A.; Newman, A.E.; Laidler, J.J.

    1992-01-01

    The Integral Fast Reactor (IFR) is being developed as a future commercial power source that promises to have important advantages over present reactors, including improved resource conservation and waste management. The spent metal alloy fuels from an IFR will be processed in an electrochemical cell operating at 500 degree C with a molten chloride salt electrolyte and cadmium metal anode. After the actinides have been recovered from several batches of core and blanket fuels, the salt cadmium in this electrorefiner will be treated to separate fission products from residual transuranic elements. This treatment produces a waste salt that contains the alkali metal, alkaline earth, and halide fission products; some of the rare earths; and less than 100 nCi/g of alpha activity. The treated metal wastes contain the rest of the fission products (except T, Kr, and Xe) small amounts of uranium, and only trace amounts of transuranic elements. The current concept for the salt waste form is an aluminosilicate matrix, and the concept for the metal waste form is a corrosion-resistant metal alloy. The processes and equipment being developed to treat and immobilize the salt and metal wastes are described

  16. Development of low level liquid waste treatment systems: April-September 1981

    International Nuclear Information System (INIS)

    Williams, M.K.; Colvin, C.M.; Bond, W.H.

    1982-01-01

    The pilot plant reverse osmosis system was demonstrated to be effective in removing large percentages of cobalt-60, iodine-125, and a mixture of cesium-137, cobalt-60, and iodine-125 from two types of aqueous streams. The effectiveness of three membrane porosities, 0, 50, and 97% salt rejection, were explored with each isotope. The 97% salt rejection membrane was the most effective in each experiment. Removals as high as 97.5% of the cobalt, 92.9% of the iodine and 95.1% of the combined isotopes were achieved. The effect of possibly interfering factors on the adsorbence of cobalt-60 and iodine-129 on selected ion exchange resins were investigated. The factors thought to affect cobalt-60 adsorption were [OH - ], [NH 4 + ], and [SO 3 /sup =/]. None of the seven factors investigated had any effect on iodine-129 adsorption. Cesium-137 was removed from a 4600-gal aqueous waste containing a large amount of sodium hydroxide by treatment with sodium tetraphenyl boron. The cesium concentration of the supernatant portion was reduced from 570 to 4 counts/min/ml

  17. Treatment technologies and mechanisms for three odorants at trace level: IPMP, IBMP, and TCA.

    Science.gov (United States)

    Li, Xin; Lin, Pengfei; Wang, Jun; Liu, Yuanyuan; Li, Yong; Zhang, Xiaojian; Chen, Chao

    2016-01-01

    Odour episodes caused by algal metabolites are gaining more and more attention in recent years. Besides geosmin and 2-methylisoborneol (MIB), 2-isopropyl-3-methoxypyrazine (IPMP), 2-isobutyl-3-methoxypyrazine (IBMP), and 2,4,6-trichloroanisole (TCA) have emerged to be important off-flavour sources. Their low odour threshold concentrations (several ng ·L(-1)), which are even lower than those of MIB and geosmin, pose challenges for treatment strategies. Hence, a practical and efficient mitigation technology is needed. The possible practical technologies, including powdered activated carbon (PAC) adsorption and oxidation by chlorine and potassium permanganate, were investigated. The results indicated that chlorine and potassium permanganate oxidation of the three odorants were unfeasible while PAC adsorption was effective. As for adsorption, TCA, followed by IBMP and IPMP, was most easily removed by PAC. The Freundlich model could well describe the adsorption isotherm data. The adsorption capacities for IPMP, IBMP, and TCA were described as follows: [Formula: see text], [Formula: see text], and [Formula: see text]. For five earthy/musty odorants including geosmin and MIB, octanol/water partition coefficient, molecular weight, and polarizability all promoted adsorption while aqueous solubility showed a negative influence. The hydrophobic interaction was believed to be the dominant force in the adsorption mechanism while the π-electron interaction enhanced adsorption when a benzene ring was present. This result could be used to predict the adsorption performance of emerging odorants.

  18. Treatment of high-level wastes from the IFR fuel cycle

    Energy Technology Data Exchange (ETDEWEB)

    Johnson, T.R.; Lewis, M.A.; Newman, A.E.; Laidler, J.J.

    1992-01-01

    The Integral Fast Reactor (IFR) is being developed as a future commercial power source that promises to have important advantages over present reactors, including improved resource conservation and waste management. The spent metal alloy fuels from an IFR will be processed in an electrochemical cell operating at 500{degree}C with a molten chloride salt electrolyte and cadmium metal anode. After the actinides have been recovered from several batches of core and blanket fuels, the salt cadmium in this electrorefiner will be treated to separate fission products from residual transuranic elements. This treatment produces a waste salt that contains the alkali metal, alkaline earth, and halide fission products; some of the rare earths; and less than 100 nCi/g of alpha activity. The treated metal wastes contain the rest of the fission products (except T, Kr, and Xe) small amounts of uranium, and only trace amounts of transuranic elements. The current concept for the salt waste form is an aluminosilicate matrix, and the concept for the metal waste form is a corrosion-resistant metal alloy. The processes and equipment being developed to treat and immobilize the salt and metal wastes are described.

  19. Treatment of high-level wastes from the IFR fuel cycle

    Energy Technology Data Exchange (ETDEWEB)

    Johnson, T.R.; Lewis, M.A.; Newman, A.E.; Laidler, J.J.

    1992-08-01

    The Integral Fast Reactor (IFR) is being developed as a future commercial power source that promises to have important advantages over present reactors, including improved resource conservation and waste management. The spent metal alloy fuels from an IFR will be processed in an electrochemical cell operating at 500{degree}C with a molten chloride salt electrolyte and cadmium metal anode. After the actinides have been recovered from several batches of core and blanket fuels, the salt cadmium in this electrorefiner will be treated to separate fission products from residual transuranic elements. This treatment produces a waste salt that contains the alkali metal, alkaline earth, and halide fission products; some of the rare earths; and less than 100 nCi/g of alpha activity. The treated metal wastes contain the rest of the fission products (except T, Kr, and Xe) small amounts of uranium, and only trace amounts of transuranic elements. The current concept for the salt waste form is an aluminosilicate matrix, and the concept for the metal waste form is a corrosion-resistant metal alloy. The processes and equipment being developed to treat and immobilize the salt and metal wastes are described.

  20. Treatment of low-activity-level process wastewaters by continuous countercurrent ion exchange

    International Nuclear Information System (INIS)

    Hall, R.; Watson, J.S.; Robinson, S.M.

    1990-01-01

    A mobile pilot-scale continuous countercurrent ion-exchange (CCIX) system is being operated at the Oak Ridge National Laboratory (ORNL) for the treatment of wastewaters that contain predominantly calcium sodium, and magnesium bicarbonates and are slightly contaminated with 90 Sr and 137 Cs radioisotopes. A demonstration study is being conducted to evaluate the near-steady-state performance and feasibility of a pilot-scale CCIX column for the selective removal of strontium from wastewater. Test results show that the process removes strontium sufficiently from the wastewater to permit discharge while significantly reducing the volume of secondary waste generation. CCIX has the potential for effective use in several applications; however, it has not been frequently utilized by industries to date. The CCIX system could offer an economical alternative for decontamination of wastewaters containing trace amounts of contaminants prior to discharge into the environment. This paper discusses (a) application of the Thomas model for predicting breakthrough curves from ion exchange column tests, (b) methods for scaleup of experimental small-scale ion-exchange columns to industrial-scale columns, and (c) methods for predicting effluent compositions in a CCIX system. 20 refs., 6 figs., 2 tabs

  1. Efficacy of aerosol budesonide combined with montelukast in treatment of children with cough variant asthma and its influence on lung function indexes and serum inflammatory factor levels

    Directory of Open Access Journals (Sweden)

    Hai-Li Wu

    2016-03-01

    Full Text Available Objective: To explore the efficacy of aerosol budesonide combined with montelukast in the treatment of children with cough variant asthma (CVA and its influence on lung function indexes and serum inflammatory factor levels. Methods: A total of 102 CVA children in our hospital were randomly divided into A, B, C group (n=34. Three groups were given conventional symptomatic treatment(like phlegm dispersing, anti-infection. A group was given aerosol budesonide treatment, B group was given montelukast treatment and C group was given aerosol budesonide combined with montelukast treatment. Changes of clinical symptom scores, lung function indexes and inflammatory factor levels were compared between three groups before and after treatment. Results: After treatment, clinical symptom scores and inflammatory factor-IgE, IL-4 and TNF-毩 levels in C group were significantly lower than before treatment and that in A, B group after treatment (P<0.05; lung function index- FVC, FEV1, PEF levels were significantly higher than before treatment and that in A, B group after treatment (P<0.05. There showed obvious negative correlation between lung function index-FVC, FEV1, PEF and inflammatory factor-IgE, IL-4 and TNF-α. Conclusions: On the basis of conventional symptomatic treatment (like phlegm dispersing, anti-infection, aerosol budesonide combined with montelukast treatment could reduce the inflammatory factor levels, relieve the clinical symptoms, improve the lung function indexes.

  2. Level of agreement among Latin American glaucoma subspecialists on the diagnosis and treatment of glaucoma: results of an online survey

    Directory of Open Access Journals (Sweden)

    Daniel E. Grigera

    2013-06-01

    Full Text Available PURPOSE: The aim of this research was to assess the level of agreement among glaucoma experts in Latin America on key practices related to treatment and diagnosis of glaucoma. METHODS: An online questionnaire was sent to a multinational panel of glaucoma experts. The questionnaire contained 107 statements on the medical treatment (Part 1 and diagnosis (Part 2 of glaucoma, and was developed in Spanish and translated into English. Agreement was defined as >70% of respondents. RESULTS: Fifty participants from 14 countries completed the questionnaire. For the medical treatment of glaucoma, nearly all respondents (98% or greater confirmed that medical treatment as first-line therapy is preferred to surgery, prostaglandin analogs are the medication of first choice for primary open-angle glaucoma (POAG, longitudinal monitoring of efficacy should include intraocular pressure, structural and functional status, as well as if patients' quality of life is impaired by the high cost of medication. For the diagnosis of glaucoma section, all respondents confirmed that, after initial examination, gonioscopy should be repeated over time, standard automated perimetry is the most important functional examination for diagnosis and monitoring of primary open-angle glaucoma, central corneal thickness is important in assessment of glaucoma, and computerized imaging tests help in clinical evaluation of optic disc. CONCLUSIONS: This survey shows a high level of agreement on most aspects of glaucoma diagnosis and treatment among Latin American glaucoma experts. Areas of disagreement highlight the need for further evidence or education. These findings will be useful for guiding future efforts to optimize glaucoma practice by clinicians in Latin America.

  3. Level of agreement among Latin American glaucoma subspecialists on the diagnosis and treatment of glaucoma: results of an online survey.

    Science.gov (United States)

    Grigera, Daniel E; Mello, Paulo Augusto Arruda; Barbosa, Wilma Lelis; Casiraghi, Javier Fernando; Grossmann, Rodolfo Perez; Peyret, Alejo

    2013-01-01

    The aim of this research was to assess the level of agreement among glaucoma experts in Latin America on key practices related to treatment and diagnosis of glaucoma. An online questionnaire was sent to a multinational panel of glaucoma experts. The questionnaire contained 107 statements on the medical treatment (Part 1) and diagnosis (Part 2) of glaucoma, and was developed in Spanish and translated into English. Agreement was defined as >70% of respondents. Fifty participants from 14 countries completed the questionnaire. For the medical treatment of glaucoma, nearly all respondents (98% or greater) confirmed that medical treatment as first-line therapy is preferred to surgery, prostaglandin analogs are the medication of first choice for primary open-angle glaucoma (POAG), longitudinal monitoring of efficacy should include intraocular pressure, structural and functional status, as well as if patients' quality of life is impaired by the high cost of medication. For the diagnosis of glaucoma section, all respondents confirmed that, after initial examination, gonioscopy should be repeated over time, standard automated perimetry is the most important functional examination for diagnosis and monitoring of primary open-angle glaucoma, central corneal thickness is important in assessment of glaucoma, and computerized imaging tests help in clinical evaluation of optic disc. This survey shows a high level of agreement on most aspects of glaucoma diagnosis and treatment among Latin American glaucoma experts. Areas of disagreement highlight the need for further evidence or education. These findings will be useful for guiding future efforts to optimize glaucoma practice by clinicians in Latin America.

  4. Effect of culture levels, ultrafiltered retentate addition, total solid levels and heat treatments on quality improvement of buffalo milk plain set yoghurt.

    Science.gov (United States)

    Yadav, Vijesh; Gupta, Vijay Kumar; Meena, Ganga Sahay

    2018-05-01

    Studied the effect of culture (2, 2.5 and 3%), ultrafiltered (UF) retentate addition (0, 11, 18%), total milk solids (13, 13.50, 14%) and heat treatments (80 and 85 °C/30 min) on the change in pH and titratable acidity (TA), sensory scores and rheological parameters of yoghurt. With 3% culture levels, the required TA (0.90% LA) was achieved in minimum 6 h incubation. With an increase in UF retentate addition, there was observed a highly significant decrease in overall acceptability, body and texture and colour and appearance scores, but there was highly significant increase in rheological parameters of yoghurt samples. Yoghurt made from even 13.75% total solids containing nil UF retentate was observed to be sufficiently firm by the sensory panel. Most of the sensory attributes of yoghurt made with 13.50% total solids were significantly better than yoghurt prepared with either 13 or 14% total solids. Standardised milk heated to 85 °C/30 min resulted in significantly better overall acceptability in yoghurt. Overall acceptability of optimised yoghurt was significantly better than a branded market sample. UF retentate addition adversely affected yoghurt quality, whereas optimization of culture levels, totals milk solids and others process parameters noticeably improved the quality of plain set yoghurt with a shelf life of 15 days at 4 °C.

  5. Geotechnical reduction of void ratio in low-level radioactive waste burial sites: treatment alternatives

    International Nuclear Information System (INIS)

    Phillips, S.J.; Carlson, R.A.; McGuire, H.E.

    1981-01-01

    A substantial quantity of low-level radioactive and hazardous wastes has been interred in shallow land burial structures throughout the United States. Many of these structures (trenches, pits, and landfills) have proven to be unstable. Some surface feature manifestations such as large cracks, basins, and cave-ins are caused by voids filling and physico-chemical degradation and solubilization of the buried wastes which could result in the release of contamination. The surface features represent a potential for increased contamination transport to the biosphere via water, air, biologic, and direct pathways. Engineering alternatives for the reduction of buried waste and matrix materials voids are identified and discussed. As a guideline, a reduction of the voids within the waste to 80% or more of maximum relative dry density (a measure of in situ voids within the waste) is proposed. The advantages, disadvantages, and costs of each alternative are evaluated. Falling mass and pile driving engineering alternatives were selected for further development

  6. Level ofaggression and sense of control inself-harming youth receiving psychiatric treatment

    Directory of Open Access Journals (Sweden)

    Agnieszka Gmitrowicz

    2011-12-01

    Full Text Available Acts of autoaggression are a more and more frequent reason for psychiatric hospitalisation of adolescents. Within the last years the number of patients committing acts of deliberate self‑harm without suicidal intensions almost doubled. Deliberate self‑harm (DSH is defined as an act of direct destructiveness, in which a person wants to commit self‑harm immediately, without an intention of killing her/himself. In this paper we present the results of the study on the level and direction of aggression and the sense of control among inpatients (N=187 of the Department of Adolescent Psychiatry, Central University Hospital in Łódź. The studied group consisted of patients with deliberate self‑harm (DSH group, N=88, whereas the control group comprised the patients without such behaviours (non‑DSH group, N=99. For the study we recruited patients who were admitted to the hospital due to various mental disorders – 58 boys, mean age 16.81, SD=1.25, and 129 girls, mean age 16.5, SD=1.38. The mean age of all patients was 16.59 (SD=1.35. Patients with men‑ tal retardation were excluded from the study, due to expected difficulties with understanding the questions. We used the IPSA (Inventory of Psychological Syndrome of Aggression and “Delta” (test invented by Drwal, designed for evalua‑ tion of the sense of control. In the DSH group we found a significantly higher level of aggression, directed both inwards and outwards, a greater tendency of retaliatory behaviours and by far lower sense of internal control of one’s behaviours, as compared to the non‑DSH group. Therapeutic programs for patients with DSH should aim at the reduction of aggres‑ sion and the development of internal control over one’s behaviours.

  7. Cortisol and Brain-Derived Neurotrophic Factor Levels Prior to Treatment in Children With Obsessive-Compulsive Disorder.

    Science.gov (United States)

    Şimşek, Şeref; Gençoğlan, Salih; Yüksel, Tuğba; Kaplan, İbrahim; Alaca, Rümeysa

    2016-07-01

    In this study, we investigated serum brain-derived neurotrophic factor (BDNF), adrenocorticotropic hormone (ACTH), and cortisol levels between children with obsessive-compulsive disorder (OCD) prior to treatment and healthy controls. In addition, the study aimed to assess any correlations between OCD symptom severity and BDNF, ACTH, and cortisol levels. Twenty-nine children, aged from 7 to 17 years (male/female: 21/8) and diagnosed with OCD according to DSM-IV prior to treatment, were compared with 25 healthy control subjects (male/female: 16/9). The study was conducted between December 2012 and December 2013. The Kiddie Schedule for Affective Disorders and Schizophrenia, Present and Lifetime Version (K-SADS-PL), Children's Yale-Brown Obsessive Compulsive Scale, and Children's Depression Inventory (CDI) were administered to the children. BDNF, ACTH, and cortisol levels were detected using a prepared kit with the enzyme-linked immunosorbent assay method. BDNF, ACTH, and cortisol levels in the OCD group were significantly higher when compared with the control group (P = .02, P = .03, and P = .046, respectively). No association was detected between the severity and duration of OCD symptoms and BDNF, ACTH, and cortisol levels. CDI scores in both groups were similar. The mean (SD) duration of OCD symptoms was 17.9 (18.5) months. Our findings suggest that BDNF levels adaptively increase as a result of the damaging effects of the hypothalamic-pituitary-adrenal (HPA) axis hyperactivity on brain tissue in the early stages of OCD. HPA axis abnormalities and BDNF may play a role in the pathogenesis of the disease. © Copyright 2016 Physicians Postgraduate Press, Inc.

  8. Impact of control of blood glucose level during treatment of sudden deafness in diabetics: relationship with prognosis.

    Science.gov (United States)

    Min, Sang-Ki; Shin, Ji-Ho; Chang, Mun-Young; Min, Hyun-Jin; Kim, Kyung-Soo; Lee, Sei-Young; Yang, Hoon-Shik; Hong, Young-Ho; Mun, Seog-Kyun

    2017-03-01

    The objective of this study is to investigate the impact of control of blood glucose level during treatment of sudden deafness. A retrospective study was performed involving 197 patients from January, 2011 to September, 2015. All patients were administrated prednisolone (Pharmaprednisolone tab ® , 5 mg/T; KoreaPharma) p.o under the following regimen: 60 mg/day for 4 days, 40 mg/day for 2 days, 30 mg/day for 1 day, 20 mg/day for 1 day, and 10 mg/day for 2 days. During treatment, pure tone audiometry and blood glucose level were investigated for each patient and the results were statistically analyzed. Mean hearing improvement was 19.2 dB for the non-diabetes group and 24.8 dB for the diabetes group. The greater improvement for diabetics was not statistically significant (p = 0.146). Hearing improvement was 25.1 dB for subjects with mean blood glucose blood glucose >200 mg/dl; the difference was not statistically significant (p = 0.267). Mean blood glucose level was 200.8 mg/dl for subjects with hearing improvement >20 dB and 181.8 mg/dl for subjects with hearing improvement blood glucose level during treatment of sudden deafness does not have a direct effect on prognosis.

  9. Ghrelin levels in patients with juvenile idiopathic arthritis: relation to anti-tumor necrosis factor treatment and disease activity.

    Science.gov (United States)

    Karagiozoglou-Lampoudi, Thomais; Trachana, Maria; Agakidis, Charalampos; Pratsidou-Gertsi, Polyxeni; Taparkou, Anna; Lampoudi, Sotiria; Kanakoudi-Tsakalidou, Florentia

    2011-10-01

    Studies in adults with rheumatoid arthritis reported low serum ghrelin that increased following anti-tumor necrosis factor (TNF) infusion. Data on juvenile idiopathic arthritis (JIA) are lacking. The aim of this pilot study was to explore serum ghrelin levels in patients with JIA and the possible association with anti-TNF treatment, disease activity, and nutritional status. Fifty-two patients with JIA (14/52 on anti-TNF treatment) were studied. Juvenile idiopathic arthritis was inactive in 3 of 14 anti-TNF-treated patients and in 11 of 38 non-anti-TNF-treated patients. The nutritional status, energy intake/requirements, appetite, and fasting serum ghrelin levels were assessed. Ghrelin control values were obtained from 50 individuals with minor illness matched for age, sex, and body mass index. Ghrelin levels in patients with JIA were significantly lower than in controls (P ghrelin levels were comparable to control values only in 3 patients with anti-TNF-induced remission. Ghrelin in non-anti-TNF-treated patients in remission was low. Multiple regression analysis showed that disease activity (P = .002, CI = -84.16 to -20.01) and anti-TNF treatment (P = .003, CI = -82.51 to -18.33) were significant independent predictors of ghrelin after adjusting for other potential confounders. Ghrelin did not correlate with nutritional status, energy balance, and appetite. Serum ghrelin is low in patients with JIA and is restored to values similar to those in controls following anti-TNF-induced remission. Our study provides evidence that TNF blockade is independently associated with serum ghrelin, which possibly contributes to anti-TNF-induced remission. These preliminary results could form the basis for future research. Copyright © 2011 Elsevier Inc. All rights reserved.

  10. Surgical treatment of Renal Cell Carcinoma (RCC with level III–IV tumor venous thrombosis

    Directory of Open Access Journals (Sweden)

    M. I. Davydov

    2016-01-01

    Full Text Available Objective: to assess the results of nephrectomy, thrombectomy in RCC patients with level III–IV tumor venous thrombosis with and without cardiopulmonary bypass.Materials and methods. Medical data of 167 consecutive RCC patients with level III–IV tumor venous thrombosis underwent nephrectomy thrombectomy in N.N. Blokhin Russian Cancer Research Center between 1998 and 2012 were collected. Right side tumor was in 122 (73.1 %, left side – in 42 (25.1 %, bilateral – in 3 (1.8 % cases. The extent of thrombus was defined as intrahepatic in 82 (49.1 %, supradiaphragmatic – in 85 (50.9 % (intrapericardial – in 44 (26.3 %, intraatrial – in 39 (23.4 %, intraventricular – in 2 (1.2 % cases. Nephrectomy, thrombectomy with cardiopulmonary bypass was used in 9 (5.4 %, 158 (94.6 % patients underwent radical nephrectomy with thrombectomy without CPBP and sternotomy. Intrapericardial IVC and right atrium were exposed through transdiaphragmatic approach and providing vascular control over infradiaphragmatic IVC and renal veins.Results. Median blood loss was 6000 (600–27 000 ml. Complications rate was 62.8 %, 90-day mortality – 13.2 %. Intraoperative complications were registered in 80 (47.9 %, postoperative – in 66 (40.5 % (grade II – 16 (9.8 %, grade IIIb – 1 (0.6 %, grade IVа – 28 (17.2 %, grade IVb – 3 (1.8 %, grade V – 18 (11.1 % patients. Modified thrombectomy technique insignificantly decreased blood loss compared to thrombectomy with CPB, did nоt increase complications rate including pulmonary vein thromboembolism, or mortality. Five-year overall, cancer-specific and recurrence-free survival was 46.2, 58.3 and 47.1 %, respectively. Thrombectomy technique did nоt affect survival.Conclusion. In selected patients with mobile thrombi transdiaphragmatic approach allows to avoid the use of CPBP and decrease surgical morbidity without survival compromising.

  11. Advanced waste form and Melter development for treatment of troublesome high-level wastes

    Energy Technology Data Exchange (ETDEWEB)

    Marra, James [Savannah River Site (SRS), Aiken, SC (United States). Savannah River National Lab. (SRNL); Kim, Dong -Sang [Pacific Northwest National Lab. (PNNL), Richland, WA (United States); Maio, Vincent [Idaho National Lab. (INL), Idaho Falls, ID (United States)

    2015-10-01

    A number of waste components in US defense high level radioactive wastes (HLW) have proven challenging for current Joule heated ceramic melter (JHCM) operations and have limited the ability to increase waste loadings beyond already realized levels. Many of these “troublesome" waste species cause crystallization in the glass melt that can negatively impact product quality or have a deleterious effect on melter processing. Recent efforts at US Department of Energy laboratories have focused on understanding crystallization behavior within HLW glass melts and investigating approaches to mitigate the impacts of crystallization so that increases in waste loading can be realized. Advanced glass formulations have been developed to highlight the unique benefits of next-generation melter technologies such as the Cold Crucible Induction Melter (CCIM). Crystal-tolerant HLW glasses have been investigated to allow sparingly soluble components such as chromium to crystallize in the melter but pass out of the melter before accumulating.The Hanford site AZ-101 tank waste composition represents a waste group that is waste loading limited primarily due to high concentrations of Fe2O3 (also with high Al2O3 concentrations). Systematic glass formulation development utilizing slightly higher process temperatures and higher tolerance to spinel crystals demonstrated that an increase in waste loading of more than 20% could be achieved for this waste composition, and by extension higher loadings for wastes in the same group. An extended duration CCIM melter test was conducted on an AZ-101 waste simulant using the CCIM platform at the Idaho National Laboratory (INL). The melter was continually operated for approximately 80 hours demonstrating that the AZ-101 high waste loading glass composition could be readily processed using the CCIM technology. The resulting glass was close to the targeted composition and exhibited excellent durability in both

  12. Handling and treatment of low-level radioactive wastes from gaseous diffusion plants in the United States of America

    International Nuclear Information System (INIS)

    Wing, J.F.; Behrend, J.E.

    1984-01-01

    Gaseous diffusion plants in the United States of America currently generate very small quantities of low-level radioactive wastes. These wastes consist primarily of airborne effluent solid trapping media and liquid scrubber solutions, liquid effluent treatment sludges, waste oils and solvents, scrap metals and conventional combustible wastes such as floor sweepings, cleaning rags and shoe covers. In addition to waste emanating from current operations, large quantities of scrap metal generated during the Cascade Improvement Program are stored above ground at each of the diffusion plants. The radionuclides of primary concern are uranium and 99 Tc. Current radioactive waste treatment consists of uranium dissolution in weak acids followed by chemical precipitation and/or solvent extraction for uranium recovery. Current disposal operations consist of above ground storage of scrap metals, shallow land burial of inorganic solids and incineration of combustible wastes. With increased emphasis on reducing the potential for off-site radiological dose, several new treatment and disposal options are being studied and new projects are being planned. One project of particular interest involves the installation of a high temperature incinerator to thermally degrade hazardous organic wastes contaminated with low-level radioactive wastes. Other technologies being studied include fixation of uranium-bearing sludges in concrete before burial, decontamination of scrap metals by smelting and use of specially engineered centralized burial grounds. (author)

  13. Therapeutic effect of forearm low level light treatment on blood flow, oxygenation, and oxygen consumption

    Science.gov (United States)

    Wang, Pengbo; Sun, Jiajing; Meng, Lingkang; Li, Zebin; Li, Ting

    2018-02-01

    Low level light/laser therapy (LLLT) is considered as a novel, non-invasive, and potential therapy in a variety of psychological and physical conditions, due to its effective intricate photobiomodulation. The mechanism of LLLT is that when cells are stimulated by photons, mitochondria produce a large quantity of ATP, which accelerates biochemical responses in the cell. It is of great significance to gain a clear insight into the change or interplay of various physiological parameters. In this study, we used functional near-infrared spectroscopy (fNIRS) and venous-occlusion plethysmography to measure the LLLT-induced changes in blood flow, oxygenation, and oxygen consumption in human forearms in vivo. Six healthy human participants (4 males and 2 females) were administered with 810-nm light emitted by LED array in ten minutes and blood flow, oxygenation and oxygen consumption were detected in the entire experiment. We found that LLLT induced an increase of blood flow and oxygen consumption on the treated site. Meanwhile, LLLT took a good role in promoting oxygenation of regional tissue, which was indicated by a significant increase of oxygenated hemoglobin concentration (Δ[HbO2]), a nearly invariable deoxygenated hemoglobin concentration (Δ[Hb]) and a increase of differential hemoglobin concentration (Δ[HbD] = Δ[HbO2] - Δ[Hb]). These results not only demonstrate enormous potential of LLLT, but help to figure out mechanisms of photobiomodulation.

  14. Electrical characterization of deep levels in n-type GaAs after hydrogen plasma treatment

    International Nuclear Information System (INIS)

    Nyamhere, C.; Botha, J.R.; Venter, A.

    2011-01-01

    Deep level transient spectroscopy (DLTS) and Laplace-DLTS (L-DLTS) have been used to investigate defects in an n-type GaAs before and after exposure to a dc hydrogen plasma (hydrogenation). DLTS revealed the presence of three prominent electron traps in the material in the temperature range 20-300 K. However, L-DLTS with its higher resolution enabled the splitting of two narrowly spaced emission rates. Consequently four electron traps at, E C -0.33 eV, E C -0.36 eV, E C -0.38 eV and E C -0.56 eV were observed in the control sample. Following hydrogenation, all these traps were passivated with a new complex (presumably the M3), emerging at E C -0.58 eV. Isochronal annealing of the passivated material between 50 and 300 o C, revealed the emergence of a secondary defect, not previously observed, at E C -0.37 eV. Finally, the effect of hydrogen passivation is completely reversed upon annealing at 300 o C, as all the defects originally observed in the reference sample were recovered.

  15. Electrical characterization of deep levels in n-type GaAs after hydrogen plasma treatment

    Energy Technology Data Exchange (ETDEWEB)

    Nyamhere, C., E-mail: s210239522@live.nmmu.ac.z [Department of Physics, Nelson Mandela Metropolitan University, PO Box 77000, Port Elizabeth 6031 (South Africa); Botha, J.R.; Venter, A. [Department of Physics, Nelson Mandela Metropolitan University, PO Box 77000, Port Elizabeth 6031 (South Africa)

    2011-05-15

    Deep level transient spectroscopy (DLTS) and Laplace-DLTS (L-DLTS) have been used to investigate defects in an n-type GaAs before and after exposure to a dc hydrogen plasma (hydrogenation). DLTS revealed the presence of three prominent electron traps in the material in the temperature range 20-300 K. However, L-DLTS with its higher resolution enabled the splitting of two narrowly spaced emission rates. Consequently four electron traps at, E{sub C}-0.33 eV, E{sub C}-0.36 eV, E{sub C}-0.38 eV and E{sub C}-0.56 eV were observed in the control sample. Following hydrogenation, all these traps were passivated with a new complex (presumably the M3), emerging at E{sub C}-0.58 eV. Isochronal annealing of the passivated material between 50 and 300 {sup o}C, revealed the emergence of a secondary defect, not previously observed, at E{sub C}-0.37 eV. Finally, the effect of hydrogen passivation is completely reversed upon annealing at 300 {sup o}C, as all the defects originally observed in the reference sample were recovered.

  16. High-gradient magnetic separation for the treatment of high-level radioactive wastes

    International Nuclear Information System (INIS)

    Ebner, A.D.; Ritter, J.A.; Nunez, L.

    1999-01-01

    Argonne National Laboratory is developing an open-gradient magnetic separation (OGMS) system to fractionate and remove nonglass-forming species from high-level radioactive wastes (HLW); however, to avoid clogging, OGMS may require high-gradient magnetic separation (HGMS) as a pretreatment to remove the most magnetic species from the HLW. In this study, the feasibility of using HGMS in the pretreatment of HLW was demonstrated. A HLW simulant of hanford's C-103 tank waste, which contained precipitate hydroxides and oxides of Fe, Al, Si, and Ca, was used. Preliminary fractionation results from a 0.3-T bench-scale HGMS unit showed that a significant amount of Fe could be removed from the HLW simulant. Between 1 and 2% of the total Fe in the sludge was removed during each stage, with over 18.5% removed in the 13 stages that were carried out. Also, in each stage, the magnetically retained fraction contained about 20% more Fe than the untreated HLW; however, it also contained a significant amount of SiO 2 in relatively large particles. This indicated that SiO 2 was acting possibly as a nucleation agent for Fe (i.e., an Fe adsorbent) and that the fractionation was based more on size than on magnetic susceptibility

  17. Blood rheology and 2,3-diphosphoglycerate levels after erythropoietin treatment.

    Science.gov (United States)

    Crowley, J P; Chazan, J A; Metzger, J B; Pono, L; Valeri, C R

    1993-01-01

    Twenty-seven transfusion dependent patients with end-stage renal disease on long-term dialysis had blood cell counts, serum chemistries, blood pressure, and whole blood viscosity measured, as well as having transfusion requirements assessed. Three months after the institution of recombinant human erythropoietin (rHU-EPO) (75 u per kg per wk), there was an 88 percent fall in transfusion requirement. After four months, the hematocrit increased from 24 +/- 3.8 to 25.6 +/- 4.2 percent, mean corpuscular volume from 93 +/- 4.9 to 97 +/- 6.6 fl, 2-3-diphosphoglycerate (2,3-DPG) from 13.2 +/- 3.2 to 15.6 +/- 4.3 microM per g of Hb. Whole blood viscosity fell from 14.1 +/- 2.1 to 12.7 +/- 2.3 seconds, and ferritin levels fell from 3282 +/- 3889 to 2131 +/- 2441 ng per ml. In eight patients in whom the dose of rHU-EPO was further increased by up to 50 units per kg three times weekly for three months, the hematocrit rose further to 29.3 +/- 3.0 percent and the rise in hematocrit was accompanied by a further increase in 2,3-DPG to 17.9 +/- 2.8 microM per g of Hb (p < 0.03). There were no major side effects or vascular complications.

  18. Treatment of solid radioactive waste: The incineration of low level radioactive waste

    International Nuclear Information System (INIS)

    Dirks, F.; Hempelmann, W.

    1982-01-01

    Nuclear facilities produce large quantities of burnable solid radioactive waste which incineration can reduce in volume and change into a form capable of ultimate storage. Experiments over many years were carried out at the Karlsruhe Nuclear Research Center to determine the boundary conditions for the design and construction of incineration plants for radioactive waste. On the basis of those experiments a test facility was started up in 1971. This operating facility consists of a shaft furnace lined with ceramics with a downstream series of ceramic flue gas filters. In 1976 the plant was exchanged by the installation of a pilot facility for burning organic solvents and of a flue gas scrubber. The plant has so far been in operation for more than 28000 hours and has processed in excess of 1500 to of solid and some 300 m 3 of liquid low level radioactive wastes. Various repairs and interventions were carried out without greatly impairing availability, which was 81 % on the average. The plant design is being used by various licensees in Japan and Europe; three plants are either in operation or completed, three more are under construction or in the planning stage. On the basis of the available process an incineration plant for alpha contaminated waste will be built at the Karlsruhe Nuclear Research Center in the next few years. (orig.)

  19. Cytoprotective effect of cytoflavinum in the treatment of thermal injuries of various severity levels

    Directory of Open Access Journals (Sweden)

    Alexey J. Bozhedomov

    2012-12-01

    Full Text Available The research aimed to conduct studying of cytoprotective effect of cytoflavinum in thermal traumas of various severity levels. Material and methods – 169 patients were included into the research with thermal burns and with a favorable outcome and the severity of a thermal injury from 30 to 170 points according Frank index. 28 patients received cytoflavinum in a complex therapy in a standard dosage. Results – During the cytoflavinum usage in patients with the severity of a thermal injury more than 60 points by Frank there had been fixed: the decrease of a systemic inflammatory response syndrome (SIRS, reduction of stab neutrophils content, slower decrease of erythrocytes, smaller activation of thrombopoiesis, decrease of concentration of the vascular endothelial growth factor. In the group of patients with thermal injuries less than 60 points who had been receiving cytoflavinum there had not positive effects been fixed. Conclusion – Cytoflavinum is the most effective when the severity of a thermal trauma is more than 60 points by Frank.

  20. Clinical significance of determination of changes of serum IGF-II, CRP levels after treatment in pediatric patients with broncho-pneumonia

    International Nuclear Information System (INIS)

    Chen Chuanbin

    2006-01-01

    Objective: To investigate the changes of serum insulin-like growth factor-II (IGF-II), CRP levels after treatment in pediatric patients with bronchopneumonia. Methods: Serum IGF-II levels were measured with RIA and serum CRP levels with immune method both before and after treatment in 33 pediatric patients with bronchopneumonia and 35 controls. Results: Before treatment the serum levels of IGF-II, CRP were significantly higher in the patients than those in controls (P 0.05). Conclusion: Determination of serum IGF-II, CRP levels is clinically useful in the management of pediatric patients with bronchopneumonia. (authors)

  1. Effect of low-level laser treatment on cochlea hair-cell recovery after ototoxic hearing loss

    Science.gov (United States)

    Rhee, Chung-Ku; He, Peijie; Jung, Jae Yun; Ahn, Jin-Chul; Chung, Phil-Sang; Lee, Min Young; Suh, Myung-Whan

    2013-12-01

    The primary cause of hearing loss includes damage to cochlear hair cells. Low-level laser therapy (LLLT) has become a popular treatment for damaged nervous systems. Based on the idea that cochlea hair cells and neural cells are from same developmental origin, the effect of LLLT on hearing loss in animal models is evaluated. Hearing loss animal models were established, and the animals were irradiated by 830-nm diode laser once a day for 10 days. Power density of the laser treatment was 900 mW/cm2, and the fluence was 162 to 194 J. The tympanic membrane was evaluated after LLLT. Thresholds of auditory brainstem responses were evaluated before treatment, after gentamicin, and after 10 days of LLLT. Quantitative scanning electron microscopic (SEM) observations were done by counting remaining hair cells. Tympanic membranes were intact at the end of the experiment. No adverse tissue reaction was found. On SEM images, LLLT significantly increased the number of hair cells in middle and basal turns. Hearing was significantly improved by laser irradiation. After LLLT treatment, both the hearing threshold and hair-cell count significantly improved.

  2. Evaluation of the low-level laser therapy application parameters for skin burn treatment in experimental model: a systematic review.

    Science.gov (United States)

    Brassolatti, Patricia; de Andrade, Ana Laura Martins; Bossini, Paulo Sérgio; Otterço, Albaiza Nicoletti; Parizotto, Nivaldo Antônio

    2018-05-05

    Burn is defined as a traumatic injury of thermal origin, which affects the organic tissue. Low-level laser therapy (LLLT) has gained great prominence as a treatment in this type of injury; however, the application parameters are still controversial in the literature. The aims of this study were to review the literature studies that use LLLT as a treatment in burns conducted in an experimental model, discuss the main parameters used, and highlight the benefits found in order to choose an appropriate therapeutic window to be applied in this type of injury. The selection of the studies related to the theme was carried out in the main databases (PubMed, Cochrane Library, LILACS, Web of Science, and Scopus in the period from 2001 to 2017). Subsequently, the articles were then chosen that fell within the inclusion criteria previously established. In the end, 22 were evaluated, and the main parameters were presented. The analyzed studies presented both LLLT use in continuous and pulsed mode. Differences between the parameters used (power, fluence, and total energy) were observed. In addition, the protocols are distinct as to the type of injury and the number of treatment sessions. Among the results obtained by the authors are the improvements in the local microcirculation and cellular proliferation; however, a study reported no effects with LLLT as a treatment. LLLT is effective in accelerating the healing process. However, there is immense difficulty in establishing the most adequate protocol, due to the great discrepancy found in the applied dosimetry values.

  3. Evaluation of two protocols for low-level laser application in patients submitted to orthodontic treatment

    Directory of Open Access Journals (Sweden)

    Mariana Marquezan

    2013-02-01

    Full Text Available INTRODUCTION: Different low-level laser (LLL irradiation protocols have been tested to accelerate orthodontic tooth movement (OTM. Nevertheless, divergent results have been obtained. It was suggested that the stimulatory action of low level laser irradiation occurs during the proliferation and differentiation stages of bone cellular precursors, but not during later stages. OBJECTIVE: The purpose of this study was to determine the effect of two protocols of LLL irradiation on experimental tooth movement: One with daily irradiations and another with irradiations during the early stages. METHODS: Thirty-six rats were divided into control groups (CG1, CG2, CG3 and irradiated groups (IrG1, IrG2, IrG3 according to the presence of: experimental tooth movement, laser irradiation, type of laser irradiation protocol and date of euthanasia (3th or 8th day of experiment. At the end of experimental periods, a quantitative evaluation of the amount of OTM was made and the reactions of the periodontium were analyzed by describing cellular and tissue reactions and by counting blood vessels. RESULTS: The amount of OTM revealed no significant differences between groups in the same experimental period (p INTRODUÇÃO: diferentes protocolos de irradiação por laser de baixa potência (LBP têm sido testados para potencializar o movimento ortodôntico; entretanto, há resultados divergentes. Foi sugerido que seu efeito bioestimulador ocorre nas fases de proliferação e diferenciação celular, não agindo em estágios tardios. OBJETIVO: avaliar o efeito de dois protocolos de irradiação do LBP na movimentação ortodôntica: um com irradiações diárias e outro em que irradiações foram realizadas apenas nos períodos iniciais. MÉTODOS: trinta e seis ratos Wistar foram divididos em grupos controles (GC1, GC2 e GC3 e irradiados (GIr1, GIr2 e GIr3, de acordo com a presença de dispositivo ortodôntico, a presença de irradiação, o tipo de protocolo de irradia

  4. Predictors of the change in bilirubin levels over twelve weeks of treatment with atazanavir

    LENUS (Irish Health Repository)

    Cotter, Aoife G

    2013-05-16

    AbstractObjectiveTo determine the factors associated with change in bilirubin concentration 12 weeks after the initiation of an atazanavir (ATV)-containing antiretroviral regimen.MethodsWe performed a retrospective case note review of all patients prescribed ATV between January 2004 and October 2007 in a cohort of HIV infected subjects. Data collected included baseline demographics, hepatitis B and C serology, current antiretroviral therapy, baseline and week 12 routine bloods. The primary endpoint was the change in bilirubin concentration at 12 weeks after start of ATV. Multvariable linear regression was performed to assess the relationships between the change in bilirubin and variables of interest. Results: Eighty-three ATV-treated patients were included in the analysis of whom 46 (60.5%) were hepatitis C antibody positive. The median (interquartile range) change in bilirubin by week 12 was 16 (4, 22) umol\\/L; only 1 patient developed grade 4 hyperbilirubinaemia at week 12. After controlling for baseline bilirubin levels, HCV seropositivity and baseline ALP were associated with a smaller change in bilirubin over the 12 weeks with a trend towards lower increases in those receiving tenofovir. Sensitivity analyses reported similar associations with methadone use and injection drug use, when these variables replaced HCV sero-positivity in the model. Conclusion: Patients with hepatitis C co-infection experience smaller changes in bilirubin upon exposure to ATV. Although the underlying mechanism for this association remains unclear, these data support the safe use of this drug in this patient setting. Further research into the clinical predictors of ATV-related hyperbilirubinaemia is warranted.

  5. Development studies for the treatment of ORNL low-level liquid waste

    International Nuclear Information System (INIS)

    Campbell, D.O.; Lee, D.D.; Dillow, T.A.

    1991-11-01

    An experimental program is under way to investigate potential separation methods for application to specific problems relating to the management of low-level liquid wastes (LLLWs) at ORNL. This report summarizes experimental results that were acquired during fiscal year 1990 and have not been previously reported elsewhere. Measurements are presented for cesium and strontium removal from simulated high-salt waste compositions, using both inorganic ion- exchange sorbents and organic ion-exchange resins, and for one experiment with actual LLLW supernate solution from Melton Valley Storage Tank W-26, using inorganic sorbents. The purpose of the study was to acquire an extensive data base to support the development of flowsheets for decontamination of the LLLW currently stored at ORNL. Experimental measurements with inorganic ion exchangers focused on batch separations of cesium using several transition-metal hexacyanoferrate(2) compositions (ferrocyanides) and of strontium using titanium oxide-based sorbents. Cesium distribution coefficients in the range of 1 x 10 6 were generally observed with nickel and cobalt ferrocyanides at pH values ≤11, yielding DFs of about 100 with 100 ppm sorbent in a single-stage batch separation. Most organic ion-exchange resins are not very effective for cesium removal from such high salt concentrations, but a new resorcinol-based resin developed at the Savannah River Site was found to be considerably superior to any other such material tested. Several chelating resins were effective for removing strontium from the waste simulants. An ion-exchange column test successfully demonstrated the simultaneous removal of both cesium and strontium from a waste simulant solution

  6. Vitrification treatment options for disposal of greater-than-Class-C low-level waste in a deep geologic repository

    International Nuclear Information System (INIS)

    Fullmer, K.S.; Fish, L.W.; Fischer, D.K.

    1994-11-01

    The Department of Energy (DOE), in keeping with their responsibility under Public Law 99-240, the Low-Level Radioactive Waste Policy Amendments Act of 1985, is investigating several disposal options for greater-than-Class C low-level waste (GTCC LLW), including emplacement in a deep geologic repository. At the present time vitrification, namely borosilicate glass, is the standard waste form assumed for high-level waste accepted into the Civilian Radioactive Waste Management System. This report supports DOE's investigation of the deep geologic disposal option by comparing the vitrification treatments that are able to convert those GTCC LLWs that are inherently migratory into stable waste forms acceptable for disposal in a deep geologic repository. Eight vitrification treatments that utilize glass, glass ceramic, or basalt waste form matrices are identified. Six of these are discussed in detail, stating the advantages and limitations of each relative to their ability to immobilize GTCC LLW. The report concludes that the waste form most likely to provide the best composite of performance characteristics for GTCC process waste is Iron Enriched Basalt 4 (IEB4)

  7. Topical treatment with coenzyme Q10-containing formulas improves skin's Q10 level and provides antioxidative effects.

    Science.gov (United States)

    Knott, Anja; Achterberg, Volker; Smuda, Christoph; Mielke, Heiko; Sperling, Gabi; Dunckelmann, Katja; Vogelsang, Alexandra; Krüger, Andrea; Schwengler, Helge; Behtash, Mojgan; Kristof, Sonja; Diekmann, Heike; Eisenberg, Tanya; Berroth, Andreas; Hildebrand, Janosch; Siegner, Ralf; Winnefeld, Marc; Teuber, Frank; Fey, Sven; Möbius, Janne; Retzer, Dana; Burkhardt, Thorsten; Lüttke, Juliane; Blatt, Thomas

    2015-01-01

    Ubiquinone (coenzyme Q10, Q10) represents an endogenously synthesized lipid-soluble antioxidant which is crucial for cellular energy production but is diminished with age and under the influence of external stress factors in human skin. Here, it is shown that topical Q10 treatment is beneficial with regard to effective Q10 replenishment, augmentation of cellular energy metabolism, and antioxidant effects. Application of Q10-containing formulas significantly increased the levels of this quinone on the skin surface. In the deeper layers of the epidermis the ubiquinone level was significantly augmented indicating effective supplementation. Concurrent elevation of ubiquinol levels suggested metabolic transformation of ubiquinone resulting from increased energy metabolism. Incubation of cultured human keratinocytes with Q10 concentrations equivalent to treated skin showed a significant augmentation of energy metabolism. Moreover, the results demonstrated that stressed skin benefits from the topical Q10 treatment by reduction of free radicals and an increase in antioxidant capacity. © 2015 International Union of Biochemistry and Molecular Biology.

  8. Nutritive value of some agricultural wastes as affected by relatively low gamma irradiation levels and chemical treatments

    International Nuclear Information System (INIS)

    Al-Masri, M. R.

    2006-01-01

    An experiment was carried out to study the changes in the values of in-vitro organic matter digestibility (IVOMD) and metabolizable energy (ME) of wheat straw, sunflower seed shell, olive cake wood, date palm seeds and peanut shell after irradiation by various levels of gamma radiation (0, 20, 40, 60 kGy) or after spraying with different amounts of hydrobromic acid (HBr; 47%) and sodium hydroxide (NaOH): 0, 3, 6 ml HBr and 3, 6 g NaOH in 25 ml water/100 g DM. The results indicated that chemical treatments increased the IVOMD and ME values significantly for all samples treated except the date palm seeds. There was no significant effect of irradiation on IVOMD and ME. Combined treatments of irradiation and HBr or NaOH were also found to be ineffective in increasing the IVOMD and ME values. (Author)

  9. Laboratory Report on Performance Evaluation of Key Constituents during Pre-Treatment of High Level Waste Direct Feed

    Energy Technology Data Exchange (ETDEWEB)

    Huber, Heinz J.

    2013-06-24

    The analytical capabilities of the 222-S Laboratory are tested against the requirements for an optional start up scenario of the Waste Treatment and Immobilization Plant on the Hanford Site. In this case, washed and in-tank leached sludge would be sent directly to the High Level Melter, bypassing Pretreatment. The sludge samples would need to be analyzed for certain key constituents in terms identifying melter-related issues and adjustment needs. The analyses on original tank waste as well as on washed and leached material were performed using five sludge samples from tanks 241-AY-102, 241-AZ-102, 241-AN-106, 241-AW-105, and 241-SY-102. Additionally, solid phase characterization was applied to determine the changes in mineralogy throughout the pre-treatment steps.

  10. Long-term treatment with haloperidol affects neuropeptide S and NPSR mRNA levels in the rat brain.

    Science.gov (United States)

    Palasz, Artur; Rojczyk, Ewa; Golyszny, Milosz; Filipczyk, Lukasz; Worthington, John J; Wiaderkiewicz, Ryszard

    2016-04-01

    The brainstem-derived neuropeptide S (NPS) has a multidirectional regulatory activity, especially as a potent anxiolytic factor. Accumulating data suggests that neuroleptics affect peptidergic signalling in various brain structures. However, there is no information regarding the influence of haloperidol on NPS and NPS receptor (NPSR) expression. We assessed NPS and NPSR mRNA levels in brains of rats treated with haloperidol using quantitative real-time polymerase chain reaction. Chronic haloperidol treatment (4 weeks) led to a striking upregulation of NPS and NPSR expression in the rat brainstem. Conversely, the NPSR mRNA expression was decreased in the hippocampus and striatum. This stark increase of NPS in response to haloperidol treatment supports the hypothesis that this neuropeptide is involved in the dopamine-dependent anxiolytic actions of neuroleptics and possibly also in the pathophysiology of mental disorders. Furthermore, our findings underline the complex nature of potential interactions between dopamine receptors and brain peptidergic pathways, which has potential clinical applications.

  11. Laboratory Report on Performance Evaluation of Key Constituents during Pre-Treatment of High Level Waste Direct Feed

    International Nuclear Information System (INIS)

    Huber, Heinz J.

    2013-01-01

    The analytical capabilities of the 222-S Laboratory are tested against the requirements for an optional start up scenario of the Waste Treatment and Immobilization Plant on the Hanford Site. In this case, washed and in-tank leached sludge would be sent directly to the High Level Melter, bypassing Pretreatment. The sludge samples would need to be analyzed for certain key constituents in terms identifying melter-related issues and adjustment needs. The analyses on original tank waste as well as on washed and leached material were performed using five sludge samples from tanks 241-AY-102, 241-AZ-102, 241-AN-106, 241-AW-105, and 241-SY-102. Additionally, solid phase characterization was applied to determine the changes in mineralogy throughout the pre-treatment steps

  12. Plasma Gelsolin Levels Decrease in Diabetic State and Increase upon Treatment with F-Actin Depolymerizing Versions of Gelsolin

    Directory of Open Access Journals (Sweden)

    Neeraj Khatri

    2014-01-01

    Full Text Available The study aims to map plasma gelsolin (pGSN levels in diabetic humans and mice models of type II diabetes and to evaluate the efficacy of gelsolin therapy in improvement of diabetes in mice. We report that pGSN values decrease by a factor of 0.45 to 0.5 in the blood of type II diabetic humans and mice models. Oral glucose tolerance test in mice models showed that subcutaneous administration of recombinant pGSN and its F-actin depolymerizing competent versions brought down blood sugar levels comparable to Sitagliptin, a drug used to manage hyperglycemic condition. Further, daily dose of pGSN or its truncated versions to diabetic mice for a week kept sugar levels close to normal values. Also, diabetic mice treated with Sitagliptin for 7 days, showed increase in their pGSN values with the decrease in blood glucose as compared to their levels at the start of treatment. Gelsolin helped in improving glycemic control in diabetic mice. We propose that gelsolin level monitoring and replacement of F-actin severing capable gelsolin(s should be considered in diabetic care.

  13. Cell-free DNA levels and correlation to stage and outcome following treatment of locally advanced rectal cancer.

    Science.gov (United States)

    Boysen, Anders Kindberg; Wettergren, Yvonne; Sorensen, Boe Sandahl; Taflin, Helena; Gustavson, Bengt; Spindler, Karen-Lise Garm

    2017-11-01

    Accurate staging of rectal cancer remains essential for optimal patient selection for combined modality treatment, including radiotherapy, chemotherapy and surgery. We aimed at examining the correlation of cell free DNA with the pathologic stage and subsequent risk of recurrence for patients with locally advanced rectal cancer undergoing preoperative chemoradiation. We examined 75 patients with locally advanced rectal cancer receiving preoperative chemoradiation. Blood samples for translational use were drawn prior to rectal surgery. The level of cell free DNA was quantified by digital droplet PCR and expressed as copy number of beta 2 microglobulin. We found a median level of cell free DNA in the AJCC stages I-III of 3100, 8300, and 10,700 copies/mL respectively. For patients with 12 sampled lymph nodes or above, the median level of cell free DNA were 2400 copies/mL and 4400 copies/mL (p = 0.04) for node negative and node positive disease respectively. The median follow-up was 39 months and 11 recurrences were detected (15%). The median level for patients with recurrent disease was 13,000 copies/mL compared to 5200 copies/mL for non-recurrent patients (p = 0.08). We have demonstrated a correlation between the level of total cell free DNA and the pathologic stage and nodal involvement. Furthermore, we have found a trend towards a correlation with the risk of recurrence following resection of localized rectal cancer.

  14. Impact of metformin treatment and swimming exercise on visfatin levels in high-fat-induced obesity rats.

    Science.gov (United States)

    Gao, Ya; Wang, Changjiang; Pan, Tianrong; Luo, Li

    2014-02-01

    Visfatin is a recently discovered adipocytokine that contributes to glucose and obesity-related conditions. Until now, its responses to the insulin-sensitizing agent metformin and to exercise are largely unknown. We aim to investigate the impact of metformin treatment and/or swimming exercise on serum visfatin and visfatin levels in subcutaneous adipose tissue (SAT), peri-renal adipose tissue (PAT) and skeletal muscle (SM) of high-fat-induced obesity rats. Sprague-Dawley rats were fed a normal diet or a high-fat diet for 16 weeks to develop obesity model. The high-fat-induced obesity model rats were then randomized to metformin (MET), swimming exercise (SWI), or adjunctive therapy of metformin and swimming exercise (MAS), besides high-fat obesity control group and a normal control group, all with 10 rats per group. Zoometric and glycemic parameters, lipid profile, and serum visfatin levels were assessed at baseline and after 6 weeks of therapy. Visfatin levels in SAT, PAT and SM were determined by Western Blot. Metformin and swimming exercise improved lipid profile, and increased insulin sensitivity and body weight reduction were observed. Both metformin and swimming exercise down-regulated visfatin levels in SAT and PAT, while the adjunctive therapy conferred greater benefits, but no changes of visfatin levels were observed in SM. Our results indicate that visfatin down-regulation in SAT and PAT may be one of the mechanisms by which metformin and swimming exercise inhibit obesity.

  15. Treatment of the loss of ultimate heat sink initiating events in the IRSN level 1 PSA

    International Nuclear Information System (INIS)

    Dupuy, Patricia; Georgescu, Gabriel; Corenwinder, Francois

    2014-01-01

    The total loss of the ultimate heat sink is an initiating event which, even it is mainly of external origin, has been considered in the frame of internal events Level 1 PSA by IRSN. The on-going actions on the development of external hazards PSA and the recent incident of loss of the heat sink induced by the ingress of vegetable matter that occurred in France in 2009 have pointed out the need to improve the modeling of the loss of the heat sink initiating event and sequences to better take into account the fact that this loss may be induced by external hazards and thus affect all the site units. The paper presents the historical steps of the modeling of the total loss of the heat sink, the safety stakes of this modeling, the main assumptions used by IRSN in the associated PSA for the 900 MWe reactors and the results obtained. The total loss of the heat sink was not initially addressed in the safety demonstration of French NPPs. On the basis of the insights of the first probabilistic assessments performed in the 80's, the risks associated to this 'multiple failure situation' turned out to be very significant and design and organisational improvements were implemented on the plants. Reviews of the characterization of external hazards and of their consequences on the installations and French operating feedback have revealed that extreme hazards may induce a total loss of the heat sink. Moreover, the accident that occurred at Fukushima in 2011 has pointed out the risk of such a loss of long duration at all site units in case of extreme hazards. In this context, it seems relevant to further improve the modelling of the total loss of the heat sink by considering the external hazards that may cause this loss. In a first step, IRSN has improved the assumptions and data used in the loss of the heat sink PSA model, in particular by considering that such a loss may affect all the site units. The next challenge will be the deeper analysis of the impact of external hazards on

  16. CD4 cell levels during treatment for tuberculosis (TB in Ethiopian adults and clinical markers associated with CD4 lymphocytopenia.

    Directory of Open Access Journals (Sweden)

    Sten Skogmar

    Full Text Available BACKGROUND: The clinical correlations and significance of subnormal CD4 levels in HIV-negative patients with TB are unclear. We have determined CD4 cell levels longitudinally during anti-tuberculosis treatment (ATT in patients, with and without HIV co-infection, and their associations with clinical variables. METHOD: Adults diagnosed with TB (maximum duration of ATT for 2 weeks, and with no history of antiretroviral therapy (ART in HIV-positive subjects were included consecutively in eight out-patient clinics in Ethiopia. Healthy individuals were recruited for comparison at one of the study health centers. Data on patient characteristics and physical findings were collected by trained nurses following a structured questionnaire at inclusion and on follow-up visits at 2 and 6 months. In parallel, peripheral blood CD4 cell levels were determined. The evolution of CD4 cell levels during ATT was assessed, and the association between clinical characteristics and low CD4 cell levels at baseline was investigated using regression analysis. RESULTS: In total, 1116 TB patients were included (307 HIV-infected. Among 809 HIV-negative patients, 200 (25% had subnormal CD4 cell counts (<500 cells/mm(3, with <350 cells/mm(3 in 82 (10% individuals. CD4 cell levels increased significantly during the course of ATT in both HIV+ and HIV- TB-patients, but did not reach the levels in healthy subjects (median 896 cells/mm(3. Sputum smear status, signs of wasting (low mid upper arm circumference (MUAC, and bedridden state were significantly associated with low CD4 cell counts. CONCLUSION: A high proportion of Ethiopian TB patients have subnormal CD4 cell counts before starting treatment. Low CD4 cell levels are associated with smear positive disease and signs of wasting. The continuous increase of CD4 cell counts during the course of ATT suggest a reversible impact of active TB on CD4 cell homeostasis, which may be considered in interpretation of CD4 cell counts in HIV

  17. Successful Treatment of Resistant Discoid Lupus Erythematous (DLE With Low-Level Laser Therapy (LLLT: A Case Report

    Directory of Open Access Journals (Sweden)

    Nooshafarin Kazemikhoo

    2015-12-01

    Full Text Available Introduction Lupus is a chronic autoimmune illness characterized by production of autoantibodies against nuclear antigens. Lupus may also only appear as a skin disease. Discoid lupus erythematous (DLE, the most common form of chronic cutaneous lupus erythematous is characterized by patches of persistent erythema, adherent scaling, follicular plugging and, in the later stages scaring and atrophy. Case Presentation The case was a 33-year-old female with two years history of DLE, who referred to the laser clinic of Milad hospital with acute flare of skin lesions since seven months ego. She had four lesions (three with local alopecia, scaling and itching and one with atrophy. Serological studies for antinuclear antibodies and anti Ro/SS-A antibody were negative. After five sessions of treatment with infrared (830 nm; 200 mw and red light (630 nm; 20 mw diode laser in addition to intravenous red light laser (655 nm; 2 mw for 20 minutes and laser acupuncture with infrared diode laser (1 J/cm2 for six acupuncture points every other day, the beneficial effects started to appear, and after nine sessions, local itching of the lesions had stopped. Through a total of 27 sessions of treatment, the lesions improved completely with highly satisfactory results; and drug-therapy held to be continued. No disease flare up was seen after the one-year follow up. Conclusions To the best of our knowledge, this is the first case report on low-level laser therapy (LLLT treatment of DLE. Low-level laser therapy may be effective in treating inflammatory lesions such as cutaneous lesions of discoid lupus erythematous. More studies with higher sample size are needed to clarify the role of low level lasers in treating such lesions.

  18. Prolactin levels during short- and long-term cross-sex hormone treatment: an observational study in transgender persons.

    Science.gov (United States)

    Nota, N M; Dekker, M J H J; Klaver, M; Wiepjes, C M; van Trotsenburg, M A; Heijboer, A C; den Heijer, M

    2017-08-01

    The cause of prolactin alterations in transgender persons is often assigned to oestrogens, but the precise cause and time course during different phases of cross-sex hormone treatment (CHT) remain unclear. In this study, we prospectively examined prolactin levels in 55 female-to-males (FtMs) and 61 male-to-females (MtFs) during the first year of CHT. Because long-term prolactin data were not available in this population, we studied these levels in a retrospective population of 25 FtMs and 38 MtFs who underwent gonadectomy. FtMs were treated with testosterone and MtFs with estradiol, with or without the anti-androgen cyproterone acetate (CPA) (after gonadectomy CPA is cessated). During the first year of CHT, prolactin decreased with 25% (95CI: -33%, -12%) in FtMs and increased with 193% (95CI: 156%, 219%) in MtFs. Eighteen MtFs developed hyperprolactinemia (≥0.6 IU L -1 ). In the retrospective population, post-gonadectomy levels in FtMs were lower than baseline levels (-39%; 95CI: -51%, -20%) while in MtFs post-gonadectomy levels and baseline levels were comparable (-6%; 95CI: -24%, 15%). No hyperprolactinemia was found after gonadectomy. In conclusion, in FtMs, prolactin decreased consistently during CHT and in MtFs, prolactin increased during pre-surgical CHT but normalised after gonadectomy. It is likely that CPA induces increasing prolactin levels in MtFs. © 2016 Blackwell Verlag GmbH.

  19. Fast voxel-level dosimetry for 177Lu labelled peptide treatments

    International Nuclear Information System (INIS)

    Hippeläinen, E; Tenhunen, M; Sohlberg, A

    2015-01-01

    In peptide receptor radionuclide therapy (PRRT), voxel-level radiation absorbed dose calculations can be performed using several different methods. Each method has it strengths and weaknesses; however, Monte Carlo (MC) simulation is presently considered the most accurate method at providing absorbed dose distributions. Unfortunately MC simulation is time-consuming and often impractical to carry out in a clinical practice. In this work, a fast semi-Monte Carlo (sMC) absorbed dose calculation method for 177 Lu PRRT dosimetry is presented. The sMC method is based on a local electron absorption assumption and fast photon MC simulations. The sMC method is compared against full MC simulation code built on PENELOPE (vxlPen) using digital phantoms to assess the accuracy of these assumptions.Due to the local electron absorption assumption of sMC, the potential errors in cross-fire dose from electrons and photons emitted by 177 Lu were first evaluated using an ellipsoidal kidney model by comparing vxlPen and sMC. The photon cross-fire dose from background to kidney and kidney to background with varying kidney-to-background activity concentration ratios were calculated. In addition, kidney to kidney photon and electron cross-dose with different kidney to kidney distances were studied. Second, extended cardiac-torso (XCAT) phantoms were created with liver lesions and with realistic activity distributions and tissue densities. The XCAT phantoms were used to simulate SPECT projections and 3D activity distribution images were reconstructed using an OSEM algorithm. Image-based dose rate distributions were calculated using vxlPen and sMC. Total doses and dose rate volume histograms (DrVH) produced by the two methods were compared.The photon cross-fire dose from the kidney increased the background’s absorbed dose by 5% or more up to 5.8 cm distance with 20 : 1 kidney to background activity concentration ratio. On the other hand, the photon cross-fire dose from the background to

  20. A hybrid fuzzy-ontology based intelligent system to determine level of severity and treatment recommendation for Benign Prostatic Hyperplasia.

    Science.gov (United States)

    Torshizi, Abolfazl Doostparast; Zarandi, Mohammad Hossein Fazel; Torshizi, Ghazaleh Doostparast; Eghbali, Kamyar

    2014-01-01

    This paper deals with application of fuzzy intelligent systems in diagnosing severity level and recommending appropriate therapies for patients having Benign Prostatic Hyperplasia. Such an intelligent system can have remarkable impacts on correct diagnosis of the disease and reducing risk of mortality. This system captures various factors from the patients using two modules. The first module determines severity level of the Benign Prostatic Hyperplasia and the second module, which is a decision making unit, obtains output of the first module accompanied by some external knowledge and makes an appropriate treatment decision based on its ontology model and a fuzzy type-1 system. In order to validate efficiency and accuracy of the developed system, a case study is conducted by 44 participants. Then the results are compared with the recommendations of a panel of experts on the experimental data. Then precision and accuracy of the results were investigated based on a statistical analysis. Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

  1. Laboratory studies on leaching of low grade uranium ores and treatment of low level liquid waste generated by leaching experiments

    International Nuclear Information System (INIS)

    Palabrica, O.T.; Antonino, E.J.; Caluag, L.A.; Villamater, D.

    1980-07-01

    Acid leaching experiments of preconcentrated uranium ore were carried out at a pulp density of 50% solids, using sulfuric acid with sodium chlorate as oxidant. The different leaching parameters considered in this work were temperature, oxidant level and leaching time. In the experimental procedure, the concentration of oxidant and the temperature were varied to determine how they affect the leaching process. Experimental results are illustrated in tabulated form for better interpretation. Uranium analyses were done by fluorimetric and delayed-neutron activation analysis. An anion exchange method using Dowex 1 x 8, 200-400 mesh (Cl - ) was used in treating the low-level liquid waste generated by leaching experiments. The purpose of this treatment was to minimize radioactive contamination in the waste materials and also to recover some of the uranium left in the liquid waste. (author)

  2. Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain

    Directory of Open Access Journals (Sweden)

    Elphick Maurice R

    2009-07-01

    Full Text Available Abstract Activation of spinal microglia contributes to aberrant pain responses associated with neuropathic pain states. Endocannabinoids (ECs are present in the spinal cord, and inhibit nociceptive processing; levels of ECs may be altered by microglia which modulate the turnover of endocannabinoids in vitro. Here, we investigate the effect of minocycline, an inhibitor of activated microglia, on levels of the endocannabinoids anandamide and 2-arachidonoylglycerol (2-AG, and the related compound N-palmitoylethanolamine (PEA, in neuropathic spinal cord. Selective spinal nerve ligation (SNL in rats resulted in mechanical allodynia and the presence of activated microglia in the ipsilateral spinal cord. Chronic daily treatment with minocycline (30 mg/kg, ip for 14 days significantly reduced the development of mechanical allodynia at days 5, 10 and 14 post-SNL surgery, compared to vehicle-treated SNL rats (P P P P P

  3. Early prediction of treatment response by serum CRP levels in patients with advanced esophageal cancer who underwent definitive chemoradiotherapy

    International Nuclear Information System (INIS)

    Yoneda, Masayuki; Fujiwara, Hitoshi; Okamura, Shinichi

    2010-01-01

    Serum C reactive protein (CRP) has been shown to be associated with the progression of esophageal cancer. The purpose of this study was to examine the relationship between treatment response and serum CRP levels in time course during definitive chemoradiotherapy (CRT) in terms of early prediction of CRT response by serum CRP. The subjects of this study were 36 patients with cT3/cT4 esophageal squamous cell carcinoma who underwent definitive CRT in our hospital. Serum CRP levels during definitive CRT (pretreatment, 1W, 2W and 3W after CRT initiation) were compared between CR and non-CR group. In addition, partition model was constructed to discriminate CR with non-CR and the prediction accuracy was evaluated. The patients were consisted of 28 males and 8 females. At pretreatment diagnosis, tumors were categorized as T3 (n=21) and T4 (n=15). Thirty four patients received FP-based chemotherapy and 2 patients received docetaxel-based chemotherapy. Treatment responses were categorized as CR (n=8), partial response (PR) (n=14), no change (NC) (n=2) and progressive disease (PD) (n=12). Serum CRP levels at the time of 2W after CRT initiation (CRT2W) in CR group were low compared to those in non-CR group (p=0.071). The partition model was constructed based on CRP levels at CRT2W. The prediction accuracies to discriminate CR from non-CR by CRP ≤0.1 were 50%, 82%, and 75% in sensitivity, specificity and accuracy, respectively. Serum CRP is a useful biomarker for an early prediction of CRT response. (author)

  4. Allocation of substance use disorder patients to appropriate levels of care: feasibility of matching guidelines in routine practice in Dutch treatment centres

    NARCIS (Netherlands)

    Merkx, Maarten J. M.; Schippers, Gerard M.; Koeter, Maarten J. W.; Vuijk, Pieter Jelle; Oudejans, Suzan; de Vries, Carlijn C. Q.; van den Brink, Wim

    2007-01-01

    AIMS: To examine the feasibility of implementing evidence-based guidelines for patient-treatment-matching to levels of care in two Dutch substance abuse treatment centres. DESIGN: Multi-centre observational follow-up study. SETTING: Two large substance abuse treatment centres (SATCs). PARTICIPANTS:

  5. Formation and filtration characteristics of solids generated in a high level liquid waste treatment process. Filtration characteristics of solids formed in simulated high level liquid waste

    International Nuclear Information System (INIS)

    Kondo, Y.; Kubota, M.

    1997-01-01

    The filtration characteristics of solids generated in a simulated high level liquid waste (HLLW) were experimentally examined, when the simulated HLLW was processed according to the ordinary way of actual HLLW treatment process. The filtration characteristics of solids depended on the particle size. The phosphomolybdic acid, which was very fine particle with about 0.1 μm diameter, made slurry a 'difficult-to-filter' slurry, if the phosphomolybdic acid content (wt%) to the whole solids in a slurry exceeded 50wt%. On the contrary, the zirconium compounds (zirconium molybdate and zirconium telluride) had positive effect on filtration characteristics because of their relatively large particle size of about 3 to 5 μm. When the zirconium compounds content was above 50 wt%, slurry became a 'easy-to-filter' slurry. A centrifugal sedimentation was discussed as a solid/liquid separation technique for very fine particles such as phosphomolybdic acid. The theoretical feed flow rate corresponded to 0.1 μm diameter particles was about 20 1/h at the centrifugal acceleration of about 8000 G. (author)

  6. Serum total homocysteine and lipoprotein (a) levels in acute myocardial infarction and their response to treatment with vitamins serum total homocysteine and lipoprotein (a) levels in acute myocardial infarction and their response to treatment with vitamins

    International Nuclear Information System (INIS)

    Haq, A.M.M.; Huque, M.M.

    2011-01-01

    To assess the relationship of serum total homocysteine (tHcy) and lipoprotein (a) [Lp(a)] levels with systemic hypertension, Diabetes mellitus and smoking as risk factors in patients with acute myocardial infarction (AMI) and changes in the former levels with vitamins supplementation. Study Design: An interventional study. Place and Duration of Study: Medical College for Women and Hospital (MCW and H), Dhaka, Bangladesh, from July 2008 to December 2009. Methodology: Consecutive AMI patients were recruited from the Coronary Care Unit (CCU) at MCW and H, Dhaka. Blood samples were collected at inclusion (Patient-I0). They were given conventional treatments and prescribed vitamins (vitamins B6=25 mg, B12=2 mg and folic acid=2.5 mg) daily for 2 months. After follow-up, blood samples were taken again (Patient-II0). A group of 25 normal subjects were also included as controls. Serum tHcy and Lp(a) were measured by kinetic method and nephelometric method respectively. Results: Serum tHcy (macor mol/L) and Lp(a) (mg/dl) levels were elevated in Patient-I that reduced in Patient-II after vitamins supplementation, but not to the normal control level. tHcy of Patient-I0 was 25.1 +- 4.7 macro mol/L, of Patient-II0 was 20.1 +- 4.5 mu mol/L and of controls 12.1 +- 3.3, p 0.1). However, in a significant proportion of patients tHcy and Lp(a) levels were reduced to control levels (tHcy: p < 0.001, Lp(a): p < 0.01). Conclusion: These results indicated that tHcy and Lp(a) levels were possibly atherogenic risk factors independent of conventional risk factors. Since both tHcy and Lp(a) levels responded in a similar fashion, a common point of the metabolic and pathogenetic pathways of tHcy and Lp(a) may be influenced by the vitamins supplementation. (author)

  7. [Evaluation of immunosuppressive treatment on homocystein levels in patients after kidney transplantation during a 2 year observation period].

    Science.gov (United States)

    Aksamit, Dariusz; Janda, Katarzyna; Kuźniewski, Marek; Krzanowski, Marcin; Ignacak, Ewa; Betkowska-Prokop, Alina; Chowaniec, Eve; Sułowicz, Wladysław

    2012-01-01

    The aim of the study was to evaluate the influence of the type of prescribed immunosuppression: cyclosporine A (CsA) vs. tacrolimus (Tac) on remote homocystein levels in patients (pts) after kidney transplantation (Ktx). The study included 51 pts (17 F, 34 M) aged 15 to 62 years (mean 38.1) after cadaver Ktx. The mean observation period equaled 21.2 months (6 -24); while total observation period was 90 personlyears. Before Ktx, 46 pts were treated with maintenance hemodialysis (HD), while 5 by peritoneal dialysis (PD). After Ktx, patients had immunosuppression prescribed according to the following schemes: prednisone (P) + CsA + azathioprine (AZA) - 12 pts; P + CsA + mycophenolate mofetil (MMF) -26 pts; P + Tac + MMF - 11 pts; and P + Tac + AZA - 2 pts. Hcy level was measured using high performance liquid chromatography (HPLC). Serum creatinine level was measured by standard method using the Hitachi 917 analyzer. Creatinine clearance was calculated based on the Cockcroft-Gault formula. Patient's blood was drawn before Ktx and 3, 6, 9, 12,15, 18, 21 and 24 months post procedure. Delayed graft function (DGF) after Ktx was diagnosed in 29 pts (56.9%) and this group required from 4 to 28 HD sessions (mean 14 sessions). Hcy level did not significantly differ between pts requiring (29 pts) and not requiring (22 pts) HD treatment after Ktx. It was also noted that the number of performed HD sessions did not significantly correlate with Hcy levels 24 months after Ktx (R =0.04, p=0.81). No relationship was found (non-parametric Spearman test) between the drop in Hcy level 3 months after Ktx as compare with value before Ktx and ischemia time (R=0.09, p=0.49), number of compatible HLA A and B (R=0.07, p=0.63), and DR antigens (R=0.09, p=0.51). Decrease in Hcy level (before Ktx and 24 months after Ktx) did not significantly correlate with the above parameters, respectively: R=-0.14, p=0.40; R=0.06, p=0.73; R=0.12, p=0.45; R=0.11, p=0.50. Decrease in Hcy level (before Ktx and 3

  8. Interleukin-32 levels in gingival crevicular fluid and saliva of patients with chronic periodontitis after periodontal treatment.

    Science.gov (United States)

    Öngöz Dede, F; Balli, U; Bozkurt Doğan, Ş; Güven, B

    2017-06-01

    The cytokine, interleukin (IL)-32, is a relatively new discovery. However, it is very powerful for stimulating tumor necrosis factor-alpha (TNF-α) under inflammatory conditions. The objective of this research was to explore fluctuations in the levels of TNF-α, IL-32 and IL-10, in both saliva and gingival crevicular fluid. The focus was on measurements taken before and after clinical treatment of chronic periodontitis. For the purposes of the study, a total of 27 patients with chronic periodontitis and 27 controls (periodontally healthy) were recruited. Important clinical periodontal criteria were established before and 4 wk after the start of the research. The chronic periodontitis group was given an initial form of periodontal care. Samples of saliva and gingival crevicular fluid were collected exactly 4 wk preceding and 4 wk following the care. The levels of IL-10, IL-32 and TNF-α present in saliva and gingival crevicular fluid were recorded via the use of an ELISA. At baseline, the levels of TNF-α and IL-32 in the gingival crevicular fluid and saliva were significantly higher among patients in the chronic periodontitis group than among patients in the control group (p chronic periodontitis group than the control group (p chronic periodontitis group when compared with the baseline readings. However, the levels of IL-10 were significantly higher (p periodontitis. © 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

  9. Serum levels of interleukin 6 in schizophrenic patients during treatment augmentation with sarcosine (results of the PULSAR study).

    Science.gov (United States)

    Strzelecki, Dominik; Urban-Kowalczyk, Małgorzata; Wysokiński, Adam

    2018-03-01

    Augmentation of sarcosine, a natural inhibitor of the glycine transporter type I, normalizes glutamatergic neurotransmission, having beneficial impact on primary negative symptoms in schizophrenia and may also influence immune system and interleukin 6 (IL-6) levels. Finding a relationship between initial IL-6 serum concentrations or its changes and severity of symptoms as a result of sarcosine addition to stable antipsychotic treatment. Fifity-eight individuals with schizophrenia with predominantly negative symptoms completed a 6-month randomized, double-blind placebo-controlled prospective study. Patients received 2 g of sarcosine (n = 29) or placebo (n = 30) daily per os. We measured IL-6 levels and severity of symptoms at the beginning, after 6 weeks and 6 months. As main clinical tools, we used Positive and Negative Syndrome Scale (PANSS) and Calgary depression scale for schizophrenia (CDSS). Augmentation with sarcosine had no effect on IL-6 serum levels in all time points. We noted significant improvements in negative symptoms, general psychopathology, and total PANSS score in the sarcosine group. We found correlation of initial serum IL-6 with severity of positive symptoms and negative association between IL-6 levels reduction and positive symptoms reduction. Sarcosine does not significantly affect IL-6 concentrations but IL-6 may be involved in mechanisms related to the presence of positive symptoms. Copyright © 2018 John Wiley & Sons, Ltd.